0000704415-17-000022.txt : 20170504 0000704415-17-000022.hdr.sgml : 20170504 20170504130722 ACCESSION NUMBER: 0000704415-17-000022 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 63 CONFORMED PERIOD OF REPORT: 20170331 FILED AS OF DATE: 20170504 DATE AS OF CHANGE: 20170504 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TIVITY HEALTH, INC. CENTRAL INDEX KEY: 0000704415 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 621117144 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-19364 FILM NUMBER: 17813017 BUSINESS ADDRESS: STREET 1: 701 COOL SPRINGS BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 BUSINESS PHONE: 6156144929 MAIL ADDRESS: STREET 1: 701 COOL SPRINGS BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHWAYS, INC. DATE OF NAME CHANGE: 20170104 FORMER COMPANY: FORMER CONFORMED NAME: TIVITY HEALTH, INC DATE OF NAME CHANGE: 20161230 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHWAYS, INC DATE OF NAME CHANGE: 20060201 10-Q 1 form10-q_33117.htm TIVITY HEALTH, INC. FORM 10-Q



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 10-Q

[X]  Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Quarterly Period Ended March 31, 2017
or

 [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from _____  to _____
Commission file number 000-19364

TIVITY HEALTH, INC.
(Exact name of registrant as specified in its charter)


Delaware
 
62-1117144
(State or other jurisdiction of
 
(I.R.S. Employer
incorporation or organization)
 
Identification No.)
 
701 Cool Springs Boulevard, Franklin, TN  37067
(Address of principal executive offices) (Zip code)

(615) 614-4929
(Registrant's telephone number, including area code)


 
(Former name, former address and former fiscal year, if changed since last report)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

Yes  No  

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§
 

232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes  No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non- accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer                      Accelerated filer ☒                          Smaller reporting company
Non-accelerated filer ☐    (Do not check if a smaller reporting company)                    Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes   No

As of April 30, 2017, there were outstanding 39,197,878 shares of the registrant's common stock, par value $.001 per share ("common stock").




2


Tivity Health, Inc.
Form 10-Q

Table of Contents

Part I
   
Page
 
Item 1.
Financial Statements
4
 
Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
25
 
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
34
 
Item 4.
Controls and Procedures
34
       
Part II
     
 
Item 1.
Legal Proceedings
34
 
Item 1A.
Risk Factors
34
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
35
 
Item 3.
Defaults Upon Senior Securities
35
 
Item 4.
Mine Safety Disclosures
35
 
Item 5.
Other Information
35
 
Item 6.
Exhibits
35








3


PART I

Item 1. Financial Statements

TIVITY HEALTH, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)

ASSETS


 
 
 
March 31, 2017
 
 
December 31, 2016
   
Current assets:
 
 
 
 
     
Cash and cash equivalents
 
$
664
 
 
$
1,602
   
Accounts receivable, net
 
 
66,942
 
 
 
50,424
   
Prepaid expenses
 
 
3,662
 
 
 
3,409
   
Other current assets
 
 
2,288
 
 
 
2,250
   
Cash convertible notes hedges, current
   
82,445
     
   
Income taxes receivable
 
 
 
 
 
426
   
Total current assets
 
 
156,001
 
 
 
58,111
   
 
 
 
 
 
 
 
 
   
Property and equipment:
 
 
 
 
 
 
 
   
Leasehold improvements
 
 
10,144
 
 
 
10,144
   
Computer equipment and related software
 
 
23,404
 
 
 
23,024
   
Furniture and office equipment
 
 
8,670
 
 
 
8,670
   
Capital projects in process
 
 
2,506
 
 
 
2,079
   
 
 
 
44,724
 
 
 
43,917
   
Less accumulated depreciation
 
 
(36,379
)
 
 
(35,586
)
 
 
 
 
8,345
 
 
 
8,331
   
 
 
 
 
 
 
 
 
   
Other assets
 
 
6,646
 
 
 
6,688
   
Cash convertible notes hedges, long-term
   
     
48,361
   
Long-term deferred tax asset
 
 
57,129
 
 
 
59,562
   
Intangible assets, net
   
29,049
     
29,049
   
Goodwill, net
   
334,680
 
 
 
334,680
   
Total assets
 
$
591,850
 
 
$
544,782
   


See accompanying notes to the Consolidated Financial Statements.

4


TIVITY HEALTH, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)
(Unaudited)

LIABILITIES AND STOCKHOLDERS' EQUITY


 
 
March 31, 2017
 
 
December 31, 2016
 
Current liabilities:
 
 
 
 
 
 
Accounts payable
 
$
27,577
 
 
$
26,029
 
Accrued salaries and benefits
 
 
7,999
 
 
 
18,686
 
Accrued liabilities
 
 
38,215
 
 
 
33,623
 
Other current liabilities
 
 
364
 
 
 
397
 
Cash conversion derivative, current
   
82,445
     
 
Current portion of long-term debt
 
 
147,102
 
 
 
46,046
 
Current portion of long-term liabilities
 
 
5,831
 
 
 
7,582
 
Total current liabilities
 
 
309,533
 
 
 
132,363
 
 
 
 
 
 
 
 
 
 
Long-term debt
 
 
60,196
 
 
 
164,297
 
Cash conversion derivative, long-term
   
     
48,361
 
Other long-term liabilities
 
 
8,149
 
 
 
10,463
 
 
 
 
 
 
 
 
 
 
Stockholders' equity:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preferred stock $.001 par value, 5,000,000 shares authorized, none outstanding
 
 
 
 
 
 
Common stock $.001 par value, 120,000,000 shares authorized, 39,188,902 and 38,933,580 shares outstanding, respectively
 
 
39
 
 
 
39
 
Additional paid-in capital
 
 
344,108
 
 
 
341,270
 
Accumulated deficit
 
 
(97,602
 
 
(119,327
)
Treasury stock, at cost, 2,254,953 shares in treasury
 
 
(28,182
)
 
 
(28,182
)
Accumulated other comprehensive loss
 
 
(4,391
)
 
 
(4,502
)
Total stockholders' equity
 
 
213,972
 
 
 
189,298
 
Total liabilities and stockholders' equity
 
$
591,850
 
 
$
544,782
 
 

See accompanying notes to the Consolidated Financial Statements.

5


TIVITY HEALTH, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except earnings (loss) per share data)
(Unaudited)

 
 
Three Months Ended
 
 
 
 
March 31,
 
 
 
 
2017
 
 
2016
 
 
 
 
 
 
 
 
 
 
Revenues
 
$
140,970
 
 
$
126,012
 
 
Cost of services (exclusive of depreciation and amortization of $657 and $1,530, respectively, included below)
 
 
102,399
 
 
 
91,377
 
 
Selling, general & administrative expenses
 
 
8,361
 
 
 
9,411
 
 
Depreciation and amortization
 
 
787
 
 
 
1,872
 
 
Restructuring and related charges
 
 
737
 
 
 
39
 
 
 
 
 
 
 
 
 
 
 
 
Operating income
 
 
28,686
 
 
 
23,313
 
 
Interest expense
 
 
3,834
 
 
 
4,105
 
 
 
 
 
 
 
 
 
 
 
 
Income before income taxes
 
 
24,852
 
 
 
19,208
 
 
Income tax expense
 
 
9,371
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income from continuing operations
 
 
15,481
 
 
 
19,208
 
 
Loss from discontinued operations, net of income tax benefit
 
 
(220
 
 
(33,105
)
 
Net income (loss) 
 
 
15,261
 
 
 
(13,897
)
 
Less: net income (loss) attributable to non-controlling interest
 
 
 
 
 
 
312
   
Net income (loss) attributable to Tivity Health, Inc.
 
$
 
15,261
 
 
$
(14,209
 
)
 
 
 
 
 
 
 
 
 
 
 
Earnings (loss) per share attributable to
      Tivity Health, Inc. - basic:
 
 
 
 
 
 
 
 
 
   Continuing operations
 
$
0.40
 
 
$
0.53
 
 
   Discontinued operations
 
$
(0.01
 
$
(0.93
)
 
   Net income (loss) (1)
 
$
0.39
 
 
$
(0.39
)
 
  
 
 
 
 
 
 
 
 
 
Earnings (loss) per share attributable to
      Tivity Health, Inc. - diluted:
 
 
 
 
 
 
 
 
 
   Continuing operations
 
$
0.38
 
 
$
0.52
 
 
   Discontinued operations
 
$
(0.01
 
(0.91
)
 
   Net income (loss) (1)
 
$
0.38
 
 
(0.39
)
 
 
 
 
 
 
 
 
 
 
 
Comprehensive income (loss)
 
$
15,372
 
 
$
(12,851
)
 
 
 
 
 
 
 
 
 
 
 
Weighted average common shares
 
 
 
 
 
 
 
 
 
 and equivalents:
 
 
 
 
 
 
 
 
 
  Basic
 
 
39,069
 
 
 
36,109
 
 
  Diluted
 
 
40,541
 
 
 
36,861
 
 
                   
(1) Figures may not add due to rounding.
 
                 


See accompanying notes to the Consolidated Financial Statements.

6


TIVITY HEALTH, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In thousands)
(Unaudited)


 
 
Three Months Ended March 31,
   
 
 
2017
 
 
2016
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
$
15,261
 
 
$
(13,897
)
 
Other comprehensive income, net of tax
 
 
 
 
 
 
 
 
 
Net change in fair value of interest rate swaps, net of tax
 
 
 
 
 
24
 
 
Foreign currency translation adjustment, net of tax
 
 
111
 
 
 
1,022
 
 
Total other comprehensive income, net of tax
 
111
 
 
1,046
 
 
Comprehensive income (loss)
 
$
15,372
 
 
$
(12,851
)
 
                   
 
See accompanying notes to the Consolidated Financial Statements.

7


TIVITY HEALTH, INC.
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
For the Three Months Ended March 31, 2017
(In thousands)
(Unaudited)


 
 
Preferred
Stock
 
 
Common
Stock
 
 
Additional
Paid-in
Capital
 
 
Accumulated Deficit
 
 
Treasury
Stock
 
 
Accumulated Other
Comprehensive
Income (Loss) 
 
 
Total
 
Balance,
December 31, 2016
 
$
 
 
$
39
 
 
$
341,270
 
 
$
(119,327
 
 
)
 
$
(28,182
)
 
$
(4,502
)
$
189,298
 
   
Comprehensive income
 
 
 
 
 
 
 
 
 
 
 
15,261
 
 
 
 
 
 
111
 
 
15,372
     
Cumulative effect of a change in accounting principle - adoption of ASU 2016-09
   
 
 
 
 
 
 
74
 
 
 
6,464
 
 
 
 
 
 
 
 
6,538
     
Exercise of stock options
 
 
 
 
 
 
 
 
2,250
 
 
 
 
 
 
 
 
 
 
 
2,250
 
   
Tax effect of stock options and restricted stock units
 
 
 
 
 
 
 
 
(932
)
 
 
 
 
 
 
 
 
 
 
(932
)
   
Share-based employee compensation expense
 
 
 
 
 
 
 
 
1,446
 
 
 
 
 
 
 
 
 
 
 
1,446
 
   
Balance,
March 31, 2017
 
$
 
 
$
39
 
 
$
344,108
 
 
 $
(97,602
)
 
$
(28,182
)
 
$
(4,391
)
$
213,972
 
   

See accompanying notes to the Consolidated Financial Statements.

8


TIVITY HEALTH, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)

 
 
Three Months Ended
March 31,
 
 
 
2017
 
 
2016
 
Cash flows from operating activities:
 
 
 
 
 
 
Net income from continuing operations
 
$
15,481
 
 
$
19,208
 
Net loss from discontinued operations
   
(220
)
   
(33,105
)
Adjustments to reconcile net income (loss) to net cash provided by operating activities, net of business acquisitions:
 
 
 
 
 
 
 
 
Depreciation and amortization
 
 
793
 
 
 
12,746
 
Amortization of deferred loan costs
 
 
516
 
 
 
554
 
Amortization of debt discount
 
 
1,931
 
 
 
1,826
 
Share-based employee compensation expense
 
 
1,446
 
 
 
2,427
 
Loss on sale of TPHS business
   
310
     
 
Equity in income from joint ventures
 
 
 
 
 
(132
Deferred income taxes
 
 
8,972
 
 
 
(191
)
(Increase) decrease in accounts receivable, net
 
 
(16,459
 
 
7,471
 
(Increase) decrease in other current assets
 
 
(441
 
 
1,955
 
Increase (decrease) in accounts payable
 
 
1,337
 
 
 
(1,175
Decrease in accrued salaries and benefits
 
 
(12,099
 
 
(227
Increase (decrease) in other current liabilities
 
 
2,642
 
 
 
(2,013
Other
 
 
(1,185
 
 
(1,734
Net cash flows provided by operating activities
 
$
3,024
 
 
$
7,610
 
 
 
 
 
 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
 
 
 
 
Acquisition of property and equipment
 
$
(1,234
)
 
$
(6,450
)
Investment in joint ventures
 
 
 
 
 
(453
)
Other
 
 
 
 
 
(275
)
Net cash flows used in investing activities
 
$
(1,234
)
 
$
(7,178
)
 
 
 
 
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
 
 
 
 
Proceeds from issuance of long-term debt
 
$
109,975
 
 
$
131,500
 
Payments of long-term debt
 
 
(115,465
)
 
 
(136,084
)
Payments related to tax withholding for share-based compensation
 
 
(885
 
 
(213
Exercise of stock options
 
 
2,250
 
 
 
 
Change in cash overdraft and other
 
 
1,155
 
 
 
4,600
 
Net cash flows used in financing activities
 
$
(2,970
)
 
$
(197
)
 
 
 
 
 
 
 
 
 
Effect of exchange rate changes on cash
 
$
242
 
 
$
989
 
 
 
 
 
 
 
 
 
 
Less: net increase in discontinued operations cash and cash equivalents
 
$
   
$
588
 
                 
Net (decrease) increase in cash and cash equivalents
 
$
(938
 
$
636
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents, beginning of period
 
 
1,602
 
 
 
233
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents, end of period
 
$
664
 
 
$
869
 
 
 
 
 
 
 
 
 
 


See accompanying notes to the Consolidated Financial Statements.

9


TIVITY HEALTH INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1.
Basis of Presentation

Our financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles in the United States ("U.S. GAAP").  In our opinion, the accompanying consolidated financial statements of Tivity Health, Inc. and its wholly-owned subsidiaries (collectively, "Tivity Health," the "Company," or such terms as "we," "us," or "our") reflect all adjustments consisting of normal, recurring accruals necessary for a fair statement. We have reclassified certain items in prior periods to conform to current classifications.

Our results from continuing operations do not include the results of the total population health services ("TPHS") business, which we sold effective July 31, 2016.  The TPHS business included our partnerships with Blue Zones, LLC and Dr. Dean Ornish (the Blue Zones Project by Healthways™ and Dr. Dean Ornish's Program for Reversing Heart Disease™, respectively), our joint venture with Gallup, Inc. ("Gallup"), Navvis Healthcare, LLC ("Navvis"), MeYou Health, LLC ("MeYou Health"), and our international operations, including our joint venture with SulAméricaWhile Navvis and MeYou Health were part of our TPHS business, they were sold separately to other buyers in November 2015 and June 2016, respectively.  Results of operations for the TPHS business have been classified as discontinued operations for all periods presented in the accompanying Consolidated Financial Statements.  See Note 3 for further information.

On March 11, 2015, we formed a joint venture with SulAmérica, one of the largest independent insurers in Brazil, to sell total population health services to the Brazilian market. With its contribution, SulAmérica acquired a 49% interest in the joint venture, Healthways Brasil Servicos de Consultoria LTDA ("Healthways Brazil"). We determined that our interest in Healthways Brazil represented a controlling financial interest and, therefore, prior to selling the TPHS business, consolidated the financial statements of Healthways Brazil and presented a non-controlling interest for the portion owned by SulAmérica. The net assets and results of operations of Healthways Brazil were part of the sale of the TPHS business and are included within discontinued operations in the accompanying Consolidated Financial Statements.

We have omitted certain financial information that is normally included in financial statements prepared in accordance with U.S. GAAP but that is not required for interim reporting purposes. You should read the accompanying consolidated financial statements in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2016.

2.
Recent Relevant Accounting Standards

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-09, which creates Accounting Standards Codification ("ASC") Topic 606, "Revenue from Contracts with Customers" ("ASC Topic 606") and supersedes ASC Topic 605, "Revenue Recognition." The provisions of ASC Topic 606 provide for a single comprehensive principles-based standard for the recognition of revenue across all industries and expanded disclosure about the nature, amount, timing and uncertainty of revenue, as well as certain additional quantitative and qualitative disclosures. The standard is effective for annual periods beginning after December 15, 2017, including interim periods within those years. The guidance permits the use of either a retrospective or cumulative effect transition method. We have not yet selected a transition method.  We are currently conducting analysis to quantify the adoption impact of the provisions of the new standard and evaluating our current contracts and revenue streams. The FASB has issued, and may issue in the future, interpretive guidance which may cause our evaluation to change. We believe we are following an appropriate timeline to allow for proper recognition, presentation and disclosure upon adoption effective January 1, 2018.
 
In August 2014, the FASB issued ASU No. 2014-15, "Presentation of Financial Statements – Going Concern: Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern," which requires management to evaluate whether there is substantial doubt about the entity's ability to continue as a going concern and, if so, provide certain footnote disclosures. This ASU is effective for annual periods ending after December 15, 2016, including interim reporting periods thereafter. We adopted this ASU in the fourth quarter of 2016, and it did not have an impact on our financial statements or footnote disclosures.
 
10

In February 2016, the FASB issued ASU No. 2016-02, "Leases" ("ASU 2016-02"), which requires that lessees recognize assets and liabilities for leases with lease terms greater than twelve months in the statement of financial position. ASU 2016-02 also requires improved disclosures to help users of financial statements better understand the amount, timing and uncertainty of cash flows arising from leases. The update is effective for fiscal years beginning after December 15, 2018, including interim reporting periods within those years. We are currently evaluating the impact that the adoption of ASU 2016-02 will have on our financial position, results of operations and cash flows.

In March 2016, the FASB issued ASU No. 2016-09, "Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting" ("ASU 2016-09"), which we adopted on January 1, 2017.  ASU 2016-09 requires all income tax effects of share-based awards to be recognized in the income statement, which were previously presented as a component of shareholders' equity, on a prospective basis.  In addition, any excess tax benefits that were not previously recognized because the related tax deduction had not reduced current taxes payable are to be recorded on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption, which resulted in an increase of $6.5 million to our retained earnings as of January 1, 2017.  Regarding the statement of cash flows, the standard requires the presentation of excess tax benefits as an operating activity rather than as a financing activity and that cash paid by the Company when directly withholding shares for tax withholding purposes be classified as a financing activity on a retrospective basis. The standard also allows for an accounting policy election to estimate the number of awards that are expected to vest or to account for forfeitures when they occur. We elected to account for forfeitures as they occur, which did not result in a material cumulative effect adjustment to our retained earnings as of January 1, 2017.  Finally, the standard no longer allows windfall tax benefits to be included in the assumed proceeds when applying the treasury stock method for computing diluted earnings per share ("EPS"), which results in share-based awards having a more dilutive effect on EPS.

In August 2016, the FASB issued ASU No. 2016-15, "Statement of Cash Flows" (Topic 230) ("ASU 2016-15").  ASU 2016-15 addresses how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU 2016-15 is effective in the first quarter of 2018, with early adoption permitted, and is to be applied using a retrospective approach. We are currently evaluating the potential effects of adopting the provisions of ASU 2016-15.

In January 2017, the FASB issued ASU No. 2017-04, "Intangibles - Goodwill and Other" ("ASU 2017-04"), which simplifies the subsequent measurement of goodwill by eliminating step two from the goodwill impairment test.  ASU 2017-04 is effective for annual and interim impairment tests in fiscal years beginning after December 15, 2019 and is required to be applied prospectively. Early adoption is allowed for annual goodwill impairment tests performed on testing dates after January 1, 2017. We do not anticipate that adopting this standard will have an impact on our consolidated financial statements and related disclosures.

3.
Discontinued Operations
 
On July 27, 2016, we entered into a Membership Interest Purchase Agreement (the "Purchase Agreement") with Sharecare, Inc. ("Sharecare") and Healthways SC, LLC ("Healthways SC"), a newly formed Delaware limited liability company and wholly owned subsidiary of the Company, pursuant to which Sharecare acquired the TPHS business, which closed effective July 31, 2016 ("Closing").

At Closing, Sharecare delivered to the Company an Adjustable Convertible Equity Right (the "ACER") with an initial face value of $30.0 million, which will be convertible into shares of common stock of Sharecare 24 months after the Closing at an initial conversion price of $249.87 per share, subject to customary adjustment for stock splits, stock dividends and other reorganizations of Sharecare.  Additionally, pursuant to the Purchase Agreement, we paid Sharecare $25.0 million in cash at Closing to fund projected losses of the TPHS business during the year following Closing (the "Transition Year"). Pursuant to Sharecare's acquisition of the TPHS business, our ownership interest in the joint venture with Gallup (the "Gallup Joint Venture") was transferred to Sharecare. We agreed with Sharecare to be responsible for two-thirds of the remaining payment obligations in respect of the purchase price to be paid in connection with Sharecare's acquisition of additional membership interest in the Gallup Joint Venture. This obligation is currently expected to result in aggregate payments by us of approximately $4.2 million, payable in five equal quarterly installments that began in the fourth quarter of 2016 and will end in the fourth quarter of 2017. As of March 31, 2017, this obligation totaled $2.5 million and was included in accrued liabilities.
 
11

 The Purchase Agreement provided for post-closing adjustments based on (i) net working capital (which is expected to result in an increase in the face amount of the ACER due to a net working capital surplus, as further discussed below), (ii) negative cash flows of the TPHS business during the Transition Year in excess of $25.0 million (which may result in a reduction in the face amount of the ACER up to a maximum reduction of $20.0 million), and (iii) any successful claims for indemnification by Sharecare (which may result in a reduction in the face amount of the ACER, unless the Company elects, in its sole discretion, to satisfy any such successful claims with cash payments).
 
We recorded the ACER net of the $20.0 million face value maximum negative cash flow adjustment, or $10.0 million face value, at its estimated fair value of $2.7 million as of Closing.  We have classified this amount as an equity receivable included in other assets.  We will record the $20.0 million face value contingent portion of the ACER at its estimated fair value as of the date the contingency is resolved, expected to be approximately 12 months from Closing.  As of March 31, 2017, we recorded an estimate of the net working capital adjustment (a surplus), which resulted in an estimated fair value of the ACER of $5.4 million.  The working capital adjustment is subject to a review process, which is currently underway.

The terms of the Purchase Agreement also impacted other existing contractual commitments, including the elimination of the minimum fee requirements under our technology services outsourcing agreement with HP Enterprise Services, LLC.

   The following table presents financial results of the TPHS business included in "loss from discontinued operations" for the three months ended March 31, 2017 and 2016.
 
 
 
Three Months Ended
March 31,
   
(In thousands)
 
2017
 
 
2016
 
 
 
 
 
 
 
 
 
 
Revenues
 
$
 
 
$
63,205
 
 
Cost of services
 
 
220
 
 
 
72,625
 
 
Selling, general & administrative expenses
 
 
137
 
 
 
7,061
 
 
Depreciation and amortization
 
 
 
 
 
10,874
 
 
Restructuring and related charges
 
 
 
 
 
5,702
 
 
Equity in income from joint ventures
 
 
 
 
 
132
 
 
Pretax loss on discontinued operations
 
$
(357
 
$
(32,925
 
Pretax loss on sale of TPHS business
 
 
(310
 
 
 
 
Total pretax loss on discontinued operations
 
$
(667
 
$
(32,925
 
Income tax (benefit) expense
 
 
(447
)
 
 
180
 
 
Loss from discontinued operations, net of income tax benefit
 
$
(220
 
$
(33,105
 
 
The depreciation, amortization and significant operating and investing non-cash items of the discontinued operations were as follows: 
 
 
Three Months Ended
March 31,
 
(In thousands)
 
2017
   
2016
 
       
   Depreciation and amortization on discontinued operations
 
$
 
 
$
10,874
 
       
   Capital expenditures on discontinued operations
 
 
 
 
 
5,420
 
       
   Share-based compensation on discontinued operations
 
 
 
 
 
768
 
       
 
 
 
 
 
 
 
 
 
       

4.
Share-Based Compensation


We currently have four types of share-based awards outstanding to our employees and directors: stock options, restricted stock units, restricted stock and market stock units. We believe that our share-based awards align the interests of our employees and directors with those of our stockholders.

We recognize share-based compensation expense for the market stock units if the requisite service period
 
12

is rendered, even if the market condition is never satisfied. For the three months ended March 31, 2017, we recognized share-based compensation costs of $1.4 million.  For the three months ended March 31, 2016, we recognized share-based compensation costs of $2.4 million, of which $0.8 million is in discontinued operations.  Beginning in January 2017 with the adoption of ASU 2016-09, we account for forfeitures as they occur.

A summary of our stock options as of March 31, 2017 and the changes during the three months then ended is presented below:
 
 
 
 
 
Options
 
Shares
(In thousands)
 
 
Weighted
Average Exercise
Price
Per Share
 
 
Weighted Average
Remaining
Contractual
Term
 
 
Aggregate Intrinsic Value (In thousands)
 
Outstanding at January 1, 2017
 
 
1,024
 
 
$
14.02
 
 
 
 
 
 
 
Granted
 
 
 
 
 
 
 
 
 
 
 
 
Exercised
 
 
(181
)
 
 
12.36
 
 
 
 
 
 
 
Forfeited
 
 
 
 
 
 
 
 
 
 
 
 
Expired
 
 
(45
)
 
 
45.36
 
 
 
 
 
 
 
Outstanding at March 31, 2017
 
 
798
 
 
$
12.63
 
 
 
4.7
 
 
$
13,139
 
Exercisable at March 31, 2017
 
 
732
 
 
$
12.33
 
 
 
4.5
 
 
$
12,275
 

The following table shows a summary of our restricted stock and restricted stock units as of March 31, 2017, as well as activity during the three months then ended:

 
 
Restricted Stock and
Restricted Stock Units
 
 
 
Shares
(In thousands)
 
 
Weighted-
Average
Grant Date
Fair Value
 
Nonvested at January 1, 2017
 
 
939
 
 
$
13.11
 
Granted
 
 
4
 
 
 
27.97
 
Vested
 
 
(98
)
 
 
10.47
 
Forfeited
 
 
(37
)
 
 
11.70
 
Nonvested at March 31, 2017
 
 
808
 
 
$
13.57
 

The following table shows a summary of our market stock units as of March 31, 2017, as well as activity during the three months then ended:

 
 
 
 
Market Stock Units
 
 
 
 
 
Shares
(In thousands)
 
 
Weighted-
Average
Grant Date
Fair Value
 
Nonvested at January 1, 2017
 
 
 
 
406
 
 
$
8.75
 
Granted
 
 
 
 
 
 
 
 
Vested
 
 
 
 
(8
 
 
5.46
 
Forfeited
 
 
 
 
(25
 
 
5.95
 
Nonvested at March 31, 2017
 
 
 
 
373
 
 
$
9.01
 

5.
Income Taxes

For the three months ended March 31, 2017, we had an effective income tax rate from continuing operations of 37.7%.  For the three months ended March 31, 2016, we followed the intra-period tax allocation guidance in ASC 740-20 and the example in ASC 740-20-55-14, which requires that the amount of tax attributable to the current year income from continuing operations be determined by a computation that does not consider the tax effects of items that are excluded from income from continuing operations (e.g.
 
13

discontinued operations).  We had net operating loss carryforwards from 2015 subject to a valuation allowance at December 31, 2015, which, upon reversal of the valuation allowance in the first quarter of 2016, we utilized to offset income from continuing operations for the three months ended March 31, 2016.

At March 31, 2017, we had approximately $160.5 million of federal loss carryforwards and approximately $191.2 million of state loss carryforwards.

We file income tax returns in the U.S. Federal jurisdiction and in various state and foreign jurisdictions.  Our 2014 federal income tax return is currently under IRS examination.  Tax years remaining subject to examination in the U.S. Federal jurisdiction include 2013 to present.

6.
Long-Term Debt

The Company's long-term debt, net of unamortized deferred loan costs, consisted of the following at March 31, 2017 and December 31, 2016:

(In thousands)
 
March 31, 2017
 
 
December 31, 2016
 
Cash Convertible Notes, net of unamortized discount
 
$
139,790
 
 
$
137,859
 
Prior Credit Agreement:
 
 
 
 
 
 
 
 
Term Loan
 
 
55,000
 
 
 
60,000
 
Revolver
 
 
13,250
 
 
 
13,500
 
Capital lease obligations and other
 
 
1,029
 
 
 
1,270
 
 
 
 
209,069
 
 
 
212,629
 
Less: deferred loan costs
   
(1,771
)
   
(2,286
)
     
207,298
     
210,343
 
Less: current portion
 
 
(147,102
)
 
 
(46,046
)
 
 
$
60,196
 
 
$
164,297
 

Credit Facility

On June 8, 2012, we entered into the Fifth Amended and Restated Revolving Credit and Term Loan Agreement (as amended, the "Prior Credit Agreement").  The Prior Credit Agreement provided us with a $125 million revolving credit facility that includes a swingline sub facility of $20 million and a $75 million sub facility for letters of credit.  The Prior Credit Agreement also provided a $200 million term loan facility, $55 million of which remained outstanding at March 31, 2017, and an uncommitted incremental accordion facility of $100 million.  On April 21, 2017, we entered into a new revolving credit and term loan agreement, as described in detail below.
 
Borrowings under the Prior Credit Agreement generally bore interest at variable rates based on a margin or spread in excess of either (1) the one-month, two-month, three-month or six-month rate (or with the approval of affected lenders, nine-month or twelve-month rate) for Eurodollar deposits ("LIBOR", which may not be less than zero), or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50% and (c) one-month LIBOR plus 1.00% (the "Base Rate"), as selected by the Company.  The LIBOR margin varied between 1.75% and 3.00%, and the Base Rate margin varied between 0.75% and 2.00%, depending on our leverage ratio.  The Prior Credit Agreement also provided for an annual fee ranging between 0.30% and 0.50% of the unused commitments under the revolving credit facility.  Extensions of credit under the Prior Credit Agreement were secured by guarantees from all of the Company's active domestic subsidiaries and by security interests in substantially all of the Company's and such subsidiaries' assets.

On August 4, 2016, we entered into the Eighth Amendment to the Prior Credit Agreement (the "Eighth Amendment").  The Eighth Amendment extended the expiration date of the revolving credit facility and the maturity date of the term loan facility under the Prior Credit Agreement from June 8, 2017 to June 8, 2018 (the "Extended Maturity Date").  The Eighth Amendment contemplated that some lenders might not agree to the Extended Maturity Date and preserved June 8, 2017 as the non-extended maturity date (the "Non-Extended Maturity Date") for such lenders.  Lenders holding $45.3 million of the revolving commitments and $25.4 million of outstanding term loans as of August 4, 2016 did not consent to the Extended Maturity Date.  On the Non-Extended Maturity Date, the revolving commitments of non-consenting revolving lenders will terminate and any outstanding term loans and revolving loans owed to non-consenting lenders must be paid in full.  The outstanding revolving loans under the revolving credit facility held by consenting lenders must be paid in full on June 8, 2018.  We are required to repay term loans in quarterly principal installments aggregating 2.50% of the original aggregate principal amount of the
 
14

term loans ($5.0 million) during each of the remaining quarters prior to maturity on June 8, 2018, at which time the entire unpaid principal balance of the term loans held by consenting lenders is due and payable.  As of March 31, 2017, availability under the revolving credit facility totaled $104.3 million.

 On April 21, 2017, we entered into a new Revolving Credit and Term Loan Agreement (the "Credit Agreement") with a group of lenders, which replaced the Prior Credit Agreement.  The Credit Agreement provides us with (1) a $100 million revolving credit facility that includes a $25 million sublimit for swingline loans and a $75 million sublimit for letters of credit, (2) a $70 million term loan A facility, (3) a $150 million delayed draw term loan facility, and (4) an uncommitted incremental accordion facility of $100 million.

We used the proceeds of the term loan A and cash on hand to repay all of the outstanding indebtedness under the Prior Credit Agreement and to pay transaction costs and expenses.  Proceeds of revolving loans and delayed draw term loans may be used to repay outstanding indebtedness (including amounts payable upon or in respect of any conversion of the Cash Convertible Notes discussed below and the repayment of any revolving loans borrowed for such purposes), to finance working capital needs, to finance acquisitions, to finance the repurchase of our common stock, to finance capital expenditures and for other general corporate purposes of the Company and its subsidiaries.  Delayed draw term loans may not be borrowed after July 2, 2018.

We are required to repay outstanding revolving loans in full on April 21, 2022.  We are required to repay the term loan A in quarterly principal installments aggregating (1) $875,000 each for the first twelve quarters following the closing, and (2) $1,312,500 each for the remaining quarters prior to maturity on April 21, 2022.  We are required to repay the delayed draw term loans in quarterly principal installments calculated as follows: (1) for each of the first twelve quarters following the closing, 1.250% of the aggregate principal amount of the delayed draw term loans funded as of the last day of the immediately preceding quarter; and (2) for each of the remaining quarters prior to maturity on April 21, 2022, 1.875% of the aggregate principal amount of the delayed draw term loans funded as of the last day of the immediately preceding quarter.  At maturity on April 21, 2022, the entire unpaid principal balances of the term loan A and the delayed draw term loans are due and payable.  As a result of entering into the Credit Agreement, as of March 31, 2017 we reclassified $37.3 million from current liabilities to long-term debt; this amount was due within one year from March 31, 2017 under the Prior Credit Agreement.

Borrowings under the Credit Agreement generally bear interest at variable rates based on a margin or spread in excess of either (1) the one-month, two-month, three-month or six-month LIBOR rate (or with the approval of affected lenders, the twelve-month LIBOR rate), which may not be less than zero, or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50%, and (c) one-month LIBOR plus 1.00% (the "Base Rate"), as selected by the Company.  The LIBOR margin varies between 1.50% and 2.75%, and the Base Rate margin varies between 0.50% and 1.75%, depending on our net leverage ratio.  The Credit Agreement also provides for annual fees ranging between 0.20% and 0.50% of the unused commitments under the revolving credit facility and the delayed draw term loan facility.  Extensions of credit under the Credit Agreement are secured by guarantees from all of the Company's active material subsidiaries and by security interests in substantially all of the Company's and such subsidiaries' assets.

Each of the Prior Credit Agreement and the Credit Agreement contains financial covenants that require us to maintain, as defined, specified ratios or levels of (1) funded debt to EBITDA and (2) fixed charge coverage. The Prior Credit Agreement and the Credit Agreement also contain various other affirmative and negative covenants that are typical for financings of this type.  Among other things, they limit repurchases of our common stock and the amount of dividends that we can pay to holders of our common stock.

1.50% Cash Convertible Senior Notes Due 2018

On July 16, 2013, we completed the issuance of $150.0 million aggregate principal amount of cash convertible senior notes due 2018 (the "Cash Convertible Notes"), which bear interest at a rate of 1.50% per year, payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2014. The Cash Convertible Notes will mature on July 1, 2018, unless earlier repurchased or converted into cash in accordance with their terms prior to such date. At the option of the holders, the Cash Convertible Notes are convertible into cash based on the conversion rate set forth below only upon occurrence of certain triggering events as defined in the Indenture dated as of July 8, 2013 by and between the Company and U.S. Bank National Association, none of which had occurred as of December 31, 2016 and one of which had occurred as of March 31, 2017, as further detailed below. Accordingly, we have classified the Cash Convertible Notes as long-term debt at December 31, 2016 and as current liabilities at March 31, 2017.

15

The Cash Convertible Notes become convertible into cash during any calendar quarter (and only during such calendar quarter), if the last reported sale price of the Company's common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to approximately $25.30 per share ("Trading Price Condition"). The Trading Price Condition was satisfied on March 17, 2017 for the calendar quarter ending March 31, 2017, and accordingly, the Convertible Notes will be convertible at any time at the option of the holders during the period from April 1, 2017 through June 30, 2017. The initial cash conversion rate is 51.3769 shares of the Company's common stock per $1,000 principal amount of the Convertible Notes (equivalent to an initial conversion price of $19.4640 per share of common stock). The settlement on any Convertible Notes surrendered for conversion during this period will occur on the third business day following the end of the applicable "Observation Period" with respect to such conversion (i.e., the period that begins on the date that a holder surrendered the Convertible Notes for conversion in accordance with the requirements of the indenture and ends on the 80th consecutive trading day following such date). The indenture requires the Company to satisfy the entire settlement amount for any conversions (determined in accordance with the provisions of the indenture) in cash, and the notes are not convertible into the Company's common stock or any other securities under any circumstances.  Even if holders do not elect to convert their Cash Convertible Notes, we are required under applicable accounting rules to classify the Cash Convertible Notes that are convertible as a current rather than long-term liability.  Accordingly, the Cash Convertible Notes, net of the unamortized discount, and related deferred loan costs are classified as current liabilities at March 31, 2017.

 The Cash Convertible Notes are our senior unsecured obligations and rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the Cash Convertible Notes. As a result of this transaction, we recognized deferred loan costs of approximately $3.9 million, which are being amortized over the term of the Cash Convertible Notes using the effective interest method.

The cash conversion feature of the Cash Convertible Notes is a derivative liability (the "Cash Conversion Derivative") that requires bifurcation from the Cash Convertible Notes in accordance with FASB ASC Topic 815, "Derivatives and Hedging" ("ASC Topic 815"), and is carried at fair value.  At December 31, 2016, because the Cash Convertible Notes were classified as long-term debt, the Cash Conversion Derivative was classified as long-term liabilities.  Due to the satisfaction of the Trading Price Condition in March 2017 and the resulting classification of the Cash Convertible Notes as a current liability at March 31, 2017, the Cash Conversion Derivative is recorded in current liabilities at March 31, 2017. The fair value of the Cash Conversion Derivative at the time of issuance of the Cash Convertible Notes was $36.8 million, which was recorded as a debt discount for purposes of accounting for the debt component of the Cash Convertible Notes. The debt discount is being amortized over the term of the Cash Convertible Notes using the effective interest method. For the three months ended March 31, 2017, we recorded $1.9 million of interest expense related to the amortization of the debt discount based upon an effective interest rate of 5.7%. The net carrying amount of the Cash Convertible Notes at March 31, 2017 and December 31, 2016 was $139.8 million and $137.9 million, respectively, net of the unamortized discount of $10.2 million and $12.1 million, respectively.
 
In connection with the issuance of the Cash Convertible Notes, we entered into privately negotiated convertible note hedge transactions (the "Cash Convertible Notes Hedges"), which are cash-settled and are intended to reduce our exposure to potential cash payments that we would be required to make if holders elect to convert the Cash Convertible Notes at a time when our stock price exceeds the conversion price. The initial cost of the Cash Convertible Notes Hedges was $36.8 million. At December 31, 2016, because the Cash Convertible Notes were classified as long-term debt, the Cash Convertible Notes Hedges were classified as long-term assets.  Due to the satisfaction of the Trading Price Condition in March 2017 and the resulting classification of the Cash Convertible Notes as a current liability at March 31, 2017, the Cash Convertible Notes Hedges are classified in current assets at March 31, 2017.  The Cash Convertible Notes Hedges are recorded as a derivative asset under ASC Topic 815 and are carried at fair value.  See Note 9 for additional information regarding the Cash Convertible Notes Hedges and the Cash Conversion Derivative and their fair values.

In July 2013, we also sold separate privately negotiated warrants (the "Warrants") initially relating, in the aggregate, to a notional number of shares of our common stock underlying the Cash Convertible Notes Hedges. The Warrants have an initial strike price of approximately $25.95 per share, which effectively increases the conversion price of the Cash Convertible Notes to a 60% premium to our stock price on July 1, 2013. The Warrants will be net share settled by issuing a number of shares of our common stock per Warrant corresponding to the excess of the market price per share of our common stock (as measured on each warrant exercise date under the terms of the Warrants) over the applicable strike price of the Warrants. The Warrants meet the definition of derivatives under the guidance in ASC Topic 815; however, because these instruments have been determined to
 
16

be indexed to our own stock and meet the criteria for equity classification under ASC Topic 815, the Warrants have been accounted for as an adjustment to our additional paid-in-capital.

When the market value per share of our common stock exceeds the strike price of the Warrants, the Warrants have a dilutive effect on net income per share, and the "treasury stock" method is used in calculating the dilutive effect on earnings per share.  See Note 10 for additional information on such dilutive effect.

7.
Commitments and Contingencies

Summary

We are subject to contractual disputes, claims and legal proceedings that arise from time to time in the ordinary course of our business. While we are unable to estimate a range of potential losses, we do not believe that any of the legal proceedings pending against us as of the date of this report, some of which are expected to be covered by insurance policies, will have a material adverse effect on our financial statements. As these matters are subject to inherent uncertainties, our view of these matters may change in the future.

Contractual Commitments

In October 2012, we entered into the Gallup Joint Venture that required us to make payments over a five year period beginning January 2013. Pursuant to Sharecare's acquisition of the TPHS business, our ownership interest in the Gallup Joint Venture was transferred to Sharecare. We agreed with Sharecare to be responsible for two-thirds of the remaining payment obligations in respect of the purchase price to be paid in connection with Sharecare's acquisition of additional membership interest in the Gallup Joint Venture. This obligation is currently expected to result in aggregate payments by us of approximately $4.2 million, payable in five equal quarterly installments that began in the fourth quarter of the 2016 calendar year and will end in the fourth quarter of 2017. As of March 31, 2017, this obligation totaled $2.5 million and was included in accrued liabilities. The financial impact of the strategic relationship with Gallup and the Gallup Joint Venture are reflected in discontinued operations for all periods presented as each of these were a part of the TPHS business.

8.
Fair Value Measurements

We account for certain assets and liabilities at fair value. Fair value is defined as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.

Fair Value Hierarchy

The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. We categorize each of our fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are:

Level 1:   Quoted prices in active markets for identical assets or liabilities;

Level 2:
Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-based valuation techniques in which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

Level 3:   Unobservable inputs that are supported by little or no market activity and typically reflect management's estimates of assumptions that market participants would use in pricing the asset or liability.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table presents our assets and liabilities measured at fair value on a recurring basis at March 31, 2017 and March 31, 2016:

17

 
(In thousands)
 
March 31, 2017
 
 
December 31, 2016
 
Level 3:
 
 
 
 
 
 
Assets:
               
   Cash Convertible Notes Hedges
 
 $
82,445
 
 
 $
48,361
 
Liabilities:
 
 
 
 
 
 
 
 
   Cash Conversion Derivative
 
 $
82,445
 
 
 $
48,361
 

The fair values of the Cash Convertible Notes Hedges and the Cash Conversion Derivative are measured using Level 3 inputs because these instruments are not actively traded. They are valued using an option pricing model that uses observable and unobservable market data for inputs, such as expected time to maturity of the derivative instruments, the risk-free interest rate, the expected volatility of our common stock, and other factors. The Cash Convertible Notes Hedges and the Cash Conversion Derivative were designed such that changes in their fair values would offset one another, with minimal impact to the consolidated statements of operations. Therefore, the sensitivity of changes in the unobservable inputs to the option pricing model for such instruments is mitigated.

The following table presents our financial instruments measured at fair value on a recurring basis using unobservable inputs (Level 3):

(In thousands)
 
Balance at December 31, 2016
 
 
Purchases of Level 3 Instruments
 
 
Settlements of Level 3 Instruments
 
 
Gains (Losses) Included in Earnings
 
 
Balance at March 31, 2017
 
Cash Convertible Notes Hedges
 
$
48,361
 
 
$
 
 
$
 
 
$
34,084
 
 
$
82,445
 
Cash Conversion Derivative
 
 
(48,361
)
 
 
 
 
 
 
 
 
(34,084
 
 
(82,445
)

The gains and losses included in earnings noted above represent the change in the fair value of these financial instruments and are recorded each period in the consolidated statements of operations. The gains and losses on the Cash Convertible Notes Hedges and Cash Conversion Derivative are recorded as selling, general and administrative expenses.

Fair Value of Other Financial Instruments

In addition to the Cash Convertible Notes Hedges and the Cash Conversion Derivative, the estimated fair values of which are disclosed above, the estimated fair value of each class of financial instruments at March 31, 2017 was as follows:

Cash and cash equivalents – The carrying amount of $0.7 million approximates fair value because of the short maturity of those instruments (less than three months).

Long-term debt – The estimated fair value of outstanding borrowings under the Prior Credit Agreement, which includes a revolving credit facility and a term loan facility (see Note 6), and the Cash Convertible Notes are determined based on the fair value hierarchy as discussed above.

The revolving credit facility and the term loan facility are not actively traded and therefore are classified as Level 2 valuations based on the market for similar instruments. The estimated fair value is based on the average of the prices set by the issuing bank given current market conditions and is not necessarily indicative of the amount we could realize in a current market exchange. The estimated fair value and carrying amount of outstanding borrowings under the Prior Credit Agreement at March 31, 2017 were each $68.3 million.

The Cash Convertible Notes are actively traded and therefore are classified as Level 1 valuations. The estimated fair value at March 31, 2017 was $226.9 million, which is based on the most recent trading price of the Cash Convertible Notes as of March 31, 2017, and the par value was $150.0 million. The carrying amount of the Cash Convertible Notes at March 31, 2017 was $139.8 million, which is net of the debt discount discussed in Note 6.



18

9.
Derivative Instruments and Hedging Activities

We use derivative instruments to manage risks related to interest (through December 30, 2016), the Cash Convertible Notes, and, prior to the sale of the TPHS business, foreign currencies. We account for derivatives in accordance with ASC Topic 815, which establishes accounting and reporting standards requiring that certain derivative instruments be recorded on the balance sheet as either an asset or liability measured at fair value. Additionally, changes in the derivative's fair value will be recognized currently in earnings unless specific hedge accounting criteria are met. As permitted under our master netting arrangements, the fair value amounts of our prior interest rate swaps and foreign currency options and/or forward contracts are presented on a net basis by counterparty in the consolidated balance sheets.

Derivative Instruments Designated as Hedging Instruments

Cash Flow Hedges

Derivative instruments that are designated and qualify as cash flow hedges are recorded at estimated fair value in the consolidated balance sheets, with the effective portion of the gains and losses being reported in accumulated other comprehensive income or loss ("accumulated OCI"). We did not maintain any cash flow hedges during the three months ended March 31, 2017.  Cash flow hedges for the three months ended March 31, 2016 consisted solely of an interest rate swap agreement, which effectively modified our exposure to interest rate risk by converting a portion of our floating rate debt to a fixed rate obligation, thus reducing the impact of interest rate changes on future interest expense. Under this agreement, which terminated on December 30, 2016, we received a variable rate of interest based on LIBOR (as defined in Note 6), and we paid a fixed rate of interest with an interest rate of 1.480% plus a spread (see Note 6). Gains and losses on this interest rate swap agreement were reclassified to interest expense in the same period during which the hedged transaction affected earnings or the period in which all or a portion of the hedge became ineffective.

The following table shows the effect of our cash flow hedges on the consolidated balance sheets during the three months ended March 31, 2017 and 2016:

(In thousands)
 
 
For the Three Months Ended
 
Derivatives in Cash Flow Hedging Relationships
 
 
March 31, 2017
 
March 31, 2016
 
Loss related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect
 
 
 $
92
 
Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect
 
 
 $
(133

Gains and losses representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings. During the three months ended March 31, 2017 and 2016, there were no gains or losses on cash flow hedges recognized in our consolidated statements of operations resulting from hedge ineffectiveness.

Derivative Instruments Not Designated as Hedging Instruments

Our Cash Conversion Derivative, Cash Convertible Notes Hedges and, prior to July 31, 2016, foreign currency options and/or forward contracts, do not qualify for hedge accounting treatment under U.S. GAAP and are measured at fair value, with gains and losses recognized immediately in the consolidated statements of operations. These derivative instruments not designated as hedging instruments did not have a material impact on our consolidated statements of operations for the three months ended March 31, 2017 and 2016.

The Cash Conversion Derivative is accounted for as a derivative liability and carried at fair value. In order to offset the risk associated with the Cash Conversion Derivative, we entered into Cash Convertible Notes Hedges, which are cash-settled and are intended to reduce our exposure to potential cash payments that we would be required to make if holders elect to convert the Cash Convertible Notes at a time when our stock price exceeds the conversion price. The Cash Convertible Notes Hedges are accounted for as a derivative asset and carried at fair value.

The gains and losses resulting from a change in fair values of the Cash Conversion Derivative and the Cash Convertible Notes Hedges are reported in the consolidated statements of operations.

19

 
Three Months Ended
March 31,
 
 
(In thousands)
 2017
 
2016
 
Statements of Operations Classification
Cash Convertible Notes Hedges:
 
 
 
 
    
Net unrealized gain (loss)
 
$
34,084
 
 
$
(7,603
Selling, general and administrative expenses
Cash Conversion Derivative:
 
 
 
 
 
 
 
 
     
Net unrealized (loss) gain
 
$
(34,084
 
$
7,603
 
Selling, general and administrative expenses

Prior to the sale of the TPHS business, we also entered into foreign currency options and/or forward contracts in order to minimize our earnings exposure to fluctuations in foreign currency exchange rates.  Our foreign currency exchange contracts required current period mark-to-market accounting, with any change in fair value being recorded each period in the consolidated statements of operations in selling, general and administrative expenses. We do not execute transactions or hold derivative financial instruments for trading or other purposes.

Financial Instruments

The estimated fair values of derivative instruments at March 31, 2017 and December 31, 2016 were as follows:

(In thousands) 
March 31,
2017
 
December 31, 2016
 
Assets:
 
 
 
 
 
 
 
 
 
 
Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Cash convertible notes hedges, current
 
 
 
82,445
 
 
 $
 
 
 
Cash convertible notes hedges, long-term
 
 
 
 
 
 
 
48,361
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Cash conversion derivative, current
 
 
 
82,445
 
 
 
 
 
Cash conversion derivative, long-term
 
 
 
 
 
 
 
48,361
 
 
 

See Note 8 for more information on fair value measurements.
























20




10.
Earnings (Loss) Per Share

The following is a reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share for the three months ended March 31, 2017 and 2016:

(In thousands except per share data)
 
Three Months Ended
March 31,
 
 
 
2017
 
 
2016
 
Numerator:
           
Net income from continuing operations attributable to Tivity Health, Inc. - numerator for earnings per share
 
$
15,481
 
 
$
19,208
 
Net loss from discontinued operations attributable to Tivity Health, Inc. - numerator for loss per share
   
(220
 
)
   
(33,417
)
Net income (loss) attributable to Tivity Health, Inc. - numerator for earnings (loss) per share
 
$
15,261
     
(14,209
)
 
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
 
Shares used for basic income (loss) per share
 
 
39,069
 
 
 
36,109
 
Effect of dilutive stock options and restricted stock units outstanding:
 
 
 
 
 
 
 
 
Non-qualified stock options
 
 
442
 
 
 
165
 
Restricted stock units
 
 
611
 
 
 
426
 
Market stock units
   
293
     
161
 
Warrants related to Cash Convertible Notes
 
 
126
 
 
 
 
Shares used for diluted income (loss) per share
 
 
40,541
 
 
 
36,861
 
 
 
 
 
 
 
 
 
 
Earnings (loss) per share attributable to Tivity Health, Inc. - basic:
 
 
 
 
 
 
 
 
Continuing operations
 
$
0.40
 
 
$
0.53
 
Discontinued operations
 
$
(0.01
)
 
$
(0.93
)
Net income (loss) (1)
 
$
0.39
 
 
$
(0.39
)
                 
Earnings (loss) per share attributable to Tivity Health, Inc. - diluted:
 
 
 
 
 
 
 
 
Continuing operations
 
$
0.38
 
 
$
0.52
 
Discontinued operations
 
$
(0.01
)
 
$
(0.91
)
Net income (loss) (1)
 
$
0.38
 
 
$
(0.39
)
 
 
 
 
 
 
 
 
 
Dilutive securities outstanding not included in the computation of earnings (loss) per share because their effect is anti-dilutive:
 
 
 
 
 
 
 
 
Non-qualified stock options
 
 
16
 
 
 
1,486
 
Restricted stock units
 
 
18
 
 
 
679
 
Warrants related to Cash Convertible Notes
 
 
 
 
 
7,707
 
CareFirst Convertible Note
 
 
 
 
 
892
 
CareFirst Warrants
 
 
 
 
 
591
 
                 
(1) Figures may not add due to rounding.
 
               


11.
Accumulated OCI

The following tables summarize the changes in accumulated OCI, net of tax, for the three months ended March 31, 2017 and 2016:
 (In thousands)
 
 
Foreign Currency Translation Adjustments
 
Accumulated OCI, net of tax, as of January 1, 2017
 
 
$
(4,502
)
Other comprehensive income before reclassifications, net of tax of $36
 
 
 
111
 
Accumulated OCI, net of tax, as of March 31, 2017
 
 
$
(4,391
)


21

 (In thousands)
 
Net Change in Fair Value of Interest Rate Swaps
 
 
Foreign Currency Translation Adjustments
 
 
Total
 
Accumulated OCI, net of tax, as of January 1, 2016
 
$
(239
)
 
$
(4,000
)
 
$
(4,239
)
Other comprehensive income (loss) before reclassifications, net of tax of $37 and $0, respectively
 
 
(56
)
 
 
1,022
 
 
 
966
 
Amounts reclassified from accumulated OCI, net of tax
 
 
80
 
 
 
 
 
 
80
 
Net increase in other comprehensive income (loss), net of tax
 
 
24
 
 
 
1,022
 
 
 
1,046
 
Accumulated OCI, net of tax, as of March 31, 2016
 
$
(215
)
 
$
(2,978
)
 
$
(3,193
)

The following table provides details about reclassifications out of accumulated OCI for the three months ended March 31, 2017 and 2016:

 
Three Months Ended March 31,
 
Statement of Operations
 (In thousands)
2017
 
2016
 
Classification
Interest rate swaps
 
$
 
 
$
133
 
Interest expense
 
 
 
 
 
 
(53
)
Income tax benefit
 
 
$
 
 
$
80
 
Net of tax

See Note 9 for further discussion of our interest rate swaps.

12.
Restructuring and Related Charges

In the third quarter of 2015, we began developing our reorganization and cost rationalization plan (the "2015 Restructuring Plan") that commenced in October 2015, which was intended to improve efficiency and deliver greater value to our customers and stakeholders. Completion of the 2015 Restructuring Plan occurred with the completion of the sale of the TPHS business in July 2016. We incurred a total of approximately $24 million in restructuring charges related to the 2015 Restructuring Plan, substantially all of which resulted in or will result in cash expenditures.
 
The following table shows the costs incurred for the three months ended March 31, 2017 related to our 2015 Restructuring Plan and other restructuring costs:

(In thousands)
 
Severance and Other
Employee-Related Costs
 
 
Consulting and Other Costs (1)
 
 
 
Total
Accrued restructuring and related charges liability as of January 1, 2017
 
$
4,242
   
$
63
     
$
4,305
 
Restructuring charges
   
     
       
 
Payments
   
(717
)
   
(3
)
     
(720
)
Adjustments (2)
   
41
     
       
41
 
Accrued restructuring and related charges liability as of March 31, 2017
 
$
3,566
   
$
60
     
$
3,626
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Consulting and other costs consist of third-party consulting charges incurred in connection with the 2015 Restructuring Plan. 

(2) Adjustments consist primarily of foreign currency translation adjustments.  

In the third quarter of 2016, we began the reorganization of our corporate support infrastructure (the "2016 Restructuring Plan"), which was intended to deliver greater value to our customers and stakeholders. Completion of the 2016 Restructuring Plan occurred during the first quarter of 2017. We incurred a total of approximately $5.7
 
22

million in restructuring charges related to the 2016 Restructuring Plan, substantially all of which resulted in or will result in cash expenditures.

The following table shows the costs incurred for the three months ended March 31, 2017 directly related to our 2016 Restructuring Plan and other restructuring costs:

(In thousands)
 
Severance and Other
Employee-Related Costs
 
 
Consulting and Other Costs (1)
 
 
 
Total
Accrued restructuring and related charges liability as of January 1, 2017
 
$
3,851
 
 
$
48
 
 
 
$
3,899
 
Restructuring charges
   
794
 
 
 
16
 
 
 
 
810
 
Payments
   
(2,054
)
   
(64
)
     
(2,118
)
Adjustments (2)
   
(73
 
 
 
 
 
 
(73
)
Accrued restructuring and related charges liability as of March 31, 2017
 
$
2,518
 
 
$
 
 
 
 
2,518
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

(1) Consulting and other costs consist of third-party consulting charges incurred in connection with the 2016 Restructuring Plan. 
 
(2) Adjustments consist primarily of actual employee tax and benefit amounts differing from previous estimates.  

13.
Subsequent Event

On April 21, 2017, we entered into the Credit Agreement with a group of lenders for whom SunTrust Bank acts as administrative agent, which replaced the Prior Credit Agreement.  The Credit Agreement provides us with (1) a $100 million revolving credit facility that includes a $25 million sublimit for swingline loans and a $75 million sublimit for letters of credit, (2) a $70 million term loan A facility, (3) a $150 million delayed draw term loan facility, and (4) an uncommitted incremental accordion facility of $100 million.

We used the proceeds of the term loan A and cash on hand to repay all of the outstanding indebtedness under the Prior Credit Agreement and to pay transaction costs and expenses.  Proceeds of revolving loans and delayed draw term loans may be used to repay outstanding indebtedness (including amounts payable upon or in respect of any conversion of the Cash Convertible Notes and the repayment of any revolving loans borrowed for such purposes), to finance working capital needs, to finance acquisitions, to finance the repurchase of our common stock, to finance capital expenditures, and for other general corporate purposes of the Company and its subsidiaries.  Delayed draw term loans may not be borrowed after July 2, 2018.

We are required to repay outstanding revolving loans in full on April 21, 2022.  We are required to repay the term loan A in quarterly principal installments aggregating (1) $875,000 each for the first twelve quarters following the closing, and (2) $1,312,500 each for the remaining quarters prior to maturity on April 21, 2022.  We are required to repay the delayed draw term loans in quarterly principal installments calculated as follows: (1) for each of the first twelve quarters following the closing, 1.250% of the aggregate principal amount of the delayed draw term loans funded as of the last day of the immediately preceding quarter; and (2) for each of the remaining quarters prior to maturity on April 21, 2022, 1.875% of the aggregate principal amount of the delayed draw term loans funded as of the last day of the immediately preceding quarter.  At maturity on April 21, 2022, the entire unpaid principal balances of the term loan A and the delayed draw term loans are due and payable.

Borrowings under the Credit Agreement generally bear interest at variable rates based on a margin or spread in excess of either (1) the one-month, two-month, three-month or six-month LIBOR rate (or with the approval of affected lenders, the twelve-month LIBOR rate), which may not be less than zero, or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50%, and (c) the Base Rate, as selected by the Company.  The LIBOR margin varies between 1.50% and 2.75%, and the Base Rate margin varies between 0.50% and 1.75%, depending on our net leverage ratio.  The Credit Agreement also provides for annual fees ranging between 0.20% and 0.50% of the unused commitments under the revolving credit facility and the delayed draw term loan facility.  Extensions of credit under the Credit Agreement are secured by guarantees from all of the
 
23

Company's active material subsidiaries and by security interests in substantially all of the Company's and such subsidiaries' assets.

The Credit Agreement contains financial covenants that require us to maintain, as defined, specified ratios or levels of (1) funded debt to EBITDA and (2) fixed charge coverage. The Credit Agreement contains various other affirmative and negative covenants that are typical for financings of this type.  Among other things, it limits repurchases of our common stock and the amount of dividends that we can pay to holders of our common stock.



24



Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Overview

Tivity Health, Inc. was founded and incorporated in Delaware in 1981.  Through our three programs, SilverSneakers® senior fitness, Prime® fitness and WholeHealth LivingTM, we are focused on targeted population health for those aged 50 and older. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans. We also offer Prime fitness, a fitness facility access program, through commercial health plans, employers and insurance exchanges. Our national network of fitness centers delivers both SilverSneakers and Prime fitness. Our fitness networks encompass approximately 16,000 participating locations and more than 1,000 alternative locations that provide classes outside of traditional fitness centers.  We sell access to our WholeHealth Living network primarily to commercial health plans. Our WholeHealth Living network includes over 88,000 complementary, alternative, and physical medicine practitioners to serve individuals through health plans and employers who seek health services such as physical therapy, occupational therapy, speech therapy, chiropractic care, acupuncture, and more.

Effective July 31, 2016, we sold our total population health services ("TPHS") business to Sharecare, Inc. ("Sharecare").  The TPHS business took a systematic approach to keeping healthy people healthy, eliminating or reducing lifestyle risks and optimizing care for persistent or chronic conditions.  The TPHS business included our partnerships with Blue Zones, LLC, and Dr. Dean Ornish (the Blue Zones Project by Healthways™ and Dr. Dean Ornish's Program for Reversing Heart Disease™, respectively), our joint venture with Gallup, Inc. ("Gallup"), Navvis Healthcare, LLC ("Navvis"), MeYou Health, LLC ("MeYou Health"), and our international operations.  While Navvis and MeYou Health were part of our TPHS business, they were sold separately to other buyers in November 2015 and June 2016, respectively.  Results of operations for the TPHS business have been classified as discontinued operations for all periods presented in the Consolidated Financial Statements.

In January 2017, we rebranded and changed the name of the Company from Healthways, Inc. to Tivity Health, Inc. to better align with our portfolio of fitness and health improvement programs.  The Company is headquartered at 701 Cool Springs Boulevard, Franklin, Tennessee 37067.

Forward-Looking Statements

This report contains forward-looking statements, which are based upon current knowledge, assumptions, beliefs, estimates and expectations, involve a number of risks and uncertainties, and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical statements of fact and those regarding the intent, belief, or expectations of the Company, including, without limitation, all statements regarding the Company's future earnings, revenues, and results of operations, and can be identified by the use of words like "may," "believe," "will," "can," "expect," "project," "estimate," "anticipate," "plan," or "continue" and similar expressions.  Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may vary from those in the forward-looking statements as a result of various factors, including, but not limited to:

·
the effectiveness of management's strategies and decisions;

·
the effectiveness of the reorganization of our business and our ability to realize the anticipated benefits;

·
the risks associated with recent changes to our senior management team;

·
our ability to sign and implement new contracts for our solutions;

·
our ability to accurately forecast the costs required to successfully implement new contracts;

·
our ability to renew and/or maintain contracts with our customers under existing terms or restructure these contracts on terms that would not have a material negative impact on our results of operations;

25

·
our ability to effectively compete against other entities, whose financial, research, staff, and marketing resources may exceed our resources;

·
our ability to accurately forecast our revenues, margins, earnings and net income, as well as any potential charges that we may incur as a result of changes in our business and leadership;

·
the impact of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (the "ACA"), on our operations and/or the demand for our services;

·
our ability to anticipate change and respond to emerging trends for healthcare and the impact of the same on demand for our services;

·
the risks associated with deriving a significant concentration of our revenues from a limited number of customers;

·
our ability and/or the ability of our customers to enroll participants and to accurately forecast their level of enrollment and participation in our programs in a manner and within the timeframe anticipated by us;

·
the ability of our customers to maintain the number of covered lives enrolled in the plans during the terms of our agreements;

·
our ability to service our debt, make principal and interest payments as those payments become due, and remain in compliance with our debt covenants;

·
the risks associated with changes in macroeconomic conditions, which may reduce the demand and/or the timing of purchases for our services from customers or potential customers, reduce the number of covered lives of our existing customers, or restrict our ability to obtain additional financing;

·
counterparty risk associated with the Cash Convertible Notes Hedges;

·
the risks associated with valuation of the Cash Convertible Notes Hedges and the Cash Conversion Derivative, which may result in volatility to our consolidated statements of operations if these transactions do not completely offset one another;

·
our ability to integrate new or acquired businesses, services, or technologies into our business and to accurately forecast the related costs;

·
our ability to anticipate and respond to strategic changes, opportunities, and emerging trends in our industry and/or business and to accurately forecast the related impact on our revenues and earnings;

·
the impact of any impairment of our goodwill, intangible assets, or other long-term assets;

·
our ability to develop new products;

·
our ability to obtain adequate financing to provide the capital that may be necessary to support our operations;

·
the risks associated with data privacy or security breaches, computer hacking, network penetration and other illegal intrusions of our information systems or those of third-party vendors or other service providers, which may result in unauthorized access by third parties to customer, employee or our information or patient health information and lead to enforcement actions, fines and other litigation against us;

·
the impact of any new or proposed legislation, regulations and interpretations relating to Medicare or Medicare Advantage;

·
the impact of future state and federal legislation and regulations applicable to our business, including ACA, on our ability to deliver our services and on the financial health of our customers and their willingness to purchase our services;

26

·
current geopolitical turmoil, the continuing threat of domestic or international terrorism, and the potential emergence of a health pandemic or infectious disease outbreak;

·
the impact of legal proceedings involving us and/or our subsidiaries; and

·
other risks detailed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016 and our other filings with the Securities and Exchange Commission.

We undertake no obligation to update or revise any such forward-looking statements.

Customer Contracts

Our customer contracts generally have terms of approximately three years.  Some of our contracts allow the customer to terminate early.

Business Strategy

Our "A-B-C-D" strategy is designed to (A) add new members in our three existing networks - SilverSneakers, Prime fitness and WholeHealth Living, (B) build engagement and participation among our current eligible members, (C) collaborate with partners to add new products and services that will leverage the value of our brand, and (D) deepen relationships with our partners and their instructors within our national network.  In addition to the A-B-C-D strategy, we are focused on supporting the ability of our health plan customers to meet the needs of their members as well as providing a valuable service to improve the health and well-being of the consumers we serve through our networks and with our products.

We engage and support our members based on the needs and preferences of our customers.  Within our fitness networks, we have approximately 16,000 participating locations and more than 1,000 alternative locations that provide classes outside of traditional fitness centers. More than 13,000 of these participating locations within the national network deliver our proprietary SilverSneakers fitness program, and more than 10,000 of these locations offer Prime fitness. 

Critical Accounting Policies

We describe our significant accounting policies in Note 1 to the Consolidated Financial Statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.  We prepare the Consolidated Financial Statements in conformity with U.S. GAAP, which requires us to make estimates and judgments that affect the reported amounts of assets and liabilities and related disclosures at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.

Following the sale of the TPHS business, we believe the following accounting policies are the most critical in understanding the estimates and judgments that are involved in preparing our financial statements and the uncertainties that could impact our results of operations, financial condition and cash flows.

Revenue Recognition

We recognize revenue as services are performed when persuasive evidence of an arrangement exists, collectability is reasonably assured, and amounts are fixed or determinable.

Our fees are generally billed per member per month ("PMPM"), upon member participation, or a combination of both. For PMPM fees, we generally determine our contract fees by multiplying the contractually negotiated PMPM rate by the number of members eligible for or receiving our services during the month. Some of our contracts are performance-based and place a portion of our fees at risk based on achieving certain performance metrics.

We generally bill our customers each month for the entire amount of the fees contractually due for the prior month's enrollment, which typically includes the amount, if any, that is performance-based and may be
 
27

subject to refund should we not meet performance targets.  Fees for participation are typically billed in the month after the services are provided.

We recognize revenue as follows: (1) we recognize the fixed portion of PMPM fees and fees for service as revenue during the period we perform our services; and (2) we recognize performance-based revenue based on the most recent assessment of our performance, which represents the amount that the customer would legally be obligated to pay if the contract were terminated as of the latest balance sheet date.

We are currently evaluating the impact that the adoption of ASU No. 2014-09, (as discussed under "Recent Relevant Accounting Standards" below) will have on our revenue recognition policies and procedures, financial position, results of operations, cash flows, financial disclosures and control framework.

Impairment of Intangible Assets and Goodwill

We review goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (during the fourth quarter of our fiscal year) or more frequently whenever events or circumstances indicate that the carrying value may not be recoverable. Following the sale of the TPHS business, a single reporting unit remains.

We may elect to perform a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If we conclude during the qualitative assessment that this is the case or if we elect not to perform a qualitative assessment, we perform a quantitative review as described below.

During a quantitative review of goodwill, we estimate the fair value of a reporting unit using a combination of a discounted cash flow model and a market-based approach, and in the event we have multiple reporting units, we reconcile the aggregate fair value of our reporting units to our consolidated market capitalization. Estimating fair value requires significant judgments, including management's estimate of future cash flows, which is dependent on internal forecasts, estimation of the long-term growth rate for our business, the useful life over which cash flows will occur, and determination of our weighted average cost of capital, as well as relevant comparable company earnings multiples for the market-based approach. Changes in these estimates and assumptions could materially affect the estimate of fair value and potential goodwill impairment for each reporting unit.

If we determine that the carrying value of goodwill is impaired based upon an impairment review, we calculate any impairment using a fair-value-based goodwill impairment test as required by U.S. GAAP. The fair value of a reporting unit is the price that would be received upon a sale of the unit as a whole in an orderly transaction between market participants at the measurement date.

Except for a tradename that has an indefinite life and is not subject to amortization, we amortize identifiable intangible assets over their estimated useful lives using the straight-line method. We assess the potential impairment of intangible assets subject to amortization whenever events or changes in circumstances indicate that the carrying values may not be recoverable. If we determine that the carrying value of other identifiable intangible assets may not be recoverable, we calculate any impairment using an estimate of the asset's fair value based on the estimated price that would be received to sell the asset in an orderly transaction between market participants. We estimated the fair value of our indefinite-lived intangible asset, a tradename, using a present value technique, which requires management's estimate of future revenues attributable to this tradename, estimation of the long-term growth rate and royalty rate for this revenue, and determination of our weighted average cost of capital.  Changes in these estimates and assumptions could materially affect the estimate of fair value for the tradename.

Income Taxes

The objectives of accounting for income taxes are to recognize the amount of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in an entity's financial statements or tax returns.  Accounting for income taxes requires significant judgment in evaluating tax positions and in determining income tax provisions, including determination of deferred tax assets, deferred tax liabilities, and any valuation allowances that might be required against deferred tax assets.

28

Valuation allowances are established when necessary to reduce deferred tax assets to the amounts that are expected to be realized. When we determine that it is more likely than not that we will be able to realize our deferred tax assets in the future, an adjustment to the deferred tax asset is made and reflected in income. This determination will be made by considering various factors, including the reversal and timing of existing temporary differences, tax planning strategies, and estimates of future taxable income exclusive of the reversal of temporary differences.

We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. U.S. GAAP also provides guidance on derecognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, and income tax disclosures. Judgment is required in assessing the future tax consequences of events that have been recognized in our financial statements or tax returns. Variations in the actual outcome of these future tax consequences could materially impact our consolidated financial position, results of operations, and cash flows.

Share-Based Compensation

We measure and recognize compensation expense for all share-based payment awards over the required vesting period based on estimated fair values at the date of grant. Determining the fair value of stock options at the grant date requires judgment in developing assumptions, which involve a number of variables.  These variables include, but are not limited to, the expected stock price volatility over the term of the awards and expected stock option exercise behavior.


29

Executive Overview of Results

The key financial results for the three months ended March 31, 2017 are:

·
Revenues from continuing operations of $141.0 million, up 11.9% from $126.0 million for the same period in 2016;

·
Pre-tax income from continuing operations of $24.9 million, up 29.4% from $19.2 million for the same period in 2016;

·
Income tax expense from continuing operations of $9.4 million compared to $0 for the same period in 2016;

·
Restructuring charges of $0.7 million; and

·
Loss from discontinued operations, net of income tax benefit, of $0.2 million compared to $33.1 million for the same period in 2016.

Results of Operations

The following table sets forth the components of the consolidated statements of operations for the three months ended March 31, 2017 and 2016 expressed as a percentage of revenues for continuing operations.
 
 
 
Three Months Ended
March 31,
 
 
 
2017
 
 
2016
 
 
 
 
 
 
 
 
Revenues
 
 
100.0
%
 
 
100.0
%
Cost of services (exclusive of depreciation and amortization included below)
 
 
72.6
%
 
 
72.5
%
Selling, general and administrative expenses
 
 
5.9
%
 
 
7.5
%
Depreciation and amortization
 
 
0.6
%
 
 
1.5
%
Restructuring and related charges
 
 
 0.5
%
 
 
%
Operating income (1)
 
 
20.3
%
 
 
18.5
%
 
 
 
 
 
 
 
 
 
Interest expense
 
 
2.7
%
 
 
3.3
%
Income before income taxes (1)
 
 
17.6
%
 
 
15.2
%
Income tax expense
 
 
6.6
%
 
 
%
 
 
 
 
 
 
 
 
 
Net income from continuing operations (1)
 
 
11.0
%
 
 
15.2
%
Loss from discontinued operations, net of income tax benefit
   
(0.2
 
)%
   
 
(26.3
 
)%
Net income (loss) (1)
   
10.8
%
   
(11.0
)%
Net loss attributable to non-controlling interest
 
 
0.0
%
 
 
(0.2
)%
Net income (loss) attributable to Tivity Health, Inc. (1)
 
 
 10.8
 
 
(11.3
)% 

(1) Figures may not add due to rounding.

Revenues

Revenues from continuing operations for the three months ended March 31, 2017 increased $15.0 million, or 11.9%, over the three months ended March 31, 2016, primarily as a result of the following: an increase of $15.7 million due to both a net increase in the number of members eligible to participate in our fitness solutions as well as a net increase in the average participation per member in such solutions, an increase of $4.2 million due to contracts with new customers or expanded contracts with existing customers, and a decrease of $4.9 million due to contract terminations.



30

Cost of Services

Cost of services from continuing operations (excluding depreciation and amortization) as a percentage of revenues did not materially change from the first quarter of 2016 (72.5%) to the first quarter of 2017 (72.6%).   Overall, this slight increase is primarily attributable to expenses associated with strategic business initiatives during the three months ended March 31, 2017 intended to drive growth in 2018, mostly offset by an improvement in contract margin during the three months ended March 31, 2017 due to a favorable change in the composition of visits, which resulted in a lower average cost per visit.

Selling, General and Administrative Expenses

Selling, general and administrative expenses from continuing operations as a percentage of revenues decreased from 7.5% for the first quarter of 2016 to 5.9% for the first quarter of 2017.  Overall, this decrease is primarily attributable to cost savings from the reorganization of our corporate support infrastructure that we began implementing in the third quarter of 2016 and completed in the first quarter of 2017 (the "2016 Restructuring Plan").

Depreciation and Amortization

Depreciation and amortization expense from continuing operations decreased $1.1 million from the three months ended March 31, 2016 to the three months ended March 31, 2017, primarily due to a decrease in the amount of depreciable assets.

Restructuring and Related Charges

During the three months ended March 31, 2017, we incurred restructuring charges from continuing operations of $0.7 million, which consisted primarily of severance and other employee-related costs, primarily in connection with the 2016 Restructuring PlanWe incurred a total of approximately $5.7 million in restructuring charges related to the 2016 Restructuring Plan.  The 2016 Restructuring Plan is expected to create cost savings beginning in 2017, with total annualized savings of approximately $15.0 million to $16.0 million, approximately half of which we expect to be reinvested into business initiatives during 2017 intended to drive increased growth in 2018.

During the three months ended March 31, 2016, we incurred immaterial restructuring charges from continuing operations of $39,000 in connection with a reorganization and cost rationalization plan that began in October 2015 and was completed with the sale of the TPHS business in July 2016.

Interest Expense

Interest expense from continuing operations remained relatively consistent for the three months ended March 31, 2017 and 2016.

Income Tax Expense

For the three months ended March 31, 2017, we had an effective income tax rate from continuing operations of 37.7%.  For the three months ended March 31, 2016, we followed the intra-period tax allocation guidance in ASC 740-20 and the example in ASC 740-20-55-14, which requires that the amount of tax attributable to the current year income from continuing operations be determined by a computation that does not consider the tax effects of items that are excluded from income from continuing operations (e.g. discontinued operations).  We had net operating loss carryforwards from 2015 subject to a valuation allowance at December 31, 2015, which, upon reversal of the valuation allowance in the first quarter of 2016, we utilized to offset income from continuing operations for the three months ended March 31, 2016.

Liquidity and Capital Resources

Overview

As of March 31, 2017, we had a working capital deficit of $153.5 million, including the classification of the Cash Convertible Notes, net of unamortized discount, of $139.8 million as a current liability at March 31, 2017
 
31

(as discussed in Note 6 of the Notes to Consolidated Financial Statements in this Report) As of May 1, 2017, the holders of the Cash Convertible Notes have not elected to convert their Cash Convertible Notes.

On April 21, 2017, we entered into the Credit Agreement, which replaces the Prior Credit Agreement.  The Credit Agreement provides us with (1) a $100 million revolving credit facility that includes a $25 million sublimit for swingline loans and a $75 million sublimit for letters of credit, (2) a $70 million term loan A facility, (3) a $150 million delayed draw term loan facility, and (4) an uncommitted incremental accordion facility of $100 million.

We used the proceeds of the term loan A and cash on hand to repay all of the outstanding indebtedness under the Prior Credit Agreement and to pay transaction costs and expenses.  As of April 21, 2017, after entering into the Credit Agreement, our availability under the Credit Agreement included $91.7 million under the revolving credit facility and $150 million under the delayed draw term facility (which can be borrowed at our option until July 2, 2018).  Proceeds of revolving loans and delayed draw term loans may be used to repay outstanding indebtedness (including amounts payable upon or in respect of any conversion of the Cash Convertible Notes discussed below and the repayment of any revolving loans borrowed for such purposes), to finance working capital needs, to finance acquisitions, to finance the repurchase of our common stock, to finance capital expenditures and for other general corporate purposes of the Company and its subsidiaries.  Delayed draw term loans may not be borrowed after July 2, 2018.

We are required to repay outstanding revolving loans in full on April 21, 2022.  We are required to repay the term loan A in quarterly principal installments aggregating (1) $875,000 each for the first twelve quarters following the closing, and (2) $1,312,500 each for the remaining quarters prior to maturity on April 21, 2022.  We are required to repay the delayed draw term loans in quarterly principal installments calculated as follows: (1) for each of the first twelve quarters following the closing, 1.250% of the aggregate principal amount of the delayed draw term loans funded as of the last day of the immediately preceding quarter; and (2) for each of the remaining quarters prior to maturity on April 21, 2022, 1.875% of the aggregate principal amount of the delayed draw term loans funded as of the last day of the immediately preceding quarter.  At maturity on April 21, 2022, the entire unpaid principal balances of the term loan A and the delayed draw term loans are due and payable.

We believe our cash on hand, cash flows from operations, and available borrowings are sufficient to fund our operations, debt payments, and capital expenditures for the next twelve months and the foreseeable future.

Cash Flows Provided by Operating Activities

Operating activities during the three months ended March 31, 2017 provided cash of $3.0 million compared to $7.6 million during the three months ended March 31, 2016. The decrease in operating cash flow resulted primarily from the following:

·
a decrease in cash collections on accounts receivable; and
·
higher payments related to short-term employee incentive compensation.

These decreases were partially offset by an increase in operating cash flows related to a fixed royalty payment in the first quarter of 2016 that did not recur in the first quarter of 2017.

Cash Flows Used in Investing Activities

Investing activities during the three months ended March 31, 2017 used $1.2 million in cash, as compared to $7.2 million during the three months ended March 31, 2016, which was primarily due to decreased capital expenditures in 2017 associated with our technology platform.

Cash Flows Provided By/Used in Financing Activities

Financing activities during the three months ended March 31, 2017 used $3.0 million in cash, while financing activities during the three months ended March 31, 2016 used $0.2 million in cash.  This decrease is primarily due to higher net payments under the Prior Credit Agreement as well as a decrease in the change in cash overdraft.  These decreases were somewhat offset by increased proceeds from the exercise of stock options.

 

32

Credit Facility
 
For a detailed description of the Prior Credit Agreement and the new Credit Agreement, refer to Note 6 of the Notes to Consolidated Financial Statements in this Report.  The Prior Credit Agreement contains financial covenants that require us to maintain specified ratios or levels at March 31, 2017 of (1) a maximum total funded debt to EBITDA of 3.50 and (2) a minimum total fixed charge coverage of 1.50.  We were in compliance with all of the financial covenant requirements of the Prior Credit Agreement as of March 31, 2017. 

Cash Convertible Senior Notes

For a detailed description of the Cash Convertible Notes, Cash Convertible Notes Hedges, Cash Conversion Derivative, and Warrants (as such terms are defined in Note 6 of the Notes to Consolidated Financial Statements) entered into in July 2013, refer to Note 6 of the Notes to Consolidated Financial Statements included in this Report.  Aside from the initial premium paid, we will not be required to make any cash payments under the Cash Convertible Notes Hedges and could be entitled to receive an amount of cash from the option counterparties generally equal to the amount by which the market price per share of common stock exceeds the strike price of the Cash Convertible Note Hedges during the relevant valuation period. The strike price under the Cash Convertible Notes Hedges is initially equal to the conversion price of the Cash Convertible Notes.

The Cash Convertible Notes become convertible into cash during any calendar quarter (and only during such calendar quarter) if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to approximately $25.30 per share. This condition was satisfied on March 17, 2017 for the calendar quarter ending March 31, 2017, and accordingly, the Convertible Notes will be convertible at any time at the option of the holders during the period beginning on April 1, 2017 and ending on June 30, 2017.  The initial cash conversion rate is 51.3769 shares of the Company's common stock per $1,000 principal amount of the Convertible Notes (equivalent to an initial conversion price of $19.4640 per share of common stock). The settlement on any Convertible Notes surrendered for conversion during this period will occur on the third business day following the end of the applicable "Observation Period" with respect to such conversion (i.e., the period that begins on the date that a holder surrendered the Convertible Notes for conversion in accordance with the requirements of the indenture and ends on the 80th consecutive trading day following such date). The indenture requires the Company to satisfy the entire settlement amount for any conversions (determined in accordance with the provisions of the indenture) in cash, and the notes are not convertible into the Company's common stock or any other securities under any circumstances.

The estimated fair value based on the last traded price of the Cash Convertible Note at March 31, 2017 was $226.9 million (as discussed in Note 8 of the Notes to Consolidated Financial Statements included in this Report). Additionally, if the market price per share of our common stock exceeds the strike price of the Warrants on any warrant exercise date, we will be obligated to issue to the option counterparties a number of shares based on the amount by which the then-current market price per share of our common stock exceeds the then-effective strike price of each Warrant. We will not receive any additional proceeds if the Warrants are exercised.

General

We believe that cash flows from operating activities, our available cash, and our anticipated available credit under the Credit Agreement will continue to enable us to meet our contractual obligations and fund our current operations and debt payments for at least the next 12 months.  We cannot assure you that we would always be able to secure additional financing if needed and, if such funds were available, whether the terms or conditions would be acceptable to us.

If contract development accelerates or acquisition opportunities arise, we may need to issue additional debt or equity securities to provide the funding for these increased growth opportunities. We may also issue debt or equity securities in connection with future acquisitions or strategic alliances.  We cannot assure you that we would be able to issue additional debt or equity securities on terms that would be acceptable to us.

Recent Relevant Accounting Standards

See Note 2 of the Notes to Consolidated Financial Statements included in this Report for discussion of recent relevant accounting standards.

 

33

Item 3. Quantitative and Qualitative Disclosures About Market Risk
 
We are subject to market risk related to interest rate changes, primarily as a result of the Prior Credit Agreement and the Credit Agreement Borrowings under the Prior Credit Agreement generally bore interest at variable rates based on a margin or spread in excess of either (1) one-month, two-month, three-month or six-month (or with the approval of affected lenders, nine-month or twelve-month) LIBOR or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50% and (c) one-month LIBOR plus 1.00% (the "Base Rate"), as selected by the Company.  The LIBOR margin varied between 1.75% and 3.00%, and the Base Rate margin varied between 0.75% and 2.00%, depending on our leverage ratio. 

We estimate that a one-point interest rate change in our floating rate debt would have resulted in a change in interest expense of approximately $0.2 million for the three months ended March 31, 2017.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company's principal executive officer and principal financial officer have reviewed and evaluated the effectiveness of the Company's disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) promulgated under the Exchange Act) as of March 31, 2017. Based on that evaluation, the principal executive officer and principal financial officer have concluded that the Company's disclosure controls and procedures are effective.  They are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the U.S. Securities and Exchange Commission's rules and forms and to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company's management, including the principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There have been no changes in the Company's internal controls over financial reporting during the three months ended March 31, 2017 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Part II Other Information

Item 1. Legal Proceedings

We are subject to contractual disputes, claims and legal proceedings that arise from time to time in the ordinary course of our business.  While we are unable to estimate a range of potential losses, we do not believe that any of the legal proceedings pending against us as of the date of this Report, some of which are expected to be covered by insurance policies, will have a material adverse effect on our financial statements.  As these matters are subject to inherent uncertainties, our view of these matters may change in the future.

Item 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the risks and uncertainties previously reported under the caption "Part I — Item 1A. Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016, the occurrence of which could materially and adversely affect our business, prospects, financial condition and operating results. The risks previously reported and described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016 and in this report are not the only risks facing our business. Additional risks and uncertainties not currently known to us or those we currently deem to be immaterial may also materially and adversely affect our business operations.

There have been no material changes to our risk factors previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.


34

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Not Applicable.
 
Item 3. Defaults Upon Senior Securities

Not Applicable.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information

Not Applicable.


Item 6. Exhibits

(a)
Exhibits

31.1
 
Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002 made by Donato Tramuto, Chief Executive Officer
     
31.2
 
Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002 made by Glenn Hargreaves, Interim Chief Financial Officer
     
32
 
Certification Pursuant to 18 U.S.C section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 made by Donato Tramuto, Chief Executive Officer, and Glenn Hargreaves, Interim Chief Financial Officer
     
101.INS
 
XBRL Instance Document
 
 
 
101.SCH
 
XBRL Taxonomy Extension Schema
 
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase
 
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase
 
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase
 
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase



35


SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
 
 
Tivity Health, Inc.
 
 
 
 
(Registrant)
 
 
 
 
 
Date:
  May 4, 2017
 
By
/s/ Glenn Hargreaves
 
 
 
 
 
 
 
 
 
Interim Chief Financial Officer
 
 
 
 
(Principal Financial Officer)





36

EX-31.1 2 ex31-1_033117.htm EX-31.1, SECTION 302 CEO CERTIFICATION

Exhibit 31.1
CERTIFICATION

I, Donato Tramuto, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Tivity Health, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date:    May 4, 2017

 
/s/ Donato Tramuto
 
 
Donato Tramuto
 
 
Chief Executive Officer
 

EX-31.2 3 ex31-2_033117.htm EX-31.2, SECTION 302 CFO CERTIFICATION
Exhibit 31.2
CERTIFICATION

I, Glenn Hargreaves, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Tivity Health, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date:    May 4, 2017

 
/s/ Glenn Hargreaves
 
 
Glenn Hargreaves
 
 
Interim Chief Financial Officer
 


EX-32 4 ex32_033117.htm EX-32, SECTION 906 CEO AND CFO CERTIFICATION

Exhibit 32



CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Tivity Health, Inc. (the "Company") on Form 10-Q for the quarter ended March 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, Donato Tramuto, Chief Executive Officer of the Company, and Glenn Hargreaves, Interim Chief Financial Officer of the Company, each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1)      The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




/s/ Donato Tramuto
Donato Tramuto
Chief Executive Officer
May 4, 2017
 
 
 
/s/ Glenn Hargreaves
Glenn Hargreaves
Interim Chief Financial Officer
May 4, 2017

EX-101.INS 5 tvty-20170331.xml XBRL INSTANCE DOCUMENT 0000704415 2017-01-01 2017-03-31 0000704415 2017-04-30 0000704415 2016-12-31 0000704415 2017-03-31 0000704415 2016-01-01 2016-03-31 0000704415 us-gaap:RetainedEarningsMember 2016-12-31 0000704415 us-gaap:TreasuryStockMember 2016-12-31 0000704415 us-gaap:CommonStockMember 2016-12-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0000704415 us-gaap:PreferredStockMember 2016-12-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0000704415 us-gaap:TreasuryStockMember 2017-01-01 2017-03-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-03-31 0000704415 us-gaap:RetainedEarningsMember 2017-01-01 2017-03-31 0000704415 us-gaap:PreferredStockMember 2017-01-01 2017-03-31 0000704415 us-gaap:CommonStockMember 2017-01-01 2017-03-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-03-31 0000704415 us-gaap:CommonStockMember 2017-03-31 0000704415 us-gaap:RetainedEarningsMember 2017-03-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2017-03-31 0000704415 us-gaap:TreasuryStockMember 2017-03-31 0000704415 us-gaap:PreferredStockMember 2017-03-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-03-31 0000704415 2015-12-31 0000704415 2016-03-31 0000704415 tvty:SulAméricaMember 2015-03-11 0000704415 tvty:AccountingStandardsUpdate201609Member 2017-01-01 2017-03-31 0000704415 2016-07-31 0000704415 tvty:SharecareMember tvty:AdjustableConvertibleEquityRightMember 2016-07-31 0000704415 2016-07-28 2016-07-31 0000704415 tvty:SharecareMember 2016-07-28 2016-07-31 0000704415 tvty:SharecareMember 2017-01-01 2017-03-31 0000704415 tvty:SharecareMember 2017-03-31 0000704415 tvty:TPHSBusinessMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2017-01-01 2017-03-31 0000704415 tvty:TPHSBusinessMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2016-01-01 2016-03-31 0000704415 us-gaap:SegmentDiscontinuedOperationsMember 2016-01-01 2016-03-31 0000704415 us-gaap:SegmentDiscontinuedOperationsMember 2017-01-01 2017-03-31 0000704415 us-gaap:EmployeeStockOptionMember 2016-12-31 0000704415 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-03-31 0000704415 us-gaap:EmployeeStockOptionMember 2017-03-31 0000704415 tvty:MarketStockUnitsMember 2016-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2016-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-03-31 0000704415 tvty:MarketStockUnitsMember 2017-01-01 2017-03-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2017-03-31 0000704415 tvty:MarketStockUnitsMember 2017-03-31 0000704415 us-gaap:StateAndLocalJurisdictionMember 2017-03-31 0000704415 us-gaap:InternalRevenueServiceIRSMember 2017-03-31 0000704415 us-gaap:ConvertibleDebtMember 2016-12-31 0000704415 us-gaap:CapitalLeaseObligationsMember 2016-12-31 0000704415 tvty:TermLoanFacilityMember tvty:PriorCreditAgreementMember 2017-03-31 0000704415 us-gaap:CapitalLeaseObligationsMember 2017-03-31 0000704415 tvty:PriorCreditAgreementMember 2017-03-31 0000704415 tvty:TermLoanFacilityMember tvty:PriorCreditAgreementMember 2016-12-31 0000704415 us-gaap:RevolvingCreditFacilityMember tvty:PriorCreditAgreementMember 2017-03-31 0000704415 us-gaap:RevolvingCreditFacilityMember tvty:PriorCreditAgreementMember 2016-12-31 0000704415 us-gaap:SubsequentEventMember tvty:CreditAgreementMember 2017-04-21 2017-04-21 0000704415 tvty:PriorCreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2017-01-01 2017-03-31 0000704415 tvty:CreditAgreementMember us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember 2017-04-21 0000704415 tvty:PriorCreditAgreementMember tvty:SwinglineSubFacilityMember 2012-06-08 0000704415 us-gaap:LetterOfCreditMember tvty:CreditAgreementMember us-gaap:SubsequentEventMember 2017-04-21 0000704415 tvty:CreditAgreementMember tvty:SwinglineSubFacilityMember us-gaap:SubsequentEventMember 2017-04-21 0000704415 us-gaap:RevolvingCreditFacilityMember tvty:PriorCreditAgreementMember 2012-06-08 0000704415 tvty:PriorCreditAgreementMember tvty:TermLoanFacilityMember 2012-06-08 0000704415 tvty:UncommittedIncrementalAccordionFacilityMember tvty:PriorCreditAgreementMember 2012-06-08 0000704415 tvty:CreditAgreementMember tvty:UncommittedIncrementalAccordionFacilityMember us-gaap:SubsequentEventMember 2017-04-21 0000704415 tvty:PriorCreditAgreementMember us-gaap:LetterOfCreditMember 2012-06-08 0000704415 us-gaap:SubsequentEventMember tvty:CreditAgreementMember tvty:TermLoanFacilityAMember 2017-04-21 0000704415 us-gaap:SubsequentEventMember tvty:CreditAgreementMember tvty:DelayedDrawTermLoanFacilityMember 2017-04-21 0000704415 tvty:CreditAgreementMember us-gaap:SubsequentEventMember us-gaap:LondonInterbankOfferedRateLIBORMember us-gaap:MinimumMember 2017-04-21 2017-04-21 0000704415 tvty:FederalFundsRateMember tvty:PriorCreditAgreementMember 2017-01-01 2017-03-31 0000704415 tvty:OneMonthLondonInterbankOfferedRateLIBORMember us-gaap:SubsequentEventMember tvty:CreditAgreementMember 2017-04-21 2017-04-21 0000704415 tvty:FederalFundsRateMember us-gaap:SubsequentEventMember tvty:CreditAgreementMember 2017-04-21 2017-04-21 0000704415 us-gaap:LondonInterbankOfferedRateLIBORMember tvty:PriorCreditAgreementMember 2017-01-01 2017-03-31 0000704415 us-gaap:MaximumMember tvty:CreditAgreementMember us-gaap:BaseRateMember us-gaap:SubsequentEventMember 2017-04-21 2017-04-21 0000704415 us-gaap:MaximumMember us-gaap:SubsequentEventMember us-gaap:LondonInterbankOfferedRateLIBORMember tvty:CreditAgreementMember 2017-04-21 2017-04-21 0000704415 us-gaap:SubsequentEventMember us-gaap:MinimumMember tvty:CreditAgreementMember us-gaap:BaseRateMember 2017-04-21 2017-04-21 0000704415 us-gaap:MaximumMember us-gaap:LondonInterbankOfferedRateLIBORMember tvty:PriorCreditAgreementMember 2017-01-01 2017-03-31 0000704415 tvty:PriorCreditAgreementMember us-gaap:BaseRateMember us-gaap:MaximumMember 2017-01-01 2017-03-31 0000704415 us-gaap:MinimumMember us-gaap:LondonInterbankOfferedRateLIBORMember tvty:PriorCreditAgreementMember 2017-01-01 2017-03-31 0000704415 us-gaap:MinimumMember us-gaap:BaseRateMember tvty:PriorCreditAgreementMember 2017-01-01 2017-03-31 0000704415 us-gaap:MinimumMember tvty:CreditAgreementMember us-gaap:SubsequentEventMember 2017-04-21 2017-04-21 0000704415 us-gaap:MaximumMember tvty:PriorCreditAgreementMember 2017-01-01 2017-03-31 0000704415 tvty:PriorCreditAgreementMember us-gaap:MinimumMember 2017-01-01 2017-03-31 0000704415 us-gaap:MaximumMember us-gaap:SubsequentEventMember tvty:CreditAgreementMember 2017-04-21 2017-04-21 0000704415 tvty:EighthAmendmentToPriorCreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2017-01-01 2017-03-31 0000704415 tvty:TermLoanFacilityMember tvty:EighthAmendmentToPriorCreditAgreementMember 2017-01-01 2017-03-31 0000704415 tvty:EighthAmendmentToPriorCreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2016-08-04 0000704415 tvty:TermLoanFacilityMember tvty:EighthAmendmentToPriorCreditAgreementMember 2016-08-04 0000704415 tvty:EighthAmendmentToPriorCreditAgreementMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember tvty:TermLoanFacilityMember 2016-08-04 2016-08-04 0000704415 us-gaap:DebtInstrumentRedemptionPeriodOneMember us-gaap:SubsequentEventMember tvty:CreditAgreementMember tvty:TermLoanFacilityAMember 2017-04-21 2017-04-21 0000704415 tvty:TermLoanFacilityAMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember tvty:CreditAgreementMember us-gaap:SubsequentEventMember 2017-04-21 2017-04-21 0000704415 tvty:DelayedDrawTermLoanFacilityMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember tvty:CreditAgreementMember us-gaap:SubsequentEventMember 2017-04-21 2017-04-21 0000704415 us-gaap:DebtInstrumentRedemptionPeriodOneMember tvty:DelayedDrawTermLoanFacilityMember tvty:CreditAgreementMember us-gaap:SubsequentEventMember 2017-04-21 2017-04-21 0000704415 tvty:CreditAgreementMember 2017-03-31 0000704415 us-gaap:RevolvingCreditFacilityMember 2017-03-31 0000704415 us-gaap:SeniorNotesMember 2013-07-16 0000704415 us-gaap:MinimumMember us-gaap:SeniorNotesMember 2017-01-01 2017-03-31 0000704415 us-gaap:SeniorNotesMember 2017-01-01 2017-03-31 0000704415 us-gaap:SeniorNotesMember 2013-07-16 2013-07-16 0000704415 us-gaap:SeniorNotesMember 2017-03-31 0000704415 us-gaap:SeniorNotesMember 2016-12-31 0000704415 us-gaap:SeniorNotesMember 2013-07-31 0000704415 tvty:CashConvertibleNotesHedgeMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-03-31 0000704415 tvty:CashConvertibleNotesHedgeMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2016-12-31 0000704415 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member tvty:CashConversionDerivativeMember 2016-12-31 0000704415 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member tvty:CashConversionDerivativeMember 2017-03-31 0000704415 tvty:CashConversionDerivativeMember 2016-12-31 0000704415 tvty:CashConvertibleNotesHedgeMember 2016-12-31 0000704415 tvty:CashConvertibleNotesHedgeMember 2017-01-01 2017-03-31 0000704415 tvty:CashConversionDerivativeMember 2017-01-01 2017-03-31 0000704415 tvty:CashConvertibleNotesHedgeMember 2017-03-31 0000704415 tvty:CashConversionDerivativeMember 2017-03-31 0000704415 tvty:CashConvertibleNotesMember 2017-03-31 0000704415 tvty:PriorCreditAgreementMember 2017-03-31 0000704415 tvty:CashConvertibleNotesHedgeMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-03-31 0000704415 us-gaap:SellingGeneralAndAdministrativeExpensesMember tvty:CashConversionDerivativeMember 2017-01-01 2017-03-31 0000704415 us-gaap:SellingGeneralAndAdministrativeExpensesMember tvty:CashConvertibleNotesHedgeMember 2016-01-01 2016-03-31 0000704415 tvty:CashConversionDerivativeMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-01-01 2016-03-31 0000704415 us-gaap:DesignatedAsHedgingInstrumentMember tvty:CashConvertibleNotesHedgeMember 2016-12-31 0000704415 us-gaap:DesignatedAsHedgingInstrumentMember tvty:CashConvertibleNotesHedgeMember 2017-03-31 0000704415 us-gaap:DesignatedAsHedgingInstrumentMember tvty:CashConversionDerivativeMember 2017-03-31 0000704415 tvty:CashConversionDerivativeMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-12-31 0000704415 tvty:MarketStockUnitsMember 2016-01-01 2016-03-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-03-31 0000704415 tvty:HwayWarrantsRelatedToCashConvertibleNotesMember 2016-01-01 2016-03-31 0000704415 tvty:HwayWarrantsRelatedToCashConvertibleNotesMember 2017-01-01 2017-03-31 0000704415 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-03-31 0000704415 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-03-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-03-31 0000704415 tvty:CarefirstConvertibleNoteMember 2017-01-01 2017-03-31 0000704415 us-gaap:WarrantMember 2016-01-01 2016-03-31 0000704415 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-03-31 0000704415 tvty:HwayWarrantsRelatedToCashConvertibleNotesMember 2017-01-01 2017-03-31 0000704415 tvty:CarefirstConvertibleNoteMember 2016-01-01 2016-03-31 0000704415 tvty:HwayWarrantsRelatedToCashConvertibleNotesMember 2016-01-01 2016-03-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-03-31 0000704415 us-gaap:WarrantMember 2017-01-01 2017-03-31 0000704415 us-gaap:AccumulatedTranslationAdjustmentMember 2016-12-31 0000704415 us-gaap:AccumulatedTranslationAdjustmentMember 2015-12-31 0000704415 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-12-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-03-31 0000704415 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-01-01 2016-03-31 0000704415 us-gaap:AccumulatedTranslationAdjustmentMember 2016-01-01 2016-03-31 0000704415 us-gaap:AccumulatedTranslationAdjustmentMember 2017-01-01 2017-03-31 0000704415 us-gaap:AccumulatedTranslationAdjustmentMember 2016-03-31 0000704415 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-03-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-03-31 0000704415 us-gaap:AccumulatedTranslationAdjustmentMember 2017-03-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-03-31 0000704415 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:InterestRateSwapMember 2017-01-01 2017-03-31 0000704415 tvty:RestructuringPlan2016Member 2016-12-31 0000704415 tvty:RestructuringPlan2016Member us-gaap:OtherRestructuringMember 2016-12-31 0000704415 tvty:RestructuringPlan2015Member us-gaap:EmployeeSeveranceMember 2016-12-31 0000704415 tvty:RestructuringPlan2015Member 2016-12-31 0000704415 us-gaap:EmployeeSeveranceMember tvty:RestructuringPlan2016Member 2016-12-31 0000704415 tvty:RestructuringPlan2015Member us-gaap:OtherRestructuringMember 2016-12-31 0000704415 tvty:RestructuringPlan2016Member us-gaap:EmployeeSeveranceMember 2017-01-01 2017-03-31 0000704415 us-gaap:EmployeeSeveranceMember tvty:RestructuringPlan2015Member 2017-01-01 2017-03-31 0000704415 tvty:RestructuringPlan2016Member 2017-01-01 2017-03-31 0000704415 us-gaap:OtherRestructuringMember tvty:RestructuringPlan2016Member 2017-01-01 2017-03-31 0000704415 tvty:RestructuringPlan2015Member us-gaap:OtherRestructuringMember 2017-01-01 2017-03-31 0000704415 tvty:RestructuringPlan2015Member 2017-01-01 2017-03-31 0000704415 tvty:RestructuringPlan2015Member 2017-03-31 0000704415 us-gaap:OtherRestructuringMember tvty:RestructuringPlan2016Member 2017-03-31 0000704415 us-gaap:OtherRestructuringMember tvty:RestructuringPlan2015Member 2017-03-31 0000704415 us-gaap:EmployeeSeveranceMember tvty:RestructuringPlan2015Member 2017-03-31 0000704415 us-gaap:EmployeeSeveranceMember tvty:RestructuringPlan2016Member 2017-03-31 0000704415 tvty:RestructuringPlan2016Member 2017-03-31 0000704415 us-gaap:SubsequentEventMember tvty:CreditAgreementMember tvty:TermLoanAFacilityMember 2017-04-21 0000704415 us-gaap:SubsequentEventMember tvty:CreditAgreementMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember tvty:TermLoanAFacilityMember 2017-04-21 2017-04-21 0000704415 tvty:TermLoanAFacilityMember tvty:CreditAgreementMember us-gaap:SubsequentEventMember us-gaap:DebtInstrumentRedemptionPeriodOneMember 2017-04-21 2017-04-21 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure tvty:Installment tvty:Award tvty:TradingDay false --12-31 2017-03-31 No No Yes Accelerated Filer TIVITY HEALTH, INC. 0000704415 39197878 2017 Q1 10-Q 26029000 27577000 66942000 50424000 33623000 38215000 36379000 35586000 -4502000 -4391000 341270000 344108000 0 0 0 932000 0 0 932000 0 0 1446000 1446000 0 0 0 2400000 10200000 1400000 800000 516000 554000 1931000 1826000 1900000 1486000 679000 0 591000 16000 0 892000 7707000 18000 0 591850000 544782000 58111000 156001000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.35pt; margin-right: 14.75pt; text-indent: 34.4pt;">Our financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles in the United States ("U.S. GAAP").&#160; In our opinion, the accompanying consolidated financial statements of Tivity Health, Inc. and its wholly-owned subsidiaries (collectively, "Tivity Health," the "Company," or such terms as "we," "us," or "our") reflect all adjustments consisting of normal, recurring accruals necessary for a fair statement.&#160;We have reclassified certain items in prior periods to conform to current classifications.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.35pt; margin-right: 14.75pt; text-indent: 34.4pt;"><font style="font-size: 10pt; font-family: Arial, sans-serif;">Our results from continuing operations do not include the results of the total population health services ("TPHS") business, which we sold effective July 31, 2016.&#160; The TPHS business included our partnerships with Blue Zones, LLC and Dr. Dean Ornish (the Blue Zones Project by Healthways&#8482;&#160;and Dr. Dean Ornish's Program for Reversing Heart Disease&#8482;, respectively), our joint venture with Gallup, Inc. ("Gallup"), Navvis Healthcare, LLC ("Navvis"), MeYou Health, LLC ("MeYou Health"), and our international operations, including our joint venture with </font>SulAm&#233;rica<font style="font-size: 10pt; font-family: Arial, sans-serif;">.&#160; </font>While Navvis and MeYou Health were part of our TPHS business, they were sold separately to other buyers in November 2015 and June 2016, respectively.&#160; <font style="font-size: 10pt; font-family: Arial, sans-serif;">Results of operations for the TPHS business have been classified as discontinued operations for all periods&#160;presented in the accompanying Consolidated Financial Statements.&#160; See Note 3 for further information.</font></div><div style="margin-top: 1pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.35pt; margin-right: 9.8pt; text-indent: 34.4pt;">On&#160;March 11, 2015, we formed a joint venture with&#160;SulAm&#233;rica, one of the largest independent insurers in Brazil, to sell total population health services to the Brazilian market. With its contribution, SulAm&#233;rica acquired a 49% interest in the joint venture, Healthways Brasil Servicos de Consultoria LTDA&#160;("Healthways Brazil"). We determined that our interest in Healthways Brazil represented a controlling financial interest and, therefore,&#160;prior to selling the TPHS business, consolidated the financial statements of Healthways Brazil and presented a non-controlling interest for the portion owned by SulAm&#233;rica. The net assets and results of operations of Healthways Brazil were part of the sale of the TPHS business and are included within discontinued operations in the accompanying Consolidated Financial Statements.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.35pt; margin-right: 9.8pt; text-indent: 34.4pt;">We have omitted certain financial information that is normally included in financial statements prepared in accordance with U.S. GAAP but that is not required for interim reporting purposes. You should read the accompanying consolidated financial statements in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2016.</div></div> 5420000 0 23404000 23024000 1602000 664000 233000 869000 -938000 636000 25.95 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 36pt; vertical-align: top; align: right;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">7.</div></td><td style="width: auto; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">Commitments and Contingencies</div></td></tr></table></div><div style="margin-top: 0.1pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left; margin-left: 39.65pt; margin-right: 12.9pt;"><u>Summary</u></div><div style="margin-top: 0.2pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-top: 3.85pt; margin-right: 8.5pt; text-indent: 39.65pt;">We are subject to contractual disputes, claims and legal proceedings that arise from time to time in the ordinary course of our business<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font> While we are unable to estimate a range of potential losses<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> we do not believe that any of the legal proceedings pending against us as of the date of this report, some of which are expected to be covered by insurance policies, will have a material adverse effect on our financial statements<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font> As these matters are subject to inherent uncertainties<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> our view of these matters may change in the future.</div><div style="margin-top: 0.05pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left; margin-left: 39.65pt; margin-right: 12.9pt;"><u>Contractual Commitments</u></div><div style="margin-top: 0.2pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 40.5pt;">In October 2012, we entered into the Gallup Joint Venture that required us to make payments over a&#160;five year period beginning January 2013.&#160;Pursuant to Sharecare's acquisition of the TPHS business, our ownership interest in the Gallup Joint Venture was transferred to Sharecare. We agreed with Sharecare to be responsible for two-thirds of the remaining payment obligations in respect of the purchase price to be paid in connection with Sharecare's acquisition of additional membership interest in the Gallup Joint Venture. This obligation is currently expected to result in aggregate payments by us of approximately $4.2 million, payable in five equal quarterly installments that began in the fourth quarter of the 2016 calendar year and will end in the fourth quarter of 2017.&#160;As of March 31, 2017, this obligation totaled $2.5 million and was included in accrued liabilities. The financial impact of the strategic relationship with Gallup and the Gallup Joint Venture are reflected in discontinued operations for all periods presented as each of these were a part of the TPHS business.</div></div> 120000000 120000000 39000 39000 0.001 0.001 39188902 38933580 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%; margin-top: 3.85pt;"><tr><td style="width: 40.5pt; vertical-align: top; align: right;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 4.5pt; margin-top: 3.85pt;">11.</div></td><td style="width: auto; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-top: 3.85pt;">Accumulated OCI</div></td></tr></table></div><div style="margin-top: 0.25pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.4pt; margin-right: 7.1pt; text-indent: 34.4pt;">The following tables summarize the changes in accumulated OCI, net of tax, for the three months ended March 31, 2017 and 2016:</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.4pt; margin-right: 7.1pt; text-indent: 34.4pt;">&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 80.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;<font style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold;">(In thousands)</font></div></td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.37%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 15.6%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Foreign Currency Translation Adjustments</div></td><td style="width: 1.69%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 80.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accumulated OCI, net of tax, as of January 1, 2017</div></td><td style="width: 0.7%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.37%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.42%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(4,502</div></td><td style="width: 1.69%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 80.64%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Other comprehensive income before reclassifications, net of tax of $36</div></td><td style="width: 0.7%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.37%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.42%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.18%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">111</div></td><td style="width: 1.69%; vertical-align: bottom; background-color: #ffffff;">&#160;</td></tr><tr><td style="width: 80.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accumulated OCI, net of tax, as of March 31, 2017</div></td><td style="width: 0.7%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.37%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.42%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.18%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(4,391</div></td><td style="width: 1.69%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr></table><div style="margin-top: 0.35pt;"><br /></div><div style="margin-top: 0.35pt;"><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 80%;"><tr><td style="width: 63.03%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;<font style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold;">(In thousands)</font></div></td><td style="width: 0.66%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 9.75%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Net Change in Fair Value of Interest Rate Swaps</div></td><td style="width: 0.67%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 12.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Foreign Currency Translation Adjustments</div></td><td style="width: 0.67%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.66%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 11.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Total</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.03%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accumulated OCI, net of tax, as of January 1, 2016</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 8.62%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(239</div></td><td style="width: 0.67%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 10.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(4,000</div></td><td style="width: 0.67%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 10%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(4,239</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 63.03%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Other comprehensive income (loss) before reclassifications, net of tax of $37 and $0, respectively</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 8.62%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(56</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10.98%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">1,022</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">966</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;">&#160;</td></tr><tr><td style="width: 63.03%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Amounts reclassified from accumulated OCI, net of tax</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 8.62%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">80</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10.98%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">80</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.03%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Net increase in other comprehensive income (loss), net of tax</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 8.62%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">24</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10.98%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">1,022</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">1,046</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;">&#160;</td></tr><tr><td style="width: 63.03%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accumulated OCI, net of tax, as of March 31, 2016</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 8.62%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(215</div></td><td style="width: 0.67%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 10.98%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(2,978</div></td><td style="width: 0.67%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 10%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(3,193</div></td><td style="width: 0.68%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr></table><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">The following table provides details about reclassifications out of accumulated OCI for the three months ended March 31, 2017 and 2016:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 37.97%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="7" style="width: 23.07%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Three Months Ended March 31,</div></td><td style="width: 0.98%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 37.98%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Statement of Operations</div></td></tr><tr><td style="width: 37.97%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;<font style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold;">(In thousands)</font></div></td><td colspan="3" style="width: 11.04%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2017</div></td><td style="width: 0.98%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="3" style="width: 11.05%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2016</div></td><td style="width: 0.98%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 37.98%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Classification</div></td></tr><tr><td style="width: 37.97%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Interest rate swaps</div></td><td style="width: 0.97%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 8.97%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 8.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">133</div></td><td style="width: 0.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 37.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: center;">Interest expense</div></td></tr><tr><td style="width: 37.97%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.97%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 8.97%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.98%; vertical-align: top; background-color: #ffffff;">&#160;</td><td style="width: 0.98%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(53</div></td><td style="width: 0.98%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 37.98%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: center;">Income tax benefit</div></td></tr><tr><td style="width: 37.97%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.97%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 8.97%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">80</div></td><td style="width: 0.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 37.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: center;">Net of tax</div></td></tr></table><div style="margin-top: 0.1pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; margin-top: 3.85pt; margin-right: 14.95pt; text-indent: 30.75pt;">See Note 9 for further discussion of our interest rate swaps.</div></div> -12851000 15372000 0 111000 15261000 0 0 0 2079000 2506000 1530000 657000 102399000 91377000 51.3769 19.4640 20 139800000 68300000 25.30 P30D 0.005 0.01 0.005 0.01 70000000 150000000 150000000 150000000 70000000 5000000 875000 1312500 1312500 875000 10200000 12100000 0.015 2022-04-21 2018-06-08 0.057 3900000 2286000 1771000 8972000 -191000 57129000 59562000 10874000 0 1872000 787000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%; margin-top: 3.85pt;"><tr><td style="width: 40.5pt; vertical-align: top; align: right;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 4.5pt; margin-top: 3.85pt;">9.</div></td><td style="width: auto; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-top: 3.85pt;">Derivative Instruments and Hedging Activities</div></td></tr></table></div><div style="margin-top: 0.1pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; margin-top: 0.2pt; text-indent: 36pt;">We use derivative instruments to manage risks related to interest (through December 30, 2016), the Cash Convertible Notes, and, prior to the sale of the TPHS business, foreign currencies. We account for derivatives in accordance with ASC Topic 815, which establishes accounting and reporting standards requiring that certain derivative instruments be recorded on the balance sheet as either an asset or liability measured at fair value. Additionally, changes in the derivative's fair value will be recognized currently in earnings unless specific hedge accounting criteria are met. As permitted under our master netting arrangements, the fair value amounts of our prior interest rate swaps and foreign currency options and/or forward contracts are presented on a net basis by counterparty in the consolidated balance sheets.</div><div style="margin-top: 0.2pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left; margin-left: 5.35pt;"><u>Derivative Instruments Designated as Hedging Instruments</u></div><div style="margin-top: 0.35pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left; margin-left: 39.75pt; margin-top: 3.85pt; margin-right: 5.55pt;">Cash Flow Hedges</div><div style="margin-top: 0.25pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.35pt; margin-right: 13.55pt; text-indent: 34.4pt;">Derivative instruments that are designated and qualify as cash flow hedges are recorded at estimated fair value in the consolidated balance sheets<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> with the effective portion of the gains and losses being reported in accumulated other comprehensive income or loss ("accumulated OCI")<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font> We did not maintain any cash flow hedges during the three months ended March 31, 2017.&#160; Cash flow hedges for the three months ended March 31, 2016 consisted solely of an interest rate swap agreement, which effectively modified our exposure to interest rate risk by converting a portion of our floating rate debt to a fixed rate obligation<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> thus reducing the impact of interest rate changes on future interest expense<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font> Under this agreement<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> which terminated on December 30, 2016, we received a variable rate of interest based on LIBOR (as defined in Note 6)<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> and we paid a fixed rate of interest with an interest rate of 1.48<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">0</font>% plus a spread (see Note 6)<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font> Gains and losses on this interest rate swap agreement were reclassified to interest expense in the same period during which the hedged transaction affected earnings or the period in which all or a portion of the hedge became ineffective<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font></div><div style="margin-top: 0.2pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.35pt; margin-right: 11.7pt; text-indent: 34.4pt;">The following table shows the effect of our cash flow hedges on the consolidated balance sheets during the three months ended March 31, 2017 and 2<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">0</font>16:</div><div style="margin-top: 0.1pt;"><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 65.79%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">(In thousands)</div></td><td style="width: 1.41%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="3" style="width: 31.01%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">For the Three Months Ended</div></td><td style="width: 1.23%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 65.79%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Derivatives in Cash Flow Hedging Relationships</div></td><td style="width: 1.41%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.16%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31, 2017</div></td><td style="width: 2.86%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.98%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31, 2016</div></td><td style="width: 1.23%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 65.79%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Loss related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect</div></td><td style="width: 1.41%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.16%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 2.86%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;$</div></td><td style="width: 13.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">92</div></td><td style="width: 1.23%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 65.79%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect</div></td><td style="width: 1.41%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.16%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 2.86%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;$</div></td><td style="width: 13.98%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(133</div></td><td style="width: 1.23%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td></tr></table><div style="margin-top: 0.2pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.35pt; margin-right: 0.7pt; text-indent: 34.4pt;">Gains and losses representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings. During the three months ended March 31, 2017 and 2<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">0</font>16, there were no gains or losses on cash flow hedges recognized in our consolidated statements of operations resulting from hedge ineffectiveness.</div><div style="margin-top: 0.2pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left; margin-left: 5.35pt; margin-right: 8.65pt; text-indent: 34.4pt;"><u>Derivative Instruments Not Designated as Hedging Instruments</u></div><div style="margin-top: 0.4pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.35pt; margin-top: 3.85pt; margin-right: 3.15pt; text-indent: 34.4pt;">Our Cash Conversion Derivative, Cash Convertible Notes Hedges and, prior to July 31, 2016<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> foreign currency options and/or forward contracts<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> do not qualify for hedge accounting treatment under U.S<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font> GAAP and are measured at fair value, with gains and losses recognized immediately in the consolidated statements of operations. These derivative instruments not designated as hedging instruments did not have a material impact on our consolidated statements of operations for the three months ended March 31, 2017 and 2016<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font></div><div style="margin-top: 0.2pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; text-indent: 30.75pt;">The Cash Conversion Derivative is accounted for as a derivative liability and carried at fair value. In order to offset the risk associated with the Cash Conversion Derivative, we entered into Cash Convertible Notes Hedges, which are cash-settled and are intended to reduce our exposure to potential cash payments that we would be required to make if holders elect to convert the Cash Convertible Notes at a time when our stock price exceeds the conversion price. The Cash Convertible Notes Hedges are accounted for as a derivative asset and carried at fair value.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; text-indent: 30.75pt;">The gains and losses resulting from a change in fair values of the Cash Conversion Derivative and&#160;the Cash Convertible Notes Hedges are reported in the consolidated statements of operations.</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 80%;"><tr><td style="width: 31.48%; vertical-align: bottom;">&#160;</td><td colspan="7" style="width: 24.32%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Three Months Ended</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31,</div></td><td style="width: 1.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 42.56%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 31.48%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">(In thousands)</div></td><td colspan="3" style="width: 12.64%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">&#160;2017</div></td><td style="width: 1.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="3" style="width: 10.44%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2016</div></td><td style="width: 1.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 42.56%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Statements of Operations Classification</div></td></tr><tr><td style="width: 31.48%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash Convertible Notes Hedges:</div></td><td colspan="3" style="width: 12.64%; vertical-align: bottom;">&#160;</td><td style="width: 1.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="3" style="width: 10.44%; vertical-align: bottom;">&#160;</td><td style="width: 1.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 42.56%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;&#160;&#160;&#160;</div></td></tr><tr><td style="width: 31.48%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Net unrealized gain (loss)</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 10.94%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">34,084</div></td><td style="width: 1.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 8.74%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(7,603</div></td><td style="width: 1.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 42.56%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: center;">Selling, general and administrative expenses</div></td></tr><tr><td style="width: 31.48%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash Conversion Derivative:</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10.94%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 8.74%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 42.56%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;&#160;&#160;&#160;&#160;</div></td></tr><tr><td style="width: 31.48%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Net unrealized (loss) gain</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 10.94%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(34,084</div></td><td style="width: 1.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 8.74%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">7,603</div></td><td style="width: 1.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 42.56%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: center;">Selling, general and administrative expenses</div></td></tr></table><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-right: 5.8pt; text-indent: 36pt;">Prior to the sale of the TPHS business, we also entered into foreign currency options and/or forward contracts in order to minimize our earnings exposure to fluctuations in foreign currency exchange rates.&#160; Our foreign currency exchange contracts required current period mark-to-market accounting, with any change in fair value being recorded each period in the consolidated statements of operations in selling, general and administrative expenses.&#160;We do not execute transactions or hold derivative financial instruments for trading or other purposes.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left; margin-right: 5.8pt; text-indent: 36pt;">Financial Instruments</div><div style="margin-top: 0.15pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; margin-right: 10.9pt; text-indent: 34.4pt;">The estimated fair values of derivative instruments at March 31, 2017 and December 31, 2<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">0</font>16 were as follows:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 58.55%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;"><font style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold;">(In thousands)</font>&#160;</div></td><td colspan="5" style="width: 18.43%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31,</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2017</div></td><td colspan="2" style="width: 2.65%; vertical-align: bottom;">&#160;</td><td colspan="5" style="width: 20.12%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">December 31, 2016</div></td><td style="width: 0.24%; vertical-align: top;">&#160;</td></tr><tr><td style="width: 58.55%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">Assets:</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 16.87%; vertical-align: top;">&#160;</td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 3.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 17.35%; vertical-align: top;">&#160;</td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.93%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: top;">&#160;</td></tr><tr><td style="width: 58.55%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left;">Derivatives not designated as hedging instruments:</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 16.87%; vertical-align: top;">&#160;</td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 3.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 17.35%; vertical-align: top;">&#160;</td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.93%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: top;">&#160;</td></tr><tr><td style="width: 58.55%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 18pt;">Cash convertible notes hedges, current</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 4.34%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$&#160;</div></td><td style="width: 12.53%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">82,445</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 3.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.25%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;$</div></td><td style="width: 14.1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.93%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.55%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 18pt;">Cash convertible notes hedges, long-term</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 4.34%; vertical-align: bottom;">&#160;</td><td style="width: 12.53%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 3.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.25%; vertical-align: bottom;">&#160;</td><td style="width: 14.1%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">48,361</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.93%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.55%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">Liabilities:</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 4.34%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.53%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 3.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.25%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.93%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.55%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left;">Derivatives not designated as hedging instruments:</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 4.34%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.53%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 3.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.25%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.1%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.93%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.55%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 18pt;">Cash conversion derivative, current</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 4.34%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$&#160;</div></td><td style="width: 12.53%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">82,445</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 3.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.25%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$&#160;</div></td><td style="width: 14.1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.93%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.55%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 18pt;">Cash conversion derivative, long-term</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 4.34%; vertical-align: bottom;">&#160;</td><td style="width: 12.53%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 3.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.25%; vertical-align: bottom;">&#160;</td><td style="width: 14.1%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">48,361</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.93%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr></table><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">See Note 8 for more information on fair value measurements.</div></div> 0 82445000 0 48361000 0 82445000 82445000 0 48361000 0 48361000 0 82445000 48361000 48361000 82445000 0.0148 0 92000 133000 0 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 36pt; vertical-align: top; align: right;"><div style="font-size: 9.5pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 4.5pt;">4.</div></td><td style="width: auto; vertical-align: top;"><div style="font-size: 9.5pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">&#160;Share-Based Compensation</div></td></tr></table></div><div style="margin-top: 0.35pt;"><br /></div><div style="margin-top: 0.3pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; text-indent: 30.75pt;">We currently have four types of share-based awards outstanding to our employees and directors: stock options, restricted stock units, restricted stock and market stock units. We believe that our share-based awards align the interests of our employees and directors with those of our stockholders.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; text-indent: 30.75pt;">We recognize share-based compensation expense for the market stock units if the requisite service period </div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; text-indent: 30.75pt;">&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">is rendered, even if the market<font style="font-size: 11pt; font-family: Arial, sans-serif;">&#160;</font>condition is never satisfied. For the three months ended March 31, 2017, we recognized share-based compensation costs of $1.4&#160;million.&#160;&#160;For the three months ended March 31, 2016, we recognized share-based compensation costs of $2.4 million, of which $0.8 million is in discontinued operations.&#160; Beginning in January 2017 with the adoption of ASU 2016-09, we account for forfeitures as they occur<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font></div><div style="margin-top: 0.15pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; margin-top: 0.15pt; text-indent: 36pt;">A summary of our stock options as of March 31, 2017 and the changes during the three months then ended is presented below:</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; margin-top: 0.15pt; text-indent: 36pt;">&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 80%;"><tr><td style="width: 46.91%; vertical-align: bottom;"><div>&#160;</div><div>&#160;</div><div>&#160;</div><div>&#160;</div><div>&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Options</div></td><td style="width: 0.67%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.72%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Shares</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">(In thousands)</div></td><td style="width: 0.66%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.66%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 10.07%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Average Exercise</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Price</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Per Share</div></td><td style="width: 0.66%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 10.59%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Weighted Average</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Remaining</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Contractual</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Term</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.47%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Aggregate Intrinsic Value (In thousands)</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 46.91%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Outstanding at January 1, 2017</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.73%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">1,024</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 9%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">14.02</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 10.59%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.47%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 46.91%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Granted</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.73%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 10.59%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.47%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 46.91%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Exercised</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.73%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(181</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 9%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">12.36</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 10.59%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.47%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 46.91%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Forfeited</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.73%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 10.59%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.47%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 46.91%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Expired</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.73%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(45</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">45.36</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 10.59%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.47%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 46.91%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Outstanding at March 31, 2017</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.73%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">798</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">12.63</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.09%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 9.5%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">4.7</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 12.4%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">13,139</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 46.91%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Exercisable at March 31, 2017</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.73%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">732</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">12.33</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.09%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 9.5%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">4.5</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 12.4%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">12,275</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr></table><div style="margin-top: 3.85pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; margin-right: 6.5pt; text-indent: 30.75pt;">The following table shows a summary of our restricted stock and restricted stock units as of March 31, 2017<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> as well as activity during the three months then ended:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 54.44%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="6" style="width: 44.58%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Restricted Stock and</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Restricted Stock Units</div></td><td style="width: 0.26%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 54.44%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 21.34%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Shares</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">(In thousands)</div></td><td style="width: 0.86%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 21.65%; vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Weighted-</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Grant Date</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Fair Value</div></td><td style="width: 0.26%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 54.44%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Nonvested at January 1, 2017</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 20.62%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">939</div></td><td style="width: 0.86%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.49%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 20.16%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">13.11</div></td><td style="width: 0.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 54.44%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Granted</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 20.62%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">4</div></td><td style="width: 0.86%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.49%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 20.16%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">27.97</div></td><td style="width: 0.26%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 54.44%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Vested</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 20.62%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(98</div></td><td style="width: 0.86%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.49%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 20.16%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">10.47</div></td><td style="width: 0.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 54.44%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Forfeited</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 20.62%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(37</div></td><td style="width: 0.86%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.49%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 20.16%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">11.70</div></td><td style="width: 0.26%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 54.44%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Nonvested at March 31, 2017</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 20.62%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">808</div></td><td style="width: 0.86%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.49%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 20.16%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">13.57</div></td><td style="width: 0.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr></table><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; margin-right: 21.35pt; text-indent: 30.75pt;">The following table shows a summary of our market stock units as of March 31, 2017<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> as well as activity during the three months then ended:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 53.82%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.35%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="6" style="width: 43.48%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Market Stock Units</div></td><td style="width: 0.48%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.82%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">&#160;</div></td><td style="width: 0.35%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 19.86%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Shares</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">(In thousands)</div></td><td style="width: 2.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 20.23%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Weighted-</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Grant Date</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Fair Value</div></td><td style="width: 0.48%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.82%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Nonvested at January 1, 2017</div></td><td style="width: 0.35%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.62%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">406</div></td><td style="width: 2.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.41%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 16.82%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">8.75</div></td><td style="width: 0.48%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.82%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Granted</div></td><td style="width: 0.35%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.24%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.62%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 2.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.41%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 16.82%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.48%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.82%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Vested</div></td><td style="width: 0.35%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.62%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(8</div></td><td style="width: 2.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.41%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 16.82%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">5.46</div></td><td style="width: 0.48%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.82%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Forfeited</div></td><td style="width: 0.35%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.24%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.62%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(25</div></td><td style="width: 2.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.41%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 16.82%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">5.95</div></td><td style="width: 0.48%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.82%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Nonvested at March 31, 2017</div></td><td style="width: 0.35%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.24%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.62%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">373</div></td><td style="width: 2.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.41%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 16.82%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">9.01</div></td><td style="width: 0.48%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr></table></div> -447000 180000 -667000 -32925000 -32925000 -357000 72625000 220000 0 63205000 7061000 137000 0 10874000 2500000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 4.91%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </div></td><td style="width: 95.09%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: justify;">Discontinued Operations</div></td></tr></table><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">On July 27, 2016, we entered into a Membership Interest Purchase Agreement (the "Purchase Agreement") with Sharecare, Inc. ("Sharecare") and Healthways SC, LLC ("Healthways SC"), a newly formed Delaware limited liability company and wholly owned subsidiary of the Company, pursuant to which Sharecare acquired the TPHS business, which closed effective&#160;July 31, 2016 ("Closing").</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">At Closing, Sharecare delivered to the Company an Adjustable Convertible Equity Right (the "ACER") with an initial face value of $30.0 million, which will be convertible into shares of common stock of Sharecare 24 months after the Closing at an initial conversion price of $249.87 per share, subject to customary adjustment for stock splits, stock dividends and other reorganizations of Sharecare.&#160; Additionally, pursuant to the Purchase Agreement, we paid Sharecare $25.0 million in cash at Closing to fund projected losses of the TPHS business during the year following Closing (the "Transition Year").&#160;Pursuant to Sharecare's acquisition of the TPHS business, our ownership interest in the joint venture with Gallup (the "Gallup Joint Venture") was transferred to Sharecare.&#160;We agreed with Sharecare to be responsible for two-thirds of the remaining payment obligations in respect of the purchase price to be paid in connection with Sharecare's acquisition of additional membership interest in the Gallup Joint Venture.&#160;This obligation is currently expected to result in aggregate payments by us of approximately $4.2 million, payable in five equal quarterly installments that began in the fourth quarter of 2016 and will end in the fourth quarter of 2017. As of March 31, 2017, this obligation totaled $2.5 million and was included in accrued liabilities.</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">&#160;The Purchase Agreement provided for post-closing adjustments based on (i) net working capital (which is expected to result in an increase in the face amount of the ACER due to a net working capital surplus, as further discussed below), (ii) negative cash flows of the TPHS business during the Transition Year in excess of $25.0 million (which may result in a reduction in the face amount of the ACER up to a maximum reduction of $20.0 million), and (iii) any successful claims for indemnification by Sharecare (which may result in a reduction in the face amount of the ACER, unless the Company elects, in its sole discretion, to satisfy any such successful claims with cash payments).</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; text-indent: 30.75pt;">We recorded the ACER net of the $20.0 million face value maximum negative cash flow adjustment, or $10.0 million face value, at its estimated fair value of $2.7 million as of Closing.&#160; We have classified this amount as an equity receivable included in other assets.&#160; We will record the $20.0 million face value contingent portion of the ACER at its estimated fair value as of the date the contingency is resolved, expected to be approximately 12 months from Closing.&#160; As of March 31, 2017, we recorded&#160;an estimate of the net working capital adjustment (a surplus), which resulted in an estimated fair value&#160;of the ACER of $5.4 million.&#160; The working capital adjustment&#160;is&#160;subject to a review process, which is currently underway<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font></div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; text-indent: 30.75pt;">The terms of the Purchase Agreement also impacted other existing contractual commitments, including the elimination of&#160;the minimum fee requirements under our technology services outsourcing agreement with HP Enterprise Services, LLC.</div><div><br /></div><div style="text-align: left; margin-left: 5.25pt; text-indent: 36pt;">The following table presents financial results of the TPHS business included in "loss from discontinued operations" for the three months ended March 31, 2017 and 2016.</div><div style="text-align: left; margin-left: 5.25pt;">&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 63.55%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.26%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="6" style="width: 33.18%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Three Months Ended</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31,</div></td><td style="width: 1.38%; vertical-align: top;">&#160;</td><td style="width: 0.64%; vertical-align: top;">&#160;</td></tr><tr><td style="width: 63.55%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">(In thousands)</div></td><td style="width: 1.26%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 15.82%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2017</div></td><td style="width: 2.02%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 14.16%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2016</div></td><td style="width: 1.38%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.26%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 15.82%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.02%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 14.16%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.38%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Revenues</div></td><td style="width: 1.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 2.02%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 12.51%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">63,205</div></td><td style="width: 1.38%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Cost of services</div></td><td style="width: 1.26%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.08%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">220</div></td><td style="width: 2.02%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.51%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">72,625</div></td><td style="width: 1.38%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Selling, general &amp; administrative expenses</div></td><td style="width: 1.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">137</div></td><td style="width: 2.02%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.51%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">7,061</div></td><td style="width: 1.38%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Depreciation and amortization</div></td><td style="width: 1.26%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.08%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 2.02%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.51%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">10,874</div></td><td style="width: 1.38%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Restructuring and related charges</div></td><td style="width: 1.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 2.02%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.51%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">5,702</div></td><td style="width: 1.38%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Equity in income&#160;from joint ventures</div></td><td style="width: 1.26%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.08%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 2.02%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.51%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">132</div></td><td style="width: 1.38%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td style="width: 0.64%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Pretax loss on discontinued operations</div></td><td style="width: 1.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(357</div></td><td style="width: 2.02%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: center;">$</div></td><td style="width: 12.51%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(32,925</div></td><td style="width: 1.38%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Pretax loss on sale of TPHS business</div></td><td style="width: 1.26%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.08%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(310</div></td><td style="width: 2.02%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.51%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 1.38%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 7.2pt;">Total pretax loss on discontinued operations</div></td><td style="width: 1.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(667</div></td><td style="width: 2.02%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: center;">$</div></td><td style="width: 12.51%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(32,925</div></td><td style="width: 1.38%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Income tax (benefit) expense</div></td><td style="width: 1.26%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.08%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(447</div></td><td style="width: 2.02%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 1.18%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.51%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">180</div></td><td style="width: 1.38%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td style="width: 0.64%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Loss from discontinued operations, net of income tax benefit</div></td><td style="width: 1.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.08%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(220</div></td><td style="width: 2.02%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 12.51%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(33,105</div></td><td style="width: 1.38%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr></table><div style="margin-bottom: 3pt; font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center; margin-top: 3pt; text-indent: 36pt;">&#160;</div><div style="margin-bottom: 3pt; font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-top: 3pt; text-indent: 36pt;">The depreciation, amortization and significant operating and investing non-cash items of the discontinued operations were as follows:&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 69.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">&#160;</div></td><td style="width: 0.14%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="8" style="width: 29.9%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Three Months Ended</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31,</div></td></tr><tr><td style="width: 69.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">(In thousands)</div></td><td style="width: 0.14%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 15.09%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2017</div></td><td style="width: 0.56%; vertical-align: bottom;">&#160;</td><td style="width: 0.56%; vertical-align: bottom;">&#160;</td><td colspan="2" style="width: 13.12%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2016</div></td><td style="width: 0.14%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: bottom;">&#160;</td></tr><tr style="height: 19px;"><td style="width: 69.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;&#160;&#160;Depreciation and amortization on discontinued operations</div></td><td style="width: 0.14%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">$</div></td><td style="width: 13.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.56%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 11.99%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">10,874</div></td><td style="width: 0.14%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: top; background-color: #ffffff;">&#160;</td></tr><tr><td style="width: 69.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;&#160;&#160;Capital expenditures on discontinued operations</div></td><td style="width: 0.14%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.56%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 11.99%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">5,420</div></td><td style="width: 0.14%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: top; background-color: #ffffff;">&#160;</td></tr><tr><td style="width: 69.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;&#160;&#160;Share-based compensation on discontinued operations</div></td><td style="width: 0.14%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.56%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 11.99%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">768</div></td><td style="width: 0.14%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: top;">&#160;</td></tr></table></div> 0.39 -0.39 0.38 -0.39 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 40.5pt; vertical-align: top; align: right;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 4.5pt;">10.</div></td><td style="width: auto; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">Earnings (Loss) Per Share</div></td></tr></table></div><div style="margin-top: 0.1pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.35pt; margin-right: 5.7pt; text-indent: 34.4pt;">The following is a reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share for the three months ended March 31, 2017 and 2016:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 66.88%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 18pt; text-indent: -18pt;">(In thousands except per share data)</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="6" style="width: 30.86%; vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Three Months Ended</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31,</div></td><td style="width: 1.31%; vertical-align: top;">&#160;</td></tr><tr><td style="width: 66.88%; vertical-align: top;">&#160;</td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 14.24%; vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2017</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 14.3%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2016</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Numerator:</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td colspan="2" style="width: 14.24%; vertical-align: top; background-color: #eaf9e8;">&#160;</td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td colspan="2" style="width: 14.3%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net income from continuing operations attributable to Tivity Health, Inc. - numerator for earnings per share</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">15,481</div></td><td style="width: 1.31%; vertical-align: top;">&#160;</td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">19,208</div></td><td style="width: 1.31%; vertical-align: top;">&#160;</td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Net loss from discontinued operations attributable to Tivity Health, Inc. - numerator for loss per share</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 13.05%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(220</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div>&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 13.11%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(33,417</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 66.88%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net income (loss) attributable to Tivity Health, Inc. - numerator for earnings (loss) per share</div></td><td style="width: 0.96%; vertical-align: bottom;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.05%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">15,261</div></td><td style="width: 1.31%; vertical-align: bottom;">&#160;</td><td style="width: 1.01%; vertical-align: bottom;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 4px double;">&#160;</td><td style="width: 13.11%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(14,209</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Denominator:</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Shares used for basic income (loss) per share</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">39,069</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">36,109</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Effect of dilutive stock options and restricted stock units outstanding:</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Non-qualified stock options</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">442</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">165</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Restricted stock units</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">611</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">426</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Market stock units</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">293</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">161</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Warrants related to Cash Convertible Notes</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">126</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Shares used for diluted income (loss) per share</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">40,541</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">36,861</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Earnings (loss) per share attributable to Tivity Health, Inc. - basic:</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Continuing operations</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">0.40</div></td><td style="width: 1.31%; vertical-align: top;">&#160;</td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">0.53</div></td><td style="width: 1.31%; vertical-align: top;">&#160;</td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Discontinued operations</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.05%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(0.01</div></td><td style="width: 1.31%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.11%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(0.93</div></td><td style="width: 1.31%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net income (loss) <sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(1)</sup></div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.05%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">0.39</div></td><td style="width: 1.31%; vertical-align: top;">&#160;</td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.11%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(0.39</div></td><td style="width: 1.31%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;">&#160;</td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.31%; vertical-align: top; background-color: #eaf9e8;">&#160;</td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.31%; vertical-align: top; background-color: #eaf9e8;">&#160;</td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Earnings (loss) per share attributable to Tivity Health, Inc. - diluted:</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Continuing operations</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">0.38</div></td><td style="width: 1.31%; vertical-align: top; background-color: #eaf9e8;">&#160;</td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">0.52</div></td><td style="width: 1.31%; vertical-align: top; background-color: #eaf9e8;">&#160;</td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Discontinued operations</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.05%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(0.01</div></td><td style="width: 1.31%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(0.91</div></td><td style="width: 1.31%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net income (loss) <sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(1)</sup></div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.05%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">0.38</div></td><td style="width: 1.31%; vertical-align: top; background-color: #eaf9e8;">&#160;</td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.11%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(0.39</div></td><td style="width: 1.31%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Dilutive securities outstanding not included in the computation of earnings (loss) per share because their effect is anti-dilutive:</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Non-qualified stock options</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">16</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">1,486</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Restricted stock units</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">18</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">679</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Warrants related to Cash Convertible Notes</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">7,707</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">CareFirst Convertible Note</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">892</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">CareFirst Warrants</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">591</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;">&#160;</td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="text-indent: 18pt;"><font style="font-size: 10pt; font-family: Arial, sans-serif;"><sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(1)</sup></font><font style="font-size: 1px; width: 9pt; display: inline-block;">&#160;</font><font style="font-size: 10pt; font-family: Arial, sans-serif;">Figures may not add due to rounding.</font></div></td><td style="width: 0.96%; vertical-align: bottom;">&#160;</td><td style="width: 1.19%; vertical-align: bottom;">&#160;</td><td style="width: 13.05%; vertical-align: bottom;">&#160;</td><td style="width: 1.31%; vertical-align: bottom;">&#160;</td><td style="width: 1.01%; vertical-align: bottom;">&#160;</td><td style="width: 1.19%; vertical-align: bottom;">&#160;</td><td style="width: 13.11%; vertical-align: bottom;">&#160;</td><td style="width: 1.31%; vertical-align: bottom;">&#160;</td></tr></table></div> 989000 242000 0.377 18686000 7999000 0.49 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.25pt; text-indent: 34.4pt;">The following table presents our financial instruments measured at fair value on a recurring basis using unobservable inputs (Level 3):</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 80%;"><tr><td style="width: 29.33%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">(In thousands)</div></td><td style="width: 0.54%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.38%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Balance at December 31, 2016</div></td><td style="width: 1.54%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 11.34%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Purchases of Level 3 Instruments</div></td><td style="width: 0.54%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 11.28%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Settlements of Level 3 Instruments</div></td><td style="width: 0.54%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.88%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Gains (Losses) Included in Earnings</div></td><td style="width: 1.2%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.22%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Balance at March 31, 2017</div></td><td style="width: 1.04%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 29.33%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash Convertible Notes Hedges</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 12.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">48,361</div></td><td style="width: 1.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 10.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 10.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 12.7%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">34,084</div></td><td style="width: 1.2%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 12.12%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">82,445</div></td><td style="width: 1.04%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 29.33%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash Conversion Derivative</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(48,361</div></td><td style="width: 1.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10.24%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10.18%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.7%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(34,084</div></td><td style="width: 1.2%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.12%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(82,445</div></td><td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr></table></div> 0 0 0 0 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%; margin-top: 3.85pt;"><tr><td style="width: 36pt; vertical-align: top; align: right;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 4.5pt; margin-top: 3.85pt;">8.</div></td><td style="width: auto; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-top: 3.85pt;">Fair Value Measurements</div></td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; margin-right: 15.5pt; text-indent: 34.4pt;">We account for certain assets and liabilities at fair value<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font> Fair value is defined as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left; margin-left: 39.65pt; margin-right: 13.05pt;">Fair Value Hierarchy</div><div style="margin-top: 1pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; margin-right: 8.85pt; text-indent: 34.4pt;">The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font> We categorize each of our fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font> These levels are:</div><div style="margin-top: 0.95pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; margin-right: 6pt; text-indent: 12.75pt;">Level 1: &#160; Quoted prices in active markets for identical assets or liabilities;</div><div style="margin-top: 0.05pt;"><br /></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: Arial, sans-serif; width: 54pt; vertical-align: top; align: right;">Level 2:</td><td style="width: auto; vertical-align: top; text-align: left;"><div style="font-size: 10pt; font-family: Arial, sans-serif;">Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">-</font>based valuation techniques in which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and</div></td></tr></table></div><div style="margin-top: 0.05pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 63pt; margin-right: 14.75pt; text-indent: -44.25pt;">Level 3: &#160; Unobservable inputs that are supported by little or no market activity and typically reflect management's estimates of assumptions that market participants would use in pricing the asset or liability.</div><div style="margin-top: 0.05pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left; margin-left: 41.65pt;">Assets and Liabilities Measured at Fair Value on a Recurring Basis</div><div style="margin-top: 0.05pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.25pt; margin-right: 5.55pt; text-indent: 34.4pt;">The following table presents our assets and liabilities measured at fair value on a recurring basis at March 31, 2017 and March 31<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> 2016:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 53.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">(In thousands)</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 20.44%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31, 2017</div></td><td style="width: 1.07%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 21.28%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">December 31, 2016</div></td><td style="width: 1.07%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.76%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Level 3:</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 20.44%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.07%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 21.28%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.07%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Assets:</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 2.54%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 17.9%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.07%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.18%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 2.54%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 18.74%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.07%; vertical-align: bottom; background-color: #ffffff;">&#160;</td></tr><tr><td style="width: 53.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;&#160;&#160;Cash Convertible Notes Hedges</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;$</div></td><td style="width: 17.9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">82,445</div></td><td style="width: 1.07%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;$</div></td><td style="width: 18.74%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">48,361</div></td><td style="width: 1.07%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.76%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Liabilities:</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.9%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.07%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 18.74%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.07%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;&#160;&#160;Cash Conversion Derivative</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;$</div></td><td style="width: 17.9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">82,445</div></td><td style="width: 1.07%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;$</div></td><td style="width: 18.74%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">48,361</div></td><td style="width: 1.07%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr></table><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.25pt; margin-top: 3.8pt; margin-right: 5.35pt; text-indent: 34.4pt;">The fair values of the Cash Convertible Notes Hedges and the Cash Conversion Derivative are measured using Level 3 inputs because these instruments are not actively traded. They are valued using an option pricing model that uses observable and unobservable market data for inputs, such as expected time to maturity of the derivative instruments<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> the risk-free interest rate<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> the expected volatility of our common stock<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> and other factors. The Cash Convertible Notes Hedges and the Cash Conversion Derivative were designed such that changes in their fair values would offset one another<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> with minimal impact to the consolidated statements of operations. Therefore<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> the sensitivity of changes in the unobservable inputs to the option pricing model for such instruments is mitigated.</div><div style="margin-top: 1pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.25pt; text-indent: 34.4pt;">The following table presents our financial instruments measured at fair value on a recurring basis using unobservable inputs (Level 3):</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 80%;"><tr><td style="width: 29.33%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">(In thousands)</div></td><td style="width: 0.54%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.38%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Balance at December 31, 2016</div></td><td style="width: 1.54%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 11.34%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Purchases of Level 3 Instruments</div></td><td style="width: 0.54%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 11.28%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Settlements of Level 3 Instruments</div></td><td style="width: 0.54%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.88%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Gains (Losses) Included in Earnings</div></td><td style="width: 1.2%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.22%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Balance at March 31, 2017</div></td><td style="width: 1.04%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 29.33%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash Convertible Notes Hedges</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 12.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">48,361</div></td><td style="width: 1.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 10.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 10.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 12.7%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">34,084</div></td><td style="width: 1.2%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 12.12%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">82,445</div></td><td style="width: 1.04%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 29.33%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash Conversion Derivative</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(48,361</div></td><td style="width: 1.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10.24%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10.18%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.7%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(34,084</div></td><td style="width: 1.2%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 0.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.12%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(82,445</div></td><td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr></table><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.25pt; margin-top: 3.85pt; margin-right: 8.2pt; text-indent: 34.4pt;">The gains and losses included in earnings noted above represent the change in the fair value of these financial instruments and are recorded each period in the consolidated statements of operations. The gains and losses on the Cash Convertible Notes Hedges and Cash Conversion Derivative are recorded as selling, general and administrative expenses.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left; margin-left: 41.65pt;">Fair Value of Other Financial Instruments</div><div style="margin-top: 1pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.25pt; margin-right: 5.25pt; text-indent: 34.4pt;">In addition to the Cash Convertible Notes Hedges and the Cash Conversion Derivative<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> the estimated fair values of which are disclosed above<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> the estimated fair value of each class of financial instruments at March 31, 2<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">0</font>17 was as follows:</div><div style="margin-top: 0.05pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.25pt; margin-right: 5.25pt; text-indent: 34.4pt;">Cash and cash equivalents &#8211; The carrying amount of $<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">0.</font>7 million approximates fair value because of the short maturity of those instruments (less than three months).</div><div style="margin-top: 0.05pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.25pt; margin-right: 5.25pt; text-indent: 34.4pt;">Long-term debt &#8211; The estimated fair value of outstanding borrowings under the <font style="font-size: 10pt; font-family: 'Times New Roman', serif;">Prior </font>Credit Agreement, which includes a revolving credit facility and a term loan facility (see Note 6), and the Cash Convertible Notes are determined based on the fair value hierarchy as discussed above<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font></div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.25pt; margin-right: 5.25pt; text-indent: 34.4pt;">The revolving credit facility and the term loan facility are not actively traded and therefore are classified as Level 2 valuations based on the market for similar instruments. The estimated fair value is based on the average of the prices set by the issuing bank given current market conditions and is not necessarily indicative of the amount we could realize in a current market exchange. The estimated fair value and carrying amount of outstanding borrowings under the Prior Credit Agreement at March 31<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> 2<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">0</font>17 were each $68<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font>3 million<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font></div><div style="margin-top: 0.95pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.25pt; margin-right: 5.3pt; text-indent: 34.4pt;">The Cash Convertible Notes are actively traded and therefore are classified as Level 1 valuations. The estimated fair value at March 31, 2017 was $226<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font>9 million, which is based on the most recent trading price of the Cash Convertible Notes as of March 31, 2017, and the par value was $150.0 million. The carrying amount of the Cash Convertible Notes at March 31, 2017 was $139<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font>8 million, which is net of the debt discount discussed in Note 6<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">.</font></div></div> -48361000 48361000 82445000 -82445000 34084000 -34084000 8670000 8670000 0 34084000 -34084000 0 -7603000 7603000 334680000 334680000 0 48361000 82445000 0 15481000 19208000 -0.91 -0.01 0.53 0.40 0 132000 24852000 19208000 -33105000 -220000 -33105000 -220000 -0.93 -0.01 0.52 0.38 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 36pt; vertical-align: top; align: right;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 4.5pt;">5.</div></td><td style="width: auto; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">Income Taxes</div></td></tr></table></div><div style="margin-top: 0.1pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; margin-top: 3.8pt; margin-right: 11.35pt; text-indent: 30.75pt;"><font style="font-family: Arial, 'sans-serif';"><font style="font-size: 10pt;">For the three months ended March 31, 2017, we had an effective income tax rate from continuing operations of 37.7%.&#160; For the three months ended March 31, 2016, we followed the </font>intra</font>-period tax allocation guidance in ASC 740-20 and the example in ASC 740-20-55-14, which requires that the amount of tax attributable to the current year income from continuing operations be determined by a computation that does not consider the tax effects of items that are excluded from income from continuing operations (e.g.Discontinued operations).&#160; We had net operating loss carryforwards from 2015 subject to a valuation allowance at December 31, 2015, which, upon reversal of the valuation allowance in the first quarter of 2016, we utilized to offset income from continuing operations for the three months ended March 31, 2016.</div><div style="margin-top: 3.8pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: Arial, 'sans-serif';">At March 31, 2017, we had approximately $160.5 million of federal loss carryforwards and approximately $191.2 million of state loss carryforwards.</font></div><div style="margin-top: 3.8pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; text-indent: 31.5pt;">We file income tax returns in the U.S. Federal jurisdiction and in various state and foreign jurisdictions.&#160; Our 2014 federal income tax return is currently under IRS examination.&#160; Tax years remaining subject to examination in the U.S. Federal jurisdiction include 2013 to present.</div></div> 0 9371000 -53000 0 -220000 -33417000 426000 0 2642000 -2013000 -1175000 1337000 16459000 -7471000 441000 -1955000 -227000 -12099000 161000 426000 0 126000 611000 293000 165000 442000 29049000 29049000 4105000 3834000 133000 0 10144000 10144000 544782000 591850000 132363000 309533000 2017-04-21 2012-06-08 0.002 0.005 0.003 0.005 55000000 2017-06-08 2018-06-08 100000000 20000000 75000000 25000000 125000000 200000000 100000000 100000000 75000000 104300000 226900000 68300000 137859000 1270000 55000000 1029000 139790000 60000000 13250000 13500000 209069000 212629000 207298000 210343000 25400000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 40.5pt; vertical-align: top; align: right;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 4.5pt;">6.</div></td><td style="width: auto; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">Long-Term Debt</div></td></tr></table></div><div style="margin-top: 0.1pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; margin-right: 5.8pt; text-indent: 31.5pt;">The Company's long-term debt, net of unamortized deferred loan costs, consisted of the following at March 31, 2017 and December 31<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> 2016:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 58.42%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">(In thousands)</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 19.87%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31, 2017</div></td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 19.16%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">December 31, 2016</div></td><td style="width: 0.69%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Cash Convertible Notes, net of unamortized discount</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.15%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 18.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">139,790</div></td><td style="width: 0.7%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 17.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">137,859</div></td><td style="width: 0.69%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Prior Credit Agreement:</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.15%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 18.72%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.98%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.69%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">Term Loan</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.15%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 18.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">55,000</div></td><td style="width: 0.7%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">60,000</div></td><td style="width: 0.69%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">Revolver</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.15%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 18.72%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">13,250</div></td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.98%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">13,500</div></td><td style="width: 0.69%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Capital lease obligations and other</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.15%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 18.72%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">1,029</div></td><td style="width: 0.7%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.98%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">1,270</div></td><td style="width: 0.69%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.15%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 18.72%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">209,069</div></td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.98%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">212,629</div></td><td style="width: 0.69%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Less: deferred loan costs</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.15%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 18.72%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(1,771</div></td><td style="width: 0.7%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 17.98%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(2,286</div></td><td style="width: 0.69%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom;">&#160;</td><td style="width: 0.58%; vertical-align: bottom;">&#160;</td><td style="width: 1.15%; vertical-align: bottom;">&#160;</td><td style="width: 18.72%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">207,298</div></td><td style="width: 0.7%; vertical-align: bottom;">&#160;</td><td style="width: 0.58%; vertical-align: bottom;">&#160;</td><td style="width: 1.18%; vertical-align: bottom;">&#160;</td><td style="width: 17.98%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">210,343</div></td><td style="width: 0.69%; vertical-align: bottom;">&#160;</td></tr><tr><td style="width: 58.42%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Less: current portion</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.15%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 18.72%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(147,102</div></td><td style="width: 0.7%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.98%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(46,046</div></td><td style="width: 0.69%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.15%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 18.72%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">60,196</div></td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 17.98%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">164,297</div></td><td style="width: 0.69%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr></table><div style="margin-top: 0.35pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left; margin-left: 4.5pt;">Credit Facility</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; text-indent: 31.5pt;">On June 8, 2012, we entered into the Fifth Amended and Restated Revolving Credit and Term Loan Agreement&#160;(as amended, the "Prior Credit Agreement").&#160; The Prior Credit Agreement provided us with a $125 million revolving credit facility that includes a swingline sub facility of $20 million and a $75 million sub facility for letters of credit.&#160; The Prior Credit Agreement also provided a $200 million term loan facility, $55&#160;million of which remained outstanding at March 31, 2017, and an uncommitted incremental accordion facility of $100&#160;million.&#160; On April 21, 2017, we entered into a new revolving credit and term loan agreement, as described in detail below.</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; text-indent: 31.5pt;">Borrowings under the Prior Credit Agreement generally bore interest at variable rates based on a margin or spread in excess of either (1) the one-month, two-month, three-month or six-month rate (or with the approval of affected lenders, nine-month or twelve-month rate) for Eurodollar deposits ("LIBOR", which may not be less than zero), or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50% and (c) one-month LIBOR plus 1.00% (the "Base Rate"), as selected by the Company.&#160; The LIBOR margin varied between 1.75% and 3.00%, and the Base Rate margin varied between 0.75% and 2.00%, depending on our leverage ratio.&#160; The Prior Credit Agreement also provided for an annual fee ranging between 0.30% and 0.50% of the unused commitments under the revolving credit facility.&#160; Extensions of credit under the Prior Credit Agreement were secured by guarantees from all of the Company's active domestic subsidiaries and by security interests in substantially all of the Company's and such subsidiaries' assets.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">On August 4, 2016, we entered into the Eighth Amendment to the Prior Credit Agreement (the "Eighth Amendment").&#160; The Eighth Amendment extended the expiration date of the revolving credit facility and the maturity date of the term loan facility under the Prior Credit Agreement from June 8, 2017 to June 8, 2018 (the "Extended Maturity Date").&#160; The Eighth Amendment contemplated that some lenders might not agree to the Extended Maturity Date and preserved June 8, 2017 as the non-extended maturity date (the "Non-Extended Maturity Date") for such lenders.&#160; Lenders holding $45.3 million of the revolving commitments and $25.4 million of outstanding term loans as of August 4, 2016 did not consent to the Extended Maturity Date.&#160; On the Non-Extended Maturity Date, the revolving commitments of non-consenting revolving lenders will terminate and any outstanding term loans and revolving loans owed to non-consenting lenders must be paid in full.&#160; The outstanding revolving loans under the revolving credit facility held by consenting lenders must be paid in full on June 8, 2018.&#160; We are required to repay term loans in quarterly principal installments aggregating&#160;2.50% of the original aggregate principal amount of the term loans ($5.0 million) during each of the remaining quarters prior to maturity on June 8, 2018, at which time the entire unpaid principal balance of the term loans held by consenting lenders is due and payable.&#160; As of March 31, 2017, availability under the revolving credit facility totaled $104.3&#160;million.</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">&#160;On April 21, 2017, we entered into a new Revolving Credit and Term Loan Agreement (the "Credit Agreement") with a group of lenders, which replaced the Prior Credit Agreement.&#160; The Credit Agreement provides us with (1) a $100 million revolving credit facility that includes a $25 million sublimit for swingline loans and a $75 million sublimit for letters of credit, (2) a $70 million term loan A facility, (3) a $150 million delayed draw term loan facility, and (4) an uncommitted incremental accordion facility of $100 million.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">We used the proceeds of the term loan A and cash on hand to repay all of the outstanding indebtedness under the Prior Credit Agreement and to pay transaction costs and expenses.&#160; Proceeds of revolving loans and delayed draw term loans may be used to repay outstanding indebtedness (including amounts payable upon or in respect of any conversion of the Cash Convertible Notes discussed below and the repayment of any revolving loans borrowed for such purposes), to finance working capital needs, to finance acquisitions, to finance the repurchase of our common stock, to finance capital expenditures and for other general corporate purposes of the Company and its subsidiaries.&#160; Delayed draw term loans may not be borrowed after July 2, 2018.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">We are required to repay outstanding revolving loans in full on April 21, 2022.&#160;&#160;We are required to repay the term loan A in quarterly principal installments aggregating (1)&#160;$875,000 each for the first twelve quarters following the closing, and (2) $1,312,500 each for the remaining quarters prior to maturity on April 21, 2022.&#160; We are required to repay the delayed draw term loans in quarterly principal installments calculated as follows: (1) for each of the first twelve quarters following the closing, 1.250% of the aggregate principal amount of the delayed draw term loans funded as of the last day of the immediately preceding quarter; and (2) for each of the remaining quarters prior to maturity on April 21, 2022, 1.875% of the aggregate principal amount of the delayed draw term loans funded as of the last day of the immediately preceding quarter.&#160; At maturity on April 21, 2022, the entire unpaid principal balances of the term loan A and the delayed draw term loans are due and payable.&#160; <font style="font-size: 10pt; font-family: Arial, sans-serif;">As a result of entering into the Credit Agreement, as of March 31, 2017 we reclassified $37.3 million from current liabilities to long-term debt; this amount was due within one year from March 31, 2017 under the Prior Credit Agreement. </font></div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">Borrowings under the Credit Agreement generally bear interest at variable rates based on a margin or spread in excess of either (1) the one-month, two-month, three-month or six-month LIBOR rate (or with the approval of affected lenders, the twelve-month LIBOR rate), which may not be less than zero, or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50%, and (c) one-month LIBOR plus 1.00% (the "Base Rate"), as selected by the Company.&#160; The LIBOR margin varies between 1.50% and 2.75%, and the Base Rate margin varies between 0.50% and 1.75%, depending on our net leverage ratio.&#160; The Credit Agreement also provides for annual fees ranging between 0.20% and 0.50% of the unused commitments under the revolving credit facility and the delayed draw term loan facility.&#160; Extensions of credit under the Credit Agreement are secured by guarantees from all of the Company's active material subsidiaries and by security interests in substantially all of the Company's and such subsidiaries' assets.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">Each of the Prior Credit Agreement and the Credit Agreement contains financial covenants that require us to maintain, as defined, specified ratios or levels of (1) funded debt to EBITDA and (2) fixed charge coverage. The Prior Credit Agreement and the Credit Agreement also contain various other affirmative and negative covenants that are typical for financings of this type.&#160; Among other things, they limit repurchases of our common stock and the amount of dividends that we can pay to holders of our common stock.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left;">1.50%&#160;Cash Convertible Senior Notes Due 2018</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">On July 16, 2013, we completed the issuance of $150.0 million aggregate principal amount of cash convertible senior notes due 2018 (the "Cash Convertible Notes"), which bear interest at a rate of 1.50% per year, payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2014. The Cash Convertible Notes will mature on July 1, 2018, unless earlier repurchased or converted into cash in accordance with their terms prior to such date. At the option of the holders, the Cash Convertible Notes are convertible into cash based on the conversion rate set forth below&#160;only upon occurrence of certain triggering events as defined in the Indenture dated as of July 8, 2013 by and between the Company and U.S. Bank&#160;National Association, none of which had o<font style="font-size: 10pt; font-family: Arial, sans-serif; background-color: #ffffff;">ccurred as of&#160;December 31,&#160;2016 and one of which had occurred as of March 31, 2017, as further detailed below. Accordingly, we have classified the Cash Convertible Notes as long-term debt at&#160;December 31, 2016 and as current liabilities at March 31, 2017</font>. </div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: Arial, sans-serif; background-color: #ffffff;">The Cash Convertible Notes become convertible into cash during any calendar quarter (and only during such calendar quarter), if the last reported sale price of the Company's common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to approximately $25.30 per share ("Trading Price Condition"). The Trading Price Condition was satisfied on March 17, 2017 for the calendar quarter ending March 31, 2017, and accordingly, the Convertible Notes will be convertible at any time at the option of the holders during the period from April 1, 2017 through June 30, 2017. The initial cash conversion rate is 51.3769 shares of the Company's common stock per $1,000 principal amount of the Convertible Notes (equivalent to an initial conversion price of $19.4640 per share of common stock). The settlement on any Convertible Notes surrendered for conversion during this period will occur on the third business day following the end of the applicable "Observation Period" with respect to such conversion (i.e., the period that begins on the date that a holder surrendered the Convertible Notes for conversion in accordance with the requirements of the indenture and ends on the 80th consecutive trading day following such date). The indenture requires the Company to satisfy the entire settlement amount for any conversions (determined in accordance with the provisions of the indenture) in cash, and the notes are not convertible into the Company's common stock or any other securities under any circumstances.&#160; </font>Even if holders do not elect to convert their Cash Convertible Notes, we are required under applicable accounting rules to classify the Cash Convertible Notes that are convertible as a current rather than long-term liability.&#160; Accordingly, the Cash Convertible Notes, net of the unamortized discount, and related deferred loan costs are classified as current liabilities at March 31, 2017.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">&#160;The Cash Convertible Notes are our senior unsecured obligations and rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the Cash Convertible Notes. As a result of this transaction, we recognized deferred loan costs of approximately $3.9 million, which are being amortized over the term of the Cash Convertible Notes using the effective interest method.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">The cash conversion feature of the Cash Convertible Notes is a derivative liability (the "Cash Conversion Derivative") that requires bifurcation from the Cash Convertible Notes in accordance with FASB&#160;ASC Topic 815, "Derivatives and Hedging" ("ASC Topic 815"), and is carried at fair value.&#160; At December 31, 2016, because the Cash Convertible Notes were classified as long-term debt, the Cash Conversion Derivative was classified as long-term liabilities.&#160; Due to the satisfaction of the Trading Price Condition in March 2017 and the resulting classification of the Cash Convertible Notes as a current liability at March 31, 2017, the Cash Conversion Derivative is recorded in current liabilities at March 31, 2017. The fair value of the Cash Conversion Derivative at the time of issuance of the Cash Convertible Notes was $36.8 million, which was recorded as a debt discount for purposes of accounting for the debt component of the Cash Convertible Notes. The debt discount is being amortized over the term of the Cash Convertible Notes using the effective interest method. For the three months ended&#160;March 31,&#160;2017, we recorded $1.9 million of interest expense related to the amortization of the debt discount based upon an effective interest rate of 5.7%. The net carrying amount of the Cash Convertible Notes at March 31, 2017 and December 31, 2016 was $139.8 million and $137.9 million,&#160;respectively,&#160;net of the unamortized discount of $10.2 million and $12.1 million, respectively.</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">In connection with the issuance of the Cash Convertible Notes, we entered into privately negotiated convertible note hedge transactions (the "Cash Convertible Notes Hedges"), which are cash-settled and are intended to reduce our exposure to potential cash payments that we would be required to make if holders elect to convert the Cash Convertible Notes at a time when our stock price exceeds the conversion price. The initial cost of the Cash Convertible Notes Hedges was $36.8 million. At December 31, 2016, because the Cash Convertible Notes were classified as long-term debt, the Cash Convertible Notes Hedges were classified as long-term assets.&#160; Due to the satisfaction of the Trading Price Condition in March 2017 and the resulting classification of the Cash Convertible Notes as a current liability at March 31, 2017, the Cash Convertible Notes Hedges are classified in current assets at March 31, 2017.&#160; The Cash Convertible Notes Hedges are recorded as a derivative asset under ASC Topic 815 and are carried at fair value.&#160; See Note&#160;9 for additional information regarding the Cash Convertible Notes Hedges and the Cash Conversion Derivative and their fair values.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">In July 2013, we also sold separate privately negotiated warrants (the "Warrants") initially relating, in the aggregate, to a notional number of shares of our common stock underlying the Cash Convertible Notes Hedges. The Warrants have an initial strike price of approximately&#160;$25.95 per share, which effectively increases the conversion price of the Cash Convertible Notes to a 60% premium to our stock price on July 1, 2013. The Warrants will be net share settled by issuing a number of shares of our common stock per Warrant corresponding to the excess of the market price per share of our common stock (as measured on each warrant exercise date under the terms of the Warrants) over the applicable strike price of the Warrants. The Warrants meet the definition of derivatives under the guidance in ASC Topic 815; however, because these instruments have been determined to be indexed to our own stock and meet the criteria for equity classification under ASC Topic 815, the Warrants have been accounted for as an adjustment to our additional paid-in-capital.</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">&#160;</div><div>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: Arial, 'sans-serif';">&#160; When the market value per share of our common stock exceeds the strike price of the Warrants, the Warrants have a dilutive effect on net income per share, and the "treasury stock" method is used in calculating the dilutive effect on earnings per share.&#160; See Note 10 for additional information on such dilutive effect.</font></div></div> 46046000 147102000 60196000 164297000 37300000 3024000 7610000 -1234000 -7178000 -14209000 15261000 -2970000 -197000 0 312000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; text-indent: 36pt;">In May&#160;2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU")&#160;No. 2014-09, which creates Accounting Standards Codification ("ASC") Topic 606, "Revenue from Contracts with Customers" ("ASC Topic 606")&#160;and supersedes ASC Topic 605, "Revenue Recognition." The provisions of&#160;ASC Topic 606&#160;provide for a single comprehensive principles-based standard for the recognition of revenue across all industries and expanded disclosure about the nature, amount, timing and uncertainty of revenue,&#160;as well as certain additional quantitative and qualitative disclosures.&#160;The standard&#160;is effective for annual periods beginning after December 15, 2017, including interim periods within those years.&#160;<font style="font-size: 10pt; font-family: Arial, sans-serif;">The guidance permits the use of either a retrospective or cumulative effect transition method. We have not yet selected a transition method.&#160; We are currently conducting analysis to quantify the adoption impact of the provisions of the new standard and evaluating our current contracts and revenue streams. The FASB has issued, and may issue in the future, interpretive guidance which may cause our evaluation to change. We believe we are following an appropriate timeline to allow for proper recognition, presentation and disclosure upon adoption effective January 1, 2018.</font></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; text-indent: 36pt;">&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; text-indent: 36pt;">In August 2014, the FASB issued ASU No. 2014-15,&#160;"Presentation of Financial Statements &#8211; Going Concern: Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern,"&#160;which requires management to evaluate whether there is substantial doubt about the entity's ability to continue as a going concern and, if so, provide certain footnote disclosures. This ASU is effective for annual periods ending after December 15, 2016, including interim reporting periods thereafter. We adopted this ASU in the fourth quarter of 2016, and it did not have an impact on our financial statements or footnote disclosures.</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; text-indent: 36pt;">&#160;</div><div style="margin-bottom: 3pt; font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; margin-top: 3pt; text-indent: 31.5pt;">In February 2016, the FASB issued ASU No. 2016-02, "Leases"<font style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic;">&#160;</font>("ASU 2016-02"), which requires that lessees recognize assets and liabilities for leases with lease terms greater than twelve months in the statement of financial position. ASU 2016-02 also requires improved disclosures to help users of financial statements better understand the amount, timing and uncertainty of cash flows arising from leases. The update is effective for fiscal years beginning after December 15, 2018, including interim reporting periods within those years. We are currently evaluating the impact that the adoption of ASU 2016-02 will have on our financial position, results of operations and cash flows.</div><div style="margin-bottom: 3pt; margin-top: 3pt;"><br /></div><div style="margin-bottom: 3pt; font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; margin-top: 3pt; text-indent: 31.5pt;">In March 2016, the FASB issued ASU No. 2016-09, "Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting" ("ASU 2016-09"), which we adopted on January 1, 2017.&#160;&#160;ASU 2016-09 <font style="font-size: 10pt; font-family: Arial, sans-serif;">requires all income tax effects of share-based awards to be recognized in the income statement, which were previously presented as a component of shareholders' equity, on a prospective basis.&#160; In addition, any excess tax benefits that were not previously recognized because the related tax deduction had not reduced current taxes payable are to be recorded on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption, which resulted in an increase of $6.5 million to our retained earnings as of January 1, 2017.&#160; Regarding the statement of cash flows, the standard requires the presentation of excess tax benefits as an operating activity rather than as a financing activity and that cash paid by the Company when directly withholding shares for tax withholding purposes be classified as a financing activity on a retrospective basis. The standard also allows for an accounting policy election to estimate the number of awards that are expected to vest or to account for forfeitures when they occur. We elected to account for forfeitures as they occur, which did not result in a material cumulative effect adjustment to our retained earnings as of January 1, 2017.&#160; Finally, the standard no longer allows windfall tax benefits to be included in the assumed proceeds when applying the treasury stock method for computing diluted earnings per share ("EPS"), which results in share-based awards having a more dilutive effect on EPS.</font></div><div style="margin-bottom: 3pt; margin-top: 3pt;"><br /></div><div style="margin-bottom: 3pt; font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; margin-top: 3pt; text-indent: 31.5pt;">In August 2016, the FASB issued ASU No. 2016-15, "Statement of Cash Flows" (Topic 230) ("ASU 2016-15"). &#160;ASU 2016-15 addresses how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU 2016-15 is effective in the first quarter of 2018, with early adoption permitted, and is to be applied using a retrospective approach.&#160;We are currently evaluating the potential effects of adopting the provisions of ASU 2016-15.</div><div style="margin-bottom: 3pt; margin-top: 3pt;"><br /></div><div style="margin-bottom: 3pt; font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; margin-top: 3pt; text-indent: 31.5pt;">In January 2017, the FASB issued ASU No. 2017-04,<font style="font-size: 11pt; font-family: Arial, sans-serif;">&#160;"</font>Intangibles - Goodwill and Other" ("ASU 2017-04"), which simplifies the subsequent measurement of goodwill by eliminating step two from the goodwill impairment test.&#160; ASU 2017-04 is effective for annual and interim impairment tests in fiscal years beginning after December 15, 2019 and is required to be applied prospectively. Early adoption is allowed for annual goodwill impairment tests performed on testing dates after January 1, 2017.&#160;We do not anticipate that adopting this standard will have an impact on our consolidated financial statements and related disclosures.</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 39.7pt; vertical-align: top; align: right;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 5.25pt;">2.</div></td><td style="width: auto; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">Recent Relevant Accounting Standards</div></td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; text-indent: 36pt;">In May&#160;2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU")&#160;No. 2014-09, which creates Accounting Standards Codification ("ASC") Topic 606, "Revenue from Contracts with Customers" ("ASC Topic 606")&#160;and supersedes ASC Topic 605, "Revenue Recognition." The provisions of&#160;ASC Topic 606&#160;provide for a single comprehensive principles-based standard for the recognition of revenue across all industries and expanded disclosure about the nature, amount, timing and uncertainty of revenue,&#160;as well as certain additional quantitative and qualitative disclosures.&#160;The standard&#160;is effective for annual periods beginning after December 15, 2017, including interim periods within those years.&#160;<font style="font-size: 10pt; font-family: Arial, sans-serif;">The guidance permits the use of either a retrospective or cumulative effect transition method. We have not yet selected a transition method.&#160; We are currently conducting analysis to quantify the adoption impact of the provisions of the new standard and evaluating our current contracts and revenue streams. The FASB has issued, and may issue in the future, interpretive guidance which may cause our evaluation to change. We believe we are following an appropriate timeline to allow for proper recognition, presentation and disclosure upon adoption effective January 1, 2018.</font></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; text-indent: 36pt;">&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; text-indent: 36pt;">In August 2014, the FASB issued ASU No. 2014-15,&#160;"Presentation of Financial Statements &#8211; Going Concern: Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern,"&#160;which requires management to evaluate whether there is substantial doubt about the entity's ability to continue as a going concern and, if so, provide certain footnote disclosures. This ASU is effective for annual periods ending after December 15, 2016, including interim reporting periods thereafter. We adopted this ASU in the fourth quarter of 2016, and it did not have an impact on our financial statements or footnote disclosures.</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; text-indent: 36pt;">&#160;</div><div style="margin-bottom: 3pt; font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; margin-top: 3pt; text-indent: 31.5pt;">In February 2016, the FASB issued ASU No. 2016-02, "Leases"<font style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic;">&#160;</font>("ASU 2016-02"), which requires that lessees recognize assets and liabilities for leases with lease terms greater than twelve months in the statement of financial position. ASU 2016-02 also requires improved disclosures to help users of financial statements better understand the amount, timing and uncertainty of cash flows arising from leases. The update is effective for fiscal years beginning after December 15, 2018, including interim reporting periods within those years. We are currently evaluating the impact that the adoption of ASU 2016-02 will have on our financial position, results of operations and cash flows.</div><div style="margin-bottom: 3pt; margin-top: 3pt;"><br /></div><div style="margin-bottom: 3pt; font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; margin-top: 3pt; text-indent: 31.5pt;">In March 2016, the FASB issued ASU No. 2016-09, "Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting" ("ASU 2016-09"), which we adopted on January 1, 2017.&#160;&#160;ASU 2016-09 <font style="font-size: 10pt; font-family: Arial, sans-serif;">requires all income tax effects of share-based awards to be recognized in the income statement, which were previously presented as a component of shareholders' equity, on a prospective basis.&#160; In addition, any excess tax benefits that were not previously recognized because the related tax deduction had not reduced current taxes payable are to be recorded on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption, which resulted in an increase of $6.5 million to our retained earnings as of January 1, 2017.&#160; Regarding the statement of cash flows, the standard requires the presentation of excess tax benefits as an operating activity rather than as a financing activity and that cash paid by the Company when directly withholding shares for tax withholding purposes be classified as a financing activity on a retrospective basis. The standard also allows for an accounting policy election to estimate the number of awards that are expected to vest or to account for forfeitures when they occur. We elected to account for forfeitures as they occur, which did not result in a material cumulative effect adjustment to our retained earnings as of January 1, 2017.&#160; Finally, the standard no longer allows windfall tax benefits to be included in the assumed proceeds when applying the treasury stock method for computing diluted earnings per share ("EPS"), which results in share-based awards having a more dilutive effect on EPS.</font></div><div style="margin-bottom: 3pt; margin-top: 3pt;"><br /></div><div style="margin-bottom: 3pt; font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; margin-top: 3pt; text-indent: 31.5pt;">In August 2016, the FASB issued ASU No. 2016-15, "Statement of Cash Flows" (Topic 230) ("ASU 2016-15"). &#160;ASU 2016-15 addresses how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU 2016-15 is effective in the first quarter of 2018, with early adoption permitted, and is to be applied using a retrospective approach.&#160;We are currently evaluating the potential effects of adopting the provisions of ASU 2016-15.</div><div style="margin-bottom: 3pt; margin-top: 3pt;"><br /></div><div style="margin-bottom: 3pt; font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; margin-top: 3pt; text-indent: 31.5pt;">In January 2017, the FASB issued ASU No. 2017-04,<font style="font-size: 11pt; font-family: Arial, sans-serif;">&#160;"</font>Intangibles - Goodwill and Other" ("ASU 2017-04"), which simplifies the subsequent measurement of goodwill by eliminating step two from the goodwill impairment test.&#160; ASU 2017-04 is effective for annual and interim impairment tests in fiscal years beginning after December 15, 2019 and is required to be applied prospectively. Early adoption is allowed for annual goodwill impairment tests performed on testing dates after January 1, 2017.&#160;We do not anticipate that adopting this standard will have an impact on our consolidated financial statements and related disclosures.</div></div> 2013 191200000 160500000 23313000 28686000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 39.65pt; vertical-align: top; align: right;"><div style="font-size: 9.5pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 5.2pt;">1.</div></td><td style="width: auto; vertical-align: top;"><div style="font-size: 9.5pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">Basis of Presentation</div></td></tr></table></div><div style="margin-top: 0.1pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.35pt; margin-right: 14.75pt; text-indent: 34.4pt;">Our financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles in the United States ("U.S. GAAP").&#160; In our opinion, the accompanying consolidated financial statements of Tivity Health, Inc. and its wholly-owned subsidiaries (collectively, "Tivity Health," the "Company," or such terms as "we," "us," or "our") reflect all adjustments consisting of normal, recurring accruals necessary for a fair statement.&#160;We have reclassified certain items in prior periods to conform to current classifications.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.35pt; margin-right: 14.75pt; text-indent: 34.4pt;"><font style="font-size: 10pt; font-family: Arial, sans-serif;">Our results from continuing operations do not include the results of the total population health services ("TPHS") business, which we sold effective July 31, 2016.&#160; The TPHS business included our partnerships with Blue Zones, LLC and Dr. Dean Ornish (the Blue Zones Project by Healthways&#8482;&#160;and Dr. Dean Ornish's Program for Reversing Heart Disease&#8482;, respectively), our joint venture with Gallup, Inc. ("Gallup"), Navvis Healthcare, LLC ("Navvis"), MeYou Health, LLC ("MeYou Health"), and our international operations, including our joint venture with </font>SulAm&#233;rica<font style="font-size: 10pt; font-family: Arial, sans-serif;">.&#160; </font>While Navvis and MeYou Health were part of our TPHS business, they were sold separately to other buyers in November 2015 and June 2016, respectively.&#160; <font style="font-size: 10pt; font-family: Arial, sans-serif;">Results of operations for the TPHS business have been classified as discontinued operations for all periods&#160;presented in the accompanying Consolidated Financial Statements.&#160; See Note 3 for further information.</font></div><div style="margin-top: 1pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.35pt; margin-right: 9.8pt; text-indent: 34.4pt;">On&#160;March 11, 2015, we formed a joint venture with&#160;SulAm&#233;rica, one of the largest independent insurers in Brazil, to sell total population health services to the Brazilian market. With its contribution, SulAm&#233;rica acquired a 49% interest in the joint venture, Healthways Brasil Servicos de Consultoria LTDA&#160;("Healthways Brazil"). We determined that our interest in Healthways Brazil represented a controlling financial interest and, therefore,&#160;prior to selling the TPHS business, consolidated the financial statements of Healthways Brazil and presented a non-controlling interest for the portion owned by SulAm&#233;rica. The net assets and results of operations of Healthways Brazil were part of the sale of the TPHS business and are included within discontinued operations in the accompanying Consolidated Financial Statements.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.35pt; margin-right: 9.8pt; text-indent: 34.4pt;">We have omitted certain financial information that is normally included in financial statements prepared in accordance with U.S. GAAP but that is not required for interim reporting purposes. You should read the accompanying consolidated financial statements in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2016.</div></div> 1046000 111000 1022000 1046000 24000 0 37000 36000 966000 -56000 1022000 111000 1022000 111000 -1185000 -1734000 2288000 2250000 6646000 6688000 0 24000 10463000 8149000 397000 364000 36800000 0 275000 213000 885000 720000 64000 2118000 717000 3000 2054000 453000 0 6450000 1234000 5000000 5000000 0.001 0.001 0 0 0 0 3662000 3409000 1155000 4600000 131500000 109975000 2250000 0 -13897000 15261000 -80000 0 8331000 8345000 43917000 44724000 4200000 0 -80000 -80000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">The following table provides details about reclassifications out of accumulated OCI for the three months ended March 31, 2017 and 2016:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 37.97%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="7" style="width: 23.07%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Three Months Ended March 31,</div></td><td style="width: 0.98%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 37.98%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Statement of Operations</div></td></tr><tr><td style="width: 37.97%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;<font style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold;">(In thousands)</font></div></td><td colspan="3" style="width: 11.04%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2017</div></td><td style="width: 0.98%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="3" style="width: 11.05%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2016</div></td><td style="width: 0.98%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 37.98%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Classification</div></td></tr><tr><td style="width: 37.97%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Interest rate swaps</div></td><td style="width: 0.97%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 8.97%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 8.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">133</div></td><td style="width: 0.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 37.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: center;">Interest expense</div></td></tr><tr><td style="width: 37.97%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.97%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 8.97%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.98%; vertical-align: top; background-color: #ffffff;">&#160;</td><td style="width: 0.98%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(53</div></td><td style="width: 0.98%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 37.98%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: center;">Income tax benefit</div></td></tr><tr><td style="width: 37.97%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.97%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 8.97%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.1%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">80</div></td><td style="width: 0.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 37.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: center;">Net of tax</div></td></tr></table></div> 115465000 136084000 737000 39000 794000 0 810000 16000 0 0 3899000 48000 4242000 4305000 3851000 63000 3626000 0 60000 3566000 2518000 2518000 5700000 24000000 -73000 0 41000 -73000 0 41000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%; margin-top: 3.85pt;"><tr><td style="width: 36pt; vertical-align: top; align: right;"><div style="font-size: 9.5pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-top: 3.85pt;">12.</div></td><td style="width: auto; vertical-align: top;"><div style="font-size: 9.5pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-top: 3.85pt;">Restructuring and Related Charges</div></td></tr></table></div><div style="margin-top: 1pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">In the third quarter of 2015,&#160;we began developing our reorganization and cost rationalization plan (the "2015 Restructuring Plan")&#160;that commenced in October 2015, which was intended to improve efficiency and deliver greater value to our customers and stakeholders.&#160;Completion of the 2015 Restructuring Plan&#160;occurred with the completion of the sale of the TPHS business in July 2016. We incurred a total of approximately $24 million in restructuring charges related to the 2015 Restructuring Plan, substantially all of which resulted in or will result in cash expenditures.</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">The following table shows the costs incurred for the three months ended March 31, 2017 related to our 2015 Restructuring Plan and other restructuring costs:</div><div style="margin-top: 0.05pt;"><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 90%;"><tr><td style="width: 47.9%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">(In thousands)</div></td><td style="width: 0.74%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 15.57%; vertical-align: middle; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Severance and Other</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Employee-Related Costs</div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 14.97%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Consulting and Other Costs <sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(1)</sup></div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.74%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="3" style="width: 16.46%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Total</div></td></tr><tr><td style="width: 47.9%; vertical-align: middle; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Accrued restructuring and related charges liability as of January 1, 2017</div></td><td style="width: 0.74%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">4,242</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">63</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.74%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">4,305</div></td><td style="width: 0.9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td></tr><tr><td style="width: 47.9%; vertical-align: middle; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Restructuring charges</div></td><td style="width: 0.74%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.76%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.74%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.9%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td></tr><tr><td style="width: 47.9%; vertical-align: middle; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Payments</div></td><td style="width: 0.74%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(717</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(3</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.74%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(720</div></td><td style="width: 0.9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">)</div></td></tr><tr><td style="width: 47.9%; vertical-align: middle; padding-bottom: 2px; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Adjustments <sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(2)</sup></div></td><td style="width: 0.74%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">41</div></td><td style="width: 0.76%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;">&#160;</td><td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;">&#160;</td><td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.76%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;">&#160;</td><td style="width: 0.76%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;">&#160;</td><td style="width: 0.74%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">41</div></td><td style="width: 0.9%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;">&#160;</td></tr><tr><td style="width: 47.9%; vertical-align: middle;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Accrued restructuring and related charges liability as of March 31, 2017</div></td><td style="width: 0.74%; vertical-align: bottom;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.28%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">3,566</div></td><td style="width: 0.76%; vertical-align: bottom;">&#160;</td><td style="width: 1%; vertical-align: bottom;">&#160;</td><td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.28%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">60</div></td><td style="width: 0.76%; vertical-align: bottom;">&#160;</td><td style="width: 0.76%; vertical-align: bottom;">&#160;</td><td style="width: 0.74%; vertical-align: bottom;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.28%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">3,626</div></td><td style="width: 0.9%; vertical-align: bottom; border-bottom: #000000 4px double;">&#160;</td></tr><tr><td style="width: 47.9%; vertical-align: middle;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.74%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.74%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.9%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td></tr></table><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; margin-top: 0.15pt; text-indent: -9pt;"><sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(1)</sup> Consulting and other costs consist of third-party consulting charges incurred in connection with the 2015 Restructuring Plan.&#160;</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;"><sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(2)</sup> Adjustments <font style="font-size: 10pt; font-family: Arial, sans-serif; background-color: #ffffff;">consist primarily of foreign currency translation adjustments</font>.&#160;&#160;</div><div style="margin-top: 0.15pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">In the third quarter of 2016,&#160;we began the reorganization of our corporate support infrastructure (the "2016 Restructuring Plan"), which was intended to deliver greater value to our customers and stakeholders.&#160;Completion of the 2016 Restructuring Plan&#160;occurred during the first quarter of 2017. We incurred a total of approximately $5.7 million in restructuring charges related to the 2016 Restructuring Plan, substantially all of which resulted in or will result in cash expenditures.</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-top: 0.15pt; text-indent: 36pt;">The following table shows the costs incurred for the three months ended March 31, 2017 directly related to our 2016 Restructuring Plan and other restructuring costs:</div><div style="margin-top: 0.15pt;"><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 90%;"><tr><td style="width: 47.82%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">(In thousands)</div></td><td style="width: 0.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 15.5%; vertical-align: middle; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Severance and Other</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Employee-Related Costs</div></td><td style="width: 1.4%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 15.51%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Consulting and Other Costs <sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(1)</sup></div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="3" style="width: 16.3%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Total</div></td></tr><tr><td style="width: 47.82%; vertical-align: middle; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Accrued restructuring and related charges liability as of January 1, 2017</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.21%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">3,851</div></td><td style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.23%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">48</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.7%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.18%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">3,899</div></td><td style="width: 0.84%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td></tr><tr><td style="width: 47.82%; vertical-align: middle; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Restructuring charges</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 14.21%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">794</div></td><td style="width: 1.4%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.23%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">16</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.7%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">810</div></td><td style="width: 0.84%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td></tr><tr><td style="width: 47.82%; vertical-align: middle; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Payments</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 14.21%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(2,054</div></td><td style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 14.23%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(64</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.7%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 14.18%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(2,118</div></td><td style="width: 0.84%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">)</div></td></tr><tr><td style="width: 47.82%; vertical-align: middle; padding-bottom: 2px; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Adjustments<sup style="font-size: smaller; vertical-align: text-top; line-height: 1;"> (2)</sup></div></td><td style="width: 0.64%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 14.21%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(73</div></td><td style="width: 1.4%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 14.23%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.76%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.7%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 14.18%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(73</div></td><td style="width: 0.84%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">)</div></td></tr><tr><td style="width: 47.82%; vertical-align: middle;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Accrued restructuring and related charges liability as of March 31, 2017</div></td><td style="width: 0.64%; vertical-align: bottom;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.21%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">2,518</div></td><td style="width: 1.4%; vertical-align: bottom;">&#160;</td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.23%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.76%; vertical-align: bottom;">&#160;</td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.18%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">2,518</div></td><td style="width: 0.84%; vertical-align: bottom; border-bottom: #000000 4px double;">&#160;</td></tr><tr style="height: 13px;"><td style="width: 47.82%; vertical-align: middle;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.21%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.4%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.23%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.18%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.84%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td></tr></table><div style="margin-top: 0.15pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 25.25pt; margin-top: 0.15pt;"><sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(1)</sup> Consulting and other costs consist of third-party consulting charges incurred in connection with the 2016 Restructuring Plan.&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div><div><sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(2)</sup> Adjustments consist primarily of actual employee tax and benefit amounts differing from previous estimates.</div></div> -119327000 -97602000 12275000 P4Y8M12D P4Y6M 126012000 140970000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.4pt; margin-right: 7.1pt; text-indent: 34.4pt;">The following tables summarize the changes in accumulated OCI, net of tax, for the three months ended March 31, 2017 and 2016:</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.4pt; margin-right: 7.1pt; text-indent: 34.4pt;">&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 80.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;<font style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold;">(In thousands)</font></div></td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.37%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 15.6%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Foreign Currency Translation Adjustments</div></td><td style="width: 1.69%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 80.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accumulated OCI, net of tax, as of January 1, 2017</div></td><td style="width: 0.7%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.37%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.42%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(4,502</div></td><td style="width: 1.69%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 80.64%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Other comprehensive income before reclassifications, net of tax of $36</div></td><td style="width: 0.7%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.37%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.42%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.18%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">111</div></td><td style="width: 1.69%; vertical-align: bottom; background-color: #ffffff;">&#160;</td></tr><tr><td style="width: 80.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accumulated OCI, net of tax, as of March 31, 2017</div></td><td style="width: 0.7%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.37%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.42%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.18%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(4,391</div></td><td style="width: 1.69%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr></table><div style="margin-top: 0.35pt;"><br /></div><div style="margin-top: 0.35pt;"><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 80%;"><tr><td style="width: 63.03%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;<font style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold;">(In thousands)</font></div></td><td style="width: 0.66%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 9.75%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Net Change in Fair Value of Interest Rate Swaps</div></td><td style="width: 0.67%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 12.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Foreign Currency Translation Adjustments</div></td><td style="width: 0.67%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.66%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 11.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Total</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.03%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accumulated OCI, net of tax, as of January 1, 2016</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 8.62%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(239</div></td><td style="width: 0.67%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 10.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(4,000</div></td><td style="width: 0.67%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 10%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(4,239</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 63.03%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Other comprehensive income (loss) before reclassifications, net of tax of $37 and $0, respectively</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 8.62%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(56</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10.98%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">1,022</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">966</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;">&#160;</td></tr><tr><td style="width: 63.03%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Amounts reclassified from accumulated OCI, net of tax</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 8.62%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">80</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10.98%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">80</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.03%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Net increase in other comprehensive income (loss), net of tax</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 8.62%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">24</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10.98%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">1,022</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">1,046</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;">&#160;</td></tr><tr><td style="width: 63.03%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accumulated OCI, net of tax, as of March 31, 2016</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 8.62%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(215</div></td><td style="width: 0.67%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 10.98%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(2,978</div></td><td style="width: 0.67%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 10%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(3,193</div></td><td style="width: 0.68%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; margin-top: 0.15pt; text-indent: 36pt;">A summary of our stock options as of March 31, 2017 and the changes during the three months then ended is presented below:</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; margin-top: 0.15pt; text-indent: 36pt;">&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 80%;"><tr><td style="width: 46.91%; vertical-align: bottom;"><div>&#160;</div><div>&#160;</div><div>&#160;</div><div>&#160;</div><div>&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Options</div></td><td style="width: 0.67%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.72%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Shares</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">(In thousands)</div></td><td style="width: 0.66%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.66%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 10.07%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Average Exercise</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Price</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Per Share</div></td><td style="width: 0.66%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 10.59%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Weighted Average</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Remaining</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Contractual</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Term</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.47%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Aggregate Intrinsic Value (In thousands)</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 46.91%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Outstanding at January 1, 2017</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.73%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">1,024</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 9%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">14.02</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 10.59%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.47%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 46.91%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Granted</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.73%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 10.59%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.47%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 46.91%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Exercised</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.73%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(181</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 9%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">12.36</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 10.59%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.47%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 46.91%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Forfeited</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.73%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 10.59%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.47%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 46.91%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Expired</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.73%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(45</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">45.36</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 10.59%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 13.47%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 46.91%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Outstanding at March 31, 2017</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.73%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">798</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">12.63</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.09%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 9.5%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">4.7</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 12.4%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">13,139</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 46.91%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Exercisable at March 31, 2017</div></td><td style="width: 0.67%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.73%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">732</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">12.33</div></td><td style="width: 0.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.09%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 9.5%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">4.5</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 12.4%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">12,275</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 4.5pt; margin-right: 5.8pt; text-indent: 31.5pt;">The Company's long-term debt, net of unamortized deferred loan costs, consisted of the following at March 31, 2017 and December 31<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> 2016:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 58.42%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">(In thousands)</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 19.87%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31, 2017</div></td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 19.16%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">December 31, 2016</div></td><td style="width: 0.69%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Cash Convertible Notes, net of unamortized discount</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.15%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 18.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">139,790</div></td><td style="width: 0.7%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 17.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">137,859</div></td><td style="width: 0.69%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Prior Credit Agreement:</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.15%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 18.72%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.98%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.69%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">Term Loan</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.15%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 18.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">55,000</div></td><td style="width: 0.7%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">60,000</div></td><td style="width: 0.69%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">Revolver</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.15%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 18.72%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">13,250</div></td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.98%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">13,500</div></td><td style="width: 0.69%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Capital lease obligations and other</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.15%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 18.72%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">1,029</div></td><td style="width: 0.7%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.98%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">1,270</div></td><td style="width: 0.69%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.15%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 18.72%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">209,069</div></td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.98%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">212,629</div></td><td style="width: 0.69%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Less: deferred loan costs</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.15%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 18.72%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(1,771</div></td><td style="width: 0.7%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 17.98%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(2,286</div></td><td style="width: 0.69%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom;">&#160;</td><td style="width: 0.58%; vertical-align: bottom;">&#160;</td><td style="width: 1.15%; vertical-align: bottom;">&#160;</td><td style="width: 18.72%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">207,298</div></td><td style="width: 0.7%; vertical-align: bottom;">&#160;</td><td style="width: 0.58%; vertical-align: bottom;">&#160;</td><td style="width: 1.18%; vertical-align: bottom;">&#160;</td><td style="width: 17.98%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">210,343</div></td><td style="width: 0.69%; vertical-align: bottom;">&#160;</td></tr><tr><td style="width: 58.42%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Less: current portion</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.15%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 18.72%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(147,102</div></td><td style="width: 0.7%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.98%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(46,046</div></td><td style="width: 0.69%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 58.42%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.15%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 18.72%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">60,196</div></td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 17.98%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">164,297</div></td><td style="width: 0.69%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; text-indent: 30.75pt;">The gains and losses resulting from a change in fair values of the Cash Conversion Derivative and&#160;the Cash Convertible Notes Hedges are reported in the consolidated statements of operations.</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 80%;"><tr><td style="width: 31.48%; vertical-align: bottom;">&#160;</td><td colspan="7" style="width: 24.32%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Three Months Ended</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31,</div></td><td style="width: 1.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 42.56%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 31.48%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">(In thousands)</div></td><td colspan="3" style="width: 12.64%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">&#160;2017</div></td><td style="width: 1.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="3" style="width: 10.44%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2016</div></td><td style="width: 1.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 42.56%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Statements of Operations Classification</div></td></tr><tr><td style="width: 31.48%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash Convertible Notes Hedges:</div></td><td colspan="3" style="width: 12.64%; vertical-align: bottom;">&#160;</td><td style="width: 1.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="3" style="width: 10.44%; vertical-align: bottom;">&#160;</td><td style="width: 1.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 42.56%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;&#160;&#160;&#160;</div></td></tr><tr><td style="width: 31.48%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Net unrealized gain (loss)</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 10.94%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">34,084</div></td><td style="width: 1.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 8.74%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(7,603</div></td><td style="width: 1.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 42.56%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: center;">Selling, general and administrative expenses</div></td></tr><tr><td style="width: 31.48%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash Conversion Derivative:</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 10.94%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.58%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 8.74%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 42.56%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;&#160;&#160;&#160;&#160;</div></td></tr><tr><td style="width: 31.48%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Net unrealized (loss) gain</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 10.94%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(34,084</div></td><td style="width: 1.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 0.58%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.12%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 8.74%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">7,603</div></td><td style="width: 1.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 42.56%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: center;">Selling, general and administrative expenses</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.35pt; margin-right: 5.7pt; text-indent: 34.4pt;">The following is a reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share for the three months ended March 31, 2017 and 2016:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 66.88%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 18pt; text-indent: -18pt;">(In thousands except per share data)</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="6" style="width: 30.86%; vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Three Months Ended</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31,</div></td><td style="width: 1.31%; vertical-align: top;">&#160;</td></tr><tr><td style="width: 66.88%; vertical-align: top;">&#160;</td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 14.24%; vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2017</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 14.3%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2016</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Numerator:</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td colspan="2" style="width: 14.24%; vertical-align: top; background-color: #eaf9e8;">&#160;</td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td colspan="2" style="width: 14.3%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net income from continuing operations attributable to Tivity Health, Inc. - numerator for earnings per share</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">15,481</div></td><td style="width: 1.31%; vertical-align: top;">&#160;</td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">19,208</div></td><td style="width: 1.31%; vertical-align: top;">&#160;</td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Net loss from discontinued operations attributable to Tivity Health, Inc. - numerator for loss per share</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 13.05%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(220</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div>&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 13.11%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(33,417</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 66.88%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net income (loss) attributable to Tivity Health, Inc. - numerator for earnings (loss) per share</div></td><td style="width: 0.96%; vertical-align: bottom;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.05%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">15,261</div></td><td style="width: 1.31%; vertical-align: bottom;">&#160;</td><td style="width: 1.01%; vertical-align: bottom;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 4px double;">&#160;</td><td style="width: 13.11%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(14,209</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Denominator:</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Shares used for basic income (loss) per share</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">39,069</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">36,109</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Effect of dilutive stock options and restricted stock units outstanding:</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Non-qualified stock options</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">442</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">165</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Restricted stock units</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">611</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">426</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Market stock units</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">293</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">161</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Warrants related to Cash Convertible Notes</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">126</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Shares used for diluted income (loss) per share</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">40,541</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">36,861</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Earnings (loss) per share attributable to Tivity Health, Inc. - basic:</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Continuing operations</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">0.40</div></td><td style="width: 1.31%; vertical-align: top;">&#160;</td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">0.53</div></td><td style="width: 1.31%; vertical-align: top;">&#160;</td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Discontinued operations</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.05%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(0.01</div></td><td style="width: 1.31%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.11%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(0.93</div></td><td style="width: 1.31%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net income (loss) <sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(1)</sup></div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.05%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">0.39</div></td><td style="width: 1.31%; vertical-align: top;">&#160;</td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.11%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(0.39</div></td><td style="width: 1.31%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;">&#160;</td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.31%; vertical-align: top; background-color: #eaf9e8;">&#160;</td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.31%; vertical-align: top; background-color: #eaf9e8;">&#160;</td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Earnings (loss) per share attributable to Tivity Health, Inc. - diluted:</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Continuing operations</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">0.38</div></td><td style="width: 1.31%; vertical-align: top; background-color: #eaf9e8;">&#160;</td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">0.52</div></td><td style="width: 1.31%; vertical-align: top; background-color: #eaf9e8;">&#160;</td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Discontinued operations</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.05%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(0.01</div></td><td style="width: 1.31%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(0.91</div></td><td style="width: 1.31%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net income (loss) <sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(1)</sup></div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.05%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">0.38</div></td><td style="width: 1.31%; vertical-align: top; background-color: #eaf9e8;">&#160;</td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.11%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(0.39</div></td><td style="width: 1.31%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Dilutive securities outstanding not included in the computation of earnings (loss) per share because their effect is anti-dilutive:</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Non-qualified stock options</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">16</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">1,486</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Restricted stock units</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">18</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">679</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Warrants related to Cash Convertible Notes</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">7,707</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">CareFirst Convertible Note</div></td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">892</div></td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">CareFirst Warrants</div></td><td style="width: 0.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.05%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">591</div></td><td style="width: 1.31%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 66.88%; vertical-align: top; background-color: #eaf9e8;">&#160;</td><td style="width: 0.96%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 13.05%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.01%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 13.11%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.31%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td></tr><tr><td style="width: 66.88%; vertical-align: top;"><div style="text-indent: 18pt;"><font style="font-size: 10pt; font-family: Arial, sans-serif;"><sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(1)</sup></font><font style="font-size: 1px; width: 9pt; display: inline-block;">&#160;</font><font style="font-size: 10pt; font-family: Arial, sans-serif;">Figures may not add due to rounding.</font></div></td><td style="width: 0.96%; vertical-align: bottom;">&#160;</td><td style="width: 1.19%; vertical-align: bottom;">&#160;</td><td style="width: 13.05%; vertical-align: bottom;">&#160;</td><td style="width: 1.31%; vertical-align: bottom;">&#160;</td><td style="width: 1.01%; vertical-align: bottom;">&#160;</td><td style="width: 1.19%; vertical-align: bottom;">&#160;</td><td style="width: 13.11%; vertical-align: bottom;">&#160;</td><td style="width: 1.31%; vertical-align: bottom;">&#160;</td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; margin-right: 6.5pt; text-indent: 30.75pt;">The following table shows a summary of our restricted stock and restricted stock units as of March 31, 2017<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> as well as activity during the three months then ended:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 54.44%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="6" style="width: 44.58%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Restricted Stock and</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Restricted Stock Units</div></td><td style="width: 0.26%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 54.44%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 21.34%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Shares</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">(In thousands)</div></td><td style="width: 0.86%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 21.65%; vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Weighted-</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Grant Date</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Fair Value</div></td><td style="width: 0.26%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 54.44%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Nonvested at January 1, 2017</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 20.62%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">939</div></td><td style="width: 0.86%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.49%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 20.16%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">13.11</div></td><td style="width: 0.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 54.44%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Granted</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 20.62%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">4</div></td><td style="width: 0.86%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.49%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 20.16%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">27.97</div></td><td style="width: 0.26%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 54.44%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Vested</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 20.62%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(98</div></td><td style="width: 0.86%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.49%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 20.16%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">10.47</div></td><td style="width: 0.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 54.44%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Forfeited</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 20.62%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(37</div></td><td style="width: 0.86%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.49%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 20.16%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">11.70</div></td><td style="width: 0.26%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 54.44%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Nonvested at March 31, 2017</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 20.62%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">808</div></td><td style="width: 0.86%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.72%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.49%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 20.16%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">13.57</div></td><td style="width: 0.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 7.25pt; margin-right: 5.55pt; text-indent: 34.4pt;">The following table presents our assets and liabilities measured at fair value on a recurring basis at March 31, 2017 and March 31<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> 2016:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 53.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">(In thousands)</div></td><td style="width: 1.19%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 20.44%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31, 2017</div></td><td style="width: 1.07%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 21.28%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">December 31, 2016</div></td><td style="width: 1.07%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.76%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Level 3:</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 20.44%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.07%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 21.28%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.07%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Assets:</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 2.54%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 17.9%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.07%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.18%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 2.54%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 18.74%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.07%; vertical-align: bottom; background-color: #ffffff;">&#160;</td></tr><tr><td style="width: 53.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;&#160;&#160;Cash Convertible Notes Hedges</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;$</div></td><td style="width: 17.9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">82,445</div></td><td style="width: 1.07%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;$</div></td><td style="width: 18.74%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">48,361</div></td><td style="width: 1.07%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.76%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Liabilities:</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.9%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.07%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.54%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 18.74%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.07%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;&#160;&#160;Cash Conversion Derivative</div></td><td style="width: 1.19%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;$</div></td><td style="width: 17.9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">82,445</div></td><td style="width: 1.07%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.54%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;$</div></td><td style="width: 18.74%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">48,361</div></td><td style="width: 1.07%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">The following table shows the costs incurred for the three months ended March 31, 2017 related to our 2015 Restructuring Plan and other restructuring costs:</div><div style="margin-top: 0.05pt;"><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 90%;"><tr><td style="width: 47.9%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">(In thousands)</div></td><td style="width: 0.74%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 15.57%; vertical-align: middle; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Severance and Other</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Employee-Related Costs</div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 14.97%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Consulting and Other Costs <sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(1)</sup></div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.74%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="3" style="width: 16.46%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Total</div></td></tr><tr><td style="width: 47.9%; vertical-align: middle; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Accrued restructuring and related charges liability as of January 1, 2017</div></td><td style="width: 0.74%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">4,242</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">63</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.74%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">4,305</div></td><td style="width: 0.9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td></tr><tr><td style="width: 47.9%; vertical-align: middle; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Restructuring charges</div></td><td style="width: 0.74%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.76%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.74%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.9%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td></tr><tr><td style="width: 47.9%; vertical-align: middle; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Payments</div></td><td style="width: 0.74%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(717</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(3</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.74%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(720</div></td><td style="width: 0.9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">)</div></td></tr><tr><td style="width: 47.9%; vertical-align: middle; padding-bottom: 2px; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Adjustments <sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(2)</sup></div></td><td style="width: 0.74%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">41</div></td><td style="width: 0.76%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;">&#160;</td><td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;">&#160;</td><td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.76%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;">&#160;</td><td style="width: 0.76%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;">&#160;</td><td style="width: 0.74%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 14.28%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">41</div></td><td style="width: 0.9%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;">&#160;</td></tr><tr><td style="width: 47.9%; vertical-align: middle;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Accrued restructuring and related charges liability as of March 31, 2017</div></td><td style="width: 0.74%; vertical-align: bottom;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.28%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">3,566</div></td><td style="width: 0.76%; vertical-align: bottom;">&#160;</td><td style="width: 1%; vertical-align: bottom;">&#160;</td><td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.28%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">60</div></td><td style="width: 0.76%; vertical-align: bottom;">&#160;</td><td style="width: 0.76%; vertical-align: bottom;">&#160;</td><td style="width: 0.74%; vertical-align: bottom;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.28%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">3,626</div></td><td style="width: 0.9%; vertical-align: bottom; border-bottom: #000000 4px double;">&#160;</td></tr><tr><td style="width: 47.9%; vertical-align: middle;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.74%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.74%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.9%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td></tr></table><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; margin-top: 0.15pt; text-indent: -9pt;"><sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(1)</sup> Consulting and other costs consist of third-party consulting charges incurred in connection with the 2015 Restructuring Plan.&#160;</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;"><sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(2)</sup> Adjustments <font style="font-size: 10pt; font-family: Arial, sans-serif; background-color: #ffffff;">consist primarily of foreign currency translation adjustments</font>.&#160;&#160;</div><div style="margin-top: 0.15pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-top: 0.15pt; text-indent: 36pt;">The following table shows the costs incurred for the three months ended March 31, 2017 directly related to our 2016 Restructuring Plan and other restructuring costs:</div><div style="margin-top: 0.15pt;"><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 90%;"><tr><td style="width: 47.82%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">(In thousands)</div></td><td style="width: 0.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 15.5%; vertical-align: middle; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Severance and Other</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Employee-Related Costs</div></td><td style="width: 1.4%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 15.51%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Consulting and Other Costs <sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(1)</sup></div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="3" style="width: 16.3%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Total</div></td></tr><tr><td style="width: 47.82%; vertical-align: middle; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Accrued restructuring and related charges liability as of January 1, 2017</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.21%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">3,851</div></td><td style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.23%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">48</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.7%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.18%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">3,899</div></td><td style="width: 0.84%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td></tr><tr><td style="width: 47.82%; vertical-align: middle; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Restructuring charges</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 14.21%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">794</div></td><td style="width: 1.4%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.23%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">16</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td><td style="width: 0.7%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">810</div></td><td style="width: 0.84%; vertical-align: bottom; background-color: #eaf9e8;">&#160;</td></tr><tr><td style="width: 47.82%; vertical-align: middle; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Payments</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 14.21%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(2,054</div></td><td style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 14.23%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(64</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 0.7%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 0.68%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td style="width: 14.18%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(2,118</div></td><td style="width: 0.84%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">)</div></td></tr><tr><td style="width: 47.82%; vertical-align: middle; padding-bottom: 2px; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Adjustments<sup style="font-size: smaller; vertical-align: text-top; line-height: 1;"> (2)</sup></div></td><td style="width: 0.64%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 14.21%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(73</div></td><td style="width: 1.4%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 14.23%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.76%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.7%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom; padding-bottom: 2px; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;">&#160;</td><td style="width: 14.18%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(73</div></td><td style="width: 0.84%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">)</div></td></tr><tr><td style="width: 47.82%; vertical-align: middle;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Accrued restructuring and related charges liability as of March 31, 2017</div></td><td style="width: 0.64%; vertical-align: bottom;">&#160;</td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.21%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">2,518</div></td><td style="width: 1.4%; vertical-align: bottom;">&#160;</td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 14.23%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.76%; vertical-align: bottom;">&#160;</td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.18%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">2,518</div></td><td style="width: 0.84%; vertical-align: bottom; border-bottom: #000000 4px double;">&#160;</td></tr><tr style="height: 13px;"><td style="width: 47.82%; vertical-align: middle;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.21%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 1.4%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.23%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.7%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.68%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.18%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.84%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td></tr></table><div style="margin-top: 0.15pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 25.25pt; margin-top: 0.15pt;"><sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(1)</sup> Consulting and other costs consist of third-party consulting charges incurred in connection with the 2016 Restructuring Plan.&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div><div><sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(2)</sup> Adjustments consist primarily of actual employee tax and benefit amounts differing from previous estimates.</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; margin-right: 10.9pt; text-indent: 34.4pt;">The estimated fair values of derivative instruments at March 31, 2017 and December 31, 2<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">0</font>16 were as follows:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 58.55%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;"><font style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold;">(In thousands)</font>&#160;</div></td><td colspan="5" style="width: 18.43%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31,</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2017</div></td><td colspan="2" style="width: 2.65%; vertical-align: bottom;">&#160;</td><td colspan="5" style="width: 20.12%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">December 31, 2016</div></td><td style="width: 0.24%; vertical-align: top;">&#160;</td></tr><tr><td style="width: 58.55%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">Assets:</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 16.87%; vertical-align: top;">&#160;</td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 3.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 17.35%; vertical-align: top;">&#160;</td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.93%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: top;">&#160;</td></tr><tr><td style="width: 58.55%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left;">Derivatives not designated as hedging instruments:</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 16.87%; vertical-align: top;">&#160;</td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 3.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 17.35%; vertical-align: top;">&#160;</td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.93%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: top;">&#160;</td></tr><tr><td style="width: 58.55%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 18pt;">Cash convertible notes hedges, current</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 4.34%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$&#160;</div></td><td style="width: 12.53%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">82,445</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 3.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.25%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;$</div></td><td style="width: 14.1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.93%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.55%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 18pt;">Cash convertible notes hedges, long-term</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 4.34%; vertical-align: bottom;">&#160;</td><td style="width: 12.53%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 3.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.25%; vertical-align: bottom;">&#160;</td><td style="width: 14.1%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">48,361</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.93%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.55%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">Liabilities:</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 4.34%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.53%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 3.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.25%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.93%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.55%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-style: italic; text-align: left;">Derivatives not designated as hedging instruments:</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 4.34%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.53%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 3.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.25%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.1%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.93%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.55%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 18pt;">Cash conversion derivative, current</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 4.34%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$&#160;</div></td><td style="width: 12.53%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">82,445</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 3.01%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.25%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$&#160;</div></td><td style="width: 14.1%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.93%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 58.55%; vertical-align: top;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 18pt;">Cash conversion derivative, long-term</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.08%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 4.34%; vertical-align: bottom;">&#160;</td><td style="width: 12.53%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 3.01%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.25%; vertical-align: bottom;">&#160;</td><td style="width: 14.1%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">48,361</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.93%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.24%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.35pt; margin-right: 11.7pt; text-indent: 34.4pt;">The following table shows the effect of our cash flow hedges on the consolidated balance sheets during the three months ended March 31, 2017 and 2<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">0</font>16:</div><div style="margin-top: 0.1pt;"><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 65.79%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">(In thousands)</div></td><td style="width: 1.41%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="3" style="width: 31.01%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">For the Three Months Ended</div></td><td style="width: 1.23%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 65.79%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Derivatives in Cash Flow Hedging Relationships</div></td><td style="width: 1.41%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.16%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31, 2017</div></td><td style="width: 2.86%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.98%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31, 2016</div></td><td style="width: 1.23%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 65.79%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Loss related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect</div></td><td style="width: 1.41%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.16%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 2.86%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;$</div></td><td style="width: 13.98%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">92</div></td><td style="width: 1.23%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 65.79%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect</div></td><td style="width: 1.41%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 14.16%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 2.86%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#160;$</div></td><td style="width: 13.98%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(133</div></td><td style="width: 1.23%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td></tr></table></div> 8361000 9411000 2427000 1446000 0 11.70 5.95 12.36 0 27.97 0 45.36 0 4000 0 37000 25000 45000 13.11 8.75 9.01 13.57 406000 939000 808000 373000 12.33 732000 10.47 5.46 98000 8000 14.02 12.63 0 1024000 798000 13139000 0 0 0 0 2250000 2250000 0 181000 213972000 189298000 -4502000 -4000000 -239000 -4239000 -2978000 -215000 -3193000 -4391000 -119327000 -28182000 39000 -4502000 0 189298000 341270000 39000 -97602000 344108000 -28182000 213972000 0 -4391000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%; margin-top: 3.85pt;"><tr><td style="width: 40.5pt; vertical-align: top; align: right;"><div style="font-size: 9.5pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-top: 3.85pt;">13.</div></td><td style="width: auto; vertical-align: top;"><div style="font-size: 9.5pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left; margin-top: 3.85pt;">Subsequent Event</div></td></tr></table></div><div style="margin-top: 0.15pt;"><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">On April 21, 2017, we entered into the Credit Agreement with a group of lenders for whom SunTrust Bank acts as administrative agent, which replaced the Prior Credit Agreement.&#160; The Credit Agreement provides us with (1) a $100 million revolving credit facility that includes a $25 million sublimit for swingline loans and a $75 million sublimit for letters of credit, (2) a $70 million term loan A facility, (3) a $150 million delayed draw term loan facility, and (4) an uncommitted incremental accordion facility of $100 million.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">We used the proceeds of the term loan A and cash on hand to repay all of the outstanding indebtedness under the Prior Credit Agreement and to pay transaction costs and expenses.&#160; Proceeds of revolving loans and delayed draw term loans may be used to repay outstanding indebtedness (including amounts payable upon or in respect of any conversion of the Cash Convertible Notes and the repayment of any revolving loans borrowed for such purposes), to finance working capital needs, to finance acquisitions, to finance the repurchase of our common stock, to finance capital expenditures, and for other general corporate purposes of the Company and its subsidiaries.&#160; Delayed draw term loans may not be borrowed after July 2, 2018.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">We are required to repay outstanding revolving loans in full on April 21, 2022.&#160;&#160;We are required to repay the term loan A in quarterly principal installments aggregating (1) $875,000 each for the first twelve quarters following the closing, and (2) $1,312,500 each for the remaining quarters prior to maturity on April 21, 2022.&#160; We are required to repay the delayed draw term loans in quarterly principal installments calculated as follows: (1) for each of the first twelve quarters following the closing, 1.250% of the aggregate principal amount of the delayed draw term loans funded as of the last day of the immediately preceding quarter; and (2) for each of the remaining quarters prior to maturity on April 21, 2022, 1.875% of the aggregate principal amount of the delayed draw term loans funded as of the last day of the immediately preceding quarter.&#160; At maturity on April 21, 2022, the entire unpaid principal balances of the term loan A and the delayed draw term loans are due and payable.</div><div><br /></div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">Borrowings under the Credit Agreement generally bear interest at variable rates based on a margin or spread in excess of either (1) the one-month, two-month, three-month or six-month LIBOR rate (or with the approval of affected lenders, the twelve-month LIBOR rate), which may not be less than zero, or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50%, and (c) the Base Rate, as selected by the Company.&#160; The LIBOR margin varies between 1.50% and 2.75%, and the Base Rate margin varies between 0.50% and 1.75%, depending on our net leverage ratio.&#160; The Credit Agreement also provides for annual fees ranging between 0.20% and 0.50% of the unused commitments under the revolving credit facility and the delayed draw term loan facility.&#160; Extensions of credit under the Credit Agreement are secured by guarantees from all of the Company's active material subsidiaries and by security interests in substantially all of the Company's and such subsidiaries' assets.</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">&#160;</div><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 36pt;">The Credit Agreement contains financial covenants that require us to maintain, as defined, specified ratios or levels of (1) funded debt to EBITDA and (2) fixed charge coverage. The Credit Agreement contains various other affirmative and negative covenants that are typical for financings of this type.&#160; Among other things, it limits repurchases of our common stock and the amount of dividends that we can pay to holders of our common stock.</div></div> 2254953 2254953 28182000 28182000 45300000 40541000 36861000 39069000 36109000 7582000 5831000 -588000 0 0 -310000 793000 12746000 5 0.667 0 0 0 6464000 0 74000 6538000 6500000 25000000 5400000 P24M 132000 0 2700000 249.87 20000000 -310000 0 0 5702000 30000000 768000 0 10000000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="margin-bottom: 3pt; font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-top: 3pt; text-indent: 36pt;">The depreciation, amortization and significant operating and investing non-cash items of the discontinued operations were as follows:&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 69.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">&#160;</div></td><td style="width: 0.14%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="8" style="width: 29.9%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Three Months Ended</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31,</div></td></tr><tr><td style="width: 69.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">(In thousands)</div></td><td style="width: 0.14%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 15.09%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2017</div></td><td style="width: 0.56%; vertical-align: bottom;">&#160;</td><td style="width: 0.56%; vertical-align: bottom;">&#160;</td><td colspan="2" style="width: 13.12%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2016</div></td><td style="width: 0.14%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: bottom;">&#160;</td></tr><tr style="height: 19px;"><td style="width: 69.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;&#160;&#160;Depreciation and amortization on discontinued operations</div></td><td style="width: 0.14%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">$</div></td><td style="width: 13.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.56%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 11.99%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">10,874</div></td><td style="width: 0.14%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: top; background-color: #ffffff;">&#160;</td></tr><tr><td style="width: 69.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;&#160;&#160;Capital expenditures on discontinued operations</div></td><td style="width: 0.14%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.96%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.56%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 11.99%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">5,420</div></td><td style="width: 0.14%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: top; background-color: #ffffff;">&#160;</td></tr><tr><td style="width: 69.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;&#160;&#160;Share-based compensation on discontinued operations</div></td><td style="width: 0.14%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.96%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.56%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.13%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 11.99%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">768</div></td><td style="width: 0.14%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.56%; vertical-align: top;">&#160;</td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: left; margin-left: 5.25pt; text-indent: 36pt;">The following table presents financial results of the TPHS business included in "loss from discontinued operations" for the three months ended March 31, 2017 and 2016.</div><div style="text-align: left; margin-left: 5.25pt;">&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 63.55%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.26%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="6" style="width: 33.18%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Three Months Ended</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">March 31,</div></td><td style="width: 1.38%; vertical-align: top;">&#160;</td><td style="width: 0.64%; vertical-align: top;">&#160;</td></tr><tr><td style="width: 63.55%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">(In thousands)</div></td><td style="width: 1.26%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 15.82%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2017</div></td><td style="width: 2.02%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 14.16%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">2016</div></td><td style="width: 1.38%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.26%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 15.82%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.02%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 14.16%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.38%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Revenues</div></td><td style="width: 1.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 2.02%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 12.51%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">63,205</div></td><td style="width: 1.38%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Cost of services</div></td><td style="width: 1.26%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.08%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">220</div></td><td style="width: 2.02%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.51%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">72,625</div></td><td style="width: 1.38%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Selling, general &amp; administrative expenses</div></td><td style="width: 1.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">137</div></td><td style="width: 2.02%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.51%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">7,061</div></td><td style="width: 1.38%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Depreciation and amortization</div></td><td style="width: 1.26%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.08%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 2.02%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.51%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">10,874</div></td><td style="width: 1.38%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Restructuring and related charges</div></td><td style="width: 1.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 2.02%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.51%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">5,702</div></td><td style="width: 1.38%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Equity in income&#160;from joint ventures</div></td><td style="width: 1.26%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.08%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 2.02%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.51%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">132</div></td><td style="width: 1.38%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td style="width: 0.64%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Pretax loss on discontinued operations</div></td><td style="width: 1.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(357</div></td><td style="width: 2.02%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: center;">$</div></td><td style="width: 12.51%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(32,925</div></td><td style="width: 1.38%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Pretax loss on sale of TPHS business</div></td><td style="width: 1.26%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.08%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(310</div></td><td style="width: 2.02%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.51%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 1.38%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; text-indent: 7.2pt;">Total pretax loss on discontinued operations</div></td><td style="width: 1.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.08%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(667</div></td><td style="width: 2.02%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: center;">$</div></td><td style="width: 12.51%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(32,925</div></td><td style="width: 1.38%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Income tax (benefit) expense</div></td><td style="width: 1.26%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 13.08%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(447</div></td><td style="width: 2.02%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)</div></td><td style="width: 1.18%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 12.51%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">180</div></td><td style="width: 1.38%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td style="width: 0.64%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 63.55%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Loss from discontinued operations, net of income tax benefit</div></td><td style="width: 1.26%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.75%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 13.08%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(220</div></td><td style="width: 2.02%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 1.18%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.66%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 12.51%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(33,105</div></td><td style="width: 1.38%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 0.64%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr></table></div> 4 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left; margin-left: 5.25pt; margin-right: 21.35pt; text-indent: 30.75pt;">The following table shows a summary of our market stock units as of March 31, 2017<font style="font-size: 10pt; font-family: 'Times New Roman', serif;">,</font> as well as activity during the three months then ended:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 60%;"><tr><td style="width: 53.82%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.35%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="6" style="width: 43.48%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Market Stock Units</div></td><td style="width: 0.48%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.82%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: left;">&#160;</div></td><td style="width: 0.35%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 19.86%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Shares</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">(In thousands)</div></td><td style="width: 2.28%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td colspan="2" style="width: 20.23%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Weighted-</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Grant Date</div><div style="font-size: 10pt; font-family: Arial, sans-serif; font-weight: bold; text-align: center;">Fair Value</div></td><td style="width: 0.48%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.82%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Nonvested at January 1, 2017</div></td><td style="width: 0.35%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.62%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">406</div></td><td style="width: 2.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.41%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 16.82%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">8.75</div></td><td style="width: 0.48%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.82%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Granted</div></td><td style="width: 0.35%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.24%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.62%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 2.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.41%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 16.82%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">&#8212;</div></td><td style="width: 0.48%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.82%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Vested</div></td><td style="width: 0.35%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.24%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.62%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(8</div></td><td style="width: 2.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.41%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 16.82%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">5.46</div></td><td style="width: 0.48%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.82%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Forfeited</div></td><td style="width: 0.35%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.24%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.62%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">(25</div></td><td style="width: 2.28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">)&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.41%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 16.82%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">5.95</div></td><td style="width: 0.48%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr><tr><td style="width: 53.82%; vertical-align: top; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">Nonvested at March 31, 2017</div></td><td style="width: 0.35%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 0.76%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 2.24%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 17.62%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">373</div></td><td style="width: 2.28%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 1.11%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td><td style="width: 3.41%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">$</div></td><td style="width: 16.82%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: right;">9.01</div></td><td style="width: 0.48%; vertical-align: bottom; background-color: #eaf9e8;"><div style="font-size: 10pt; font-family: Arial, sans-serif; text-align: left;">&#160;</div></td></tr></table></div> 1000 0.6 0.01875 0.0125 0.025 0 0.0175 0.0275 0.005 0.015 0.03 0.02 0.0175 0.0075 Figures may not add due to rounding. Consulting and other costs consist of third-party consulting charges incurred in connection with the 2016 Restructuring Plan. Consulting and other costs consist of third-party consulting charges incurred in connection with the 2015 Restructuring Plan. Adjustments consist primarily of actual employee tax and benefit amounts differing from previous estimates. Adjustments consist primarily of foreign currency translation adjustments. EX-101.SCH 6 tvty-20170331.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 010000 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 010100 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 020100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 030000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 040000 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 050000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 060100 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 060200 - Disclosure - Recent Relevant Accounting Standards link:presentationLink link:calculationLink link:definitionLink 060300 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 060400 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 060500 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 060600 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 060700 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 060800 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 060900 - Disclosure - Derivative Investments and Hedging Activities link:presentationLink link:calculationLink link:definitionLink 061000 - Disclosure - Earnings (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 061100 - Disclosure - Accumulated OCI link:presentationLink link:calculationLink link:definitionLink 061200 - Disclosure - Restructuring and Related Charges link:presentationLink link:calculationLink link:definitionLink 061300 - Disclosure - Subsequent Event link:presentationLink link:calculationLink link:definitionLink 070100 - Disclosure - Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 070200 - Disclosure - Recent Relevant Accounting Standards (Policies) link:presentationLink link:calculationLink link:definitionLink 080300 - Disclosure - Discontinued Operations (Tables) link:presentationLink link:calculationLink link:definitionLink 080400 - Disclosure - Share-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 080600 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 080800 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 080900 - Disclosure - Derivative Investments and Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 081000 - Disclosure - Earnings (Loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 081100 - Disclosure - Accumulated OCI (Tables) link:presentationLink link:calculationLink link:definitionLink 081200 - Disclosure - Restructuring and Related Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 090100 - Disclosure - Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 090200 - Disclosure - Recent Relevant Accounting Standards (Details) link:presentationLink link:calculationLink link:definitionLink 090300 - Disclosure - Discontinued Operations (Details) link:presentationLink link:calculationLink link:definitionLink 090400 - Disclosure - Share-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 090500 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 090600 - Disclosure - Long-Term Debt, Summary of Long-term Debt, Net of Unamortized Deferred Loan Costs (Details) link:presentationLink link:calculationLink link:definitionLink 090602 - Disclosure - Long-Term Debt, Line of Credit and Term Loan (Details) link:presentationLink link:calculationLink link:definitionLink 090602 - Disclosure - Long-Term Debt, Summary of Long-term Debt, Net of Unamortized Deferred Loan Costs (Details) Calc 2 link:presentationLink link:calculationLink link:definitionLink 090604 - Disclosure - Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 090700 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 090800 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 090900 - Disclosure - Derivative Investments and Hedging Activities (Details) link:presentationLink link:calculationLink link:definitionLink 091000 - Disclosure - Earnings (Loss) Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 091100 - Disclosure - Accumulated OCI (Details) link:presentationLink link:calculationLink link:definitionLink 091102 - Disclosure - Accumulated OCI, Reclassifications Out of Accumulated OCI (Details) link:presentationLink link:calculationLink link:definitionLink 091200 - Disclosure - Restructuring and Related Charges (Details) link:presentationLink link:calculationLink link:definitionLink 091300 - Disclosure - Subsequent Event (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 tvty-20170331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 tvty-20170331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 tvty-20170331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Amendment Flag Current Fiscal Year End Date Document Period End Date Entity [Domain] Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Legal Entity [Axis] Document Type Award Type [Axis] Accounts payable Accounts receivable, net Accrued liabilities Accumulated Other Comprehensive Income Loss [Table] Accumulated Other Comprehensive Income Loss [Line Items] Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Foreign Currency Translation Adjustments [Member] Accumulated OCI [Abstract] Accumulated Other Comprehensive Income (Loss) [Member] Accumulated Other Comprehensive Income (Loss) [Member] Net Change in Fair Value of Interest Rate Swaps [Member] Accumulated other comprehensive loss Additional paid-in capital Additional Paid-in Capital [Member] Adjustments to reconcile net income (loss) to net cash provided by operating activities, net of business acquisitions: Tax effect of stock options and restricted stock units Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation Adjustments for New Accounting Pronouncements [Axis] Share-based employee compensation expense Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Share-based compensation costs Amortization of deferred loan costs Amortization of debt discount Interest expense related to amortization of debt discount Antidilutive Securities [Axis] Dilutive securities outstanding not included in the computation of earnings (loss) per share because their effect is anti-dilutive (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities, Name [Domain] Total assets Assets ASSETS Assets [Abstract] Current assets: Total current assets Assets, Current Base Rate [Member] Basis of Presentation Capital expenditures on discontinued operations Capital Expenditure, Discontinued Operations Capital Lease Obligations and Other [Member] Computer equipment and related software Cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Net (decrease) increase in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Class of Warrant or Right [Axis] Warrants strike price (in dollars per share) Class of Warrant or Right [Domain] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies [Abstract] Common Stock [Member] Common stock, shares authorized (in shares) Common stock $.001 par value, 120,000,000 shares authorized, 39,188,902 and 38,933,580 shares outstanding, respectively Common Stock, Value, Issued Common stock, par value (in dollars per share) Common stock, shares outstanding (in shares) Accumulated OCI Comprehensive Income (Loss) Note [Text Block] Comprehensive income (loss) Comprehensive income (loss) Comprehensive income Capital projects in process Cash Convertible Notes, Net of Unamortized Discount [Member] Convertible Debt [Member] Cost of services, depreciation and amortization Cost of Services, Depreciation and Amortization Cost of services (exclusive of depreciation and amortization of $657 and $1,530, respectively, included below) Cost of Services Credit Facility [Axis] Credit Facility [Domain] Derivatives Not Designated as Hedging Instruments [Member] Designated as Hedging Instrument [Member] Debt, Long-term and Short-term, Combined Amount [Abstract] Debt Instrument [Line Items] Initial cash conversion rate Debt Instrument, Convertible, Conversion Ratio Initial conversion price (in dollars per share) Remaining Quarters Prior to Maturity [Member] Debt Instrument, Redemption, Period Two [Member] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Domain] Schedule of Long-term Debt Instruments [Table] Debt Instrument [Axis] Number of trading days Debt Instrument, Carrying Amount Trading price condition (in dollars per share) Debt Instrument, Convertible, Stock Price Trigger Consecutive trading days First 12 Quarters Following the Closing [Member] Debt Instrument, Redemption, Period One [Member] Basis spread on variable rate Basis spread on variable rate Aggregate principal of convertible notes Debt instrument, face amount Debt Instrument, Name [Domain] Periodic principal payment Debt Instrument, Periodic Payment, Principal Debt instrument, unamortized discount Debt Instrument, Unamortized Discount Interest rate for notes Maturity date Debt Instrument, Maturity Date Effective interest rate Deferred loan costs Debt Issuance Costs, Gross Less: deferred loan costs Debt Issuance Costs, Net Deferred income taxes Long-term deferred tax asset Depreciation and amortization on discontinued operations Depreciation and Amortization, Discontinued Operations Depreciation and amortization Depreciation, Depletion and Amortization Derivative Instrument Risk [Axis] Derivative Instrument [Axis] Derivative Investments and Hedging Activities Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivative assets, current Derivative Asset, Current Liabilities measured at fair value on a recurring basis Derivative Liability, Fair Value, Amount Not Offset Against Collateral [Abstract] Derivative assets, long-term Derivative Asset, Noncurrent Assets [Abstract] Derivative Asset [Abstract] Derivative Investments and Hedging Activities [Abstract] Assets measured at fair value on a recurring basis Derivative Asset, Fair Value, Amount Not Offset Against Collateral [Abstract] Cash conversion derivative, current Derivative liabilities, current Cash conversion derivative, long-term Derivative liabilities, long-term Liabilities [Abstract] Fair Value Derivative Asset, Fair Value, Gross Asset Fair Value Fair Values of Derivative Instruments [Abstract] Derivative, Fair Value, Net [Abstract] Fixed interest rate Loss related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect Derivative Contract Type [Domain] Derivative Contract [Domain] Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion Derivatives, Fair Value [Line Items] Share-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Share-Based Compensation [Abstract] Income tax (benefit) expense Discontinued Operation, Tax Effect of Discontinued Operation Total pretax loss on discontinued operations Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax Discontinued Operations [Abstract] Pretax loss on discontinued operations Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax Discontinued Operations, Disposed of by Sale [Member] Significant operating and investing non-cash items of the discontinued operations [Abstract] Discontinued Operation, Alternative Cash Flow Information [Abstract] Cost of services Disposal Group, Including Discontinued Operation, Costs of Goods Sold Revenues Disposal Group, Including Discontinued Operation, Revenue Disposal Group Classification [Domain] Selling, general & administrative expenses Disposal Group, Including Discontinued Operation, General and Administrative Expense Depreciation and amortization Disposal Group, Including Discontinued Operation, Depreciation and Amortization Disposal Group Classification [Axis] Financial results included in losses from discontinued operations [Abstract] Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract] Payment obligation included in accrued liabilities Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current Disposal Group Name [Domain] Discontinued Operations Earnings (loss) per share attributable to Tivity Health, Inc. - basic [Abstract] Earnings (loss) per share attributable to Tivity Health, Inc. - basic: Earnings (loss) per share attributable to Tivity Health, Inc. - diluted: Earnings (loss) per share attributable to Tivity Health, Inc. - diluted [Abstract] Earnings Per Share, Diluted [Abstract] Net income (loss) (in dollars per share) Earnings Per Share, Basic Net income (loss) (in dollars per share) Earnings Per Share, Diluted Earnings (Loss) Per Share Earnings Per Share [Text Block] Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items] Earnings (Loss) Per Share [Abstract] Effect of exchange rate changes on cash Effective tax rate Accrued salaries and benefits Severance and Other Employee-related Costs [Member] Employee Severance [Member] Non-Qualified Stock Options [Member] Non-Qualified Stock Options [Member] Stock Options [Member] Equity Component [Domain] Percentage of ownership interest acquired in joint venture Equity Method Investment, Ownership Percentage Level 3 Financial Instruments Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Fair Value, Hierarchy [Axis] Measurement Frequency [Axis] Fair Value Measurements [Abstract] Purchases of Level 3 instruments Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Measurement Frequency [Domain] Recurring [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Measurements, Fair Value Hierarchy [Domain] Settlements of Level 3 instruments Fair Value Measurements Fair Value Disclosures [Text Block] Assets and liabilities measured at fair value on a recurring basis [Abstract] Fair Value, Assets, Liabilities and Stockholders' Equity Measured on Recurring Basis [Abstract] Level 3 [Member] Balance at end of period Balance at beginning of period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Gains (Losses) included in Earnings Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Financial Instrument [Axis] Furniture and office equipment Net unrealized gain (loss) Goodwill, net Cash convertible notes hedges, long-term Cash convertible notes hedges, current Hedging Assets, Current Hedging Designation [Axis] Hedging Designation [Domain] Income Taxes [Abstract] Net income from continuing operations Net income from continuing operations attributable to Tivity Health, Inc. - numerator for earnings per share Discontinued operations (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Continuing operations (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share Income Statement Location [Axis] Equity in income from joint ventures Income (Loss) from Equity Method Investments Income before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Income Statement Location [Domain] Net loss from discontinued operations Loss from discontinued operations, net of income tax benefit Loss from discontinued operations, net of income tax benefit Income Tax Authority [Axis] Discontinued operations (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Continuing operations (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Income Tax Authority [Domain] Income Taxes Income Tax Disclosure [Text Block] Income tax expense Income tax benefit CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) [Abstract] Disposal Groups, Including Discontinued Operations [Table] Disposal Group Name [Axis] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Net loss from discontinued operations attributable to Tivity Health, Inc. - numerator for loss per share Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Income taxes receivable Increase (decrease) in other current liabilities Increase (Decrease) in Other Current Liabilities Increase (decrease) in accounts payable (Increase) decrease in accounts receivable, net Increase (Decrease) in Accounts Receivable (Increase) decrease in other current assets Increase (Decrease) in Other Current Assets Decrease in accrued salaries and benefits Increase (Decrease) in Stockholders' Equity [Roll Forward] Effect of dilutive stock options and restricted stock units outstanding (in shares) Intangible assets, net Interest expense Interest expense Interest Rate Swaps [Member] Federal [Member] LIBOR [Member] London Interbank Offered Rate (LIBOR) [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Leasehold improvements Letters of Credit Sub Facility [Member] Sublimit for Letters of Credit [Member] Total liabilities and stockholders' equity Liabilities and Equity LIABILITIES AND STOCKHOLDERS' EQUITY LIABILITIES AND STOCKHOLDERS' EQUITY [Abstract] Total current liabilities Liabilities, Current Current liabilities: Line of Credit Facility [Table] Initiation date Unused commitment fee percentage Amount outstanding Line of Credit Facility [Line Items] Expiration date Maximum borrowing capacity Availability under the revolving credit facility under most restrictive covenant Debt Instrument, Fair Value Long-term debt, gross Long-term Debt and Capital Lease Obligations, Including Current Maturities Long term debt outstanding Total debt including debt held for sale as discontinued operations Long-term Debt Long-Term Debt [Abstract] Long-Term Debt Long-term Debt [Text Block] Current portion of long-term debt Less: current portion Long-term debt Long-term debt, excluding current portion Loss Contingencies [Table] Loss Contingencies [Line Items] Maximum [Member] Minimum [Member] Net cash flows provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from financing activities: Net cash flows used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from investing activities: Cash flows from operating activities: Numerator [Abstract] Net Income (Loss) Attributable to Parent [Abstract] Net income (loss) attributable to Tivity Health, Inc. Net income (loss) attributable to Tivity Health, Inc. - numerator for earnings (loss) per share Net Income (Loss) Attributable to Parent Net cash flows used in financing activities Net Cash Provided by (Used in) Financing Activities Less: net income (loss) attributable to non-controlling interest New Accounting Pronouncements or Change in Accounting Principle [Table] Recent Relevant Accounting Standards Recent Relevant Accounting Standards New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Adjustments for New Accounting Pronouncement [Member] Recent Relevant Accounting Standards [Abstract] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Open tax year Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Operating loss carryforwards Operating income Operating Income (Loss) Basis of Presentation [Abstract] Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Total other comprehensive income, net of tax Other Comprehensive Income (Loss), Net of Tax Other comprehensive income (loss) before reclassifications, tax Other comprehensive income (loss) before reclassifications, net of tax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Foreign currency translation adjustment, net of tax Consulting and Other Costs [Member] Other Restructuring [Member] Other Other Operating Activities, Cash Flow Statement Other comprehensive income, net of tax Other Comprehensive Income (Loss), Tax [Abstract] Other current assets Other assets Net change in fair value of interest rate swaps, net of tax Other long-term liabilities Other current liabilities Sun Trust Bank Prime Rate [Member] Prime Rate [Member] Fair value of cash conversion derivative Payments for Derivative Instrument, Financing Activities Other Payments for (Proceeds from) Other Investing Activities Payments related to tax withholding for share-based compensation Payments Related to Tax Withholding for Share-based Compensation Payments Payments for Restructuring Investment in joint ventures Payments to Acquire Interest in Joint Venture Acquisition of property and equipment Payments to Acquire Property, Plant, and Equipment Preferred Stock [Member] Preferred stock, shares authorized (in shares) Preferred stock, par value (in dollars per share) Preferred stock, shares outstanding (in shares) Preferred stock $.001 par value, 5,000,000 shares authorized, none outstanding Prepaid expenses Change in cash overdraft and other Proceeds from issuance of long-term debt Exercise of stock options Proceeds from Stock Options Exercised Net income (loss) Net income (loss) Net of tax Property and equipment: Property and equipment, net Property, Plant and Equipment, Net Property and equipment, gross Property, Plant and Equipment, Gross Contractual obligations in respect of purchase price to be paid in connection with Sharecare's acquisition of additional membership interest in Gallup Joint Venture Purchase Obligation Range [Axis] Range [Domain] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Reclassification out of Accumulated Other Comprehensive Income [Table] Amounts reclassified from accumulated other comprehensive income to: [Member] Reclassification out of Accumulated Other Comprehensive Income [Member] Reclassification Out Of Accumulated Other Comprehensive Income [Domain] Reclassification Out Of Accumulated Other Comprehensive Income [Axis] Amounts reclassified from accumulated OCI, net of tax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Reclassifications out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Changes in accumulated OCI, net of tax [Roll Forward] Payments of long-term debt Repayments of Long-term Debt Restricted Stock Units [Member] Restricted Stock Units [Member] Restricted Stock and Restricted Stock Units [Member] Restructuring and related charges Restructuring charges Accrued restructuring and related charges liability as of period end Accrued restructuring and related charges liability as of period start Restructuring Reserve Restructuring charges incurred Restructuring and Related Cost, Cost Incurred to Date Restructuring Plan [Domain] Restructuring Plan [Axis] Adjustments Restructuring Reserve, Accrual Adjustment Restructuring and Related Charges [Abstract] Restructuring Cost [Abstract] Restructuring Reserve [Roll Forward] Restructuring Type [Axis] Restructuring Cost and Reserve [Line Items] Restructuring and Related Charges Restructuring, Impairment, and Other Activities Disclosure [Text Block] Accumulated Deficit [Member] Accumulated deficit Retained Earnings (Accumulated Deficit) Revolving Credit Facility [Member] Revolver [Member] Revolving Credit Facility [Member] Exercisable Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Revenues Sales Revenue, Services, Net Changes in Accumulated Other Comprehensive Income (AOCI) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Summary of Stock Options Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Long-term Debt, Net of Unamortized Deferred Loan Costs (Details) Gains and Losses Resulting from Change in Fair Values of Derivatives Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Basic and Diluted Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Summary of Restricted Stock and Restricted Stock Units Schedule of Nonvested Share Activity [Table Text Block] Assets and Liabilities Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Line Items] Schedule of Restructuring and Related Costs [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Restructuring Plan and Other Restructuring Costs Fair Values of Derivative Instruments Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Effect of Cash Flow Hedges on the Consolidated Balance Sheets Derivative Instruments, Gain (Loss) [Table Text Block] Discontinued Operations [Member] Selling, general & administrative expenses Selling, General and Administrative Expenses [Member] 1.50% Cash Convertible Senior Notes Due 2018 [Member] Summary of stock options [Abstract] Share-based employee compensation expense Share-based Compensation Granted (in dollars per share) Forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted-Average Grant Date Fair Value [Roll Forward] Exercised (in dollars per share) Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Granted (in shares) Expired (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Forfeited (in dollars per share) Weighted Average Exercise Price [Roll Forward] Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Nonvested, end of period (in dollars per share) Nonvested, beginning of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Nonvested, beginning of period (in shares) Nonvested, end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Exercisable, end of period (in dollars per share) Exercisable, end of period (in shares) Weighted Average Remaining Contractual Term [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Vested (in dollars per share) Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Outstanding, end of period (in dollars per share) Outstanding, beginning of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Outstanding, beginning of period (in shares) Outstanding, end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Award Type [Domain] Outstanding Shares [Roll Forward] State [Member] Statement [Line Items] Statement, Equity Components [Axis] Equity Components [Axis] CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) [Abstract] CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) [Abstract] CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) [Abstract] Statement [Table] CONSOLIDATED BALANCE SHEETS (Unaudited) [Abstract] Exercise of stock options Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Stockholders' equity: Stockholders' equity: Total stockholders' equity Balance Balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Balance Balance Stockholders' Equity Attributable to Parent Subsequent Event [Abstract] Subsequent Event [Member] Subsequent Event Subsequent Event Type [Axis] Subsequent Event [Line Items] Subsequent Event [Table] Subsequent Event Type [Domain] Financial Instruments [Domain] Treasury Stock [Member] Treasury stock (in shares) Treasury stock, at cost, 2,254,953 shares in treasury Treasury Stock, Value Type of Restructuring [Domain] Type of Adoption [Domain] Revolving commitments amount Variable Rate [Domain] Variable Rate [Axis] CareFirst Warrants [Member] Warrant [Member] Shares used for diluted income (loss) per share (in shares) Diluted (in shares) Weighted average common shares and equivalents: Denominator [Abstract] Weighted Average Number of Shares Outstanding, Diluted [Abstract] Effect of dilutive stock options and restricted stock units outstanding [Abstract] Shares used for basic income (loss) per share (in shares) Basic (in shares) Amount of long-term liabilities, classified as current. Long Term Liabilities Current Maturities Current portion of long-term liabilities A prior revolving credit facility which includes a swing line sub facility and a sub facility for letters of credit. Prior Credit Agreement [Member] Prior Credit Agreement [Member] Cash convertible senior notes due 2018. Cash Convertible Notes [Member] Cash Convertible Notes [Member] Refers to cash conversion on derivative. Cash Conversion Derivative [Member] Cash-settled hedge entered into in connection with the issuance of the Cash Convertible Notes, intended to reduce our exposure to potential cash payments that we would be required to make if holders elect to convert the Cash Convertible Notes at a time when our stock price exceeds the conversion price. Cash Convertible Notes Hedge [Member] Cash Convertible Notes Hedges [Member] Amount of increase (decrease) in cash and cash equivalents held for sale. Cash and Cash Equivalents Held for Sale, Period Increase (Decrease) Less: net increase in discontinued operations cash and cash equivalents The cash outflow associated with the sale of a business segment during the period. Payments for Divestiture of Business One Payments related to sale of TPHS business Gain (loss) from sale or disposal of an organization or integrated set of activities. Gain (Loss) On Sale Of Business One Loss on sale of TPHS business The aggregate continuing and discontinued operations expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Depreciation and Amortization including Discontinued Operations Depreciation and amortization Refers to one of the largest independent insurers in Brazil. Sul America [Member] SulAmerica [Member] Contractual Commitment [Abstract] Refers to the number of quarterly installments. Number of quarterly installments Refers to the percentage of remaining payment obligations in respect of the purchase price to be paid in connection with the acquisition. Remaining payment obligation responsibility percentage A digital health company helping people manage all their healthcare in one place. Sharecare [Member] Amount of the cumulative effect on stockholders' equity, net of related income tax effect. Cumulative Effect on Stockholders' Equity, Net Of Tax Retained earnings Cumulative effect of a change in accounting principle - adoption of ASU 2016-09 Accounting Standards Update 2016-09 Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. Accounting Standards Update 201609 [Member] ASU No. 2016-09 [Member] Derivatives in Cash Flow Hedging Relationships [Abstract] Refers to purchase agreement, value of negative cash flows during transition year. Purchase Agreement Value Of Negative Cash Flows During Transition Year Cash paid to ShareCare at closing This element refers to total fair value of adjustable convertible equity right recorded. Fair Value of Adjustable Convertible Equity Right recorded Total fair value of adjustable convertible equity right recorded Refers to the period considered for conversion of stock, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Conversion Period Of Stock Conversion Conversion period of stock conversion This element refers to equity in income (loss) from Joint Ventures. Equity in Income (Loss) from Joint Ventures Equity in income from joint ventures Fair Value of Adjustable Convertible Equity Right recorded, excluding net working capital settlement portion of ACER recorded. Fair Value of Adjustable Convertible Equity Right, excluding net working capital settlement Fair value of adjustable convertible equity right, excluding net working capital settlement Refers to the conversion price per share of shares under purchase agreement. Stock Issued During Period Conversion Of Convertible Securities Conversion Price Stock issued during period conversion of convertible securities, conversion price (in dollars per share) Refers to the name of the disposal group TPHS business. TPHS Business [Member] Refers to the maximum reduction in the face amount of adjustable convertible equity right due to negative cash flows. Maximum Reduction in Face Amount of Adjustable Convertible Equity Right Due to Negative Cash Flows Maximum reduction in face amount of adjustable convertible equity right due to negative cash flows Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation. Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation Three, before Income Tax Pretax loss on sale of TPHS business A right delivered to the Company by Sharecare upon the completion of the transactions contemplated by the Purchase Agreement (the "Closing"), with an initial face value of $30.0 million, which will be convertible into shares of common stock of Sharecare 24 months after the Closing, at an initial conversion price of $249.87 per share, subject to customary adjustment for stock splits, stock dividends and other reorganizations of Sharecare. Adjustable Convertible Equity Right [Member] Amount of restructuring and related charges attributable to disposal group, including, but not limited to, discontinued operation. Disposal Group Including Discontinued Operations Restructuring And Related Charges Restructuring and related charges Refers to the initial face amount of right shares issued under purchase agreement. Adjustable Convertible Equity Right, Initial Face Amount Adjustable convertible equity right, initial face amount Amount of share based compensation attributable to discontinued operations. Share Based Compensation Discontinued Operations Share-based compensation on discontinued operations Refers to the face amount of adjustable convertible equity right, net of the face value maximum negative cash flow adjustment. Adjustable Convertible Equity Right, Face Amount Net of Face Value Maximum Negative Cash Flow Adjustment Adjustable convertible equity right, face amount net of face value maximum negative cash flow adjustment Convertible subordinated promissory note issued to CareFirst on October 1, 2013 in the aggregate original principal amount of $20 million. CareFirst Convertible Note [Member] Shares or units awarded to employees for meeting certain market targets. Market Stock Units [Member] Warrants related to the issuance of the Cash Convertible Notes Warrants Related to Cash Convertible Notes [Member] Warrants Related to Cash Convertible Notes [Member] Tabular disclosure of information related to depreciation, amortization and significant operating and investing non-cash items of discontinued operations. Disposal Groups Including Discontinued Operations Depreciation Amortization And Significant Operating And Investing Non Cash Items Of Discontinued Operations [Text Block] Significant Operating and Investing Non-cash Items of the Discontinued Operations Tabular disclosure of income statement information related to a disposal group. Disposal Groups Including Discontinued Operations Income Statement [Text Block] Financial Results Included in Losses from Discontinued Operations Represents the number of types of share-based awards outstanding to employees and directors. Share-based Compensation Arrangement by Share-based Payment Award, Types of Share Based Awards Types of share based awards Restricted Stock and Restricted Stock Units [Abstract] Summary of nonvested shares [Abstract] Aggregate Intrinsic Value [Abstract] Tabular disclosure of the changes in outstanding market stock unit nonvested shares. Schedule of Market Stock Units [Table Text Block] Summary of Market Stock Units Face (par) amount of convertible debt instrument at time of issuance. Debt Instrument, Convertible, Face Amount Par amount of convertible note The initial strike price of the warrants effectively increase the conversion price of the notes to this percentage above the stock price. Conversion price premium percentage Conversion price premium percentage Document and Entity Information [Abstract] Represents the 2015 Restructuring which primarily focused on aligning resources with current and emerging markets and consolidating operating capacity. Restructuring Plan 2015 [Member] 2015 Restructuring Plan [Member] Represents the 2016 Restructuring Plan focused on reorganization of HWAY corporate support infrastructure. 2016 Restructuring Plan [Member] Amount of the required periodic payments expressed as a percent of the original principal amount of debt instrument. Debt Instrument, Periodic Payment, Percentage of Original Principal Amount Periodic principal payment as percentage of aggregate principal amount Interest rate at which a bank borrows funds from other banks in the London interbank market in a given month. One-Month London Interbank Offered Rate (LIBOR) [Member] One-Month LIBOR [Member] The reference rate for the variable rate of the debt instrument, such as LIBOR or the US Treasury rate and the maturity of the reference rate used, such as three months or six months LIBOR. Debt Instrument, Variable Rate Basis Variable rate basis Refers to the margin rate on the debt instrument. Debt Instrument, Margin Rate Margin rate A loan from a bank for a specified amount that has a specified repayment schedule and a floating interest rate. The borrower can withdraw predefined amounts of the total pre-approved amount of a term loan at contractual times. This special type of term loan is only offered to individuals and firms that meet and maintain certain contractual requirements and have outstanding credit ratings. Delayed Draw Term Loan Facility [Member] A loan from a bank for a specified amount that has a specified repayment schedule and a floating interest rate. Term Loan Facility [Member] Term Loan [Member] Term Loan A and Delayed Draw Term Loan [Member] A loan from a bank for a specified amount that has a specified repayment schedule and a floating interest rate. Term Loan Facility A [Member] A large loan that a company may take out in order to repay other debts. A swingline loan is much like a line of credit or a demand loan, but differs in that it must be used to repay outstanding debt. Swingline Sub Facility [Member] Sublimit for Swingline Loans [Member] A type of option that a borrower can have inserted into a syndicated credit agreement at the outset of the transaction which allows it to increase the principal under the credit agreement, subject to there being no event of default. The interest, maturity and other terms applicable to the increased commitment will be identical to those applicable to the existing credit facility to which the increase relates. Companies typically purchase an accordion feature in anticipation of the need for more capital for possible expansion opportunities. Uncommitted Incremental Accordion Facility [Member] The federal funds rate is the interest rate at which depository institutions actively trade balances held at the Federal Reserve, called federal funds, with each other, usually overnight, on an uncollateralized basis. Federal Funds Rate [Member] A credit facility agreement which includes revolving credit and term loan facility. Credit Agreement [Member] Credit Agreement [Member] Refers to the Eighth Amendment to the Prior Credit Agreement the Company entered into on August 4, 2016. Eighth Amendment To Prior Credit Agreement [Member] Eighth Amendment to Prior Credit Agreement [Member] A loan from a bank for a specified amount that has a specified repayment schedule and a floating interest rate. Term Loan A Facility [Member] EX-101.PRE 10 tvty-20170331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 11 image0.jpg begin 644 image0.jpg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end XML 12 R1.htm IDEA: XBRL DOCUMENT v3.7.0.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2017
Apr. 30, 2017
Document and Entity Information [Abstract]    
Entity Registrant Name TIVITY HEALTH, INC.  
Entity Central Index Key 0000704415  
Current Fiscal Year End Date --12-31  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Filer Category Accelerated Filer  
Entity Common Stock, Shares Outstanding   39,197,878
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q1  
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2017  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 664 $ 1,602
Accounts receivable, net 66,942 50,424
Prepaid expenses 3,662 3,409
Other current assets 2,288 2,250
Cash convertible notes hedges, current 82,445 0
Income taxes receivable 0 426
Total current assets 156,001 58,111
Property and equipment:    
Leasehold improvements 10,144 10,144
Computer equipment and related software 23,404 23,024
Furniture and office equipment 8,670 8,670
Capital projects in process 2,506 2,079
Property and equipment, gross 44,724 43,917
Less accumulated depreciation (36,379) (35,586)
Property and equipment, net 8,345 8,331
Other assets 6,646 6,688
Cash convertible notes hedges, long-term 0 48,361
Long-term deferred tax asset 57,129 59,562
Intangible assets, net 29,049 29,049
Goodwill, net 334,680 334,680
Total assets 591,850 544,782
Current liabilities:    
Accounts payable 27,577 26,029
Accrued salaries and benefits 7,999 18,686
Accrued liabilities 38,215 33,623
Other current liabilities 364 397
Cash conversion derivative, current 82,445 0
Current portion of long-term debt 147,102 46,046
Current portion of long-term liabilities 5,831 7,582
Total current liabilities 309,533 132,363
Long-term debt 60,196 164,297
Cash conversion derivative, long-term 0 48,361
Other long-term liabilities 8,149 10,463
Stockholders' equity:    
Preferred stock $.001 par value, 5,000,000 shares authorized, none outstanding 0 0
Common stock $.001 par value, 120,000,000 shares authorized, 39,188,902 and 38,933,580 shares outstanding, respectively 39 39
Additional paid-in capital 344,108 341,270
Accumulated deficit (97,602) (119,327)
Treasury stock, at cost, 2,254,953 shares in treasury (28,182) (28,182)
Accumulated other comprehensive loss (4,391) (4,502)
Total stockholders' equity 213,972 189,298
Total liabilities and stockholders' equity $ 591,850 $ 544,782
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Mar. 31, 2017
Dec. 31, 2016
Stockholders' equity:    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 120,000,000 120,000,000
Common stock, shares outstanding (in shares) 39,188,902 38,933,580
Treasury stock (in shares) 2,254,953 2,254,953
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) [Abstract]    
Revenues $ 140,970 $ 126,012
Cost of services (exclusive of depreciation and amortization of $657 and $1,530, respectively, included below) 102,399 91,377
Selling, general & administrative expenses 8,361 9,411
Depreciation and amortization 787 1,872
Restructuring and related charges 737 39
Operating income 28,686 23,313
Interest expense 3,834 4,105
Income before income taxes 24,852 19,208
Income tax expense 9,371 0
Net income from continuing operations 15,481 19,208
Loss from discontinued operations, net of income tax benefit (220) (33,105)
Net income (loss) 15,261 (13,897)
Less: net income (loss) attributable to non-controlling interest 0 312
Net income (loss) attributable to Tivity Health, Inc. $ 15,261 $ (14,209)
Earnings (loss) per share attributable to Tivity Health, Inc. - basic:    
Continuing operations (in dollars per share) $ 0.40 $ 0.53
Discontinued operations (in dollars per share) (0.01) (0.93)
Net income (loss) (in dollars per share) [1] 0.39 (0.39)
Earnings (loss) per share attributable to Tivity Health, Inc. - diluted:    
Continuing operations (in dollars per share) 0.38 0.52
Discontinued operations (in dollars per share) (0.01) (0.91)
Net income (loss) (in dollars per share) [1] $ 0.38 $ (0.39)
Comprehensive income (loss) $ 15,372 $ (12,851)
Weighted average common shares and equivalents:    
Basic (in shares) 39,069 36,109
Diluted (in shares) 40,541 36,861
[1] Figures may not add due to rounding.
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) [Abstract]    
Cost of services, depreciation and amortization $ 657 $ 1,530
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) [Abstract]    
Net income (loss) $ 15,261 $ (13,897)
Other comprehensive income, net of tax    
Net change in fair value of interest rate swaps, net of tax 0 24
Foreign currency translation adjustment, net of tax 111 1,022
Total other comprehensive income, net of tax 111 1,046
Comprehensive income (loss) $ 15,372 $ (12,851)
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - 3 months ended Mar. 31, 2017 - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total
Balance at Dec. 31, 2016 $ 0 $ 39 $ 341,270 $ (119,327) $ (28,182) $ (4,502) $ 189,298
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income 0 0 0 15,261 0 111 15,372
Cumulative effect of a change in accounting principle - adoption of ASU 2016-09 0 0 74 6,464 0 0 6,538
Exercise of stock options 0 0 2,250 0 0 0 2,250
Tax effect of stock options and restricted stock units 0 0 (932) 0 0 0 (932)
Share-based employee compensation expense 0 0 1,446 0 0 0 1,446
Balance at Mar. 31, 2017 $ 0 $ 39 $ 344,108 $ (97,602) $ (28,182) $ (4,391) $ 213,972
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash flows from operating activities:    
Net income from continuing operations $ 15,481 $ 19,208
Net loss from discontinued operations (220) (33,105)
Adjustments to reconcile net income (loss) to net cash provided by operating activities, net of business acquisitions:    
Depreciation and amortization 793 12,746
Amortization of deferred loan costs 516 554
Amortization of debt discount 1,931 1,826
Share-based employee compensation expense 1,446 2,427
Loss on sale of TPHS business 310 0
Equity in income from joint ventures 0 (132)
Deferred income taxes 8,972 (191)
(Increase) decrease in accounts receivable, net (16,459) 7,471
(Increase) decrease in other current assets (441) 1,955
Increase (decrease) in accounts payable 1,337 (1,175)
Decrease in accrued salaries and benefits (12,099) (227)
Increase (decrease) in other current liabilities 2,642 (2,013)
Other (1,185) (1,734)
Net cash flows provided by operating activities 3,024 7,610
Cash flows from investing activities:    
Acquisition of property and equipment (1,234) (6,450)
Investment in joint ventures 0 (453)
Other 0 (275)
Net cash flows used in investing activities (1,234) (7,178)
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 109,975 131,500
Payments of long-term debt (115,465) (136,084)
Payments related to tax withholding for share-based compensation (885) (213)
Exercise of stock options 2,250 0
Change in cash overdraft and other 1,155 4,600
Net cash flows used in financing activities (2,970) (197)
Effect of exchange rate changes on cash 242 989
Less: net increase in discontinued operations cash and cash equivalents 0 588
Net (decrease) increase in cash and cash equivalents (938) 636
Cash and cash equivalents, beginning of period 1,602 233
Cash and cash equivalents, end of period $ 664 $ 869
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Basis of Presentation
3 Months Ended
Mar. 31, 2017
Basis of Presentation [Abstract]  
Basis of Presentation
1.
Basis of Presentation

Our financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles in the United States ("U.S. GAAP").  In our opinion, the accompanying consolidated financial statements of Tivity Health, Inc. and its wholly-owned subsidiaries (collectively, "Tivity Health," the "Company," or such terms as "we," "us," or "our") reflect all adjustments consisting of normal, recurring accruals necessary for a fair statement. We have reclassified certain items in prior periods to conform to current classifications.

Our results from continuing operations do not include the results of the total population health services ("TPHS") business, which we sold effective July 31, 2016.  The TPHS business included our partnerships with Blue Zones, LLC and Dr. Dean Ornish (the Blue Zones Project by Healthways™ and Dr. Dean Ornish's Program for Reversing Heart Disease™, respectively), our joint venture with Gallup, Inc. ("Gallup"), Navvis Healthcare, LLC ("Navvis"), MeYou Health, LLC ("MeYou Health"), and our international operations, including our joint venture with SulAméricaWhile Navvis and MeYou Health were part of our TPHS business, they were sold separately to other buyers in November 2015 and June 2016, respectively.  Results of operations for the TPHS business have been classified as discontinued operations for all periods presented in the accompanying Consolidated Financial Statements.  See Note 3 for further information.

On March 11, 2015, we formed a joint venture with SulAmérica, one of the largest independent insurers in Brazil, to sell total population health services to the Brazilian market. With its contribution, SulAmérica acquired a 49% interest in the joint venture, Healthways Brasil Servicos de Consultoria LTDA ("Healthways Brazil"). We determined that our interest in Healthways Brazil represented a controlling financial interest and, therefore, prior to selling the TPHS business, consolidated the financial statements of Healthways Brazil and presented a non-controlling interest for the portion owned by SulAmérica. The net assets and results of operations of Healthways Brazil were part of the sale of the TPHS business and are included within discontinued operations in the accompanying Consolidated Financial Statements.

We have omitted certain financial information that is normally included in financial statements prepared in accordance with U.S. GAAP but that is not required for interim reporting purposes. You should read the accompanying consolidated financial statements in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2016.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
Recent Relevant Accounting Standards
3 Months Ended
Mar. 31, 2017
Recent Relevant Accounting Standards [Abstract]  
Recent Relevant Accounting Standards
2.
Recent Relevant Accounting Standards

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-09, which creates Accounting Standards Codification ("ASC") Topic 606, "Revenue from Contracts with Customers" ("ASC Topic 606") and supersedes ASC Topic 605, "Revenue Recognition." The provisions of ASC Topic 606 provide for a single comprehensive principles-based standard for the recognition of revenue across all industries and expanded disclosure about the nature, amount, timing and uncertainty of revenue, as well as certain additional quantitative and qualitative disclosures. The standard is effective for annual periods beginning after December 15, 2017, including interim periods within those years. The guidance permits the use of either a retrospective or cumulative effect transition method. We have not yet selected a transition method.  We are currently conducting analysis to quantify the adoption impact of the provisions of the new standard and evaluating our current contracts and revenue streams. The FASB has issued, and may issue in the future, interpretive guidance which may cause our evaluation to change. We believe we are following an appropriate timeline to allow for proper recognition, presentation and disclosure upon adoption effective January 1, 2018.
 
In August 2014, the FASB issued ASU No. 2014-15, "Presentation of Financial Statements – Going Concern: Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern," which requires management to evaluate whether there is substantial doubt about the entity's ability to continue as a going concern and, if so, provide certain footnote disclosures. This ASU is effective for annual periods ending after December 15, 2016, including interim reporting periods thereafter. We adopted this ASU in the fourth quarter of 2016, and it did not have an impact on our financial statements or footnote disclosures.
 
In February 2016, the FASB issued ASU No. 2016-02, "Leases" ("ASU 2016-02"), which requires that lessees recognize assets and liabilities for leases with lease terms greater than twelve months in the statement of financial position. ASU 2016-02 also requires improved disclosures to help users of financial statements better understand the amount, timing and uncertainty of cash flows arising from leases. The update is effective for fiscal years beginning after December 15, 2018, including interim reporting periods within those years. We are currently evaluating the impact that the adoption of ASU 2016-02 will have on our financial position, results of operations and cash flows.

In March 2016, the FASB issued ASU No. 2016-09, "Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting" ("ASU 2016-09"), which we adopted on January 1, 2017.  ASU 2016-09 requires all income tax effects of share-based awards to be recognized in the income statement, which were previously presented as a component of shareholders' equity, on a prospective basis.  In addition, any excess tax benefits that were not previously recognized because the related tax deduction had not reduced current taxes payable are to be recorded on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption, which resulted in an increase of $6.5 million to our retained earnings as of January 1, 2017.  Regarding the statement of cash flows, the standard requires the presentation of excess tax benefits as an operating activity rather than as a financing activity and that cash paid by the Company when directly withholding shares for tax withholding purposes be classified as a financing activity on a retrospective basis. The standard also allows for an accounting policy election to estimate the number of awards that are expected to vest or to account for forfeitures when they occur. We elected to account for forfeitures as they occur, which did not result in a material cumulative effect adjustment to our retained earnings as of January 1, 2017.  Finally, the standard no longer allows windfall tax benefits to be included in the assumed proceeds when applying the treasury stock method for computing diluted earnings per share ("EPS"), which results in share-based awards having a more dilutive effect on EPS.

In August 2016, the FASB issued ASU No. 2016-15, "Statement of Cash Flows" (Topic 230) ("ASU 2016-15").  ASU 2016-15 addresses how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU 2016-15 is effective in the first quarter of 2018, with early adoption permitted, and is to be applied using a retrospective approach. We are currently evaluating the potential effects of adopting the provisions of ASU 2016-15.

In January 2017, the FASB issued ASU No. 2017-04, "Intangibles - Goodwill and Other" ("ASU 2017-04"), which simplifies the subsequent measurement of goodwill by eliminating step two from the goodwill impairment test.  ASU 2017-04 is effective for annual and interim impairment tests in fiscal years beginning after December 15, 2019 and is required to be applied prospectively. Early adoption is allowed for annual goodwill impairment tests performed on testing dates after January 1, 2017. We do not anticipate that adopting this standard will have an impact on our consolidated financial statements and related disclosures.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1
Discontinued Operations
3 Months Ended
Mar. 31, 2017
Discontinued Operations [Abstract]  
Discontinued Operations
3.           
Discontinued Operations
 
On July 27, 2016, we entered into a Membership Interest Purchase Agreement (the "Purchase Agreement") with Sharecare, Inc. ("Sharecare") and Healthways SC, LLC ("Healthways SC"), a newly formed Delaware limited liability company and wholly owned subsidiary of the Company, pursuant to which Sharecare acquired the TPHS business, which closed effective July 31, 2016 ("Closing").

At Closing, Sharecare delivered to the Company an Adjustable Convertible Equity Right (the "ACER") with an initial face value of $30.0 million, which will be convertible into shares of common stock of Sharecare 24 months after the Closing at an initial conversion price of $249.87 per share, subject to customary adjustment for stock splits, stock dividends and other reorganizations of Sharecare.  Additionally, pursuant to the Purchase Agreement, we paid Sharecare $25.0 million in cash at Closing to fund projected losses of the TPHS business during the year following Closing (the "Transition Year"). Pursuant to Sharecare's acquisition of the TPHS business, our ownership interest in the joint venture with Gallup (the "Gallup Joint Venture") was transferred to Sharecare. We agreed with Sharecare to be responsible for two-thirds of the remaining payment obligations in respect of the purchase price to be paid in connection with Sharecare's acquisition of additional membership interest in the Gallup Joint Venture. This obligation is currently expected to result in aggregate payments by us of approximately $4.2 million, payable in five equal quarterly installments that began in the fourth quarter of 2016 and will end in the fourth quarter of 2017. As of March 31, 2017, this obligation totaled $2.5 million and was included in accrued liabilities.
 
 The Purchase Agreement provided for post-closing adjustments based on (i) net working capital (which is expected to result in an increase in the face amount of the ACER due to a net working capital surplus, as further discussed below), (ii) negative cash flows of the TPHS business during the Transition Year in excess of $25.0 million (which may result in a reduction in the face amount of the ACER up to a maximum reduction of $20.0 million), and (iii) any successful claims for indemnification by Sharecare (which may result in a reduction in the face amount of the ACER, unless the Company elects, in its sole discretion, to satisfy any such successful claims with cash payments).
 
We recorded the ACER net of the $20.0 million face value maximum negative cash flow adjustment, or $10.0 million face value, at its estimated fair value of $2.7 million as of Closing.  We have classified this amount as an equity receivable included in other assets.  We will record the $20.0 million face value contingent portion of the ACER at its estimated fair value as of the date the contingency is resolved, expected to be approximately 12 months from Closing.  As of March 31, 2017, we recorded an estimate of the net working capital adjustment (a surplus), which resulted in an estimated fair value of the ACER of $5.4 million.  The working capital adjustment is subject to a review process, which is currently underway.

The terms of the Purchase Agreement also impacted other existing contractual commitments, including the elimination of the minimum fee requirements under our technology services outsourcing agreement with HP Enterprise Services, LLC.

The following table presents financial results of the TPHS business included in "loss from discontinued operations" for the three months ended March 31, 2017 and 2016.
 
 
 
Three Months Ended
March 31,
  
(In thousands)
 
2017
 
 
2016
 
 
 
 
 
 
 
 
 
 
Revenues
 
$
 
 
$
63,205
 
 
Cost of services
 
 
220
 
 
 
72,625
 
 
Selling, general & administrative expenses
 
 
137
 
 
 
7,061
 
 
Depreciation and amortization
 
 
 
 
 
10,874
 
 
Restructuring and related charges
 
 
 
 
 
5,702
 
 
Equity in income from joint ventures
 
 
 
 
 
132
 
 
Pretax loss on discontinued operations
 
$
(357
 
$
(32,925
 
Pretax loss on sale of TPHS business
 
 
(310
 
 
 
 
Total pretax loss on discontinued operations
 
$
(667
 
$
(32,925
 
Income tax (benefit) expense
 
 
(447
)
 
 
180
 
 
Loss from discontinued operations, net of income tax benefit
 
$
(220
 
$
(33,105
 
 
The depreciation, amortization and significant operating and investing non-cash items of the discontinued operations were as follows: 
 
 
Three Months Ended
March 31,
(In thousands)
 
2017
  
2016
 
 
   Depreciation and amortization on discontinued operations
 
$
 
 
$
10,874
 
 
   Capital expenditures on discontinued operations
 
 
 
 
 
5,420
 
 
   Share-based compensation on discontinued operations
 
 
 
 
 
768
 
 
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
Share-Based Compensation
3 Months Ended
Mar. 31, 2017
Share-Based Compensation [Abstract]  
Share-Based Compensation
4.
 Share-Based Compensation


We currently have four types of share-based awards outstanding to our employees and directors: stock options, restricted stock units, restricted stock and market stock units. We believe that our share-based awards align the interests of our employees and directors with those of our stockholders.

We recognize share-based compensation expense for the market stock units if the requisite service period
 
is rendered, even if the market condition is never satisfied. For the three months ended March 31, 2017, we recognized share-based compensation costs of $1.4 million.  For the three months ended March 31, 2016, we recognized share-based compensation costs of $2.4 million, of which $0.8 million is in discontinued operations.  Beginning in January 2017 with the adoption of ASU 2016-09, we account for forfeitures as they occur.

A summary of our stock options as of March 31, 2017 and the changes during the three months then ended is presented below:
 
 
 
 
 
 
Options
 
Shares
(In thousands)
 
 
Weighted
Average Exercise
Price
Per Share
 
 
Weighted Average
Remaining
Contractual
Term
 
 
Aggregate Intrinsic Value (In thousands)
 
Outstanding at January 1, 2017
 
 
1,024
 
 
$
14.02
 
 
 
 
 
 
 
Granted
 
 
 
 
 
 
 
 
 
 
 
 
Exercised
 
 
(181
)
 
 
12.36
 
 
 
 
 
 
 
Forfeited
 
 
 
 
 
 
 
 
 
 
 
 
Expired
 
 
(45
)
 
 
45.36
 
 
 
 
 
 
 
Outstanding at March 31, 2017
 
 
798
 
 
$
12.63
 
 
 
4.7
 
 
$
13,139
 
Exercisable at March 31, 2017
 
 
732
 
 
$
12.33
 
 
 
4.5
 
 
$
12,275
 

The following table shows a summary of our restricted stock and restricted stock units as of March 31, 2017, as well as activity during the three months then ended:

 
 
Restricted Stock and
Restricted Stock Units
 
 
 
Shares
(In thousands)
 
 
Weighted-
Average
Grant Date
Fair Value
 
Nonvested at January 1, 2017
 
 
939
 
 
$
13.11
 
Granted
 
 
4
 
 
 
27.97
 
Vested
 
 
(98
)
 
 
10.47
 
Forfeited
 
 
(37
)
 
 
11.70
 
Nonvested at March 31, 2017
 
 
808
 
 
$
13.57
 

The following table shows a summary of our market stock units as of March 31, 2017, as well as activity during the three months then ended:

 
 
 
 
Market Stock Units
 
 
 
 
 
Shares
(In thousands)
 
 
Weighted-
Average
Grant Date
Fair Value
 
Nonvested at January 1, 2017
 
 
 
 
406
 
 
$
8.75
 
Granted
 
 
 
 
 
 
 
 
Vested
 
 
 
 
(8
 
 
5.46
 
Forfeited
 
 
 
 
(25
 
 
5.95
 
Nonvested at March 31, 2017
 
 
 
 
373
 
 
$
9.01
 
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
Income Taxes
3 Months Ended
Mar. 31, 2017
Income Taxes [Abstract]  
Income Taxes
5.
Income Taxes

For the three months ended March 31, 2017, we had an effective income tax rate from continuing operations of 37.7%.  For the three months ended March 31, 2016, we followed the intra-period tax allocation guidance in ASC 740-20 and the example in ASC 740-20-55-14, which requires that the amount of tax attributable to the current year income from continuing operations be determined by a computation that does not consider the tax effects of items that are excluded from income from continuing operations (e.g.Discontinued operations).  We had net operating loss carryforwards from 2015 subject to a valuation allowance at December 31, 2015, which, upon reversal of the valuation allowance in the first quarter of 2016, we utilized to offset income from continuing operations for the three months ended March 31, 2016.
                At March 31, 2017, we had approximately $160.5 million of federal loss carryforwards and approximately $191.2 million of state loss carryforwards.

We file income tax returns in the U.S. Federal jurisdiction and in various state and foreign jurisdictions.  Our 2014 federal income tax return is currently under IRS examination.  Tax years remaining subject to examination in the U.S. Federal jurisdiction include 2013 to present.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.7.0.1
Long-Term Debt
3 Months Ended
Mar. 31, 2017
Long-Term Debt [Abstract]  
Long-Term Debt
6.
Long-Term Debt

The Company's long-term debt, net of unamortized deferred loan costs, consisted of the following at March 31, 2017 and December 31, 2016:

(In thousands)
 
March 31, 2017
 
 
December 31, 2016
 
Cash Convertible Notes, net of unamortized discount
 
$
139,790
 
 
$
137,859
 
Prior Credit Agreement:
 
 
 
 
 
 
 
 
Term Loan
 
 
55,000
 
 
 
60,000
 
Revolver
 
 
13,250
 
 
 
13,500
 
Capital lease obligations and other
 
 
1,029
 
 
 
1,270
 
 
 
 
209,069
 
 
 
212,629
 
Less: deferred loan costs
  
(1,771
)
  
(2,286
)
   
207,298
   
210,343
 
Less: current portion
 
 
(147,102
)
 
 
(46,046
)
 
 
$
60,196
 
 
$
164,297
 

Credit Facility

On June 8, 2012, we entered into the Fifth Amended and Restated Revolving Credit and Term Loan Agreement (as amended, the "Prior Credit Agreement").  The Prior Credit Agreement provided us with a $125 million revolving credit facility that includes a swingline sub facility of $20 million and a $75 million sub facility for letters of credit.  The Prior Credit Agreement also provided a $200 million term loan facility, $55 million of which remained outstanding at March 31, 2017, and an uncommitted incremental accordion facility of $100 million.  On April 21, 2017, we entered into a new revolving credit and term loan agreement, as described in detail below.
 
Borrowings under the Prior Credit Agreement generally bore interest at variable rates based on a margin or spread in excess of either (1) the one-month, two-month, three-month or six-month rate (or with the approval of affected lenders, nine-month or twelve-month rate) for Eurodollar deposits ("LIBOR", which may not be less than zero), or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50% and (c) one-month LIBOR plus 1.00% (the "Base Rate"), as selected by the Company.  The LIBOR margin varied between 1.75% and 3.00%, and the Base Rate margin varied between 0.75% and 2.00%, depending on our leverage ratio.  The Prior Credit Agreement also provided for an annual fee ranging between 0.30% and 0.50% of the unused commitments under the revolving credit facility.  Extensions of credit under the Prior Credit Agreement were secured by guarantees from all of the Company's active domestic subsidiaries and by security interests in substantially all of the Company's and such subsidiaries' assets.

On August 4, 2016, we entered into the Eighth Amendment to the Prior Credit Agreement (the "Eighth Amendment").  The Eighth Amendment extended the expiration date of the revolving credit facility and the maturity date of the term loan facility under the Prior Credit Agreement from June 8, 2017 to June 8, 2018 (the "Extended Maturity Date").  The Eighth Amendment contemplated that some lenders might not agree to the Extended Maturity Date and preserved June 8, 2017 as the non-extended maturity date (the "Non-Extended Maturity Date") for such lenders.  Lenders holding $45.3 million of the revolving commitments and $25.4 million of outstanding term loans as of August 4, 2016 did not consent to the Extended Maturity Date.  On the Non-Extended Maturity Date, the revolving commitments of non-consenting revolving lenders will terminate and any outstanding term loans and revolving loans owed to non-consenting lenders must be paid in full.  The outstanding revolving loans under the revolving credit facility held by consenting lenders must be paid in full on June 8, 2018.  We are required to repay term loans in quarterly principal installments aggregating 2.50% of the original aggregate principal amount of the term loans ($5.0 million) during each of the remaining quarters prior to maturity on June 8, 2018, at which time the entire unpaid principal balance of the term loans held by consenting lenders is due and payable.  As of March 31, 2017, availability under the revolving credit facility totaled $104.3 million.
 
 On April 21, 2017, we entered into a new Revolving Credit and Term Loan Agreement (the "Credit Agreement") with a group of lenders, which replaced the Prior Credit Agreement.  The Credit Agreement provides us with (1) a $100 million revolving credit facility that includes a $25 million sublimit for swingline loans and a $75 million sublimit for letters of credit, (2) a $70 million term loan A facility, (3) a $150 million delayed draw term loan facility, and (4) an uncommitted incremental accordion facility of $100 million.

We used the proceeds of the term loan A and cash on hand to repay all of the outstanding indebtedness under the Prior Credit Agreement and to pay transaction costs and expenses.  Proceeds of revolving loans and delayed draw term loans may be used to repay outstanding indebtedness (including amounts payable upon or in respect of any conversion of the Cash Convertible Notes discussed below and the repayment of any revolving loans borrowed for such purposes), to finance working capital needs, to finance acquisitions, to finance the repurchase of our common stock, to finance capital expenditures and for other general corporate purposes of the Company and its subsidiaries.  Delayed draw term loans may not be borrowed after July 2, 2018.

We are required to repay outstanding revolving loans in full on April 21, 2022.  We are required to repay the term loan A in quarterly principal installments aggregating (1) $875,000 each for the first twelve quarters following the closing, and (2) $1,312,500 each for the remaining quarters prior to maturity on April 21, 2022.  We are required to repay the delayed draw term loans in quarterly principal installments calculated as follows: (1) for each of the first twelve quarters following the closing, 1.250% of the aggregate principal amount of the delayed draw term loans funded as of the last day of the immediately preceding quarter; and (2) for each of the remaining quarters prior to maturity on April 21, 2022, 1.875% of the aggregate principal amount of the delayed draw term loans funded as of the last day of the immediately preceding quarter.  At maturity on April 21, 2022, the entire unpaid principal balances of the term loan A and the delayed draw term loans are due and payable.  As a result of entering into the Credit Agreement, as of March 31, 2017 we reclassified $37.3 million from current liabilities to long-term debt; this amount was due within one year from March 31, 2017 under the Prior Credit Agreement.

Borrowings under the Credit Agreement generally bear interest at variable rates based on a margin or spread in excess of either (1) the one-month, two-month, three-month or six-month LIBOR rate (or with the approval of affected lenders, the twelve-month LIBOR rate), which may not be less than zero, or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50%, and (c) one-month LIBOR plus 1.00% (the "Base Rate"), as selected by the Company.  The LIBOR margin varies between 1.50% and 2.75%, and the Base Rate margin varies between 0.50% and 1.75%, depending on our net leverage ratio.  The Credit Agreement also provides for annual fees ranging between 0.20% and 0.50% of the unused commitments under the revolving credit facility and the delayed draw term loan facility.  Extensions of credit under the Credit Agreement are secured by guarantees from all of the Company's active material subsidiaries and by security interests in substantially all of the Company's and such subsidiaries' assets.

Each of the Prior Credit Agreement and the Credit Agreement contains financial covenants that require us to maintain, as defined, specified ratios or levels of (1) funded debt to EBITDA and (2) fixed charge coverage. The Prior Credit Agreement and the Credit Agreement also contain various other affirmative and negative covenants that are typical for financings of this type.  Among other things, they limit repurchases of our common stock and the amount of dividends that we can pay to holders of our common stock.

1.50% Cash Convertible Senior Notes Due 2018

On July 16, 2013, we completed the issuance of $150.0 million aggregate principal amount of cash convertible senior notes due 2018 (the "Cash Convertible Notes"), which bear interest at a rate of 1.50% per year, payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2014. The Cash Convertible Notes will mature on July 1, 2018, unless earlier repurchased or converted into cash in accordance with their terms prior to such date. At the option of the holders, the Cash Convertible Notes are convertible into cash based on the conversion rate set forth below only upon occurrence of certain triggering events as defined in the Indenture dated as of July 8, 2013 by and between the Company and U.S. Bank National Association, none of which had occurred as of December 31, 2016 and one of which had occurred as of March 31, 2017, as further detailed below. Accordingly, we have classified the Cash Convertible Notes as long-term debt at December 31, 2016 and as current liabilities at March 31, 2017.

The Cash Convertible Notes become convertible into cash during any calendar quarter (and only during such calendar quarter), if the last reported sale price of the Company's common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to approximately $25.30 per share ("Trading Price Condition"). The Trading Price Condition was satisfied on March 17, 2017 for the calendar quarter ending March 31, 2017, and accordingly, the Convertible Notes will be convertible at any time at the option of the holders during the period from April 1, 2017 through June 30, 2017. The initial cash conversion rate is 51.3769 shares of the Company's common stock per $1,000 principal amount of the Convertible Notes (equivalent to an initial conversion price of $19.4640 per share of common stock). The settlement on any Convertible Notes surrendered for conversion during this period will occur on the third business day following the end of the applicable "Observation Period" with respect to such conversion (i.e., the period that begins on the date that a holder surrendered the Convertible Notes for conversion in accordance with the requirements of the indenture and ends on the 80th consecutive trading day following such date). The indenture requires the Company to satisfy the entire settlement amount for any conversions (determined in accordance with the provisions of the indenture) in cash, and the notes are not convertible into the Company's common stock or any other securities under any circumstances.  Even if holders do not elect to convert their Cash Convertible Notes, we are required under applicable accounting rules to classify the Cash Convertible Notes that are convertible as a current rather than long-term liability.  Accordingly, the Cash Convertible Notes, net of the unamortized discount, and related deferred loan costs are classified as current liabilities at March 31, 2017.

 The Cash Convertible Notes are our senior unsecured obligations and rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the Cash Convertible Notes. As a result of this transaction, we recognized deferred loan costs of approximately $3.9 million, which are being amortized over the term of the Cash Convertible Notes using the effective interest method.

The cash conversion feature of the Cash Convertible Notes is a derivative liability (the "Cash Conversion Derivative") that requires bifurcation from the Cash Convertible Notes in accordance with FASB ASC Topic 815, "Derivatives and Hedging" ("ASC Topic 815"), and is carried at fair value.  At December 31, 2016, because the Cash Convertible Notes were classified as long-term debt, the Cash Conversion Derivative was classified as long-term liabilities.  Due to the satisfaction of the Trading Price Condition in March 2017 and the resulting classification of the Cash Convertible Notes as a current liability at March 31, 2017, the Cash Conversion Derivative is recorded in current liabilities at March 31, 2017. The fair value of the Cash Conversion Derivative at the time of issuance of the Cash Convertible Notes was $36.8 million, which was recorded as a debt discount for purposes of accounting for the debt component of the Cash Convertible Notes. The debt discount is being amortized over the term of the Cash Convertible Notes using the effective interest method. For the three months ended March 31, 2017, we recorded $1.9 million of interest expense related to the amortization of the debt discount based upon an effective interest rate of 5.7%. The net carrying amount of the Cash Convertible Notes at March 31, 2017 and December 31, 2016 was $139.8 million and $137.9 million, respectively, net of the unamortized discount of $10.2 million and $12.1 million, respectively.
 
In connection with the issuance of the Cash Convertible Notes, we entered into privately negotiated convertible note hedge transactions (the "Cash Convertible Notes Hedges"), which are cash-settled and are intended to reduce our exposure to potential cash payments that we would be required to make if holders elect to convert the Cash Convertible Notes at a time when our stock price exceeds the conversion price. The initial cost of the Cash Convertible Notes Hedges was $36.8 million. At December 31, 2016, because the Cash Convertible Notes were classified as long-term debt, the Cash Convertible Notes Hedges were classified as long-term assets.  Due to the satisfaction of the Trading Price Condition in March 2017 and the resulting classification of the Cash Convertible Notes as a current liability at March 31, 2017, the Cash Convertible Notes Hedges are classified in current assets at March 31, 2017.  The Cash Convertible Notes Hedges are recorded as a derivative asset under ASC Topic 815 and are carried at fair value.  See Note 9 for additional information regarding the Cash Convertible Notes Hedges and the Cash Conversion Derivative and their fair values.

In July 2013, we also sold separate privately negotiated warrants (the "Warrants") initially relating, in the aggregate, to a notional number of shares of our common stock underlying the Cash Convertible Notes Hedges. The Warrants have an initial strike price of approximately $25.95 per share, which effectively increases the conversion price of the Cash Convertible Notes to a 60% premium to our stock price on July 1, 2013. The Warrants will be net share settled by issuing a number of shares of our common stock per Warrant corresponding to the excess of the market price per share of our common stock (as measured on each warrant exercise date under the terms of the Warrants) over the applicable strike price of the Warrants. The Warrants meet the definition of derivatives under the guidance in ASC Topic 815; however, because these instruments have been determined to be indexed to our own stock and meet the criteria for equity classification under ASC Topic 815, the Warrants have been accounted for as an adjustment to our additional paid-in-capital.
 
                   When the market value per share of our common stock exceeds the strike price of the Warrants, the Warrants have a dilutive effect on net income per share, and the "treasury stock" method is used in calculating the dilutive effect on earnings per share.  See Note 10 for additional information on such dilutive effect.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2017
Commitments and Contingencies [Abstract]  
Commitments and Contingencies
7.
Commitments and Contingencies

Summary

We are subject to contractual disputes, claims and legal proceedings that arise from time to time in the ordinary course of our business. While we are unable to estimate a range of potential losses, we do not believe that any of the legal proceedings pending against us as of the date of this report, some of which are expected to be covered by insurance policies, will have a material adverse effect on our financial statements. As these matters are subject to inherent uncertainties, our view of these matters may change in the future.

Contractual Commitments

In October 2012, we entered into the Gallup Joint Venture that required us to make payments over a five year period beginning January 2013. Pursuant to Sharecare's acquisition of the TPHS business, our ownership interest in the Gallup Joint Venture was transferred to Sharecare. We agreed with Sharecare to be responsible for two-thirds of the remaining payment obligations in respect of the purchase price to be paid in connection with Sharecare's acquisition of additional membership interest in the Gallup Joint Venture. This obligation is currently expected to result in aggregate payments by us of approximately $4.2 million, payable in five equal quarterly installments that began in the fourth quarter of the 2016 calendar year and will end in the fourth quarter of 2017. As of March 31, 2017, this obligation totaled $2.5 million and was included in accrued liabilities. The financial impact of the strategic relationship with Gallup and the Gallup Joint Venture are reflected in discontinued operations for all periods presented as each of these were a part of the TPHS business.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2017
Fair Value Measurements [Abstract]  
Fair Value Measurements
8.
Fair Value Measurements

We account for certain assets and liabilities at fair value. Fair value is defined as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.

Fair Value Hierarchy

The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. We categorize each of our fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are:

Level 1:   Quoted prices in active markets for identical assets or liabilities;

Level 2:
Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-based valuation techniques in which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

Level 3:   Unobservable inputs that are supported by little or no market activity and typically reflect management's estimates of assumptions that market participants would use in pricing the asset or liability.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table presents our assets and liabilities measured at fair value on a recurring basis at March 31, 2017 and March 31, 2016:

 
(In thousands)
 
March 31, 2017
 
 
December 31, 2016
 
Level 3:
 
 
 
 
 
 
Assets:
        
   Cash Convertible Notes Hedges
 
 $
82,445
 
 
 $
48,361
 
Liabilities:
 
 
 
 
 
 
 
 
   Cash Conversion Derivative
 
 $
82,445
 
 
 $
48,361
 

The fair values of the Cash Convertible Notes Hedges and the Cash Conversion Derivative are measured using Level 3 inputs because these instruments are not actively traded. They are valued using an option pricing model that uses observable and unobservable market data for inputs, such as expected time to maturity of the derivative instruments, the risk-free interest rate, the expected volatility of our common stock, and other factors. The Cash Convertible Notes Hedges and the Cash Conversion Derivative were designed such that changes in their fair values would offset one another, with minimal impact to the consolidated statements of operations. Therefore, the sensitivity of changes in the unobservable inputs to the option pricing model for such instruments is mitigated.

The following table presents our financial instruments measured at fair value on a recurring basis using unobservable inputs (Level 3):

(In thousands)
 
Balance at December 31, 2016
 
 
Purchases of Level 3 Instruments
 
 
Settlements of Level 3 Instruments
 
 
Gains (Losses) Included in Earnings
 
 
Balance at March 31, 2017
 
Cash Convertible Notes Hedges
 
$
48,361
 
 
$
 
 
$
 
 
$
34,084
 
 
$
82,445
 
Cash Conversion Derivative
 
 
(48,361
)
 
 
 
 
 
 
 
 
(34,084
 
 
(82,445
)

The gains and losses included in earnings noted above represent the change in the fair value of these financial instruments and are recorded each period in the consolidated statements of operations. The gains and losses on the Cash Convertible Notes Hedges and Cash Conversion Derivative are recorded as selling, general and administrative expenses.

Fair Value of Other Financial Instruments

In addition to the Cash Convertible Notes Hedges and the Cash Conversion Derivative, the estimated fair values of which are disclosed above, the estimated fair value of each class of financial instruments at March 31, 2017 was as follows:

Cash and cash equivalents – The carrying amount of $0.7 million approximates fair value because of the short maturity of those instruments (less than three months).

Long-term debt – The estimated fair value of outstanding borrowings under the Prior Credit Agreement, which includes a revolving credit facility and a term loan facility (see Note 6), and the Cash Convertible Notes are determined based on the fair value hierarchy as discussed above.

The revolving credit facility and the term loan facility are not actively traded and therefore are classified as Level 2 valuations based on the market for similar instruments. The estimated fair value is based on the average of the prices set by the issuing bank given current market conditions and is not necessarily indicative of the amount we could realize in a current market exchange. The estimated fair value and carrying amount of outstanding borrowings under the Prior Credit Agreement at March 31, 2017 were each $68.3 million.

The Cash Convertible Notes are actively traded and therefore are classified as Level 1 valuations. The estimated fair value at March 31, 2017 was $226.9 million, which is based on the most recent trading price of the Cash Convertible Notes as of March 31, 2017, and the par value was $150.0 million. The carrying amount of the Cash Convertible Notes at March 31, 2017 was $139.8 million, which is net of the debt discount discussed in Note 6.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1
Derivative Investments and Hedging Activities
3 Months Ended
Mar. 31, 2017
Derivative Investments and Hedging Activities [Abstract]  
Derivative Investments and Hedging Activities
9.
Derivative Instruments and Hedging Activities

We use derivative instruments to manage risks related to interest (through December 30, 2016), the Cash Convertible Notes, and, prior to the sale of the TPHS business, foreign currencies. We account for derivatives in accordance with ASC Topic 815, which establishes accounting and reporting standards requiring that certain derivative instruments be recorded on the balance sheet as either an asset or liability measured at fair value. Additionally, changes in the derivative's fair value will be recognized currently in earnings unless specific hedge accounting criteria are met. As permitted under our master netting arrangements, the fair value amounts of our prior interest rate swaps and foreign currency options and/or forward contracts are presented on a net basis by counterparty in the consolidated balance sheets.

Derivative Instruments Designated as Hedging Instruments

Cash Flow Hedges

Derivative instruments that are designated and qualify as cash flow hedges are recorded at estimated fair value in the consolidated balance sheets, with the effective portion of the gains and losses being reported in accumulated other comprehensive income or loss ("accumulated OCI"). We did not maintain any cash flow hedges during the three months ended March 31, 2017.  Cash flow hedges for the three months ended March 31, 2016 consisted solely of an interest rate swap agreement, which effectively modified our exposure to interest rate risk by converting a portion of our floating rate debt to a fixed rate obligation, thus reducing the impact of interest rate changes on future interest expense. Under this agreement, which terminated on December 30, 2016, we received a variable rate of interest based on LIBOR (as defined in Note 6), and we paid a fixed rate of interest with an interest rate of 1.480% plus a spread (see Note 6). Gains and losses on this interest rate swap agreement were reclassified to interest expense in the same period during which the hedged transaction affected earnings or the period in which all or a portion of the hedge became ineffective.

The following table shows the effect of our cash flow hedges on the consolidated balance sheets during the three months ended March 31, 2017 and 2016:

(In thousands)
 
 
For the Three Months Ended
 
Derivatives in Cash Flow Hedging Relationships
 
 
March 31, 2017
 
March 31, 2016
 
Loss related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect
 
 
 $
92
 
Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect
 
 
 $
(133

Gains and losses representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings. During the three months ended March 31, 2017 and 2016, there were no gains or losses on cash flow hedges recognized in our consolidated statements of operations resulting from hedge ineffectiveness.

Derivative Instruments Not Designated as Hedging Instruments

Our Cash Conversion Derivative, Cash Convertible Notes Hedges and, prior to July 31, 2016, foreign currency options and/or forward contracts, do not qualify for hedge accounting treatment under U.S. GAAP and are measured at fair value, with gains and losses recognized immediately in the consolidated statements of operations. These derivative instruments not designated as hedging instruments did not have a material impact on our consolidated statements of operations for the three months ended March 31, 2017 and 2016.

The Cash Conversion Derivative is accounted for as a derivative liability and carried at fair value. In order to offset the risk associated with the Cash Conversion Derivative, we entered into Cash Convertible Notes Hedges, which are cash-settled and are intended to reduce our exposure to potential cash payments that we would be required to make if holders elect to convert the Cash Convertible Notes at a time when our stock price exceeds the conversion price. The Cash Convertible Notes Hedges are accounted for as a derivative asset and carried at fair value.

The gains and losses resulting from a change in fair values of the Cash Conversion Derivative and the Cash Convertible Notes Hedges are reported in the consolidated statements of operations.

 
Three Months Ended
March 31,
 
 
(In thousands)
 2017
 
2016
 
Statements of Operations Classification
Cash Convertible Notes Hedges:
 
 
 
 
    
Net unrealized gain (loss)
 
$
34,084
 
 
$
(7,603
Selling, general and administrative expenses
Cash Conversion Derivative:
 
 
 
 
 
 
 
 
     
Net unrealized (loss) gain
 
$
(34,084
 
$
7,603
 
Selling, general and administrative expenses

Prior to the sale of the TPHS business, we also entered into foreign currency options and/or forward contracts in order to minimize our earnings exposure to fluctuations in foreign currency exchange rates.  Our foreign currency exchange contracts required current period mark-to-market accounting, with any change in fair value being recorded each period in the consolidated statements of operations in selling, general and administrative expenses. We do not execute transactions or hold derivative financial instruments for trading or other purposes.

Financial Instruments

The estimated fair values of derivative instruments at March 31, 2017 and December 31, 2016 were as follows:

(In thousands) 
March 31,
2017
 
December 31, 2016
 
Assets:
 
 
 
 
 
 
 
 
 
 
Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Cash convertible notes hedges, current
 
 
 
82,445
 
 
 $
 
 
 
Cash convertible notes hedges, long-term
 
 
 
 
 
 
 
48,361
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Cash conversion derivative, current
 
 
 
82,445
 
 
 
 
 
Cash conversion derivative, long-term
 
 
 
 
 
 
 
48,361
 
 
 

See Note 8 for more information on fair value measurements.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1
Earnings (Loss) Per Share
3 Months Ended
Mar. 31, 2017
Earnings (Loss) Per Share [Abstract]  
Earnings (Loss) Per Share
10.
Earnings (Loss) Per Share

The following is a reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share for the three months ended March 31, 2017 and 2016:

(In thousands except per share data)
 
Three Months Ended
March 31,
 
 
 
2017
 
 
2016
 
Numerator:
      
Net income from continuing operations attributable to Tivity Health, Inc. - numerator for earnings per share
 
$
15,481
 
 
$
19,208
 
Net loss from discontinued operations attributable to Tivity Health, Inc. - numerator for loss per share
  
(220
 
)
  
(33,417
)
Net income (loss) attributable to Tivity Health, Inc. - numerator for earnings (loss) per share
 
$
15,261
   
(14,209
)
 
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
 
Shares used for basic income (loss) per share
 
 
39,069
 
 
 
36,109
 
Effect of dilutive stock options and restricted stock units outstanding:
 
 
 
 
 
 
 
 
Non-qualified stock options
 
 
442
 
 
 
165
 
Restricted stock units
 
 
611
 
 
 
426
 
Market stock units
  
293
   
161
 
Warrants related to Cash Convertible Notes
 
 
126
 
 
 
 
Shares used for diluted income (loss) per share
 
 
40,541
 
 
 
36,861
 
 
 
 
 
 
 
 
 
 
Earnings (loss) per share attributable to Tivity Health, Inc. - basic:
 
 
 
 
 
 
 
 
Continuing operations
 
$
0.40
 
 
$
0.53
 
Discontinued operations
 
$
(0.01
)
 
$
(0.93
)
Net income (loss) (1)
 
$
0.39
 
 
$
(0.39
)
         
Earnings (loss) per share attributable to Tivity Health, Inc. - diluted:
 
 
 
 
 
 
 
 
Continuing operations
 
$
0.38
 
 
$
0.52
 
Discontinued operations
 
$
(0.01
)
 
$
(0.91
)
Net income (loss) (1)
 
$
0.38
 
 
$
(0.39
)
 
 
 
 
 
 
 
 
 
Dilutive securities outstanding not included in the computation of earnings (loss) per share because their effect is anti-dilutive:
 
 
 
 
 
 
 
 
Non-qualified stock options
 
 
16
 
 
 
1,486
 
Restricted stock units
 
 
18
 
 
 
679
 
Warrants related to Cash Convertible Notes
 
 
 
 
 
7,707
 
CareFirst Convertible Note
 
 
 
 
 
892
 
CareFirst Warrants
 
 
 
 
 
591
 
         
(1) Figures may not add due to rounding.
        
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
Accumulated OCI
3 Months Ended
Mar. 31, 2017
Accumulated OCI [Abstract]  
Accumulated OCI
11.
Accumulated OCI

The following tables summarize the changes in accumulated OCI, net of tax, for the three months ended March 31, 2017 and 2016:
 
 (In thousands)
 
 
Foreign Currency Translation Adjustments
 
Accumulated OCI, net of tax, as of January 1, 2017
 
 
$
(4,502
)
Other comprehensive income before reclassifications, net of tax of $36
 
 
 
111
 
Accumulated OCI, net of tax, as of March 31, 2017
 
 
$
(4,391
)


 (In thousands)
 
Net Change in Fair Value of Interest Rate Swaps
 
 
Foreign Currency Translation Adjustments
 
 
Total
 
Accumulated OCI, net of tax, as of January 1, 2016
 
$
(239
)
 
$
(4,000
)
 
$
(4,239
)
Other comprehensive income (loss) before reclassifications, net of tax of $37 and $0, respectively
 
 
(56
)
 
 
1,022
 
 
 
966
 
Amounts reclassified from accumulated OCI, net of tax
 
 
80
 
 
 
 
 
 
80
 
Net increase in other comprehensive income (loss), net of tax
 
 
24
 
 
 
1,022
 
 
 
1,046
 
Accumulated OCI, net of tax, as of March 31, 2016
 
$
(215
)
 
$
(2,978
)
 
$
(3,193
)

The following table provides details about reclassifications out of accumulated OCI for the three months ended March 31, 2017 and 2016:

 
Three Months Ended March 31,
 
Statement of Operations
 (In thousands)
2017
 
2016
 
Classification
Interest rate swaps
 
$
 
 
$
133
 
Interest expense
 
 
 
 
 
 
(53
)
Income tax benefit
 
 
$
 
 
$
80
 
Net of tax

See Note 9 for further discussion of our interest rate swaps.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
Restructuring and Related Charges
3 Months Ended
Mar. 31, 2017
Restructuring and Related Charges [Abstract]  
Restructuring and Related Charges
12.
Restructuring and Related Charges

In the third quarter of 2015, we began developing our reorganization and cost rationalization plan (the "2015 Restructuring Plan") that commenced in October 2015, which was intended to improve efficiency and deliver greater value to our customers and stakeholders. Completion of the 2015 Restructuring Plan occurred with the completion of the sale of the TPHS business in July 2016. We incurred a total of approximately $24 million in restructuring charges related to the 2015 Restructuring Plan, substantially all of which resulted in or will result in cash expenditures.
 
The following table shows the costs incurred for the three months ended March 31, 2017 related to our 2015 Restructuring Plan and other restructuring costs:

(In thousands)
 
Severance and Other
Employee-Related Costs
 
 
Consulting and Other Costs (1)
 
 
 
Total
Accrued restructuring and related charges liability as of January 1, 2017
 
$
4,242
  
$
63
   
$
4,305
 
Restructuring charges
  
   
    
 
Payments
  
(717
)
  
(3
)
   
(720
)
Adjustments (2)
  
41
   
    
41
 
Accrued restructuring and related charges liability as of March 31, 2017
 
$
3,566
  
$
60
   
$
3,626
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Consulting and other costs consist of third-party consulting charges incurred in connection with the 2015 Restructuring Plan. 

(2) Adjustments consist primarily of foreign currency translation adjustments.  

In the third quarter of 2016, we began the reorganization of our corporate support infrastructure (the "2016 Restructuring Plan"), which was intended to deliver greater value to our customers and stakeholders. Completion of the 2016 Restructuring Plan occurred during the first quarter of 2017. We incurred a total of approximately $5.7 million in restructuring charges related to the 2016 Restructuring Plan, substantially all of which resulted in or will result in cash expenditures.
 
The following table shows the costs incurred for the three months ended March 31, 2017 directly related to our 2016 Restructuring Plan and other restructuring costs:

(In thousands)
 
Severance and Other
Employee-Related Costs
 
 
Consulting and Other Costs (1)
 
 
 
Total
Accrued restructuring and related charges liability as of January 1, 2017
 
$
3,851
 
 
$
48
 
 
 
$
3,899
 
Restructuring charges
  
794
 
 
 
16
 
 
 
 
810
 
Payments
  
(2,054
)
  
(64
)
   
(2,118
)
Adjustments (2)
  
(73
 
 
 
 
 
 
(73
)
Accrued restructuring and related charges liability as of March 31, 2017
 
$
2,518
 
 
$
 
 
 
 
2,518
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

(1) Consulting and other costs consist of third-party consulting charges incurred in connection with the 2016 Restructuring Plan. 
 
(2) Adjustments consist primarily of actual employee tax and benefit amounts differing from previous estimates.
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
Subsequent Event
3 Months Ended
Mar. 31, 2017
Subsequent Event [Abstract]  
Subsequent Event
13.
Subsequent Event

On April 21, 2017, we entered into the Credit Agreement with a group of lenders for whom SunTrust Bank acts as administrative agent, which replaced the Prior Credit Agreement.  The Credit Agreement provides us with (1) a $100 million revolving credit facility that includes a $25 million sublimit for swingline loans and a $75 million sublimit for letters of credit, (2) a $70 million term loan A facility, (3) a $150 million delayed draw term loan facility, and (4) an uncommitted incremental accordion facility of $100 million.

We used the proceeds of the term loan A and cash on hand to repay all of the outstanding indebtedness under the Prior Credit Agreement and to pay transaction costs and expenses.  Proceeds of revolving loans and delayed draw term loans may be used to repay outstanding indebtedness (including amounts payable upon or in respect of any conversion of the Cash Convertible Notes and the repayment of any revolving loans borrowed for such purposes), to finance working capital needs, to finance acquisitions, to finance the repurchase of our common stock, to finance capital expenditures, and for other general corporate purposes of the Company and its subsidiaries.  Delayed draw term loans may not be borrowed after July 2, 2018.

We are required to repay outstanding revolving loans in full on April 21, 2022.  We are required to repay the term loan A in quarterly principal installments aggregating (1) $875,000 each for the first twelve quarters following the closing, and (2) $1,312,500 each for the remaining quarters prior to maturity on April 21, 2022.  We are required to repay the delayed draw term loans in quarterly principal installments calculated as follows: (1) for each of the first twelve quarters following the closing, 1.250% of the aggregate principal amount of the delayed draw term loans funded as of the last day of the immediately preceding quarter; and (2) for each of the remaining quarters prior to maturity on April 21, 2022, 1.875% of the aggregate principal amount of the delayed draw term loans funded as of the last day of the immediately preceding quarter.  At maturity on April 21, 2022, the entire unpaid principal balances of the term loan A and the delayed draw term loans are due and payable.

Borrowings under the Credit Agreement generally bear interest at variable rates based on a margin or spread in excess of either (1) the one-month, two-month, three-month or six-month LIBOR rate (or with the approval of affected lenders, the twelve-month LIBOR rate), which may not be less than zero, or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50%, and (c) the Base Rate, as selected by the Company.  The LIBOR margin varies between 1.50% and 2.75%, and the Base Rate margin varies between 0.50% and 1.75%, depending on our net leverage ratio.  The Credit Agreement also provides for annual fees ranging between 0.20% and 0.50% of the unused commitments under the revolving credit facility and the delayed draw term loan facility.  Extensions of credit under the Credit Agreement are secured by guarantees from all of the Company's active material subsidiaries and by security interests in substantially all of the Company's and such subsidiaries' assets.
 
The Credit Agreement contains financial covenants that require us to maintain, as defined, specified ratios or levels of (1) funded debt to EBITDA and (2) fixed charge coverage. The Credit Agreement contains various other affirmative and negative covenants that are typical for financings of this type.  Among other things, it limits repurchases of our common stock and the amount of dividends that we can pay to holders of our common stock.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
Basis of Presentation (Policies)
3 Months Ended
Mar. 31, 2017
Basis of Presentation [Abstract]  
Basis of Presentation
Our financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles in the United States ("U.S. GAAP").  In our opinion, the accompanying consolidated financial statements of Tivity Health, Inc. and its wholly-owned subsidiaries (collectively, "Tivity Health," the "Company," or such terms as "we," "us," or "our") reflect all adjustments consisting of normal, recurring accruals necessary for a fair statement. We have reclassified certain items in prior periods to conform to current classifications.

Our results from continuing operations do not include the results of the total population health services ("TPHS") business, which we sold effective July 31, 2016.  The TPHS business included our partnerships with Blue Zones, LLC and Dr. Dean Ornish (the Blue Zones Project by Healthways™ and Dr. Dean Ornish's Program for Reversing Heart Disease™, respectively), our joint venture with Gallup, Inc. ("Gallup"), Navvis Healthcare, LLC ("Navvis"), MeYou Health, LLC ("MeYou Health"), and our international operations, including our joint venture with SulAméricaWhile Navvis and MeYou Health were part of our TPHS business, they were sold separately to other buyers in November 2015 and June 2016, respectively.  Results of operations for the TPHS business have been classified as discontinued operations for all periods presented in the accompanying Consolidated Financial Statements.  See Note 3 for further information.

On March 11, 2015, we formed a joint venture with SulAmérica, one of the largest independent insurers in Brazil, to sell total population health services to the Brazilian market. With its contribution, SulAmérica acquired a 49% interest in the joint venture, Healthways Brasil Servicos de Consultoria LTDA ("Healthways Brazil"). We determined that our interest in Healthways Brazil represented a controlling financial interest and, therefore, prior to selling the TPHS business, consolidated the financial statements of Healthways Brazil and presented a non-controlling interest for the portion owned by SulAmérica. The net assets and results of operations of Healthways Brazil were part of the sale of the TPHS business and are included within discontinued operations in the accompanying Consolidated Financial Statements.

We have omitted certain financial information that is normally included in financial statements prepared in accordance with U.S. GAAP but that is not required for interim reporting purposes. You should read the accompanying consolidated financial statements in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2016.
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
Recent Relevant Accounting Standards (Policies)
3 Months Ended
Mar. 31, 2017
Recent Relevant Accounting Standards [Abstract]  
Recent Relevant Accounting Standards
In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-09, which creates Accounting Standards Codification ("ASC") Topic 606, "Revenue from Contracts with Customers" ("ASC Topic 606") and supersedes ASC Topic 605, "Revenue Recognition." The provisions of ASC Topic 606 provide for a single comprehensive principles-based standard for the recognition of revenue across all industries and expanded disclosure about the nature, amount, timing and uncertainty of revenue, as well as certain additional quantitative and qualitative disclosures. The standard is effective for annual periods beginning after December 15, 2017, including interim periods within those years. The guidance permits the use of either a retrospective or cumulative effect transition method. We have not yet selected a transition method.  We are currently conducting analysis to quantify the adoption impact of the provisions of the new standard and evaluating our current contracts and revenue streams. The FASB has issued, and may issue in the future, interpretive guidance which may cause our evaluation to change. We believe we are following an appropriate timeline to allow for proper recognition, presentation and disclosure upon adoption effective January 1, 2018.
 
In August 2014, the FASB issued ASU No. 2014-15, "Presentation of Financial Statements – Going Concern: Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern," which requires management to evaluate whether there is substantial doubt about the entity's ability to continue as a going concern and, if so, provide certain footnote disclosures. This ASU is effective for annual periods ending after December 15, 2016, including interim reporting periods thereafter. We adopted this ASU in the fourth quarter of 2016, and it did not have an impact on our financial statements or footnote disclosures.
 
In February 2016, the FASB issued ASU No. 2016-02, "Leases" ("ASU 2016-02"), which requires that lessees recognize assets and liabilities for leases with lease terms greater than twelve months in the statement of financial position. ASU 2016-02 also requires improved disclosures to help users of financial statements better understand the amount, timing and uncertainty of cash flows arising from leases. The update is effective for fiscal years beginning after December 15, 2018, including interim reporting periods within those years. We are currently evaluating the impact that the adoption of ASU 2016-02 will have on our financial position, results of operations and cash flows.

In March 2016, the FASB issued ASU No. 2016-09, "Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting" ("ASU 2016-09"), which we adopted on January 1, 2017.  ASU 2016-09 requires all income tax effects of share-based awards to be recognized in the income statement, which were previously presented as a component of shareholders' equity, on a prospective basis.  In addition, any excess tax benefits that were not previously recognized because the related tax deduction had not reduced current taxes payable are to be recorded on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption, which resulted in an increase of $6.5 million to our retained earnings as of January 1, 2017.  Regarding the statement of cash flows, the standard requires the presentation of excess tax benefits as an operating activity rather than as a financing activity and that cash paid by the Company when directly withholding shares for tax withholding purposes be classified as a financing activity on a retrospective basis. The standard also allows for an accounting policy election to estimate the number of awards that are expected to vest or to account for forfeitures when they occur. We elected to account for forfeitures as they occur, which did not result in a material cumulative effect adjustment to our retained earnings as of January 1, 2017.  Finally, the standard no longer allows windfall tax benefits to be included in the assumed proceeds when applying the treasury stock method for computing diluted earnings per share ("EPS"), which results in share-based awards having a more dilutive effect on EPS.

In August 2016, the FASB issued ASU No. 2016-15, "Statement of Cash Flows" (Topic 230) ("ASU 2016-15").  ASU 2016-15 addresses how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU 2016-15 is effective in the first quarter of 2018, with early adoption permitted, and is to be applied using a retrospective approach. We are currently evaluating the potential effects of adopting the provisions of ASU 2016-15.

In January 2017, the FASB issued ASU No. 2017-04, "Intangibles - Goodwill and Other" ("ASU 2017-04"), which simplifies the subsequent measurement of goodwill by eliminating step two from the goodwill impairment test.  ASU 2017-04 is effective for annual and interim impairment tests in fiscal years beginning after December 15, 2019 and is required to be applied prospectively. Early adoption is allowed for annual goodwill impairment tests performed on testing dates after January 1, 2017. We do not anticipate that adopting this standard will have an impact on our consolidated financial statements and related disclosures.
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
Discontinued Operations (Tables)
3 Months Ended
Mar. 31, 2017
Discontinued Operations [Abstract]  
Financial Results Included in Losses from Discontinued Operations
The following table presents financial results of the TPHS business included in "loss from discontinued operations" for the three months ended March 31, 2017 and 2016.
 
 
 
Three Months Ended
March 31,
  
(In thousands)
 
2017
 
 
2016
 
 
 
 
 
 
 
 
 
 
Revenues
 
$
 
 
$
63,205
 
 
Cost of services
 
 
220
 
 
 
72,625
 
 
Selling, general & administrative expenses
 
 
137
 
 
 
7,061
 
 
Depreciation and amortization
 
 
 
 
 
10,874
 
 
Restructuring and related charges
 
 
 
 
 
5,702
 
 
Equity in income from joint ventures
 
 
 
 
 
132
 
 
Pretax loss on discontinued operations
 
$
(357
 
$
(32,925
 
Pretax loss on sale of TPHS business
 
 
(310
 
 
 
 
Total pretax loss on discontinued operations
 
$
(667
 
$
(32,925
 
Income tax (benefit) expense
 
 
(447
)
 
 
180
 
 
Loss from discontinued operations, net of income tax benefit
 
$
(220
 
$
(33,105
 
Significant Operating and Investing Non-cash Items of the Discontinued Operations
The depreciation, amortization and significant operating and investing non-cash items of the discontinued operations were as follows: 
 
 
Three Months Ended
March 31,
(In thousands)
 
2017
  
2016
 
 
   Depreciation and amortization on discontinued operations
 
$
 
 
$
10,874
 
 
   Capital expenditures on discontinued operations
 
 
 
 
 
5,420
 
 
   Share-based compensation on discontinued operations
 
 
 
 
 
768
 
 
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2017
Share-Based Compensation [Abstract]  
Summary of Stock Options
A summary of our stock options as of March 31, 2017 and the changes during the three months then ended is presented below:
 
 
 
 
 
 
Options
 
Shares
(In thousands)
 
 
Weighted
Average Exercise
Price
Per Share
 
 
Weighted Average
Remaining
Contractual
Term
 
 
Aggregate Intrinsic Value (In thousands)
 
Outstanding at January 1, 2017
 
 
1,024
 
 
$
14.02
 
 
 
 
 
 
 
Granted
 
 
 
 
 
 
 
 
 
 
 
 
Exercised
 
 
(181
)
 
 
12.36
 
 
 
 
 
 
 
Forfeited
 
 
 
 
 
 
 
 
 
 
 
 
Expired
 
 
(45
)
 
 
45.36
 
 
 
 
 
 
 
Outstanding at March 31, 2017
 
 
798
 
 
$
12.63
 
 
 
4.7
 
 
$
13,139
 
Exercisable at March 31, 2017
 
 
732
 
 
$
12.33
 
 
 
4.5
 
 
$
12,275
 
Summary of Restricted Stock and Restricted Stock Units
The following table shows a summary of our restricted stock and restricted stock units as of March 31, 2017, as well as activity during the three months then ended:

 
 
Restricted Stock and
Restricted Stock Units
 
 
 
Shares
(In thousands)
 
 
Weighted-
Average
Grant Date
Fair Value
 
Nonvested at January 1, 2017
 
 
939
 
 
$
13.11
 
Granted
 
 
4
 
 
 
27.97
 
Vested
 
 
(98
)
 
 
10.47
 
Forfeited
 
 
(37
)
 
 
11.70
 
Nonvested at March 31, 2017
 
 
808
 
 
$
13.57
 
Summary of Market Stock Units
The following table shows a summary of our market stock units as of March 31, 2017, as well as activity during the three months then ended:

 
 
 
 
Market Stock Units
 
 
 
 
 
Shares
(In thousands)
 
 
Weighted-
Average
Grant Date
Fair Value
 
Nonvested at January 1, 2017
 
 
 
 
406
 
 
$
8.75
 
Granted
 
 
 
 
 
 
 
 
Vested
 
 
 
 
(8
 
 
5.46
 
Forfeited
 
 
 
 
(25
 
 
5.95
 
Nonvested at March 31, 2017
 
 
 
 
373
 
 
$
9.01
 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
Long-Term Debt (Tables)
3 Months Ended
Mar. 31, 2017
Long-Term Debt [Abstract]  
Long-term Debt, Net of Unamortized Deferred Loan Costs (Details)
The Company's long-term debt, net of unamortized deferred loan costs, consisted of the following at March 31, 2017 and December 31, 2016:

(In thousands)
 
March 31, 2017
 
 
December 31, 2016
 
Cash Convertible Notes, net of unamortized discount
 
$
139,790
 
 
$
137,859
 
Prior Credit Agreement:
 
 
 
 
 
 
 
 
Term Loan
 
 
55,000
 
 
 
60,000
 
Revolver
 
 
13,250
 
 
 
13,500
 
Capital lease obligations and other
 
 
1,029
 
 
 
1,270
 
 
 
 
209,069
 
 
 
212,629
 
Less: deferred loan costs
  
(1,771
)
  
(2,286
)
   
207,298
   
210,343
 
Less: current portion
 
 
(147,102
)
 
 
(46,046
)
 
 
$
60,196
 
 
$
164,297
 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2017
Fair Value Measurements [Abstract]  
Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table presents our assets and liabilities measured at fair value on a recurring basis at March 31, 2017 and March 31, 2016:

 
(In thousands)
 
March 31, 2017
 
 
December 31, 2016
 
Level 3:
 
 
 
 
 
 
Assets:
        
   Cash Convertible Notes Hedges
 
 $
82,445
 
 
 $
48,361
 
Liabilities:
 
 
 
 
 
 
 
 
   Cash Conversion Derivative
 
 $
82,445
 
 
 $
48,361
 
Level 3 Financial Instruments
The following table presents our financial instruments measured at fair value on a recurring basis using unobservable inputs (Level 3):

(In thousands)
 
Balance at December 31, 2016
 
 
Purchases of Level 3 Instruments
 
 
Settlements of Level 3 Instruments
 
 
Gains (Losses) Included in Earnings
 
 
Balance at March 31, 2017
 
Cash Convertible Notes Hedges
 
$
48,361
 
 
$
 
 
$
 
 
$
34,084
 
 
$
82,445
 
Cash Conversion Derivative
 
 
(48,361
)
 
 
 
 
 
 
 
 
(34,084
 
 
(82,445
)
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1
Derivative Investments and Hedging Activities (Tables)
3 Months Ended
Mar. 31, 2017
Derivative Investments and Hedging Activities [Abstract]  
Effect of Cash Flow Hedges on the Consolidated Balance Sheets
The following table shows the effect of our cash flow hedges on the consolidated balance sheets during the three months ended March 31, 2017 and 2016:

(In thousands)
 
 
For the Three Months Ended
 
Derivatives in Cash Flow Hedging Relationships
 
 
March 31, 2017
 
March 31, 2016
 
Loss related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect
 
 
 $
92
 
Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect
 
 
 $
(133
Gains and Losses Resulting from Change in Fair Values of Derivatives
The gains and losses resulting from a change in fair values of the Cash Conversion Derivative and the Cash Convertible Notes Hedges are reported in the consolidated statements of operations.

 
Three Months Ended
March 31,
 
 
(In thousands)
 2017
 
2016
 
Statements of Operations Classification
Cash Convertible Notes Hedges:
 
 
 
 
    
Net unrealized gain (loss)
 
$
34,084
 
 
$
(7,603
Selling, general and administrative expenses
Cash Conversion Derivative:
 
 
 
 
 
 
 
 
     
Net unrealized (loss) gain
 
$
(34,084
 
$
7,603
 
Selling, general and administrative expenses
Fair Values of Derivative Instruments
The estimated fair values of derivative instruments at March 31, 2017 and December 31, 2016 were as follows:

(In thousands) 
March 31,
2017
 
December 31, 2016
 
Assets:
 
 
 
 
 
 
 
 
 
 
Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Cash convertible notes hedges, current
 
 
 
82,445
 
 
 $
 
 
 
Cash convertible notes hedges, long-term
 
 
 
 
 
 
 
48,361
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Cash conversion derivative, current
 
 
 
82,445
 
 
 
 
 
Cash conversion derivative, long-term
 
 
 
 
 
 
 
48,361
 
 
 
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
Earnings (Loss) Per Share (Tables)
3 Months Ended
Mar. 31, 2017
Earnings (Loss) Per Share [Abstract]  
Basic and Diluted Earnings Per Share
The following is a reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share for the three months ended March 31, 2017 and 2016:

(In thousands except per share data)
 
Three Months Ended
March 31,
 
 
 
2017
 
 
2016
 
Numerator:
      
Net income from continuing operations attributable to Tivity Health, Inc. - numerator for earnings per share
 
$
15,481
 
 
$
19,208
 
Net loss from discontinued operations attributable to Tivity Health, Inc. - numerator for loss per share
  
(220
 
)
  
(33,417
)
Net income (loss) attributable to Tivity Health, Inc. - numerator for earnings (loss) per share
 
$
15,261
   
(14,209
)
 
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
 
Shares used for basic income (loss) per share
 
 
39,069
 
 
 
36,109
 
Effect of dilutive stock options and restricted stock units outstanding:
 
 
 
 
 
 
 
 
Non-qualified stock options
 
 
442
 
 
 
165
 
Restricted stock units
 
 
611
 
 
 
426
 
Market stock units
  
293
   
161
 
Warrants related to Cash Convertible Notes
 
 
126
 
 
 
 
Shares used for diluted income (loss) per share
 
 
40,541
 
 
 
36,861
 
 
 
 
 
 
 
 
 
 
Earnings (loss) per share attributable to Tivity Health, Inc. - basic:
 
 
 
 
 
 
 
 
Continuing operations
 
$
0.40
 
 
$
0.53
 
Discontinued operations
 
$
(0.01
)
 
$
(0.93
)
Net income (loss) (1)
 
$
0.39
 
 
$
(0.39
)
         
Earnings (loss) per share attributable to Tivity Health, Inc. - diluted:
 
 
 
 
 
 
 
 
Continuing operations
 
$
0.38
 
 
$
0.52
 
Discontinued operations
 
$
(0.01
)
 
$
(0.91
)
Net income (loss) (1)
 
$
0.38
 
 
$
(0.39
)
 
 
 
 
 
 
 
 
 
Dilutive securities outstanding not included in the computation of earnings (loss) per share because their effect is anti-dilutive:
 
 
 
 
 
 
 
 
Non-qualified stock options
 
 
16
 
 
 
1,486
 
Restricted stock units
 
 
18
 
 
 
679
 
Warrants related to Cash Convertible Notes
 
 
 
 
 
7,707
 
CareFirst Convertible Note
 
 
 
 
 
892
 
CareFirst Warrants
 
 
 
 
 
591
 
         
(1) Figures may not add due to rounding.
        
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
Accumulated OCI (Tables)
3 Months Ended
Mar. 31, 2017
Accumulated OCI [Abstract]  
Changes in Accumulated Other Comprehensive Income (AOCI)
The following tables summarize the changes in accumulated OCI, net of tax, for the three months ended March 31, 2017 and 2016:
 
 (In thousands)
 
 
Foreign Currency Translation Adjustments
 
Accumulated OCI, net of tax, as of January 1, 2017
 
 
$
(4,502
)
Other comprehensive income before reclassifications, net of tax of $36
 
 
 
111
 
Accumulated OCI, net of tax, as of March 31, 2017
 
 
$
(4,391
)


 (In thousands)
 
Net Change in Fair Value of Interest Rate Swaps
 
 
Foreign Currency Translation Adjustments
 
 
Total
 
Accumulated OCI, net of tax, as of January 1, 2016
 
$
(239
)
 
$
(4,000
)
 
$
(4,239
)
Other comprehensive income (loss) before reclassifications, net of tax of $37 and $0, respectively
 
 
(56
)
 
 
1,022
 
 
 
966
 
Amounts reclassified from accumulated OCI, net of tax
 
 
80
 
 
 
 
 
 
80
 
Net increase in other comprehensive income (loss), net of tax
 
 
24
 
 
 
1,022
 
 
 
1,046
 
Accumulated OCI, net of tax, as of March 31, 2016
 
$
(215
)
 
$
(2,978
)
 
$
(3,193
)
Reclassifications out of Accumulated Other Comprehensive Income
The following table provides details about reclassifications out of accumulated OCI for the three months ended March 31, 2017 and 2016:

 
Three Months Ended March 31,
 
Statement of Operations
 (In thousands)
2017
 
2016
 
Classification
Interest rate swaps
 
$
 
 
$
133
 
Interest expense
 
 
 
 
 
 
(53
)
Income tax benefit
 
 
$
 
 
$
80
 
Net of tax
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
Restructuring and Related Charges (Tables)
3 Months Ended
Mar. 31, 2017
Restructuring and Related Charges [Abstract]  
Restructuring Plan and Other Restructuring Costs
The following table shows the costs incurred for the three months ended March 31, 2017 related to our 2015 Restructuring Plan and other restructuring costs:

(In thousands)
 
Severance and Other
Employee-Related Costs
 
 
Consulting and Other Costs (1)
 
 
 
Total
Accrued restructuring and related charges liability as of January 1, 2017
 
$
4,242
  
$
63
   
$
4,305
 
Restructuring charges
  
   
    
 
Payments
  
(717
)
  
(3
)
   
(720
)
Adjustments (2)
  
41
   
    
41
 
Accrued restructuring and related charges liability as of March 31, 2017
 
$
3,566
  
$
60
   
$
3,626
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Consulting and other costs consist of third-party consulting charges incurred in connection with the 2015 Restructuring Plan. 

(2) Adjustments consist primarily of foreign currency translation adjustments.  

The following table shows the costs incurred for the three months ended March 31, 2017 directly related to our 2016 Restructuring Plan and other restructuring costs:

(In thousands)
 
Severance and Other
Employee-Related Costs
 
 
Consulting and Other Costs (1)
 
 
 
Total
Accrued restructuring and related charges liability as of January 1, 2017
 
$
3,851
 
 
$
48
 
 
 
$
3,899
 
Restructuring charges
  
794
 
 
 
16
 
 
 
 
810
 
Payments
  
(2,054
)
  
(64
)
   
(2,118
)
Adjustments (2)
  
(73
 
 
 
 
 
 
(73
)
Accrued restructuring and related charges liability as of March 31, 2017
 
$
2,518
 
 
$
 
 
 
 
2,518
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

(1) Consulting and other costs consist of third-party consulting charges incurred in connection with the 2016 Restructuring Plan. 
 
(2) Adjustments consist primarily of actual employee tax and benefit amounts differing from previous estimates.
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
Basis of Presentation (Details)
Mar. 11, 2015
SulAmerica [Member]  
Schedule of Equity Method Investments [Line Items]  
Percentage of ownership interest acquired in joint venture 49.00%
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
Recent Relevant Accounting Standards (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2017
USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Retained earnings $ 6,538
ASU No. 2016-09 [Member]  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Retained earnings $ 6,500
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
Discontinued Operations (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Jul. 31, 2016
USD ($)
$ / shares
Mar. 31, 2017
USD ($)
Installment
Mar. 31, 2016
USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Adjustable convertible equity right, initial face amount $ 30,000    
Conversion period of stock conversion 24 months    
Fair value of adjustable convertible equity right, excluding net working capital settlement   $ 2,700  
Total fair value of adjustable convertible equity right recorded   5,400  
Financial results included in losses from discontinued operations [Abstract]      
Loss from discontinued operations, net of income tax benefit   (220) $ (33,105)
TPHS Business [Member] | Discontinued Operations, Disposed of by Sale [Member]      
Financial results included in losses from discontinued operations [Abstract]      
Revenues   0 63,205
Cost of services   220 72,625
Selling, general & administrative expenses   137 7,061
Depreciation and amortization   0 10,874
Restructuring and related charges   0 5,702
Equity in income from joint ventures   0 132
Pretax loss on discontinued operations   (357) (32,925)
Pretax loss on sale of TPHS business   (310) 0
Total pretax loss on discontinued operations   (667) (32,925)
Income tax (benefit) expense   (447) 180
Loss from discontinued operations, net of income tax benefit   (220) (33,105)
Significant operating and investing non-cash items of the discontinued operations [Abstract]      
Depreciation and amortization on discontinued operations   0 10,874
Capital expenditures on discontinued operations   0 5,420
Share-based compensation on discontinued operations   $ 0 $ 768
Sharecare [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Cash paid to ShareCare at closing $ 25,000    
Remaining payment obligation responsibility percentage   66.70%  
Contractual obligations in respect of purchase price to be paid in connection with Sharecare's acquisition of additional membership interest in Gallup Joint Venture   $ 4,200  
Number of quarterly installments | Installment   5  
Payment obligation included in accrued liabilities   $ 2,500  
Sharecare [Member] | Adjustable Convertible Equity Right [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Maximum reduction in face amount of adjustable convertible equity right due to negative cash flows 20,000    
Adjustable convertible equity right, face amount net of face value maximum negative cash flow adjustment $ 10,000    
Stock issued during period conversion of convertible securities, conversion price (in dollars per share) | $ / shares $ 249.87    
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
Share-Based Compensation (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2017
USD ($)
Award
$ / shares
shares
Mar. 31, 2016
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Types of share based awards | Award 4  
Share-based compensation costs | $ $ 1,400 $ 2,400
Stock Options [Member]    
Shares [Roll Forward]    
Outstanding, beginning of period (in shares) | shares 1,024  
Granted (in shares) | shares 0  
Exercised (in shares) | shares (181)  
Forfeited (in shares) | shares 0  
Expired (in shares) | shares (45)  
Outstanding, end of period (in shares) | shares 798  
Exercisable, end of period (in shares) | shares 732  
Weighted Average Exercise Price [Roll Forward]    
Outstanding, beginning of period (in dollars per share) | $ / shares $ 14.02  
Granted (in dollars per share) | $ / shares 0  
Exercised (in dollars per share) | $ / shares 12.36  
Forfeited (in dollars per share) | $ / shares 0  
Expired (in dollars per share) | $ / shares 45.36  
Outstanding, end of period (in dollars per share) | $ / shares 12.63  
Exercisable, end of period (in dollars per share) | $ / shares $ 12.33  
Weighted Average Remaining Contractual Term [Abstract]    
Outstanding 4 years 8 months 12 days  
Exercisable 4 years 6 months  
Aggregate Intrinsic Value [Abstract]    
Outstanding | $ $ 13,139  
Exercisable | $ $ 12,275  
Restricted Stock and Restricted Stock Units [Member]    
Shares [Roll Forward]    
Nonvested, beginning of period (in shares) | shares 939  
Granted (in shares) | shares 4  
Vested (in shares) | shares (98)  
Forfeited (in shares) | shares (37)  
Nonvested, end of period (in shares) | shares 808  
Weighted-Average Grant Date Fair Value [Roll Forward]    
Nonvested, beginning of period (in dollars per share) | $ / shares $ 13.11  
Granted (in dollars per share) | $ / shares 27.97  
Vested (in dollars per share) | $ / shares 10.47  
Forfeited (in dollars per share) | $ / shares 11.70  
Nonvested, end of period (in dollars per share) | $ / shares $ 13.57  
Market Stock Units [Member]    
Shares [Roll Forward]    
Nonvested, beginning of period (in shares) | shares 406  
Granted (in shares) | shares 0  
Vested (in shares) | shares (8)  
Forfeited (in shares) | shares (25)  
Nonvested, end of period (in shares) | shares 373  
Weighted-Average Grant Date Fair Value [Roll Forward]    
Nonvested, beginning of period (in dollars per share) | $ / shares $ 8.75  
Granted (in dollars per share) | $ / shares 0  
Vested (in dollars per share) | $ / shares 5.46  
Forfeited (in dollars per share) | $ / shares 5.95  
Nonvested, end of period (in dollars per share) | $ / shares $ 9.01  
Discontinued Operations [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Share-based compensation costs | $ $ 800 $ 10,200
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.7.0.1
Income Taxes (Details)
$ in Millions
3 Months Ended
Mar. 31, 2017
USD ($)
Income Taxes [Abstract]  
Effective tax rate 37.70%
Operating Loss Carryforwards [Line Items]  
Open tax year 2013
Federal [Member]  
Operating Loss Carryforwards [Line Items]  
Operating loss carryforwards $ 160.5
State [Member]  
Operating Loss Carryforwards [Line Items]  
Operating loss carryforwards $ 191.2
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
Long-Term Debt, Summary of Long-term Debt, Net of Unamortized Deferred Loan Costs (Details) - USD ($)
$ in Thousands
Mar. 31, 2017
Dec. 31, 2016
Debt, Long-term and Short-term, Combined Amount [Abstract]    
Long-term debt, gross $ 209,069 $ 212,629
Less: deferred loan costs (1,771) (2,286)
Total debt including debt held for sale as discontinued operations 207,298 210,343
Less: current portion (147,102) (46,046)
Long-term debt, excluding current portion 60,196 164,297
Cash Convertible Notes, Net of Unamortized Discount [Member]    
Debt, Long-term and Short-term, Combined Amount [Abstract]    
Long-term debt, gross   137,859
Prior Credit Agreement [Member]    
Debt, Long-term and Short-term, Combined Amount [Abstract]    
Long-term debt, gross 139,790  
Prior Credit Agreement [Member] | Term Loan [Member]    
Debt, Long-term and Short-term, Combined Amount [Abstract]    
Long-term debt, gross 55,000 60,000
Prior Credit Agreement [Member] | Revolver [Member]    
Debt, Long-term and Short-term, Combined Amount [Abstract]    
Long-term debt, gross 13,250 13,500
Capital Lease Obligations and Other [Member]    
Debt, Long-term and Short-term, Combined Amount [Abstract]    
Long-term debt, gross $ 1,029 $ 1,270
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.7.0.1
Long-Term Debt, Line of Credit and Term Loan (Details) - USD ($)
3 Months Ended
Apr. 21, 2017
Aug. 04, 2016
Mar. 31, 2017
Dec. 31, 2016
Jun. 08, 2012
Line of Credit Facility [Line Items]          
Long term debt outstanding     $ 207,298,000 $ 210,343,000  
Long-term debt     60,196,000 $ 164,297,000  
Revolving Credit Facility [Member]          
Line of Credit Facility [Line Items]          
Availability under the revolving credit facility under most restrictive covenant     $ 104,300,000    
Prior Credit Agreement [Member] | Minimum [Member]          
Line of Credit Facility [Line Items]          
Unused commitment fee percentage     0.30%    
Prior Credit Agreement [Member] | Maximum [Member]          
Line of Credit Facility [Line Items]          
Unused commitment fee percentage     0.50%    
Prior Credit Agreement [Member] | Federal Funds Rate [Member]          
Line of Credit Facility [Line Items]          
Basis spread on variable rate     0.50%    
Prior Credit Agreement [Member] | LIBOR [Member]          
Line of Credit Facility [Line Items]          
Basis spread on variable rate     1.00%    
Prior Credit Agreement [Member] | LIBOR [Member] | Minimum [Member]          
Line of Credit Facility [Line Items]          
Margin rate     1.75%    
Prior Credit Agreement [Member] | LIBOR [Member] | Maximum [Member]          
Line of Credit Facility [Line Items]          
Margin rate     3.00%    
Prior Credit Agreement [Member] | Base Rate [Member] | Minimum [Member]          
Line of Credit Facility [Line Items]          
Margin rate     0.75%    
Prior Credit Agreement [Member] | Base Rate [Member] | Maximum [Member]          
Line of Credit Facility [Line Items]          
Margin rate     2.00%    
Prior Credit Agreement [Member] | Revolving Credit Facility [Member]          
Line of Credit Facility [Line Items]          
Initiation date     Jun. 08, 2012    
Maximum borrowing capacity         $ 125,000,000
Expiration date     Jun. 08, 2017    
Prior Credit Agreement [Member] | Letters of Credit Sub Facility [Member]          
Line of Credit Facility [Line Items]          
Maximum borrowing capacity         75,000,000
Prior Credit Agreement [Member] | Swingline Sub Facility [Member]          
Line of Credit Facility [Line Items]          
Maximum borrowing capacity         20,000,000
Prior Credit Agreement [Member] | Term Loan Facility [Member]          
Line of Credit Facility [Line Items]          
Maximum borrowing capacity         200,000,000
Amount outstanding         55,000,000
Prior Credit Agreement [Member] | Uncommitted Incremental Accordion Facility [Member]          
Line of Credit Facility [Line Items]          
Maximum borrowing capacity         $ 100,000,000
Eighth Amendment to Prior Credit Agreement [Member] | Revolving Credit Facility [Member]          
Line of Credit Facility [Line Items]          
Expiration date     Jun. 08, 2018    
Revolving commitments amount   $ 45,300,000      
Eighth Amendment to Prior Credit Agreement [Member] | Term Loan Facility [Member]          
Line of Credit Facility [Line Items]          
Maturity date     Jun. 08, 2018    
Long term debt outstanding   25,400,000      
Eighth Amendment to Prior Credit Agreement [Member] | Term Loan Facility [Member] | Remaining Quarters Prior to Maturity [Member]          
Line of Credit Facility [Line Items]          
Periodic principal payment   $ 5,000,000      
Periodic principal payment as percentage of aggregate principal amount   2.50%      
Credit Agreement [Member]          
Line of Credit Facility [Line Items]          
Long-term debt     $ 37,300,000    
Credit Agreement [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Initiation date Apr. 21, 2017        
Maturity date Apr. 21, 2022        
Credit Agreement [Member] | Minimum [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Unused commitment fee percentage 0.20%        
Credit Agreement [Member] | Maximum [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Unused commitment fee percentage 0.50%        
Credit Agreement [Member] | Federal Funds Rate [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Basis spread on variable rate 0.50%        
Credit Agreement [Member] | LIBOR [Member] | Minimum [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Variable rate basis 0.00%        
Margin rate 1.50%        
Credit Agreement [Member] | LIBOR [Member] | Maximum [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Margin rate 2.75%        
Credit Agreement [Member] | One-Month LIBOR [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Basis spread on variable rate 1.00%        
Credit Agreement [Member] | Base Rate [Member] | Minimum [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Margin rate 0.50%        
Credit Agreement [Member] | Base Rate [Member] | Maximum [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Margin rate 1.75%        
Credit Agreement [Member] | Revolving Credit Facility [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Maximum borrowing capacity $ 100,000,000        
Credit Agreement [Member] | Letters of Credit Sub Facility [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Maximum borrowing capacity 75,000,000        
Credit Agreement [Member] | Swingline Sub Facility [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Maximum borrowing capacity 25,000,000        
Credit Agreement [Member] | Term Loan Facility A [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Debt instrument, face amount 70,000,000        
Credit Agreement [Member] | Term Loan Facility A [Member] | First 12 Quarters Following the Closing [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Periodic principal payment 875,000        
Credit Agreement [Member] | Term Loan Facility A [Member] | Remaining Quarters Prior to Maturity [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Periodic principal payment 1,312,500        
Credit Agreement [Member] | Delayed Draw Term Loan Facility [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Debt instrument, face amount $ 150,000,000        
Credit Agreement [Member] | Delayed Draw Term Loan Facility [Member] | First 12 Quarters Following the Closing [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Periodic principal payment as percentage of aggregate principal amount 1.25%        
Credit Agreement [Member] | Delayed Draw Term Loan Facility [Member] | Remaining Quarters Prior to Maturity [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Periodic principal payment as percentage of aggregate principal amount 1.875%        
Credit Agreement [Member] | Uncommitted Incremental Accordion Facility [Member] | Subsequent Event [Member]          
Line of Credit Facility [Line Items]          
Maximum borrowing capacity $ 100,000,000        
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.7.0.1
Long-Term Debt (Details)
3 Months Ended
Jul. 16, 2013
USD ($)
$ / shares
Mar. 31, 2017
USD ($)
TradingDay
Mar. 31, 2016
USD ($)
Dec. 31, 2016
USD ($)
Jul. 31, 2013
$ / shares
Debt Instrument [Line Items]          
Interest expense related to amortization of debt discount   $ 1,931,000 $ 1,826,000    
1.50% Cash Convertible Senior Notes Due 2018 [Member]          
Debt Instrument [Line Items]          
Aggregate principal of convertible notes $ 150,000,000        
Interest rate for notes 1.50%        
Consecutive trading days   30 days      
Trading price condition (in dollars per share) | $ / shares $ 25.30        
Initial cash conversion rate 51.3769        
Initial conversion price (in dollars per share) | $ / shares $ 19.4640        
Deferred loan costs $ 3,900,000        
Par amount of convertible note 1,000        
Fair value of cash conversion derivative $ 36,800,000        
Interest expense related to amortization of debt discount   $ 1,900,000      
Effective interest rate   5.70%      
Debt instrument, unamortized discount   $ 10,200,000   $ 12,100,000  
Warrants strike price (in dollars per share) | $ / shares         $ 25.95
Conversion price premium percentage         60.00%
1.50% Cash Convertible Senior Notes Due 2018 [Member] | Minimum [Member]          
Debt Instrument [Line Items]          
Number of trading days | TradingDay   20      
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.7.0.1
Commitments and Contingencies (Details) - Sharecare [Member]
$ in Millions
3 Months Ended
Mar. 31, 2017
USD ($)
Installment
Contractual Commitment [Abstract]  
Remaining payment obligation responsibility percentage 66.70%
Contractual obligations in respect of purchase price to be paid in connection with Sharecare's acquisition of additional membership interest in Gallup Joint Venture $ 4.2
Number of quarterly installments | Installment 5
Payment obligation included in accrued liabilities $ 2.5
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value Measurements (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Dec. 31, 2016
Mar. 31, 2016
Dec. 31, 2015
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Cash and cash equivalents $ 664 $ 1,602 $ 869 $ 233
Cash Convertible Notes Hedges [Member]        
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Balance at beginning of period 48,361      
Purchases of Level 3 instruments 0      
Settlements of Level 3 instruments 0      
Gains (Losses) included in Earnings 34,084      
Balance at end of period 82,445      
Prior Credit Agreement [Member]        
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Debt Instrument, Fair Value 68,300      
Debt Instrument, Carrying Amount 68,300      
Cash Convertible Notes [Member]        
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Debt Instrument, Fair Value 226,900      
Debt Instrument, Carrying Amount 139,800      
Aggregate principal of convertible notes 150,000      
Cash Conversion Derivative [Member]        
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Balance at beginning of period (48,361)      
Purchases of Level 3 instruments 0      
Settlements of Level 3 instruments 0      
Gains (Losses) included in Earnings (34,084)      
Balance at end of period (82,445)      
Recurring [Member] | Cash Convertible Notes Hedges [Member] | Level 3 [Member]        
Assets measured at fair value on a recurring basis        
Fair Value 82,445 48,361    
Recurring [Member] | Cash Conversion Derivative [Member] | Level 3 [Member]        
Liabilities measured at fair value on a recurring basis        
Fair Value $ 82,445 $ 48,361    
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.7.0.1
Derivative Investments and Hedging Activities (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Derivatives, Fair Value [Line Items]      
Fixed interest rate 1.48%    
Derivatives in Cash Flow Hedging Relationships [Abstract]      
Loss related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect $ 0 $ 92  
Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect 0 (133)  
Net unrealized gain (loss) 0 0  
Liabilities [Abstract]      
Derivative liabilities, current 82,445   $ 0
Derivative liabilities, long-term 0   48,361
Cash Convertible Notes Hedges [Member] | Selling, General and Administrative Expenses [Member]      
Derivatives in Cash Flow Hedging Relationships [Abstract]      
Net unrealized gain (loss) 34,084 (7,603)  
Cash Convertible Notes Hedges [Member] | Derivatives Not Designated as Hedging Instruments [Member]      
Assets [Abstract]      
Derivative assets, current 82,445   0
Derivative assets, long-term 0   48,361
Cash Conversion Derivative [Member] | Selling, General and Administrative Expenses [Member]      
Derivatives in Cash Flow Hedging Relationships [Abstract]      
Net unrealized gain (loss) (34,084) $ 7,603  
Cash Conversion Derivative [Member] | Derivatives Not Designated as Hedging Instruments [Member]      
Liabilities [Abstract]      
Derivative liabilities, current 82,445   0
Derivative liabilities, long-term $ 0   $ 48,361
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.7.0.1
Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Numerator [Abstract]    
Net income from continuing operations attributable to Tivity Health, Inc. - numerator for earnings per share $ 15,481 $ 19,208
Net loss from discontinued operations attributable to Tivity Health, Inc. - numerator for loss per share (220) (33,417)
Net income (loss) attributable to Tivity Health, Inc. - numerator for earnings (loss) per share $ 15,261 $ (14,209)
Denominator [Abstract]    
Shares used for basic income (loss) per share (in shares) 39,069 36,109
Effect of dilutive stock options and restricted stock units outstanding [Abstract]    
Shares used for diluted income (loss) per share (in shares) 40,541 36,861
Earnings (loss) per share attributable to Tivity Health, Inc. - basic [Abstract]    
Continuing operations (in dollars per share) $ 0.40 $ 0.53
Discontinued operations (in dollars per share) (0.01) (0.93)
Net income (loss) (in dollars per share) [1] 0.39 (0.39)
Earnings (loss) per share attributable to Tivity Health, Inc. - diluted [Abstract]    
Continuing operations (in dollars per share) 0.38 0.52
Discontinued operations (in dollars per share) (0.01) (0.91)
Net income (loss) (in dollars per share) [1] $ 0.38 $ (0.39)
Non-Qualified Stock Options [Member]    
Effect of dilutive stock options and restricted stock units outstanding [Abstract]    
Effect of dilutive stock options and restricted stock units outstanding (in shares) 442 165
Restricted Stock Units [Member]    
Effect of dilutive stock options and restricted stock units outstanding [Abstract]    
Effect of dilutive stock options and restricted stock units outstanding (in shares) 611 426
Market Stock Units [Member]    
Effect of dilutive stock options and restricted stock units outstanding [Abstract]    
Effect of dilutive stock options and restricted stock units outstanding (in shares) 293 161
Warrants Related to Cash Convertible Notes [Member]    
Effect of dilutive stock options and restricted stock units outstanding [Abstract]    
Effect of dilutive stock options and restricted stock units outstanding (in shares) 126 0
Non-Qualified Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive securities outstanding not included in the computation of earnings (loss) per share because their effect is anti-dilutive (in shares) 16 1,486
Restricted Stock Units [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive securities outstanding not included in the computation of earnings (loss) per share because their effect is anti-dilutive (in shares) 18 679
Warrants Related to Cash Convertible Notes [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive securities outstanding not included in the computation of earnings (loss) per share because their effect is anti-dilutive (in shares) 0 7,707
CareFirst Convertible Note [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive securities outstanding not included in the computation of earnings (loss) per share because their effect is anti-dilutive (in shares) 0 892
CareFirst Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive securities outstanding not included in the computation of earnings (loss) per share because their effect is anti-dilutive (in shares) 0 591
[1] Figures may not add due to rounding.
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.7.0.1
Accumulated OCI (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Changes in accumulated OCI, net of tax [Roll Forward]    
Balance $ 189,298  
Total other comprehensive income, net of tax 111 $ 1,046
Balance 213,972  
Accumulated Other Comprehensive Income (Loss) [Member]    
Changes in accumulated OCI, net of tax [Roll Forward]    
Balance   (4,239)
Other comprehensive income (loss) before reclassifications, net of tax   966
Amounts reclassified from accumulated OCI, net of tax   80
Total other comprehensive income, net of tax   1,046
Balance   (3,193)
Net Change in Fair Value of Interest Rate Swaps [Member]    
Changes in accumulated OCI, net of tax [Roll Forward]    
Balance   (239)
Other comprehensive income (loss) before reclassifications, net of tax   (56)
Amounts reclassified from accumulated OCI, net of tax   80
Total other comprehensive income, net of tax   24
Balance   (215)
Other comprehensive income (loss) before reclassifications, tax   37
Foreign Currency Translation Adjustments [Member]    
Changes in accumulated OCI, net of tax [Roll Forward]    
Balance (4,502) (4,000)
Other comprehensive income (loss) before reclassifications, net of tax 111 1,022
Amounts reclassified from accumulated OCI, net of tax   0
Total other comprehensive income, net of tax   1,022
Balance (4,391) (2,978)
Other comprehensive income (loss) before reclassifications, tax $ 36 $ 0
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.7.0.1
Accumulated OCI, Reclassifications Out of Accumulated OCI (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Interest expense $ 3,834 $ 4,105
Income tax benefit 9,371 0
Net of tax (15,261) 13,897
Amounts reclassified from accumulated other comprehensive income to: [Member] | Interest Rate Swaps [Member]    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Interest expense 0 133
Income tax benefit 0 (53)
Net of tax $ 0 $ 80
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.7.0.1
Restructuring and Related Charges (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2017
USD ($)
2015 Restructuring Plan [Member]  
Restructuring Reserve [Roll Forward]  
Accrued restructuring and related charges liability as of period start $ 4,305
Restructuring charges 0
Payments (720)
Adjustments 41 [1]
Accrued restructuring and related charges liability as of period end 3,626
Restructuring Cost [Abstract]  
Restructuring charges incurred 24,000
2015 Restructuring Plan [Member] | Severance and Other Employee-related Costs [Member]  
Restructuring Reserve [Roll Forward]  
Accrued restructuring and related charges liability as of period start 4,242
Restructuring charges 0
Payments (717)
Adjustments 41 [1]
Accrued restructuring and related charges liability as of period end 3,566
2015 Restructuring Plan [Member] | Consulting and Other Costs [Member]  
Restructuring Reserve [Roll Forward]  
Accrued restructuring and related charges liability as of period start 63 [2]
Restructuring charges 0 [2]
Payments (3) [2]
Adjustments 0 [1],[2]
Accrued restructuring and related charges liability as of period end 60 [2]
2016 Restructuring Plan [Member]  
Restructuring Reserve [Roll Forward]  
Accrued restructuring and related charges liability as of period start 3,899
Restructuring charges 810
Payments (2,118)
Adjustments (73) [3]
Accrued restructuring and related charges liability as of period end 2,518
Restructuring Cost [Abstract]  
Restructuring charges incurred 5,700
2016 Restructuring Plan [Member] | Severance and Other Employee-related Costs [Member]  
Restructuring Reserve [Roll Forward]  
Accrued restructuring and related charges liability as of period start 3,851
Restructuring charges 794
Payments (2,054)
Adjustments (73) [3]
Accrued restructuring and related charges liability as of period end 2,518
2016 Restructuring Plan [Member] | Consulting and Other Costs [Member]  
Restructuring Reserve [Roll Forward]  
Accrued restructuring and related charges liability as of period start 48 [4]
Restructuring charges 16 [4]
Payments (64) [4]
Adjustments 0 [3],[4]
Accrued restructuring and related charges liability as of period end $ 0 [4]
[1] Adjustments consist primarily of foreign currency translation adjustments.
[2] Consulting and other costs consist of third-party consulting charges incurred in connection with the 2015 Restructuring Plan.
[3] Adjustments consist primarily of actual employee tax and benefit amounts differing from previous estimates.
[4] Consulting and other costs consist of third-party consulting charges incurred in connection with the 2016 Restructuring Plan.
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.7.0.1
Subsequent Event (Details) - Subsequent Event [Member] - Credit Agreement [Member]
Apr. 21, 2017
USD ($)
Subsequent Event [Line Items]  
Initiation date Apr. 21, 2017
Maturity date Apr. 21, 2022
Minimum [Member]  
Subsequent Event [Line Items]  
Unused commitment fee percentage 0.20%
Maximum [Member]  
Subsequent Event [Line Items]  
Unused commitment fee percentage 0.50%
Federal Funds Rate [Member]  
Subsequent Event [Line Items]  
Basis spread on variable rate 0.50%
LIBOR [Member] | Minimum [Member]  
Subsequent Event [Line Items]  
Variable rate basis 0.00%
Margin rate 1.50%
LIBOR [Member] | Maximum [Member]  
Subsequent Event [Line Items]  
Margin rate 2.75%
One-Month LIBOR [Member]  
Subsequent Event [Line Items]  
Basis spread on variable rate 1.00%
Base Rate [Member] | Minimum [Member]  
Subsequent Event [Line Items]  
Margin rate 0.50%
Base Rate [Member] | Maximum [Member]  
Subsequent Event [Line Items]  
Margin rate 1.75%
Revolving Credit Facility [Member]  
Subsequent Event [Line Items]  
Maximum borrowing capacity $ 100,000,000
Sublimit for Swingline Loans [Member]  
Subsequent Event [Line Items]  
Maximum borrowing capacity 25,000,000
Sublimit for Letters of Credit [Member]  
Subsequent Event [Line Items]  
Maximum borrowing capacity 75,000,000
Term Loan A Facility [Member]  
Subsequent Event [Line Items]  
Debt instrument, face amount 70,000,000
Term Loan A Facility [Member] | First 12 Quarters Following the Closing [Member]  
Subsequent Event [Line Items]  
Periodic principal payment 875,000
Term Loan A Facility [Member] | Remaining Quarters Prior to Maturity [Member]  
Subsequent Event [Line Items]  
Periodic principal payment 1,312,500
Delayed Draw Term Loan Facility [Member]  
Subsequent Event [Line Items]  
Debt instrument, face amount $ 150,000,000
Delayed Draw Term Loan Facility [Member] | First 12 Quarters Following the Closing [Member]  
Subsequent Event [Line Items]  
Periodic principal payment as percentage of aggregate principal amount 1.25%
Delayed Draw Term Loan Facility [Member] | Remaining Quarters Prior to Maturity [Member]  
Subsequent Event [Line Items]  
Periodic principal payment as percentage of aggregate principal amount 1.875%
Uncommitted Incremental Accordion Facility [Member]  
Subsequent Event [Line Items]  
Maximum borrowing capacity $ 100,000,000
EXCEL 59 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 60 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 61 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 63 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 173 258 1 true 65 0 false 7 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://healthways.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 010000 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://healthways.com/role/ConsolidatedBalanceSheetsUnaudited CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 010100 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://healthways.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://healthways.com/role/ConsolidatedStatementsOfOperationsUnaudited CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 020100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (Parenthetical) Sheet http://healthways.com/role/ConsolidatedStatementsOfOperationsUnauditedParenthetical CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (Parenthetical) Statements 5 false false R6.htm 030000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) Sheet http://healthways.com/role/ConsolidatedStatementsOfComprehensiveIncomeLossUnaudited CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) Statements 6 false false R7.htm 040000 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) Sheet http://healthways.com/role/ConsolidatedStatementOfChangesInStockholdersEquityUnaudited CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) Statements 7 false false R8.htm 050000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://healthways.com/role/ConsolidatedStatementsOfCashFlowsUnaudited CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 8 false false R9.htm 060100 - Disclosure - Basis of Presentation Sheet http://healthways.com/role/BasisOfPresentation Basis of Presentation Notes 9 false false R10.htm 060200 - Disclosure - Recent Relevant Accounting Standards Sheet http://healthways.com/role/RecentRelevantAccountingStandards Recent Relevant Accounting Standards Notes 10 false false R11.htm 060300 - Disclosure - Discontinued Operations Sheet http://healthways.com/role/DiscontinuedOperations Discontinued Operations Notes 11 false false R12.htm 060400 - Disclosure - Share-Based Compensation Sheet http://healthways.com/role/SharebasedCompensation Share-Based Compensation Notes 12 false false R13.htm 060500 - Disclosure - Income Taxes Sheet http://healthways.com/role/IncomeTaxes Income Taxes Notes 13 false false R14.htm 060600 - Disclosure - Long-Term Debt Sheet http://healthways.com/role/LongtermDebt Long-Term Debt Notes 14 false false R15.htm 060700 - Disclosure - Commitments and Contingencies Sheet http://healthways.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 060800 - Disclosure - Fair Value Measurements Sheet http://healthways.com/role/FairValueMeasurements Fair Value Measurements Notes 16 false false R17.htm 060900 - Disclosure - Derivative Investments and Hedging Activities Sheet http://healthways.com/role/DerivativeInvestmentsAndHedgingActivities Derivative Investments and Hedging Activities Notes 17 false false R18.htm 061000 - Disclosure - Earnings (Loss) Per Share Sheet http://healthways.com/role/EarningsLossPerShare Earnings (Loss) Per Share Notes 18 false false R19.htm 061100 - Disclosure - Accumulated OCI Sheet http://healthways.com/role/AccumulatedOci Accumulated OCI Notes 19 false false R20.htm 061200 - Disclosure - Restructuring and Related Charges Sheet http://healthways.com/role/RestructuringAndRelatedCharges Restructuring and Related Charges Notes 20 false false R21.htm 061300 - Disclosure - Subsequent Event Sheet http://healthways.com/role/SubsequentEvent Subsequent Event Notes 21 false false R22.htm 070100 - Disclosure - Basis of Presentation (Policies) Sheet http://healthways.com/role/BasisOfPresentationPolicies Basis of Presentation (Policies) Policies http://healthways.com/role/RecentRelevantAccountingStandards 22 false false R23.htm 070200 - Disclosure - Recent Relevant Accounting Standards (Policies) Sheet http://healthways.com/role/RecentRelevantAccountingStandardsPolicies Recent Relevant Accounting Standards (Policies) Policies http://healthways.com/role/RecentRelevantAccountingStandards 23 false false R24.htm 080300 - Disclosure - Discontinued Operations (Tables) Sheet http://healthways.com/role/DiscontinuedOperationsTables Discontinued Operations (Tables) Tables http://healthways.com/role/DiscontinuedOperations 24 false false R25.htm 080400 - Disclosure - Share-Based Compensation (Tables) Sheet http://healthways.com/role/SharebasedCompensationTables Share-Based Compensation (Tables) Tables http://healthways.com/role/SharebasedCompensation 25 false false R26.htm 080600 - Disclosure - Long-Term Debt (Tables) Sheet http://healthways.com/role/LongtermDebtTables Long-Term Debt (Tables) Tables http://healthways.com/role/LongtermDebt 26 false false R27.htm 080800 - Disclosure - Fair Value Measurements (Tables) Sheet http://healthways.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://healthways.com/role/FairValueMeasurements 27 false false R28.htm 080900 - Disclosure - Derivative Investments and Hedging Activities (Tables) Sheet http://healthways.com/role/DerivativeInvestmentsAndHedgingActivitiesTables Derivative Investments and Hedging Activities (Tables) Tables http://healthways.com/role/DerivativeInvestmentsAndHedgingActivities 28 false false R29.htm 081000 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://healthways.com/role/EarningsLossPerShareTables Earnings (Loss) Per Share (Tables) Tables http://healthways.com/role/EarningsLossPerShare 29 false false R30.htm 081100 - Disclosure - Accumulated OCI (Tables) Sheet http://healthways.com/role/AccumulatedOciTables Accumulated OCI (Tables) Tables http://healthways.com/role/AccumulatedOci 30 false false R31.htm 081200 - Disclosure - Restructuring and Related Charges (Tables) Sheet http://healthways.com/role/RestructuringAndRelatedChargesTables Restructuring and Related Charges (Tables) Tables http://healthways.com/role/RestructuringAndRelatedCharges 31 false false R32.htm 090100 - Disclosure - Basis of Presentation (Details) Sheet http://healthways.com/role/BasisOfPresentationDetails Basis of Presentation (Details) Details http://healthways.com/role/BasisOfPresentationPolicies 32 false false R33.htm 090200 - Disclosure - Recent Relevant Accounting Standards (Details) Sheet http://healthways.com/role/RecentRelevantAccountingStandardsDetails Recent Relevant Accounting Standards (Details) Details http://healthways.com/role/RecentRelevantAccountingStandardsPolicies 33 false false R34.htm 090300 - Disclosure - Discontinued Operations (Details) Sheet http://healthways.com/role/DiscontinuedOperationsDetails Discontinued Operations (Details) Details http://healthways.com/role/DiscontinuedOperationsTables 34 false false R35.htm 090400 - Disclosure - Share-Based Compensation (Details) Sheet http://healthways.com/role/SharebasedCompensationDetails Share-Based Compensation (Details) Details http://healthways.com/role/SharebasedCompensationTables 35 false false R36.htm 090500 - Disclosure - Income Taxes (Details) Sheet http://healthways.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://healthways.com/role/IncomeTaxes 36 false false R37.htm 090600 - Disclosure - Long-Term Debt, Summary of Long-term Debt, Net of Unamortized Deferred Loan Costs (Details) Sheet http://healthways.com/role/LongtermDebtSummaryOfLongtermDebtNetOfUnamortizedDeferredLoanCostsDetails Long-Term Debt, Summary of Long-term Debt, Net of Unamortized Deferred Loan Costs (Details) Details 37 false false R38.htm 090602 - Disclosure - Long-Term Debt, Line of Credit and Term Loan (Details) Sheet http://healthways.com/role/LongtermDebtLineOfCreditAndTermLoanDetails Long-Term Debt, Line of Credit and Term Loan (Details) Details 38 false false R39.htm 090604 - Disclosure - Long-Term Debt (Details) Sheet http://healthways.com/role/LongtermDebtDetails Long-Term Debt (Details) Details http://healthways.com/role/LongtermDebtTables 39 false false R40.htm 090700 - Disclosure - Commitments and Contingencies (Details) Sheet http://healthways.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://healthways.com/role/CommitmentsAndContingencies 40 false false R41.htm 090800 - Disclosure - Fair Value Measurements (Details) Sheet http://healthways.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://healthways.com/role/FairValueMeasurementsTables 41 false false R42.htm 090900 - Disclosure - Derivative Investments and Hedging Activities (Details) Sheet http://healthways.com/role/DerivativeInvestmentsAndHedgingActivitiesDetails Derivative Investments and Hedging Activities (Details) Details http://healthways.com/role/DerivativeInvestmentsAndHedgingActivitiesTables 42 false false R43.htm 091000 - Disclosure - Earnings (Loss) Per Share (Details) Sheet http://healthways.com/role/EarningsLossPerShareDetails Earnings (Loss) Per Share (Details) Details http://healthways.com/role/EarningsLossPerShareTables 43 false false R44.htm 091100 - Disclosure - Accumulated OCI (Details) Sheet http://healthways.com/role/AccumulatedOciDetails Accumulated OCI (Details) Details http://healthways.com/role/AccumulatedOciTables 44 false false R45.htm 091102 - Disclosure - Accumulated OCI, Reclassifications Out of Accumulated OCI (Details) Sheet http://healthways.com/role/AccumulatedOciReclassificationsOutOfAccumulatedOciDetails Accumulated OCI, Reclassifications Out of Accumulated OCI (Details) Details 45 false false R46.htm 091200 - Disclosure - Restructuring and Related Charges (Details) Sheet http://healthways.com/role/RestructuringAndRelatedChargesDetails Restructuring and Related Charges (Details) Details http://healthways.com/role/RestructuringAndRelatedChargesTables 46 false false R47.htm 091300 - Disclosure - Subsequent Event (Details) Sheet http://healthways.com/role/SubsequentEventDetails Subsequent Event (Details) Details http://healthways.com/role/SubsequentEvent 47 false false All Reports Book All Reports tvty-20170331.xml tvty-20170331.xsd tvty-20170331_cal.xml tvty-20170331_def.xml tvty-20170331_lab.xml tvty-20170331_pre.xml true true ZIP 65 0000704415-17-000022-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000704415-17-000022-xbrl.zip M4$L#!!0 ( EII$JP]H]33?P '_0#@ 1 ='9T>2TR,#$W,#,S,2YX M;6SLO?USVSB2 /K[5=W_P/7-WB95DJ+OC\Q,7CE.,I.]3.RS/3OOWM95"B8A MBQN*U!"D;=U?_[H!DB(EBB(E4@(I;M5.9(D$^AO=C0;ZI__G96XH3]1FNF7^ M?-%IM2\4:JJ6IIN//U^XK$F8JNL7_\^[?_^WG_[2;/Y"36H3AVK*PU+Y^.&7 MR]NI;L"C3+FYO8:/5.FW8(Q66[FR%DM;?YPY2F63 M;A)3U8FAW-BZZ< #>7+EZN69 \/3"^]Y /![PN/X\P-AP>,O M&\\_]_C3@,CD#?\U>)3I<0_"L)TW_^]O7^[4&9V3YCH\.+VV>C$,S?"-^-%_ M5&=6O]L9)2$KG@A>,)\H*W3:[8[S5['?PG8_$C((GAK M2M@#G\'[ 5\91E_1J!X_"?R C_?79G#LK3A,WL"O_H.F.X]_4'/L-\YR0=_ M$]36U> %RTSQCF4VU]Y3+==T[&4\$MZ/,7BKKFV#?FQ[S_LUYD63Z"J+?XO_ MA*]THJ\P78U_ 7Z(>]Q9V%N>AU]B7J OZBS^!?PE!@?GR5DA/J/$<&;/9,E: MJC7'IT?M7O!L&O4$M5:4GU"?WC*N*;=TJG#]>HM<^_F"Z?.%@6K#OYO9=/KS M!<+0]"=KO3#M0GDC!N)F ?AJ.O3%473MYPN5/]=I=QPK (\_&SQ-P?@X2^^[ MX%M=P^^G.K45#AB-8.,3Z>KS?UV\:\/_1NU^OS/XZ!_&YK:_\JC73(Y M^[UV*8@HQ,SQZ-%O]MK!X-XO>=!CV.F61*A"]!@V.]V0?.1)C_(H650^>@71 M8QB8GV%I*!,Q/\/LYF=8G/GAZO;MSH'QYH#0QS]=P.G*FB\L$_YDER\Z^W9+ M':*;5/M(;!-=T]_H_(':)Z#\BJ#T$:$-OO9^T ",EX6AJ[HC8%0T'9X3GKCG M>KU-Q/7BG?]8/-(_O8F=9P7?FS@ 9;4M:9A_;U/"7'MYYUCJ][/@? S&Y\=V M^'-NF>?#] U\SX_EEZKJSET#DQ'7SHS:^+--9TC0)_K9A)B$GH4HI*;#^8G( M#42,%")R[7P,0QS*Y\?X2TW3'2 ?,6Z(KGTVK\A"=XAQ%A*0B'NU1&$MMU.[ MAO*XAE*GL+)(3>UF2.IF5$;"ZGS%T?,5E9&=VL.MY68?N:GS);7$9/2#ZI#J MM"&5U))46QQI+,YQ]C5KQU9*QU8>YM?KA3PIN!.+0IUX.TNVU['IF3*^3IE* MFC(]CH@,RE@2.2APP[(TA7^17;OBY*/=ZW2^?:&/Q/C(0>-&X\XU+N?_^1\O M'R<_VKI*RFD@-*J_74/LXAU6K+^-1>\$>C] OG:.LAM[J?W+90X"SCY9]E?Z M#/80SU5 5'1C6R9\5+D1#18-[T>PKJ9&;(W]OM# =G(-FI13'E8!0092>!*3 MBB!U\@EH,2JE>1T5MMP /;Y=&82QZ^D?Q+9AX&O[%@_5>8$YRB)Y,.B593Y1 MV]'AHW!D^$-"@C;M\XS85(7_EU,3$RQS%+%=&I5%[;+9 M'7L'(LJBN.L'(D;-[CB+]5LC9\[6+TS.6FV/N1#*)0KK_ENTPW*2OY+N!Q".;)]2;9\O1.=PC2*H^91:)JX[M^Y+=6V%IA:X65 M^E!Y1H6]$Z2(IW*YM26UB*6@02U9F7VW6K+DE2S)G Q^"O+RF=C:_7)!N?1\ MG"\,:TDI+SZX7B#!RBTS$?16$K(5SY-D2H]VNK%F]DF8+;$1J.5"#B-0Y/U1 M,7;^-V)_IPY'_'=3=TKN&*SQE\=1\1A6R[S'I*DU(;_C 6C-APG-QS'++&O-;^JG!4[$O?D MY=)U9I8=[,[C%L6EJ7VQ5&+\W;5UIH&\ESY\B\YM9[(X!_R%$D:O'PS]L1(;.TG,3D*X6DP7IOW*IIKN?"*J;OAF M_9[:\R\6,?TOO4*.&/&X@7EM,<+EHTUYO4*Y96.3''ZA1"Q1W< MY7*5VTP@S_E)Z"E,9BVAM81*8D/[77\#$#[%^N]Q5/AVYSXP^J<+7WQ\@O\$ M.P=KWY=;1K<@&U8GSS\$*1I^?3;0_;XS@]NGL&#ABZ28$(]=H@ MQ=H@3MUOYL.W+Y1 >:_%I]]')G* MVBK1)ZSMN/LOKJ^^U^5D0@ M?\<*U+D.WJ;VV51M3GMBX/VZM@;D.T^C.=_^06P=FV#< MXDE@[HQ9IF:9_&#H S&_7T^G%*;'G[]\?G]]6VZ%J]JV5!8(UCD=&Z=&_S]M(LX="F5G^B&K6)\2*).] M2J_PNNI-H;\VZ6\ RJS22]H67[46NKI,O"3Z62]*M<:=J\;EZMV=V0)W MLKBE=O].E>$@+_EE.-X31LN_W,3%T&$JR6O?\U'^*!?E7T_/8E632]$KO2P> M4_]/[V&6P0F0:OVOF%G(C&NO_Z77RT"S^>7D@9Z'HAT2UVYR >EDO:EDO MPZ):1]:G5[AJ+)@GKK4\121[J#&I52B]"D4\U'K-*LH1K->L6N'2*%PUUBPY M-*NX!:I6H?(E5&I=DCE=46]>G'I="CO85=*5HV\NUFO L=VHLHKKB4-[6K8"V MR7!MJVM;+;'(A\@2TT;S@:E^+:E:1'[I^M8R2XAS3B4JTI:AJ7:NV5(I-315P)=K :XX'N,TI]Y:=D >'J;-F1 M#UU:FM M3FUUZABJA#&4C$:QMCJEL#I;*MXJE?Z7LQPF>BER>),SWTN1]ZEG*2NGR[0K M6"#3>^U19X@GY1X=L/HH_JMEF9JZ97^U',K*S>HX[$(&?QW-$S"XUVR/FIUA M,5H=+=9)Q^JJ%2L?\QR*I.(F<7G-?C):5EFLY6.O18K+1[UR7_V*26BM,Z,05ZJ<-.MV;PR1D\;':ZQ84A-8-/SF!NHHM,+GPBNOT/8KCT M_3+X^"N0F=CJ;/F%/E&#LSSX[;.YRSYK19;T/73 M6\E(YQD>I9.!E6(D"$-!8&V3JQB8$@2LBBMPK;^U_AY=420U+N5RL,JHO\C: M#X#M$W'TI[*K;ZTUA9F\.#FIEO:6T7NNM;?6WA)I;_&^\WEI3+FX7[SG54+_^N9F+0GR28+$>Y_9Q:=>1FKAB<8-M<61SN(?[>/+ AA4=DN21+WC[[@E ML"-OU^LZP* M,Y1.8>KUY2067&[E/0=UX;MD!ZTJ^!E(_H$R_=%<*8C_-]4NF??(:O!RJT4\ MQN'[)7:B?I[KQC&K=FJ9KF6Z2GFF0YV96J3+)-+5WR7)Y'G4$BV?/WX$]2J7 MW[$>>EX^$UL+SE/^1NSOU+ES+/7[[Z;NE#PRC.#FB5X\AG60M4,P;BDHA:Z" MGJQ(=WOW>Z7D8W7#4P*NM:3LD)1?G\GR#V+;A!>V&VA:[ZWJU1/$V9:,J->B MM+'15HM2B41)[DVHJ"A]G"\,:TDIM^C7_"+52@F-__56/&MCLRDA@)2F&RY& M'G=X!$MW=,H^OJB&JU'MDVW-KZSYPG5XV' ]_4AL$\(#=D/MNQFQZ?ME_ 5 ME;?BB%5+KVS26TUO_Q@27,<.&1V^ J7X"AZ8ZC9SUGRF6HRWBK&7G4NB6^UJ M'M44>T% +;,[36^$4K6I/:JIK=W=\KN[29"O<7QW%,*:Z3%^5)7L@EI:+P,CA' M\_%/%W!".ELF_"FDZU)5W;DK5BX@'C-$?9_V+Y6R=L[E<,XEEJWUC%4M6V66+1T1J5Z?L"U.1UY)DN3_P,[QK4^;< HGNGLG"NYCDEJH&80S8 M)JZHNW:=ZVD*9?/*$_9[N=P2F7RSR>H*P#AZ[Q+ +' F!M]1^TF81Z["D8<"HUL+RR'"LC<(FTQ:&;AMW#I'R0T. MAM$G"C&-2C,+[N"\!'=P0L'=PJS*RVTM?YGEK_0\+\1656F1+X>%-NJK;6^% IP3^XD2IW".+_95LMPEQKJWTR+[6L M(E.G0$_A8=:"7U'!KY*/4$=WE13\6GYKOW);Z6 M*'((RC%;[]7NX,F7I JY M@Q63W"J9N;))[AG;W#I962][N=;U;TM6!L&]W[@.C?[KP MQ<.XDN?,FT+CS;Q%=$ZC./UF MMSC%\?*&1:E0],%;JM$Y;V)QPR'F+R8_8MQ.6R+;';U$.L6".P96AC7U(5Y^;W= M[JRIX)P2YMKTG0<8WJS._*'\W\+#XUC;QNYN&5MG%ABRT=O?[S[L.W1O;6A- M?P)-7R6PVQ0\:U=\&O^ /BJ>8MW0:6X%P\6Y*# ;\V'@SF.G* MM6T^C\Y48BC_0XFM?#0U!0U#>%[O.?$8/O51&(_=(#3]&ORD80)X/E@JM[6* M,+&QL/C/B$=2 Q+.?FP=)@#D([?*RA_4,)K?3>O95.Z :Y9)->4S8RZUPQ") MA_'9_\)'_2?%@[LA^VH)B!*'68?L'Y;AFF#TE\ [@]IL$Y[@"?% 5CC67E^? MWY><6[JP; <$7,%;@-P8.+PG@P?%<[O!^1^T;+N&60>+ ZM< 2L?+7NY"0S_ MW?]Y-PR7JDH---7 =_YJ&*+(6.N W-)''3P' B3Z2N9T$Y+5 _C[;E#N/__C M\_W_*+]^O/QR_VM#^?SUJA4&)CK ].'"BA(3:!06\^;G;\?O>$G7;SOZ-3 MXGNK-5%5+;!'3%F0)7DP@HE"EXOQWV_$S[YY6I^6GSB,"D@W+"!-< N[PW9W M L+]TYODP?.&31!B!VRCP6BT%VPV5:G^A(\T%),ZVV"\#1[[2IU#(!T.)_UN M+*1Q4Q0+;QJN#]K];G\O>&T75@=#)P\8KNN4Q8"*CWQ9/7$(G+W>L-M;AS-^ M_&* 3,/\WKC;&60'TK_22?E %\!_G=_WU,"_#(H?%3#(RN4<'8#_\WZ[L2T( M69TE?#)@\6OP1_ >P@6:D!@L_3G"4P037)I:>'A_<#XT_!:,NQ]1AKW1AEW) M!9QJT#"5] \&X^'Q:&AAA18 &KI<3#$L%J<]NZXCPYMTP7Y<3^_)RUZH-_N# M]H9!S3+K23%,HR#-/KAF^6"H:3IR&WRC!=&UIFXJ*EGH#C$V\ J>O($'/YM7 MXK']A+/?Z>+B'$8@?O@" 4UEB>+ M@E+PGIITJCO*U+;FPMMO/A &8H>,!"YRE5RS6E-,H2K_%$G4_]TD0P#'O;4% M:)CYXW1*50=OKA:M'7'2\)R[_-$=]_G>4H?H$)O[+22]O8ADJD>HG0L61^%. M.&23G"VA**[*'+FQZ92"\Z25@BD!M)7GRVG(OX.6D]Z:TU B@M[;/%6^+(6< M^\!67LS#RS7WRI2(6^8/^ H]L]>2,RW]'ZH_:2KU$_RWE+5>C3UO.TCA^1A':< "@\( 4,(A'\0P]V9 MW#VUX3P$MQ-P->]PZ(2L/4:<5#+N2L; ';SH]/O#S,:R9!PI:!$\H=H=LCJ> M \?S#*!/R.;B(^N2\36W5-4)F5IP#JMD'#U>K'E*F()$Y'B.KR,'0KX':+SP K<+J%$BX? MNF3P7Q&G2LC"1O^RPF5A?!C9PCONBC6%P3U_R[#(-G$(O7(]_:2;Q%2]X_R[ MR]5VE/9TUCS:A*F.AD(&FX8H#/IYH/#@*!H*A1M3UA$9$8^^?/">!#=SKKOS M0R/)2:^3@$+,A,?"(QLG.N-NDC3MCT>G-6C_5<&6RN#CF$\4'GTPT#DR=B*!P=)T MP\4V>X"\ZMJ\6DSY^*(:K@;ZQS/::'Q<)Z"DGU]"%U*XG VL<4*R?@4O4G2L MUH-X[WJQPTR'8%B!X$. *>#0_-=3?W:8G,\M9MZYHA\XR_ME_ #1.V$07X%N M'.,ZF]'_>GE5'J0HC+G\=@U==0+.8N7:QI>_ \959O8*88XO1_?V[O=4#!^N MER1*S>\K^..3;C,G8B+1+AV9O>M6LTCV(M)31#J$,Z*T?Q.:G9:JK MIAZ&J=@V6"^$E)IW\JRQQ]3+O=?8,JVPGM R6%5%%LZQ-GU4X9Q6E]._/I.E M3PB/#O<64F'-(LTT@>MMN-)M];MC=JC$DF O/'3 M,B@?%@+:'&1]MORE3' M8?O]T;B[>\J&?Q-$_-P'G<@==SJ=& @V#HX> DBJU/4 //8TD+PG3&>H@S%.4N#_GPQ MA>>;4S+7C>5;Y6_W^ASLQ%?ZK-Q:%_\[T_Z-OE4Y[X?QX\9^/SH]Q M8X2>42*#7MHZ[N@S8K(FH[8^_5%!")L0]SV:;Q6#3N&-.;$?=;.)?[Q5!JW> M8+'ZTM8?9_!MI]\:\:_YV[J)]ZN]57K]5M\'Z]JUE:G8TR & .=MGC.^/!$5 M-^*(N<0+($SNG8 **@N;+@CNS^@F?\36\()GY5EW9LHC-:E-#&.)O] %KFPD M(#^\J<-$"P,&@G>=&>4+'E_]"([^ZN+WUEU+^>7R\N;B=>L_R7SQXW^ 8_*C M\AGL+4!J+7235S3@JQ'H@(<,V*IQYRH6(9"5>_T);\;XE1+#F?$:[A;'$]?< MYYD%4#>M9[QXAKD/#*P4L7$)>*7"+U1%@V4L&\I%=)0+#LO%E0 %_K1L>%V= M*9C9!WHQY>*9PM<7+A,_7@ B%Z\5<'UQ4 5HI9!0D0\/JLP(K&HPAK=_B3NLX&\1 MX %0?\Z9 :R!8<2=9+S4! "!@>?\HZ_1D?U/UD*9?@-"'9)O_^.#K;SQ/Z\] M(IL*(%@X];YP!7H$EL@U@(7<5?"V@SD?5[O5FH5Z!/3FRQT7'?\MX#;^Z5A8 M#;FP%EBE@G[&C,N9PD2-".K(_ M_9B_NZ"'O4X#-[*&876ZAXEPE& ,'R*-JQEHMP-JS&;Z@@FU?H^E-_^?!8\V ME"]?KKC6?+!;R@=*3.4:EF@(95XA^*L'\:S[OU#"'WQ= ?>?"2#&_7'WQQ4\ M,:/]C;__:),Y%^];O$:>(3%A*-M1/NB,$D9#HZ&.L(6OIJ\;')%_63KP%:\W M=&W/0/T""N@+X2K(A;.C17L*KR"?0I6L*">C86) M<$>][%"/3S=U;4Y:G9ML#DH(%&$4F"'(M1M=5[,6H&)@2$T3/+!D $L:N"\R\H!P(^X^6"0I3? MV^3_=$ 6I)Q18/Y.,PX/.X-L(&6&F&5PUJ@2A3+GZ@$A;P3/ER_^%R19I7 M%]$W 5YPSA1P*S2*3@Z>.H'YB+.R>QX0&^^!4J^4@ @,P;E"\5_Y;,$(8!"X M00%7R0($PHJ$OHI':GQY0VD;48<0?]_F%&X"B88H#*8)D448U ! WU[P>_(P M)<"=1UCO8IC5XHNN20$M$2KB+':L&8H%*F)X<5)&C$ ZHP:+N^[P=+"FHZ@# M.[89K#VM40F-K;GN."&O."R,@445,@Z+HG#*84D+"!QY)21>29%2 M$.D XYS0V Y(A:?6*%]C][X: M!:F[+8_S<9 3&JHA:CUJY+:$GP=("([XFM&#JY/CA_5!O9Z^7R*3R#8"W2_!'N MO$N[LO&KB]B8"K^ %Q>0+Q,S=3Y_@@ MR!S^\W'UU*5S16P;5['X+V5T#/L54Q\(@W=6>Z]27"(%!*@'JR8M MFB+T\7"2!P+\0^B%AG\$#ZPH7LI E5?@#?%/K],A)][W7_=?/O#H0'/2&Z= M-WYNB;#.=M!@V!L>CG10XH$[W-]QEP0/6K["N OB1F(S3 @IO(_$ZWQ.(' ? MX'KJ37QMWV+0\_&%VJK.Z U.'_S(O%]99X-4O?9HS[,(O3 =NZ#K@]9D$*+B M/N"%5T$(RE9QQQ5?^!\I!"5(F\ M4?Z)3K_"O?Y-"JT&07Z&AUB-<)J-0/^C M@[<=0^!I& NBH3?U\T7[@O_-%D0-_D9:_GSQX>[FTQ>=.??XTD6Z6'H#KH;" MOVDH7F3]K&O.#%]M_W4%H6,'GS1_'N_!WA#GX#*K$L./R1UK\:/B?>;1=S[; MGOSW9RK"^0?+T&(R 7RBT6;LZ&A;<2"N8\7C<%RH$Z4\ :$W*_Z\X1*4(YA4OX,MO%>XMJCL3.+U):QBW?==M3<+0NF)/9 Y/+3G$;B;,NR=+<', M>JUQ#([C5LP&I4<./TV%^3SF/O --;$YZ]A$=3#9HD%4!FXXYCP-HL^%(!GT M$?//MJ52JO$:)9YA(C;87K%!Z8 1X%EH_-=+ 5HV/$MXNP[79M3?X_$SB]FV M7F(,3V3_*;P_H8A=IV>!J&MRHPC 40;@8=,9HL Z\<@A6L!Z!%H"Z.'MR317 MJ!I1J >;\?V@1HZ?:(>%K>)&_2/!WJ6*RXL O,*\"?"FV<9$ ] 6WOD29Z -Z-V"I1&:9[SGP).(",UXZLOU9-PR1QR0* M$@NE4B$:[IA2;S<84W'6EE*/ KEZR3.% 6 Y>!.R9H8ZR;F$6%JU_12KXY> M*$.1!D\Z/"KX$8)L3D#J9US&/&68NIASB,MSQ]N6]J#D9O4J9%1""U,YS&S$ M>O;;K8 9GTWE6G4L;YNYR[<$*=_!P:RUMPTGR@"4O_,=LW]X.X1X(B5!W]C8FN/Z7ZE:O;*-#;V_F(1>@9#A(V+F'>^/CPG MW] CV(]2[!>M?O&,$.['8VT26F:>RW^VFF#&;"TP;C:=@P;S+0I!(,5Z !:M M=IF\+7W_^85K@\8Q/U02TRR\:VU@A3-I:%,B@3AD=2G.G(,G!%[OGWF[,J"&6J1!U^*XVT..';FO@(R;F M(RRR%T0VVZ"(#=#0SMH&-7J90 N@'2P/?(#J;8K65JC/7Q:]3.X/F$(Q>Y/.>#QI M=Q/T,JX[X-&02&4@>^-)KS<8)QF7+4ALO5U/'/Q,3FRNWUN'[]2IS%4J,R[Q MDB:]Z<4.,B4XHR%=OQ4.Z#;0ZW3*E@G=BDKD2LJKSX7E0[N%1^X[6#KB)6EK M,?J(YVFW%Z]Q=QH6(>N9ET BUDQA/#4*D'%W520TF.>1AVG).SURKY:\-(+: M+&<&\9\"MLN9,:]&*QH2<"<<#>-;V:FS"FW6(15FBD\'MI&G BY -&V-VH'! M2C)@N9JJ8S_=5-1'RS'L>8%'3&+(>0AE?Q)W=== 'K>%VT#U5:HH_WRK_(4(O MI;MX47@QZE$6%J'78JI/E@W/F=ZI576IW&,.S*O+#UW?FXU]PXF\[ LMA_O; M%.6!J-\?;FKZP@_O-#;UBHU2N>",>R>O)BDFSU M=CE;I<)UEX&4"=F0">UT.OGYCCMQB)*V=OK6G+YHPJ+V^4J.R3[6KP\&0;/< M!X-6PBV4"LFHY]B;Y&'YI/<H(ZV.ITR25T1:>CRB5M9;5RG4S)QN\=:S>K8 M@G31[0X_H_S1;71+(V-R+TGYRA45=F1B M#N9)-XI?&;R@//U^L2CQ_*$=O8"W6$,B[7YDYI555DRR.YQ'V#9]-<@:OTBW MIU^PRRFK.%5',?;P/8]14-!H=S.59!VH&]M*"JIMVR6QB(>+L!QXA.1W,LQJ MV0_1P<,*8F1+&8I,(&]SQ:(]6_BU/0GG>,XVVDMDWSXU8[+BNLN-DPG7D#D8 MYY%&*:%HRA@"UTIVL$LH$[+AD\BB&5*WT\TJI-51M^JL::6Q\\6ZKS)A>LB* M5LYUH,0Y4:SQTOU;IK$[R:X5EQ+<*3/D)@W>V7/6-Z+$]: M5DS.281SXF%M+L7W.DZY1[$/O$-U@"GFP7&>S6A7O M>.9=%J+^&]H;M29RGQ -CER.UH]<=B&H2TRK2'?DDLO? M;T+^/D;E+YO%2?)7).#9IHP5#6\&+@1-K=%4K-I$IS.:)5 E'"-'.HI5<=\[ M+ +M[<49+*A\_+B*.&9%F];3 MN-G!33#8F4IAV6^"D0^EO8/9Q)LOI(]4Q]*P(H]R/5G.2A^^IU\53$!!9$,D MJWY(PHGP!F0O8Y9&%AP*=P:.ATIXR0^60^R*:3)ZBD5?UAW^76N]3'O\17L# M5<)UE^,@$ZZ%N1;;$MW[EC#)[Q=YH":=ZDXULP7'=!Q.OD]\3,_AY,CFFFJ0"L:Z+; MZ;JRQA>70X4M%Q;T3>W2S8; M47N?(ZW2$QN9;VF7'CFYF:8Y.G6NI_?D!?XR7*S0N;%LW+FZ=!Q;?W Y7^^M MKY:)?=-MRS#@D2#AM=$5/NBE/MQL-3O=\: #]B<9Z0, E)%& MZ_WFDVG4&?1&W9.3Z!X/"[OV4KES0/*4?_Y&YP_4_M\3D^Y;4,_R\4]7=Y8X MO65BHX#+%YU]\X'F, N(=Q#[Q%2.'';AMB3ZM! NC3&!WZ;@\M2)B(+D$M#X4M-TW% 8B@W1-? J52NR$)WX.]RT'N% ,+_ MV?2@EX;V'C$7MO4OJCH,[S:!SRIE;).N)G-L5\4Y/ILWMO4(([%?;.#3ID_; MZ>[TTKKMT63-4FZ=H&AXTWB5W4%[F!U>B_&@\([:3[J*A?/R\P,HF+Y-.;Y1$QP"J#_3! 1\<]01-9 .\.L"@'.NI@R-LYJ.S];9 M($*O/>H,.1'XIV]?+/,1#.8<1[Q?+BBWZ (8#DN<%>^':?7YZZ>+=P-LH#N< MK&B5&L" C)]A AW,GKHBV,(&0BNOP/YI8-N)S90%!#]L1FSZ^FATO$$@MM!Q M+^KUPM3K@_Q/6OUAOYV)=@*H@'9?79R&9^9L@NNDHI$E:_ZFF_K)B'S2Q#NQ= ? 8=KH6Z2CX[19[3_+?/*3B*#O:D,MN&K+&P9V@W<2VETAB M<>-P<-)L:*7[._?=)-8H+%-E;O"3\79@Y-O%7@HJ9M !+7FXS; MT<4P":STM "Q!#FZ@O@&0N!+\!7$J:(CT(+/+"8.YDU%B^&XEP\IPD9?1$M< M295[6W]\I';!NL=GY!-Z\Q5B^".FJXO^8JN71L,VH LMZ2:CJHL]4Z*VZTBF M*C1__E;KXMU-K_TABP6*!R>@UGO"=*8P<."(IL "^41LG9^QQ1V$YB>J41M6 MT$^NJ3'1C3<@S$&:R:>]X[->F__PYL3Q-Y?%=4)%!]JAJM_"8_-G/90X1OCE M3F\$0\I6NSW81O3MJ*0D\K5)F_R\J@(RH,'//-Y\(.9WY7HZI9B0XI1_]>7S M^^O;4#KVSGU@]$\7J?[Q*4+[8W"EW_6Y I_BN!+/D!70'.:5J$>_W\8^(!:G ME2!50"F/4/@8I]).KG8Y5SN%,35)<\Z1;_*I749E*ZFY.[V>7#X"C(](4PB^ MP-%:@%9 6*&&EF 3%[B]U.(>5DPPFP0[R*NZH3M+Y3(E3^ %NM4Q1-40L_KC MBHT^F YG"[[TR%Z,%B7YF<.+=R-14K/56UHA>!Q>?* &6>*&E4V>E1C&%,<6 M;V:<>)U#IV109U @APKP9A-(O[^#OQDJ%DF5@T+G1-$K)FPNDA:'V=/+8RBN MKZV7,JCK'O9T(V:_H; V:[JJW)"E]XW/I.9'K/>:*9?PO<:I?F\IN[R*C0EN MP8^:+S"U[D^FW#];B0MB.O;YD'N !V#'Y+S'[;Z7\X9/:9;)[5P5- E($$)!["T'2(T"H5%HY2):#;93:3RK2PU%"$O>WL3M;SL8.4^YB+S G=&\E**Y>AWDXB*#HSM=:;R?;D"PL_0 M//XT6^*P?.+0=C?1S8L!IQPTXF5D.=&HV]F;1M&KN_#<2F&)"W\J3#SRPD(- MI!P/&9%'FF,J8[-(!5.C6S/425!MEZ3?B./::'0_8)(Z]ZT"?W@<_42; UA# MT>TVV_UF=VM>.0QF6EHEA;[[Q-Z'T#&:PS]6B(R4[8R;[6&S/HZ&*51UQC UJ20,9>8*E6P@H\U%%Z_FA>Y1#V_ M2#92/D%\_6V.2=G>9,/.;X$BF0Y?J9,&'SSTN5?UC M3D8@O7,G>G!/QV8EJO^0*&._)R\?Q15@[\6%'@=6S(XG:V?_=DQ7+.Q9#W=. MXNF]"W;4G":J#@SH88%7I!#&M@L(C':)O[,O.GE RZU3Y"4>&'#A]VTNZPX4 M!J-.=Q*+P\[YCHQ-&BT=3 ;#>&E*CTUB&7Q#^-BFHYLNGF ,[A=OWM_\>J>\ M=YEN4A;:]MGR.!]G83'XTIHJ#TOECAA)@>C6,O?P^*OA=\GU-S$[,<"PNHOH M=;XB>(P=UH?Y>OI^B0![KH.0]N!"MG,\&C3<6U-USG@:Q;)[":#PZ!"];?R*..&+N.]Z,H_4KU1YYW3?ZW7QA M4%8RJ?P3+Z-0^&T4,1KH#QH:$R#P1EP-N!HON-IB)S'>Q=T3LK51C'=M2.@> MD?#=*<'5++P(;5>K&MYWY^>+#W';L-3#)I MU3ZW[&RY,T>N&W=BV-V.Z?FZZH+U!U5<1L&\!=330]1S+!C*Q(R$K;/O3+&I MN(X!O@]R)*^<&:R0CS.PT"I?])1>6S2'?=W@S;#BRY$:R)H&EN]@SRR+/\G0 MQ\#35O"9NRL/WFK:P-0I" ;8;>XBJ\##E@*P$U6D?S&SNL*!G^W%GVR-A[S/ M.J:][JZ4>VNAJ\JX,V@HSS-=G2F /!89S-XQQL+)06EQJ8+--[P%SQC:L36 M$/\_7=WF_<)F!.("P(C@,;IXZCU0[!R&5X#QREO$ZD&X'@I#WP,[ZE*=WSQ" M3!&C*("'X84%2V7.;U2!MV&N*=%MY8D8+FTI*X_%6#84=8:'N#C..,4*F+^Q MT%M !,/P07HT>9+>BS>,);Y+OQ";"@JJVC9!RX@C1"(%'>%$1\R]Q M$G(1 MKEYD@7,3#.@'RF 83@(05]^4AI[@N+B9K&1T=DF(TIN(R\92W%8V: T"#+AU M^V18SYPVFTO+=L$HG CII&#])K:>0&YMP>BW^C$K;62M0(N(:J:%) 9T]4\7 M0)@N47I4I-44:<5MBM#*P$3"ZZ#JX&7CFR'+L%L;D5#IFY'%.(:"8!P[T1_/ M[SDFE@ZPYZ89LRPHQ-\$"E9VGU_PUMS28"5#XL/* M0E\6(IP*.S%\(/1QQ%H@?!5<0-_%['*)8^>X!X#!U'40\^#W40*,@X?J=^P+. M#!;9@$-%:BMG/>9_=6& .D-MQ0DA%L="L(!5B=Z(BI"/_ .Q!C\F)#RBF!C MV"G>[(5:S2^C'.:JFFOHH%$!6!=$U]9$+ 0DMU ;2@%/=%K]<9[ M2/ _559 M&"""Q#]:]HKY]W/F2Y(U@?IEW=IRQUIGB38!B"@6&B^/N!;!>&K@+S2,@"U> MB)HLS^9Y<@4_&#"L>!_<=?R)K*\@PL%^ MH"I.#-+E6Z[BR"B/][J?C])IC1)=E+C>SFQF/;/04NY;](UUSMKI;V1:"D6K MY^(4,;Z'] 'I":G:2_/L7)I,W'#0&DU.V_LW1GXG&V+:G/@\B&EUF_IB]7[" MS>K27;K=;@V&4H.[O3]MK]-J']1BW.@GPRF1TX*2[(ETP]G'8N$B=!9M+-S_I+K":%+0R% M-L4L=F%892FGMC5?7QSB4I-O<[64#U)M M@_"2,H":;_:9EE>8X155B'V=C;V>*(9\.RB\[Q44P6-E#S.=5T4!LCOD)UF[%J M*?ZDA0=93%>*:M__+6C)PEM[25 M$-T=#7+OH[7V:W9#T8,*=\H+J)'3)"P4J[IS)+M*;%O?+#W_#(RV>4V7!5R= M8LDZLI*7SH$[8>$A*'@K*)M,,F3/5.&I;[[XPGB)ALVOZT,5PF4BD,%V_D9(\#2RWB,C8PX8\0K>40CN4*5^=56"2H"8ZX"D 2V M_AJN7EZ5^::WR'N07:JJG''*HIP>UB#NVI6*AGSQA1FC]<*,;K_5ZY9I9V]W M0<:QMQBS)0N&?7EW%S>/97:EKB!(E_1.I3S%RDV!%6W;:ZXZW41ADT^U5SS/ M6D[1:77E5JL$+D',72HN92^HJ)+)DX\?=Q'G*'0U2/2VC_*8T6SYM20[FNAV M;E1[YV17=SICYV*Z,A.B2G;B./ F?RI8XR4N(\/;]ES3IO V9OPPTO7:V6=A M<;LUD G]0[; 6YW$(.\4F&3;*FZW)HE>TDEJBWK]1GO$2QD,8TELW_R@9OL"ARGSJU2R:E:>H\' M;O):+:/PUE%YOE%Y'9]OQ.AV"R())!>+S5]4(T/<,0FKUD$8]I(S0 M*Q&@U_%YHO>P<:[#_WC4JK3@NL_Q9E5:<(/R3HM9T9+'[!?9ZJ$" M3"3P'! 5A8[^[6/ABL>IX:J.ZVVL8CW<^GSTQ2N6PVO36/C:1BQ#W_[X"J"@ M5M(_'^)=>P8T_-YTK";^BS6(0?%UP[^R;AE;J!?Q.':RQ#"]=93GE7(UX0'2J:YH7.-L&:/'Q) M7/VY<&WL4;%7$>#1Y(T( G'B*MM7-U/BMXAM7C7NZT>CQ)DHPKQ+\39K",I6@#I,68 Z&+<& M@]/$U9G8F:J49EN-77"6(6MEQ&"C,F+"I6MB&AK,>OQBLIV%/P%Q.YN ME#"WACM%,TUM] 87N^T=<8=L7(P:PHQU>NWXR'?5E60;#=,EJ[99D*-V/>$3 MB:9Q&7=T2I7"[[3:94KA2T_=[;:G,VR-1WMI396HT$N\W%-JT#NC5B_9+%6' M@>M&8B+Q17?57)YVA8W>*KZZQ2C5H>)Z*9,&7.FI6R]E]5)6 0;62]E^2]F) M:P(ZXTBIG1HZFF/RHSDS[XX"+P>>G^DMT^Y4\II7)DRJPY-^JR<=)C_L*5[= MUD"22TY#N]'C;J/?'YR+<.WK@,B-U3HFW82\[*DQR5;>U&])PI3#;Q ML]ID M7*81UJH@[ZGYVE8YF,3.Q]6*NRODRJRN(H9(_$=SEKIUA<)N%7B MY$\6!RNKH"6Z.$7*67_; R82)Q&NR%9GPTZ;#9,( MW)/GVRHG#F>5;I,(W-,E]"HJR'52KYR^U?%KWB)G7F-W'OGU7B<]:E;M*!6S+J MUJ5NA%]<->=/R^QX!RELZ_?E"Q2N:.MU>YULCX[GUQ,_Q?OVG',B*!3'CJ/VCUIZ3SN]ON#=OL@\^DK(Y]M%@ MYEIU@$DY$/2]S,M:.Z44LIZ6$&FE'2%8/7I*DWX@_=-0-0=;DU9YY*1_GH0/ MTF2IB+7+.A]@)6-G.2X*:6Q/8; ?W_+DM=0>5_B+EJ'C6Z"\?$RYC% J/_,3 M!M#_P "ZH?QB6XR)'U(ZG5_H$S64WNJ+6XI3(B]V,P"GYC-?3]=>QXS0$+^M\@6?L#D"-DZ(OA]Z@@6( M^0/YE^JOF);&_SU@7=].KL+8&\/-#8[GP5YA[*K/WB3+F8*]*V:FXLQ!JU0L M.+YQ65:"@W'6.F\&!A0K Q/+:&7W8&)F(QO#1/U%M :B-F4.;\J3P 5\^+/W M["T\FL;M[8>A_OSU$RSWK7:G/XX%>GV" ,XO:/%M:G!'R;$4.IU2E0O/PK)% M#CW<#(7Q=CZ/)N^:J)O8#,B=N^+MZZO/#>61+R'8.(F\>(-MQSN45T*%A&PJG/8QL$,;TJ8Y-?FQKKEQ&:2KZ=XDI&DHPB>+-DH6Z MP42?8)[0-# +*)]5"(4[O5YJ$N\%7U7)7(BA.)#"P48B:CBJ ,B_V,F\]4S( ME<60YG?ONC,N<>7 M#B&E&5?>H94O6YZV7M<[?VNB1=\J*E%.W6*$#K#^KG^(VE M,B/8#1'[43K+A>B)QT)&AV W2_@6''N'F+PQ(IAWWKYROC"L):6\]:6BZ>#0 M.);-W@)>:$B\OI@-!5U16U=%YT?\!>UOW/)41"JGA M%<9KGREZ70*U-DFNZ*(?*F\4RG0(4P#")UVE?E=/J;#>7N&4?S65CGX[ &%3 MK:& 0)H^J001<5(<.&[63HI9X_#!5_!K6)@UG3,0@#!A;A!68"A#)Z2E?/*8 MZF2^RE:/+I&02J$$W8+YSJ\NYW#G6S/1%-@45C7*Y \/\IU1UPMQAN M/\"K2\4"=]!.$H6LS4%;$4%(O1"=O%^K\$*4&*BVU?E=*LR=SY$=87N\ZK', M92&F,2OO,1C7C4F2 MTN3D1D2]UJA4?5-Y+)/4<;O(R6,:$:<7D:'4(E(R2Z4L@%'FDRL<7:JLZHR<"XP8"V9/-#9$ MRN54I$-<.4^7)FHT8-)&35: M\73K1&)]2^=$QR#M1/-?P:,V41V7&">"X#[S@6G)E:1DX";ZG?U2K=*7CX\V M?<2"@\\@U;K)=%54GBB'.(4#B?F7[OJ$'9'HB9M8[@SV0DEYX@29+"\QDE\, M*/$M&9OG@BN"1KB0F>M.GT8M^ MJ]T]3VE*]N+DQN2 H&T'6AGZGY>7?-7!Y !//S]!.$MONM"^"MF\Z5]L8L8D M,O-UFR7I(W&HVRPM&MG=YJ)0R>/2KZQ.@JQLJ0XFV9UG63')Z-[4:B*C"R4/ M)KGZTA&T"O2EY2%?=3#)U9?>5Q#.TI>6*#/M;\<7[$W+$T'62>BC)=M>=<89 M+S:5+]>68_55J01*PM3S4;SG8^2@NZW>\#S%JJ*IQSH'70M"G8,^JQST)W&< MJ,Y"EQN-.@N]5_:F(FF\.D=<-2&6B"4530W6.>):$.H<\9GEB!>Z76>(]S@] M4"I$=_G",B$;SC)G[9@K7S*M3C)++W"%.N@R(1IN33>H$]4EQ*1.5->"4">J MZT2UF'[MZ&'T2J8Z>9UR+>[#6JQ9[H-!RX7I?C[]B; -N1ZCR?ALLX85P60_ M[_[DBI;? 4>I$(S6GPQ[YRF394[%;FA7>83OX."YE=#I73),AS#ZUBOT>E-LLGE64:C4FTE\>,&XB[]\[PRI"":%+.1ENFY'*@373D,4'(W**I-EWELX0C0J*[)% M1*/'V,UM9:V3J(AP5@>3F[*9]Z:&@?\2;&6)S:)W-]B)ZZ:SBX-2=;(9INQD M,^BW^@EVY=3:%F,R\#;1TXNRW=6F>2*)/VTV&7^ZJ?"#.J0#X1'1;M-RHE]VPFIPB M<_#5,I_ (\+6T0=VS4CN/EB>%%!U,.FV6T-)4 FE<299*PJ2UO RL:,Z@M5I M]26Y]&O/%"AH1D<2J8J4V[0Z&:_S2UH2)9:H8E;+XJN^]KH7/ZO6RUJI5QU, M=BR,A>X1UO&K+. FKV+2@;MCS2I2:+NCUB1C-)!U89+$5)0UC/L'C^'.TQNM M#B9R!FROLIX4E"]@RY@UKHH\R1BG%;+XG2I@:[?Z!:^+DC"DK ';GI?(5B70 MV87)/M?BR(KKSL53)F3#RVLOHPF)75Y/IV(%KZVRBMNNM54F:2M\]94)V?#Z MW&F-VG7<*G'<&ME^/.2L8E5<]OU6[),7H!]UR3Y]*?JX7?J0^-QS+?NMWR=7 MM'RW.:5",KH3.CB[P'KC$(C_49J#'EBWFM]1#_C\G3KUB0YY3W3T6N,R;>BU M03I+!>ZH3+N[G58GX2(-";=T),=\:!LYJBDQW^ZK:[$=K!*$@V!9O>@SB;U":!CSE[: M$T#5]6LD2<$?= (HR=V1. 63T1,J$R;)2TJ9,(&U//'$='DPZ8QD+/+KMS/U M(4IVK4K%CLJH2*_5EPZ3;!=3#1-C_E/M];6R7CJ5G&N25J"*<6 D/925U5>1 MI,XC!U]%5DRR&V)9, MSHN\JI+=AY&$+65-PNQS?J].M\B&275BR3K=4O"9RDSUHS)F6UZ?NXK(F&XY MFNMR!!49M/H96Z/7>9X=R03LA'_:5+POI4D'"MKSB>WLZ]U(D@V3*H3Y>[G M49W\F.117:K3GY?LC3(U>)0QGW3NBK:?2W5R1J83'7IM?3*VN^H"8CCFZ9M]0@X-1<6\*H=D.6V]8ZO=W__YOBO+37YI-' <0TDT7/*'K!;7Y* WEGKPH M'Z=3JCIX)CC^J>;]S:]WRGN7Z29E3/GG;W3^0.W_W3(F:^ P"PO P2$?ELH= M,>CJK:: *8R@/T@P!D E@+J>QOZNX%> XRV=_GRAHB_7[K0[CL4_]7J=;P(" M8OP"_%]<&80Q?0HR@N]>ONCL6^RHS(?[>OI^B4 +D+]]-E5K3N\<(#A2]STQ MB*G2NQFESJ6I76J:CF\38\4K]GX9@8#!$(:+YX[C)^8P(95](HN9+_B!;8[D M[^UV]T+1J*K/B<%^OFCV+MXU^_T1:&Y46#+3\EQ$9!B(R/!\1*0S;A]!0@3V MRJLO%F.OE:EMS;>(24-YH%/+IOX;,//Q)4?,C;!^ DAC'WG/H10/HOC7Y@;- MS7"8PMQDIVXM7K6I0O'J=2?=@=P"IGP0]Y;"D>,BZ7 ;.MZS.-3%)A? M+$MCRIUE:$7+W8KRR83GH%U/.6 (5VWX4*Y&W>&FW=N7I&+J'C@U!*"$K*?<'@DK+Y,G.5R,^QUVWLO-X>+QB_4A,^&0DQ- MN=3FNJDS!W][HLK'%\RU2R,U'J2<66$X/3!K:>+.2WO8V5>8=A"X%K(8(3O+ M9:S3VPB\3B]C'^C"!BA%#H +VMRR'?W_CK(YDQ;],)!(@Q"(M6CM[R$ED+66 MJ#-?$3OM\:B_K[DJ1K N5=7&K[[HY$$W@"YX=?:5:]M MR8O95#A_WE(AS=3 M:")OFAAK@Q+QA3X2XR.,XBPYM0-@=I-Z 'PH+UW!+P5TAV9899(G5TBM1+& MH%YDEQV^>!=7-K/U:G2OBB945A.4WHB[VH]Z(SOXANFN9.^W)G%58EC$?(PK M-%?51+U6J)[H")^4+.57DT&K'=?F\G?76"K=$2^%'S:49ZKPJT.!?+KI6 I1A-5C,WT!5AU_88YR MX]HJ;A4HEX\VY4N=\@J;.%QL_G#Q&O3.F2F!%>6+0TMY=1%\ X^@9_$K)88S M>R9+IMQ=-90O7Z[@HF:[K7'0/AOA*/-I2%:S,7[VL%U)]GNAJ" M6R'JGZZ.A,$WN.?SX*W!#>]9-*/P.^55-.#0K[C+J>P=.!@"6E?P)!BWB]>M M&+[['X_3BF2+:%PZB@=D(T0#C1J %R>"%:8<$!F"6E1%;L^O\+0%F /\_!&H M!MRX1?WUI.3RZN.M+Q?P(H1 #@"J3(E*E2>\J!;Y\D.OW6HK@(C!_05!X6?X M4WG@(6@P 9=3QF_-QO> [7/P^T2G$_A[!7RW[_<7(5,09 &_P!%/A80@$<,S M]!\7MJX*>+K]26L\4L"HB-D:*$C_PGHXF%\%U"W><(5P,G"= !GUX& +$$E< MB?A?P$ =Z*TQ+IL6P&$K-K7L1V)ZCA6+0!XR_\K*B336Y!71V=0_KM(+HFLA M0OS0':Q("T@K*F$S)(%/#1AMZ@)H"]M"!%&M+,8$?3>D/]S%94F)'6I)XX\G MV'YO@R!RX)7_@>=0^ .\;D*(!(#^C0FE\UZ*F[S!N]N@7@L3I?LF2C?YP_^R MX!M8FTP'_!LA<;\ Z=R%!Y/WQ]_Y8_\0CZ%H$J8X".Z4VIZTQW'C#[ *2&AM MS<;A\R"E ,@">,FE%&7!>;::SDRWM8"0-IT3$#H@T4+4["K6 RBG)P. P[A ME5SB\PN?OT(LQ32O*%#-F]$\70(?_V Q/*V;8'D,0XSHS$"4'V :TT=D"D("!/&> MQ\FX'>8K UH4T,7$1T%9!5-YI;\& M!\%1GBW[.SZDDH4.+%%>B?4#N+5%,%%65)OBY+XDX')$YI9K!NJ'"Q>8.ZYX M)'8>"*,6A@MF"?@]14D"&=+ *749 OA P3""$_-*YV ^BO0OM[Y3 _MV[;*O M:R840:4O*C[$5ZBP6?<>4L\DU6K--6'4V-[4VW MO0G='[B*J7B82%L)#ZJ&QYZ(J(1]/%^P-O4@I-JPOMO*#YWX(1KHLR!K8*)5E/%&M$;%_X#Q$5]U.UW>1>75A#+'BU\'GE1"LGD6J>=#ZX,69 MS)##_(KX!O2U[_$+:^ MFF8L^JL9P_1"]@]:?9_281QPJ=D.Q>I!G:T^AWQ] M-$M/.GW&M4D-A7\1_P?<9VI#W(KZB3JX=PXKU%%1V!U\84M8>-S(,:.A0*J# M2S4/9#5FM2<&LQ0=S#>74*%5]$5G#F<50&C#+RZ/T.80[W-SW/ TT5\C*:8" M3.(IT(J#^!MNMZ'-F5(46![/"P>"LXO'$@Y59Z9E6(]+)/T3N-D L.LP^$WE M;D< +%\9?KU1/J+;# XY8'+GO<'3%P?&]GL1?!BF]GIOT 4H$\=V"O0Q58QT MA7IM<3S"%NX"(T!A%;1PDLT*DFP7(L99[^7)VWBN&0SN+Z +GK22IL-_Q])8 MREZ@PUYK4*9N=IW$AL 2@+N]6V6OU^J4JEOE/=>MWX1N?43=RM/(9P DT.AL MDM*+H_9JKR#*T,13W\.XNS)VCY3N!IMCJ&#J_9_]N_*51S,W&S<.#KP*ZMB: MF?4NH6ZK7::&SYU$0RD!N FBU&]U2M4#%%VC',RJ/+Q)9;LE 5>>!>(\?;2L M*X$$L->&74K#+@'LM9V6VTZ?YGHH[\A*4EU21@,N\357,?9Q)!U'LEVMUFNU M);ER+(].74FK59GD*GDA*QZ*#&G(L-?HMC/=TYR\8)=) MI)+7$Y[#Z>[W;;Q:[W MTK(C\WHO+R99UWMI,9 MV@W4*8&38U+BE,#&?1HD=)U"G1\H-R9RY@>.MB\@+5OJ/(%\F$B9)^BT&^-1 MO\X3E J3$N<);BES;%=UQ %/= =LT=!)46?$?JS3 F7'1,ZT0%TI4*<'Y,-$ MRO3 H#%J=^OT0*DPR<49G%)9.KT\W8/M M G;HP5B91;C$$?R-31WRPJ_'P^NGMER-4(?QLF!2@3K_5[U!Z7?U7]=QNRQQ M>_C<<05J_%_UNHU)T;5^TBI(';,?T[E96_P9MK.PIM%+E.I0O>S1A\RA^JM> M)\_B_R-+6#%>0"G4I [22Y#1VCM8EX@O=3K@2+Y.]"+&4:L;W,2(=X+CW8MU MHJ!.%!PU%!H.ZT2!/*C4B8+3XU G"NI$P0G<'M$74D$'X-4#->E4=U[[1__J M!$'9(Q^I$P3]?IX^P-$3!'5:H.3*(7-:H#/.E#RK]^XK$ZSS4;_LZFC0\/O8 MZ*OUVUN^ZT ]O3+W09DURWTP:"5B>:F0#"_UA5\$)&TT,8I@ZTMOKW60K[,]0*0\K_AWV]CY%@+;Z+(SD'&AG^Y +ZY MF9$61FPSI87N-&A$+C3@1QH9#,N[/F++1N%;>8<==?.)BM9>IF4V>?L_W:&K M!F%;W#+EF=J\YYWH;\7>;B=4.=L_35J3HF\UWR&JA^\Z=B2^.3Q\I_QX_4[Y M+E#_Y %K.DOB:6")&D*EC!9E4H#]FR^51PGB6FZT2Z4%69LOM5N#G1*6(6US MT& );.BU.F7K@96I<9'T*I(?HR.FSQ]WYE&U,PFG\K(:Q)/[WC&?$B^ZRJD" M)EEZ3DZ5; F,WNDP2;T69DVDR2*TAY<")FM^F42M.IB<5FGRT)!.:Y+H99WF MTMC,EV!58Q7'UK$[K[DZL*OL$0*;?1;K*[+0L4B5EZ1H.K]CXBAKM'2RD6Q3 MY ,W>8TMW4(J'8%+!F[9Q#=Y 2Q2? >-?K;MTNS!AB3W(Y9G_3NY\QGSZ6Y& M;-I\( PO9;3F6+)9A[!E\<8+653KP%4JLU5"3"JD*E)&L*/AN,(A2L+RG7J- MCM9!^#/_],9ES4="%F\_Z&QA,6+\ KQ;L,^F:KBX1_XAM.!=!^L=?FM8#(+& M>T#SO6&IW]_]^[\IRD]_:38_$MN$%YER0VV%KZ4-Y3UANMILBF?\&?T'X3G^ M&'](P=E@S%LZ_?E"Q3V>=J?=<2S^J=?K7"BNJ8M??V^W>Q>*1E5]3@S&]U)T M[>>+SPZ=-SL7[]JMWF2%7NQD1<$\#& >9H"Y>_&N>2C0'W3#=:BV"VSOL9R( MW>/$'F^'VYNN2,CW(WE_)\EW@Z[\$W5 X4KPO[O #]1E)^G?Q1F@K?4GFQ5 M82,6&!9>&[.K D8U" ,Z?;B[^?1%9\X]OI1S74RGG;(PI@^F#V>)C5QB/*8C M;(OXA5+X!P#(X?.RJ*TL1IVXCI5DTX^UPQ-(]"NLCG^]$NP$9':N*VO0AVO+ M8.T-B^>#K;S9\79^Q6V"9X-6CPN5]Z4M:#1HC3:KWOJM?KCN392?8?F:SA2B MV!2T6-4-;\_3JV$SW3FNDY;--T%A(&NNF_QO>."!+QC\!\^2T8#^!J<_++(* MXX9E"J_@@ ZO]YF+>A^*]3Y*4'FCH,'@XZ'I>QM#Q5V$3F<43J/^PV%KG%!, M>R*=[XPW!*7)O]NL'E+HBTH73HBI&G%(QIJBTV\@)((;%+,,UXM9>NW6>'O> M2;9*EE*5U<65G<=5V&>*$?;0Q-WCEUB@-ZNS^JUN7. HIT!GK9#;(D+R,&8= MW+;Z(8_N+]= MWHGR?N6NB09U_QFSB&.>\R19I,(H>$AF^=0TS,O[.+'"4<<_,8B./8^H,K B['@MCH"1O _$J)X6*':[)I_2=AVV_LNE=D+]O/1RW [N?I%"0IV>XX)D=(DHUR#J 4HX59K_ X MT T+I833'#7/R21FO-2K*"=:8ME-6@3DE=U>K]'/,\5TJLLQBDH5%.IL[!VA M>/M,!T4CZWM5>0*?'Y:$;N$ MY<*D0IJ2O"+6FE*&75 9XIH/J_*Z'#<[3\T;>;+9A2R%9=-B^>A;[\6<;GFJ MI;G^K!ZN0M774<6'),I(P#^_WN6;BW=1!8!DRD# ([PZSMO"3!X2PCP-O8 MX*Z.YZ0!]W3QW+"3>T&B3(2M [EJ!G+];GV4OCP1W&_$_DZ=8M:>XYUE.=HI MJY-X=-U)[X@>G02W 9R,^5*Z\SEZ 96[QH"/^@>Q;6(Z3+&I0="3=BSE"ENO M7EDF!P5/ 'VU''J^?O61KMPY:@+JZ!B%M;)*3DZU??-RBOYA!V:+WZC)?&N_ MW"I0>3]_O8;/OYVUKN++T9"4"M>27BC1;S<&_6.ZQ#+Q[&PV@602OI.OYJ>K M)AP?-?@L\_)_:@RJ';[*!VY=YE='H&66WKK,3Z;50_+@\>/6%A[I+EGB!\:. M>5>S3+I6I7(G"3?'BC HI>+*V<2$)<)$RIW$,],466.Z;$OOE15STWH=!^8/ M;EFN2&^W^GE@[+VF*OQ2]#GADSW8?]R[; MDV?T7[7!A.>D\O+=97W&H9%,\E;,0B@7CE&=RJ4\5TZ=JD80M7DY/ +$W$4, M0&Q.#(/:, MYY5+'F6^1S]W@2SA8I;?89/ZY%2^?3KS;JA:'VV2ACO5\$$/W4/W"K;KJ][D M ;>N :MKP,HLO74-F$R[S9+O<12\$5VE;&P9\.#ZB#Y>UGOG/E#Q0E;B,XDNZK5#1]D_'_GZ.WO1[_]4W))0=$RGWU<[LW/<9 M!X\EPD3*O;PSTQ19 T()>Q">FE45<,9/%4IVZIO:)0*W;%)[JA"RT^B/*R2X ME8\>B^[C)[$;46TW5<* KI/'!ET9N5$'B<_.ZH1YJT64C_@J\,Y:<"MP[DZG"NU^)XJ MG!OD(D1=ZXS]ITY? H-T;Y6*ABD\,.O M..HNB!?28(O*:SA4$ <-WDTSP8EOH]EOQI1D]-CT_ZHXM=VN=DR3RH)N/K8U9\W2@<]+)?"UCKMJ5JXT[,=%VNSQ'(5K([KSAEUBN M2^9/;US6?"1D\=:_!/.&VG=X+N(>M/D]ZM:[?_\W1?GI+\WF1W$T @]3O*@S M8CY2Q28.5<1GIEBFHA(V:S;%&\' _+7KZ4?OI5MXY]K$3<1+4\-_/O[IZD_$ MH+C-B+?,P,2W=/KSA=IM TJ==L>Q^*=>KW/!:W?XK[^WV]T+1:.J#O:(_7S1 M[%V\FXPG[78[A%.&J4^*YBA :>*C&(2\_*" M Z\NF[L.[@'*AD\_C,_GKY\NWK5;O=%H'9\T$P?87*JJC7<3,6(0&X\'$5-3 M'JA)I[K#-A";+PQK2>FMV-/^HI,'W>"GBJYN89R.8>E527*/W^C\P=J_^\&CGQ(,>)JP&"XU6@;N [:O4[GVQ?Z2(R/ M(##.\O)%9]]@SLOY?_['R\?)CSBOF#5!++LHE/U)B!II 0JH\HGHMO(/8KBT MH>#E(A\ XR?"->Z2,?CBE4_2Y6N@'6'@7VAH76[QD)N-Y]K>$Z:SAO*[:3V M*_+$;R'^;"Y%@?<_GG/?T.;K7"CO4%0A(8# Z"L(.& !�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�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�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�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